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Chapter 1 
General introduction
10 General introduction
Many decisions are made in health care. For example when a patient is diagnosed with 
a certain disease, the patient and health care provider are facing multiple decisions. 
One of these decisions for some musculoskeletal non-acute conditions, is to choose 
between non-surgical and surgical treatments. Surgery is then often not the first 
treatment of choice. Initial treatment includes non-surgical treatments and surgery is 
only considered if the patient does not respond sufficiently to non-surgical treatment. In 
the ideal world, all recommended non-surgical treatments for these conditions would be 
used first and surgery is only performed when non-surgical treatments are not effective 
enough to reduce the patient’s complaints. However, decision making in daily practice 
is far more complex and the decision to continue non-surgical treatments or to perform 
surgery needs to be customized, such as in Mary’s case. 
Mary (45) suffers from pain and loss of function due to clinical and radiological 
osteoarthritis (OA) in her right knee. She is divorced, lives with her two children (8 and 
10 years old) in an apartment on the third floor without an elevator. She is not able to 
work as a cleaning lady anymore. Her supervisor prefers that she receives a total knee 
arthroplasty (TKA), so that she can go back to work earlier. She is obese (Body Mass 
Index 37) and her general practitioner (GP) advices her to visit a dietician and a physical 
therapist to lose weight and exercise, which may reduce her complaints. However, her 
health insurance company does not cover visits at the dietician or the physical therapist 
and she cannot afford to pay for these visits herself. She uses painkillers every day, but 
these do not relieve the pain sufficiently. Her neighbor had a TKA and told her that it 
relieves the pain and improved his function. Therefore, she asks her GP to refer her to 
an orthopaedic surgeon for a TKA. The orthopaedic surgeon listens to Mary’s story and 
finds it difficult to decide. She did not receive all recommended non-surgical treatments 
as described in guidelines (e.g. physical therapy, dietary advices) and he prefers to 
follow these guidelines. He also knows that the lifespan of a prosthesis is limited. Mary 
is only 45 years old and if she reach the average life expectancy it is certain that she 
needs a revision in the future with less successful outcomes. She tells him that she has 
no choice and needs a quick solution since she cannot work, climb the stairs to her 
apartment or take care of her children. If he does not perform the surgery, she will ask 
his colleague in another hospital to perform the surgery. 
Mary’s case shows that there are multiple factors involved in the decision making 
regarding the choice between different treatments, in this case non-surgical versus 
surgical treatment. Due to all these different factors, variation in health care may exist, 
meaning that the provided care differs for patients with similar health problems [1]. 
Sometimes variation in health care is desirable [1] as a consequence of disease severity, 
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duration of complaints or preferences of the patient, such as in Mary’s case. In this case 
the decision to continue non-surgical treatments or to perform surgery care needs to 
be customized. However, unwarranted practice variation also exists. For example when 
receiving surgery depends on the patient’s geographical region. Research has shown 
that patients in regions with a relative high number of medical specialists receive more 
treatments [2]. Such practice variation is often a sign of suboptimal care [3]. National 
and international initiatives for reducing practice variation emphasize the importance to 
search for possible strategies to optimize health care and thereby reduce unwarranted 
practice variation.
Hip and knee OA and sciatica are both non-acute conditions in which the decision of 
non-surgical versus surgical treatment is complex. This is not only illustrated by the large 
practice variation in surgery rates for both conditions across regions in the Netherlands 
[3,4], but also across different countries. Reduction of practice variation may make 
health care more efficient, as non-surgical treatment is mostly less costly. This is needed 
since the demand for care is increasing, parallel with health care costs. Furthermore, 
both conditions also have a relatively heavy economic burden on the health care macro 
budget. However, the exact issues being faced regarding non-surgical treatment and 
surgery are also different between hip and knee OA on the one hand and sciatica on the 
other hand. These issues determine on their turn how care can be optimized and which 
strategies are the most suitable. 
Treatment of hip and knee osteoarthritis
OA is a degenerative joint disease primarily characterized by loss of articular cartilage. 
It is diagnosed by clinical and radiological examination. However, not all patients with 
symptoms also have radiological hip or knee OA and not all patients with radiological 
hip or knee OA have symptoms [5]. In the Netherlands, the prevalence of knee OA was 
3.6% (62% females) and 2.1%  (63% females) for hip OA in 2011 [6]. Due to the ageing 
society and obesity, the prevalence of hip and knee OA is still increasing, in parallel 
with health care costs. This will make the magnitude of the existing issues even larger 
in the future.
Patients with symptomatic hip or knee OA suffer from pain and loss of function. In the 
Netherlands, first treatment of these patients is usually provided by the general 
practitioner (GP) (figure 1). According to the (inter)national evidence based guidelines, 
the GP will start with non-surgical treatment, including pharmacological options (e.g. the 
use of acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), and 
corticosteroid injections) and non-pharmacological options (e.g. physical therapy, 
patient education, and weight loss intervention) [7-11]. These non-surgical treatments 
aim to prevent progression and reduce symptoms such as joint pain and impairment of 
functions [11]. As it was shown that non-surgical treatments in hip and knee OA care 
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Symptoms hip/ knee 
OA
Non-surgical treatment (recommended: 
education, life style advice, 
acetaminophen, NSAIDs, exercise therapy, 
dietary therapy, corticosteroid injections
Visit general 
practitioner (GP)
Orthopaedic surgeons for further
investigation (e.g. X-ray)
Recovery
Referral to an 
orthopaedic
surgeon
Type of 
prosthesis
Surgery
 Figure 1. Care trajectory hip and knee OA
are not optimally used in primary care, a stepped-care BART (Beating osteoARThritis) 
strategy was developed [12,13]. The first step consists of education, life style advice, 
and acetaminophen. If the treatment options in the first step are not sufficient, treatment 
options in the second step can be considered (exercise therapy, dietary therapy, and 
non-steroidal anti-inflammatory drugs). Multidisciplinary care, intra-articular injections, 
and TENS are treatment options in the third step and could be considered if treatment 
options in step one or two are ineffective.
Patients are referred to an orthopedic surgeon if they do not respond sufficiently to non-
surgical treatment options. Together with the orthopaedic surgeon, the decision will be 
made to start/continue non-surgical treatments or to perform a surgery depending on 
previously received treatments and disease severity. 
Treatment of sciatica
Sciatica is a common disorder with a prevalence reported from 1.2% up to 43% 
depending on its definition [14]. Sciatica patients have pain radiating into the leg, but 
definitions vary widely in terms of pain distribution and/or pain duration. Sciatica is 
mostly caused by a herniated disc with compression of the nerve root, which gives 
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radiating leg pain. In the Netherlands, yearly 75,000 persons develop symptoms of 
sciatica (almost 6 on the 1000 persons) of whom approximately 10,000 are treated 
surgically [15]. 
In the Netherlands, sciatica patients are initially diagnosed by GPs and advised to 
continue daily activities with or without physical therapy (non-surgical treatment) 
(figure 2). Seventy percent of patients with sciatica spontaneously recover in the first 
6–8 weeks or with non-surgical treatments [16]. Non-surgical treatment for sciatica is 
focused at pain reduction and consists of analgesics such as NSAIDs and physical 
therapy and the advice to stay active until spontaneous recovery from sciatica 
occurs. Other treatments that are not supported by high quality evidence or clinical 
guidelines but (widely) used are spinal manipulation, transcutaneous electrical nerve 
stimulation (TENS), acupuncture and epidural injections of glucorticoids. The Dutch 
sciatica guideline advices that in the first 6–8 weeks surgery is only an option when 
a patient suffers from severe neurologic symptoms. After these 6–8 weeks the Dutch 
multidisciplinary sciatica guideline recommends that the team of professionals involved 
in sciatica care and patients jointly decide about treatment, i.e., surgery or prolonged 
non-surgical treatment, based on the evidence regarding associated risks and benefits 
and preference of the patient (i.e. shared decision making (SDM)) [17]. 
Symptoms sciatica (no 
severe neurological 
symptoms)
6-8 weeks non-surgical treatment e.g. 
analgesics, visit physical therapist (PT)
Visit general 
practitioner (GP)
±70% recovery
Referral to a neurologist for
further investigation (e.g. MRI) Prolonged non-surgical 
treatment
Referral to a neurosurgeon/ 
orthopaedic surgeon
Surgery Recovery
SDM
SDM
SDM
 Figure 2. Care trajectory and shared decision making (SDM) in sciatica
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The neurologist evaluates the presence of a radicular pain syndrome and may order 
an MRI to visualize the affected spinal nerve(s) and to judge possible compression. 
If the MRI confirms a nerve compressing herniated disc, a surgical intervention can 
be considered. During surgery the disc herniation is removed. A large, randomized 
clinical trial showed no significant difference in clinical outcomes between non-surgical 
treatment and surgery after 1 and 2 years in patients with sciatica [18]. Other, low quality 
studies showed conflicting results [19]. However, surgery leads to more rapid relief from 
the pain, whereas non-surgical treatment is less invasive [18] but takes patients longer 
to recover. Furthermore, surgery is more costly but cost-effective because of the rapid 
relief from the pain [20]. It is unclear whether delaying surgery reduces the chance of 
full recovery or that this delay gives sciatica time to resolve spontaneously [21]. This 
leaves the decision up to the patient and health care providers.
Part 1: Implementation of evidence based guidelines
Even though guidelines are based on the best available evidence, it is known from 
the literature that health care providers do not always follow guidelines [22-24]. As 
the evidence regarding use of non-surgical treatment and when to perform surgery, 
is already specific and included in the guideline, efforts can be taken to implement 
these guidelines. To implement guidelines and thereby optimize the quality of care, 
it is important to gain insight into reasons why guidelines are not always followed (i.e. 
barriers and facilitators). This is the focus of part 1 of this thesis.
Implementation can be described as a planned process and systematic introduction 
of, in our case, guidelines. The aim being that these are given a structural place in 
professional practice, in the functioning of organizations or in health care structure [25]. 
From the literature it is known that implementation of guidelines is influenced by several 
barriers and facilitators on the levels of the innovation, the professional, the patient, 
the social context, organizational context and the external environment political and 
economic factors [26]. Mary’s case shows how multiple factors involved in the decision 
making act on different levels such as the micro level (i.e. the individual patient or the 
professional) and the macro level (i.e. the population, the insurance company and the 
environment). On a micro level, the decision making may depend on disease severity, 
working situation, family situation, financial situation, other health complaints or on the 
opinion or characteristics of the health care provider and their social context. On a 
macro level it may depend on organizational and economic factors such as the length 
of the waiting list, and insurance. All these factors may complicate the optimal use 
of non-surgical care and optimal timing of surgery with the best possible outcomes 
after surgical care. Therefore, we need to reveal barriers and facilitators that may 
hinder or facilitate the use of guidelines. Based on these barriers and facilitators an 
implementation strategy can be developed [27], which is likely to be more effective for 
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the uptake of guidelines [28-30]. The specific barriers and facilitators are likely to differ 
between conditions like hip and knee OA and sciatica, based on the evidence already 
available in the different guidelines.
Implementation of the hip and knee osteoarthritis guideline
A specific recommendation about timing of surgery and use of non-surgical treatment 
is not provided in the hip and knee OA guideline [31]. It is stated that patients should 
first receive non-surgical treatment and should only be referred to the orthopedic 
surgeon if they do not respond sufficiently to non-surgical treatment options. However, 
previous studies showed that non-surgical treatments are underused in primary care 
[32-36]. Therefore, orthopaedic surgeons have an important role in ensuring that all 
recommended non-surgical treatments have been used before considering a surgical 
intervention. 
The issues faced here are the extent to which patients have received all recommended 
non-surgical treatments before undergoing surgery, and if not, to gain more insight 
into barriers and facilitators for the use of non-surgical treatments among both patients 
and orthopedic surgeons. Including solutions for these barriers and facilitators in the 
implementation strategy can thus optimize the non-surgical treatment given to hip and 
knee OA patients. 
Implementation of the sciatica guideline
The sciatica guideline is far more specific than the hip and knee OA guideline on both 
the use of non-surgical treatment as well as on the timing of surgery [17]. The use of 
non-surgical treatment and the timing of surgical treatment are specifically described 
in the guidelines. Still, large practice variation remains in surgery rates ranging from 19 
to 319 per 100,000 inhabitants in 2012 in the Netherlands [4], unlikely to be explained 
by differences in case mix and patient preferences. It is more likely that noncompliance 
with the evidence-based guidelines regarding SDM is responsible for the varying 
surgery rates, since SDM may diminish this variation. 
The issue here seems to be more the extent to which SDM is used. The recommendation 
to use SDM is not as easy as it may sound. Figure 2 shows that SDM could take place 
at different moments in the care trajectory and with multiple health care providers, so 
one of the issues may be when SDM should take place and which health care provider 
is responsible for using SDM to choose between (prolonged) non-surgical treatment or 
surgery. This makes SDM in sciatica care complicated. Therefore, it is important to gain 
insight into specific barriers and facilitators for use of SDM to improve implementation 
of the sciatica guidelines.
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Part 2: The optimization of surgical care in hip and knee osteoarthritis
Guidelines for patients with hip and knee OA do not include specific information on 
when to perform a THA or TKA. As evidence about optimal timing of THA or TKA is 
still lacking, more evidence is needed on which factors predict the outcome after 
surgery. Using non-surgical treatments first may delay or diminish the need for surgical 
intervention in hip and knee OA patients. This is important given the limited lifespan of a 
prosthesis and the fact that outcomes are usually worse after revision than after primary 
arthroplasty [37]. However, the question is how long the surgery can be delayed without 
causing worse outcomes. This depends on the indications to perform surgery and the 
determinants for having the best possible patient outcomes after surgery. Do these differ 
between patient groups so that surgery is performed earlier for some patients? This is 
currently unknown and needed as evidence to decide on optimal timing of surgery. 
Therefore, part 2 of this thesis focusses on studying criteria and determinants to reach 
the best possible outcomes after surgical care. These new pieces of evidence can then 
be included in future guidelines.
Issues on when to perform surgery
The preoperative status of patients with hip or knee OA who have had THA or TKA 
may vary [3,38-40], suggesting that it is unclear when to perform a surgery. Therefore, 
insight is needed into the evidence base of indication criteria for primary THA and TKA 
in OA patients to determine whether it is possible for the orthopaedic surgeon to make 
an evidence-based decision about surgery. In addition, it is important to know which 
patients reach the best postoperative outcomes. Preoperative variables that predict the 
best outcomes were assessed before in a number of studies, but an overview is lacking. 
Furthermore, identified prognostic variables differed, and also gave contradictory results 
regarding the direction of the association. This may be due to the fact that some studies 
suffered from a lack of power, while other studies did not take independent effects (e.g. 
no correction for confounders) of prognostic variables into account. It is important to 
generate more understanding of these variables and their role on the outcome of a THA 
and TKA. For example should a patient first lose weight like the GP advised Mary? Or 
optimize preoperative status (e.g. health related quality of life, function or pain)? Having 
more reliable evidence on which variables predict the outcome after THA/TKA, may 
contribute to discussions on optimal timing of THA/TKA to achieve the best possible 
postoperative outcome in specific patient groups. This is important especially because 
still 10-20% of the patients is not satisfied after primary THA/TKA [41-44], possibly 
caused by not achieving the expected outcome.
Type of prosthesis
If the decision is made to replace a joint, the orthopaedic surgeon has to decide which 
implant should be used to reach the best possible outcomes. In recent decennia 
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an expansion of technological developments in prostheses have seen, usually 
introduced into clinical practice without appropriate assessment [45]. One of these new 
developments is the mobile (meniscal or rotating) bearing TKA. The mobile bearing TKA 
with a polyethylene insert has some freedom of movement. Compared with the more 
traditional fixed bearing TKA, the mobile bearing has a rotating platform that allows the 
knee to flex and extend (like the fixed bearing TKA) and to twist and turn. Contradictory 
views exist as to whether the mobile bearing prosthesis will improve functionality as 
compared with the fixed bearing prosthesis for cruciate retaining TKA and it is therefore 
important to compare these two types of knee prostheses to determine which one leads 
to the best postoperative outcomes in patients.
Brief outline of this thesis
This thesis aims to contribute to the optimal use of non-surgical treatment and timing 
of surgery among hip and knee OA and sciatica patients. In the first part we search for 
strategies to improve guideline uptake in hip and knee OA and sciatica care. For hip and 
knee OA this includes the implementation of non-surgical treatment, as recommended 
in guidelines. The study design of this problem analysis study regarding the use of 
non-surgical treatments in hip and knee OA is described in Chapter 2. In Chapter 3 
the extent of non-surgical treatment use in hip and knee OA in orthopaedic practice 
is examined, to determine the magnitude of the problem. In Chapter 4, barriers and 
facilitators to use non-surgical treatments in hip and knee OA are assessed. 
In sciatica care, the optimization of care is addressed by studying the extent to which 
SDM is used in the consideration of prolonged non-surgical care or surgery. The design 
of this study is described in Chapter 5. Chapter 6 describes barriers and facilitators 
to implement shared decision making in multidisciplinary sciatica care, based on 
qualitative interviews. These barriers and facilitators are ranked in Chapter 7, to assess 
which barriers and facilitators found in the qualitative interviews are most important to 
be included in an implementation strategy that will improve the use of shared decision 
making in sciatica care.
In the second part of this thesis, a search for new evidence related to the question of 
optimal timing of THA/ TKA in hip and knee OA patients is done, as this is currently 
not described specifically in the guidelines. First, the availability and evidence base of 
indication criteria for primary THA and TKA is assessed in hip and knee OA in Chapter 
8 to see if it is possible to make an evidence-based decision about surgery. Chapter 
9 gives an overview of the available evidence from previous studies on which factors 
predict outcomes after THA, to guide decisions on when surgery is most effective in 
specific patient groups. Subsequently, Chapter 10 contributes to the availability of 
more evidence by pooling data from existing cohorts in the Netherlands to determine 
prognostic factors for outcomes after a THA and TKA. When the final decision is made 
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for surgery Chapter 11 describes which type of prosthesis should be used in terms 
of achieving the best outcomes for patients by performing a meta-analysis of mobile 
versus fixed bearing TKA. In Chapter 12 a discussion is given on the overall findings 
and its implications. 
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ABSTRACT
Background
National and international evidence-based guidelines for hip and knee osteoarthritis 
recommend to start with (a combination of) conservative treatments, followed by 
surgical intervention if a patient does not respond sufficiently to conservative treatment 
options. Despite these recommendations, there are strong indications that conservative 
treatments are not optimally used in orthopedic practice. Our study aims to quantify the 
use of conservative treatments in Dutch orthopedic practice and to explore the barriers 
and facilitators for the use of conservative treatments that should be taken into account 
in a strategy to improve the embedding of conservative treatments in hip and knee 
osteoarthritis in orthopedic practice. 
Methods
This study consists of three phases. First, current use of conservative treatments in 
patients with hip and knee osteoarthritis will be explored using an internet-based survey 
among at least 100 patients to identify the underused conservative treatments. Second, 
barriers and facilitators for the use of conservative treatments in orthopedic practice will 
be identified using semi-structured interviews among 10 orthopedic surgeons and 5 
patients. The interviews will be followed by an internet based survey among approximately 
450 orthopedic surgeons and at least 100 patients in which the identified barriers and 
facilitators will be ranked by importance. Finally, an implementation strategy will be 
developed based on the results of the previous phases using intervention mapping. 
Discussion
The developed strategy is likely to result in an optimal and standardized use of 
conservative treatment options in hip and knee osteoarthritis in orthopedic practice, 
because it is focused on identified barriers and facilitators. In addition, the results of this 
study can be used as an example for optimizing the use of conservative care in other 
patient groups. In a subsequent study, the developed implementation strategy will be 
assessed on its effectiveness, feasibility and costs.
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BACKGROUND
Osteoarthritis (OA) is a degenerative joint disease primarily characterized by progressive 
loss of articular cartilage. It leads to pain and loss of function [1]. Approximately 10% of 
men and 18% of women older than 60 years have OA [2]. Symptomatic OA of the knee 
and the hip have the highest prevalence within the group of arthritis. Due to the ageing 
society and obesity, the prevalence of hip and knee OA is still increasing [3]. 
In 2009, 154 patients per 100,000 persons received a Total Hip Arthroplasty (THA) or 
Total Knee Arthroplasty (TKA), and 118 patients per 100,000 persons received a TKA 
in Western countries [4]. However, the lifespan of a prosthesis is limited. The revision 
rate after a TKA or THA is 12.9% after ten years [5], and revision arthroplasty is less 
successful than primary TKA or THA [6]. Therefore, it is important to delay the primary 
TKA or THA, by optimizing the use of conservative treatment options, especially in 
young people.
National and international evidence-based guidelines for hip and knee OA recommend 
to start with (a combination of) conservative treatments [7-11]. Conservative treatments 
include pharmacological options, (e.g., the use of analgesics, non-steroidal anti-
inflammatory drugs and steroid injection therapy) and non-pharmacological options 
(e.g., physical therapy, patient education and weight loss interventions). Conservative 
treatments aim to prevent progression and reduce symptoms such as joint pain and 
impairment of functions [11]. If persons do not respond (sufficiently) to conservative 
treatment options, joint replacement (i.e. THA or TKA) can be considered. Despite the 
recommendation in guidelines to start with conservative treatments and only use surgical 
intervention if a patient does not respond sufficiently to conservative treatment options, 
the use of conservative treatments in daily practice is suboptimal [12-15]. For example a 
study showed that conservative treatments were not fully exploited in 81% of the patients 
who were referred to specialized knee/hip OA outpatient clinics [12]. Information about 
conservative treatments patients receive in orthopedic practice is lacking. Furthermore, 
surgery rates are rising [16]. TKA and THA in patients with OA increased with 196% and 
50% respectively between 1995 and 2005 in the Netherlands [16]. In addition, large 
variation exists in preoperative status (e.g., disease severity) across different centers 
in Europe and Australia, which suggests differences in the timing of surgery [17,18]. 
Optimal use of conservative treatments could reduce these differences.
A few models of care were developed to optimize the use of conservative treatments. 
In Australia, a clinical pathway model and clinician and patient toolkits were developed 
to support implementation of nonsurgical management of hip and knee OA [19]. 
However, in Australia, rheumatologists play a leading role, while in the Netherlands the 
orthopedic surgeon is responsible for OA treatment in hospital care. In the Netherlands, 
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a stepped-care strategy (SCS), based on (inter)national guidelines [20,21] is developed 
to facilitate the use of conservative treatments in three steps in primary care [22,23]. The 
first step consists of education, life style advice, and acetaminophen. If the treatment 
options in the first step are not sufficient, treatment options in the second step can 
be considered (exercise therapy, dietary therapy, and non-steroidal anti-inflammatory 
drugs). Multidisciplinary care, intra-articular injections, and transcutaneous electrical 
nerve stimulation are treatment options in the third step and could be considered if 
treatment options in step one or two are ineffective. After implementation of the SCS, 
most recommended conservative treatments seem to be well used, except dietary 
therapy [23]. Both studies provide evidence to promote the use of conservative 
treatments in primary care or in a setting where the rheumatologists play a leading role, 
but strategies for the optimization of conservative treatments in orthopedic care are still 
lacking. Information about the current use of conservative treatments, and barriers and 
facilitators influencing the adoption of conservative treatments in orthopedic practice 
is needed to develop a tailored implementation strategy focused on orthopedic care.
In the Netherlands, patients with OA are usually treated by the general practitioner. 
According to guidelines patients should be referred to the orthopedic surgeon if they 
do not respond sufficiently to conservative treatment options. In orthopedic practice, 
the decision will be made to start/ continue conservative treatments or to perform a 
surgery depending on previous received treatments and disease severity. The leading 
role of an orthopedic surgeon could result in other barriers and facilitators compared 
to a setting where the rheumatologists play a leading role. This subsequently results in 
another strategy to improve the embedding of conservative therapies in hip and knee 
OA in orthopedic practice. While rheumatologists and general practitioners only provide 
conservative treatments in OA, orthopedic surgeons can provide both conservative 
treatments and surgical interventions. It is unclear to what extent factors such as lack 
of information about conservative treatment options, increasing number of orthopedic 
surgeons [16], or patient preferences play a role. It is important to explore these factors 
for the development of a tailored implementation strategy, so that orthopedic surgeons 
will provide underused treatment options in primary care, such as dietary therapy. Part 
of this implementation strategy could be the SCS or a clinical pathway model as used in 
previous implementations. 
Objective
The BART-OP study (Beating osteoARThritis in the Orthopedic Practice) aims to quantify 
the use of conservative treatments in Dutch orthopedic practice before THA or TKA 
and to explore the barriers and facilitators for the use of conservative treatments that 
should be taken into account in a strategy to improve the embedding of conservative 
treatments in hip and knee OA in orthopedic practice.
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To reach the aim of this study, we formulated the following research questions:
1. What is the current use of conservative treatments, before patients receive a 
surgery, in orthopedic practice? 
2. Which barriers and facilitators influence the use of conservative treatments in 
orthopedic practice?
3. What is an appropriate tailored implementation strategy for the 
embedding of conservative treatments in orthopedic practice?  
In a subsequent study, the developed implementation strategy will be assessed on its 
effectiveness, feasibility and costs.
METHODS
This study consists of three phases to be executed in one year:
A. The analysis of current use of conservative treatments, before patients receive a 
surgery in orthopedic practice (months 1 to 9).
B. Identification of barriers and facilitators for non-optimal conservative treatments, 
using two steps (months 1 to 9).
i. Barriers and facilitators for non-optimal conservative treatments are explored 
with interviews among orthopedic surgeons and patients.
ii. Identified barriers and facilitators are ranked by importance in a survey among 
a representative sample of orthopedic surgeons and patients.
C. The development of the implementation strategy based on the results of phases A 
and B (months 9 to 12).
The study design, study population, analysis and outcome measures are described per 
study phase.
Phase A. The analysis of current use of conservative treatments before patients 
receive a surgery in orthopedic practice
Study design
To analyze the current use of conservative treatments, before patients undergo THA or 
TKA in orthopedic practice, an internet-based survey among patients will be performed. 
The survey will include questions about which conservative treatment options are used 
before surgery. This information is needed to be able to focus the implementation strategy 
on the right conservative treatments. The content of the survey will be developed based 
on the Dutch guideline of OA of the hip and knee [11]. Reminders to non-responders will 
be sent after two weeks and again after four weeks. 
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Study population
The survey will be sent to a sample of at least 100 patients living in different regions of 
the Netherlands. Inclusion criteria for patients are: age ≥18 years, a doctor’s diagnosis 
of hip or knee OA, and who have had a TKA or THA no longer than 12 months ago or 
are on the waiting list for surgery within the next 3 months. Patients with an inability to 
understand written Dutch will be excluded from the study. We will sample these patients 
using advertisements in local newspapers, and at websites or newsletters of patient 
associations. 
Analysis
Descriptive statistics will be used to describe the current use of conservative treatment 
options in orthopedic practice. Independent t-tests or Mann Whitney U tests for 
continuous variables and Chi square tests or Fisher’s exact tests for proportions are 
used to analyze differences in the frequency of use between different regions or other 
conditions.
Outcome measures
The main outcome measure is the percentage of patients in whom the conservative 
treatment options are applied optimally before they undergo surgery, as described in 
the guideline. These results will help us to focus the implementation strategy, developed 
in phase C, on the right conservative treatments. 
Phase B. Identification of barriers and facilitators for non-optimal treatment 
Study design
Two steps will be taken to identify barriers and facilitators associated with the non-
optimal use of conservative treatments. First, semi-structured interviews among 
orthopedic surgeons and patients will be performed to explore all relevant barriers 
and facilitators for non-optimal conservative therapy. The interview questions will be 
based on the Theoretical Domains Interview framework (TDI) [24]. The TDI framework 
includes 12 theoretical construct domains derived from 33 psychological theories, and 
covering 128 explanatory constructs that enhance implementation of evidence-based 
practice [24]. In addition, barriers and facilitators reported in a previous study about 
the use of the SCS to optimize hip and knee OA in primary care [25] are included in the 
interview questions. Second, an internet-based survey will be held among a selection 
of orthopedic surgeons (n≈400) and sample of patients (n≥100) to rank barriers and 
facilitators identified in the interviews on importance. The survey will include questions 
to determine which of these barriers and facilitators are associated with the use of 
conservative treatments.
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Study population
For the semi-structured interviews, we anticipate interviewing 10 orthopedic surgeons 
involved in hip and knee surgery and 5 patients who have had a THA or TKA no longer 
than 12 months ago (≥18 years, and able to understand oral Dutch). If we do not reach 
data saturation after these interviews (three consecutive interviews without new barriers 
or facilitators [26]), we will continue interviewing until data saturation is reached. To 
obtain contrasting views on barriers and facilitators, we will apply purposive sampling. 
First, we will purposively select orthopedic surgeons and patients from Dutch regions 
with high surgery rates and from Dutch regions with relatively low surgery rates based on 
the report of Van Beek et al. (2010) about variation in clinical practice [27]. In addition, 
we will select orthopedic surgeons in such a way as to ensure diversity of hospital 
type (public hospitals and academic hospitals). It is important to include orthopedic 
surgeons of public and academic hospitals, because this may reveal other facilitators 
and barriers. For the internet based survey, Dutch orthopedic surgeons listed in the 
registry of the Dutch Orthopedic Association (NOV) or the Dutch medical address book 
will be approached for participation. Inclusion criteria are: involved in hip or knee OA, 
and access to email address. Patients (n≥100) are recruited using advertisements in 
local newspapers. Included are patients: ≥18 years who have had total hip or knee 
surgery no longer than 12 months ago, or are on the waiting list for receiving a THA or 
TKA. Patients with an inability to understand oral Dutch will be excluded from the study.
Analysis
The semi-structured interviews will be audio-taped and transcribed in full for analysis. 
The interviews will be analyzed by two researchers using open coding to ensure that 
we find all barriers and facilitators for the non-optimal use of conservative therapy. This 
qualitative analysis will be executed using the software package ATLAS.ti (ATLAS.ti 
Scientific Software Development GmBH, Berlin, Germany) for this qualitative analysis.
The subsequent survey data will allow us to rank the importance of barriers and facilitators 
and their relationship with the use of conservative treatments. These relationships will be 
assessed using multiple regression analysis. We will use SPSS 20.0 for analysis.
Outcome measures
A list of the most relevant barriers and facilitators for the optimal use of conservative 
treatments in orthopedic practice before patients with hip or knee OA receive THA or 
TKA. 
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Phase C. The development of the implementation strategy
Study design
The results of the previous phases will be used to develop a tailored implementation 
strategy for the optimal use of conservative treatments in orthopedic practice in patients 
with hip or knee OA. The results of phase A will show at which type(s) of conservative 
treatment the strategy should be aimed. Phase B results will show the most relevant 
barriers and facilitators that should be taken into account in the development of the 
strategy. From literature, it is known that, in general, multifaceted strategies are more 
effective than single strategies [28,29]. Assuming this, and our expectation that several 
barriers on different theoretical domains will be found, it is very likely that the developed 
implementation strategy includes several components directed at different levels (i.e. 
knowledge or social influences). Furthermore, it is expected that the strategy components 
will include educational outreach, an interactive educational strategy, and/or patient-
specific strategies, because these facets seem to be promising for implementation [28].
In the development process, the project team will use the intervention mapping 
approach of Bartholomew et al. [30]. This method begins with the creation of matrices, 
in which the performance objectives are set against the most important factors that 
hinder or facilitate the adoption of conservative treatments. Subsequently, the project 
team will brainstorm about the strategy components needed to achieve the performance 
objective in the presence of the barrier or facilitator mentioned in the matrix. The cells 
of the matrices are then gradually filled with implementation strategy components [30]. 
Next, the project team will translate the formulated strategy components into practical 
strategies. 
Analysis
The study group meeting will be summarized. The project members will receive a 
summary of the meeting and the formulated implementation strategy and will be asked 
whether the summary and implementation strategy is consistent with the conclusions 
reached in the meeting.
Outcome measures
A tailored implementation strategy for the embedding of conservative treatments in 
orthopedic practice in patients with hip or knee OA. 
Ethical approval
This study protocol was presented to the Medical Ethical Committee of the Leiden 
University Medical Center (CME P13.087/NV/nv). An exemption was obtained, as ethical 
approval for this type of study is not required under Dutch law.
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DISCUSSION
The goal of this study is to develop a tailored implementation strategy to optimize the 
use of conservative treatments in hip and knee OA in patients referred to the orthopedic 
surgeon. 
Several studies have been performed to develop and test implementation strategies, 
including identification of barriers that prevent implementation [31-33]. They all 
conclude that a prior inventory of barriers to develop a tailored implementation strategy 
is useful and can confirm whether barriers differ in different settings. Prior inventory 
thereby reduces the number of costly trials evaluating different implementation 
strategies [28,32,34]. Although previous studies already explored barriers for the 
use of conservative treatments, these studies were performed in other settings, and 
not focused on orthopedic care. Furthermore, the uptake of several implementation 
activities was poor, since only 9% of the participating GPs were present at the seminar 
[23]. It was very difficult to reach all GPs in seminars. This could be easier in orthopedic 
practice. Orthopedic surgeons may have more interest in OA, because it is part of 
their specialization whereas for GPs it is one of the many health problems in their daily 
practice. This highlights the importance of optimizing the use of conservative treatments 
in orthopedic practice as well, so that patients will receive optimal treatment options in 
orthopedic practice if conservative care was suboptimal in their primary care trajectory. 
Our study and the study performed in primary care together will provide useful 
information for the development of interventions based on the full spectrum of barriers 
and facilitators in primary care and orthopedic practice. This is important because a 
multidisciplinary approach is likely to be more effective to obtain optimal conservative 
therapy [35]. 
A strength of this study is the purposive sampling of orthopedic surgeons of regions 
with low and high surgery rates, because they could have contrasting views on 
barriers and facilitators. We think that this will reveal most barriers and facilitators for 
the implementation of the optimal use of conservative treatments in hip and knee OA 
in orthopedic practice. A limitation may be the selection of patients. Patients will be 
recruited via advertisement, which can lead to selection bias, because patients who 
respond to the advertisements may perceive other barriers and facilitators as most 
important compared to non-responders. Furthermore, the use of an internet-based 
survey could also induce selection bias. Knee and hip OA increases with age [3], 
but not all elderly persons do have internet or an email address. This can lead to the 
selection of younger persons compared to the average age of OA patients, while elderly 
persons may perceive other barriers and facilitators as most important. We will assess 
the impact of selection bias by comparing elderly respondents with younger ones. If 
they perceive the same barriers and facilitators we can conclude that the impact of this 
type of selection bias does not influence our results. 
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The developed strategy is likely to result in an optimal and standardized use of 
conservative treatment options in hip and knee OA in orthopedic practice. In addition, 
the results of this study can be used as an example for optimizing the use of conservative 
care in other patient groups. In a subsequent study, the developed implementation 
strategy will be assessed on its effectiveness, feasibility and costs.
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ABSTRACT
Objectives
National and international evidence-based guidelines for hip and knee osteoarthritis 
(OA) recommend to start with non-surgical treatments, followed by surgical intervention 
if a patient does not respond sufficiently to non-surgical treatments, but there are 
indications that these are not optimally used. The aim of this study was to assess the 
extent to which all recommended non surgical treatments were used by patients with 
hip or knee OA who receive(d) a total hip or knee replacement, as reported by patients 
and orthopaedic surgeons.
Setting
We performed two cross-sectional internetbased surveys among patients and 
orthopaedic surgeons throughout the Netherlands.
Participants
195 OA patients either have undergone total knee arthroplasty or total hip arthroplasty 
no longer than 12 months ago or being on the waiting list for surgery with a confirmed 
date within 3 months and 482 orthopaedic surgeons were invited to participate.
Primary and secondary outcome measures
The use of recommended non-surgical treatments including education about OA/
treatment options,  lifestyle advice, dietary therapy, physical therapy, acetaminophen, 
NSAIDs and glucocorticoid injections.
Results
174 OA patients (93%) and 172 orthopaedic surgeons (36%) completed the surveys. 
Most recommended non-surgical treatments were given tothe majority of patients (eg, 
80% education about OA, 73% physical therapy, 72% acetaminophen, 80% NSAIDs). 
However, only 6% of patients and 10% of orthopaedic surgeons reported using a 
combination of all recommended treatments. Dietary therapy was used least frequently. 
Only 11% of overweight and 30% of obese participants reported having received 
dietary therapy and 28% of orthopaedic surgeons reported to prescribe dietary therapy 
to overweight patients.
Conclusions
While most recommended non-surgical treatments were used frequently as single 
therapy, the combination is used in only a small percentage of OA patients. Especially, 
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use of dietary therapy may be improved to help patients manage their symptoms, and 
potentially delay the need for joint arthroplasty.
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INTRODUCTION
Patients with symptomatic hip or knee osteoarthritis (OA) suffer from pain and loss 
of function for which treatment is required. Different treatment options are available, 
surgical and non-surgical treatments. For patients, good quality of care is achieved 
if their symptoms are managed in the short term, but also taking into account which 
treatment option results in the best long-term patient outcomes. As the lifespan of a 
prosthesis is limited, and patient outcomes after revision arthroplasty are not as good as 
after primary surgery [1], it is generally acknowledged that total hip arthroplasty (THA) 
and total knee arthroplasty (TKA) should not be performed too early. For this reason, 
evidence based guidelines recommend to start with non-surgical treatments (eg, 
education, physical therapy, non-steroidal anti-inflammatory drugs (NSAIDs))[2-6], and 
to use surgical intervention only if a patient does not respond sufficiently to non-surgical 
treatment options in the context of end stage OA [7-13]. These recommendations are all 
based on the large body of evidence supporting the effectiveness of these non-surgical 
treatments to help patients with hip and knee OA manage their symptoms and preserve 
joint function [14].
Despite these guidelines, several studies have suggested that the use of non-surgical 
treatments in patients with hip or knee OA can be improved [7,15-18]. For instance, 
Snijders et al. [7] demonstrated that 81% of patients with hip or knee OA did not receive 
all non-surgical treatments in the primary care setting. However, patients with OA may 
receive non-surgical treatments later on in the care trajectory from their orthopaedic 
surgeon once referred to specialist care. In the Netherlands, patients with OA are 
usually treated by the general practitioner. According to guidelines, patients should be 
referred to the orthopaedic surgeon if they do not respond sufficiently to non-surgical 
treatment options. In orthopaedic practice, the decision will be made to start/continue 
non-surgical treatments or to perform a surgery depending on previous received 
treatments and disease severity. Therefore, orthopaedic surgeons have an important 
role in ensuring optimal care of patients with OA by confirming whether recommended 
non-surgical treatments have been exhaustedly used before considering a surgical 
intervention. Furthermore, surgical interventions, like a THA and TKA do not have good 
patient reported outcome in about 10-20% of patients [19-22]. This stresses even more 
the importance of good non-surgical treatment modalities before implant surgery is 
encountered. McHugh et al. [23] examined which treatments patients with OA used 
throughout the care trajectory, both before and while on the waiting list for a TKA or THA, 
and showed that only 10% of the patients had received information on pain management 
with the consequence that some patients used their own regime to take analgesics. 
This in turn may have led to insufficient effects of analgesics. However, they did not 
investigate the full range of non-surgical treatments and the estimates were reported 
by patients, so that the information may have been given to them but not remembered. 
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Given the known effectiveness of non-surgical treatments individually and for some 
combinations (eg, physical therapy with dietary therapy [24]), use of the full range of 
available recommended non-surgical treatments may improve patient outcomes [2-
6], thereby improving quality of care, and postpone the need for surgery which would 
reduce chances for a revision with worse patient outcomes than primary surgery. What 
is currently lacking and needed to provide a complete view, is an assessment of the full 
range of non-surgical treatments as well as including both patients’ and orthopaedic 
surgeons’ perspectives, as these may differ.
Therefore, the aim of this study was to assess the extent to which all recommended non-
surgical treatments were used by patients with hip or knee OA as reported by patients 
and orthopaedic surgeons, both as a single option and in combination.
MATERIALS AND METHODS
Study design 
We performed two cross-sectional internet-based surveys in November and December 
2013 and January 2014 to assess the use of non-surgical treatments in orthopaedic 
practice as reported by both patients and orthopaedic surgeons.
Population
Patients
A total of 195 patients were invited by email to participate in the survey, to estimate  a 
previously reported 19% use of non-surgical treatments among 47,000 patients with 
hip and knee OA annually in the Netherlands [25], with a 5% margin of error. Patients 
were recruited via advertisements in local newspapers across the Netherlands, and 
through the websites or newsletters of patient associations. Patients who volunteered to 
participate in the survey in reaction to the advertisements were dialed by the research 
team to provide information about the study, to answer questions and to ask whether 
they approved for participation. In addition, patients received written information before 
the start of the survey and the availability to stop during the study. In addition, patients 
received written information before the start of the survey and the availability to stop 
during the study. Inclusion criteria for patients were: age ≥ 18 years, a doctor’s diagnosis 
of hip or knee OA, and either have undergone TKA or THA no longer than 12 months ago 
or being on the waiting list for surgery with a confirmed date within 3 months. Patients 
who were unable to understand written Dutch or who had undergone or were scheduled 
for revision surgery were excluded from the study. Patients who initially indicated that 
they wanted to participate but did not respond, were sent two reminders, one after 
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one and a half weeks, and if still no response again after 3 weeks. Participants who 
completed the questionnaire received a 10 euro gift card as an incentive.
Orthopaedic surgeons
All 482 Dutch orthopaedic surgeons listed in the registry of the Netherlands Orthopaedic 
Association (NOV) and/ or the Dutch medical address book with an email address 
received an invitation to participate. All orthopaedic surgeons who treated patients with 
hip or knee OA were eligible. Orthopaedic surgeons who did not respond received two 
reminders, one after one and a half weeks and if still no response again after 3 weeks. 
Orthopaedic surgeons did not receive an incentive for their participation.
Survey development
Survey for patients
The survey for patients included questions about general patient characteristics, general 
health and symptoms of OA, and non-surgical treatment for OA. Patient characteristics 
included: age, gender, region of residence (north, middle, and south), educational level 
[basic education (none or only primary education), intermediate education (prevocational 
secondary education, senior secondary vocational training, senior secondary general 
education, pre-university education), or high education (higher professional education 
or university (bachelor, master, or PhD degree)], work situation (paid work or not), height 
(cm) and weight (kg) to calculate the body mass index (BMI), and type of insurance 
(basic and/ or additional coverage for care such as physical therapy, glucosamine 
sulfate and hyaluronic acid). Furthermore, the survey included general and disease-
specific health questions, such as duration of OA and duration of complaints of the 
affected joint, comorbidities, average pain during 6 months before surgery, measured 
on a 0 (no pain)-10 (unbearable pain) scale, and patient-perceived reasons for surgery.
Questions about healthcare use included all non-surgical options before joint replacement 
surgery as described in the Dutch stepped-care strategy (SCS) and were formulated 
as follows: “Did you receive the following treatments for the complaints of your affected 
joint before joint replacement surgery?”. The SCS is based on (inter)national guidelines 
[26,27]. The first step consists of education, life style advice, and acetaminophen. If the 
treatment options in the first step are not sufficient, treatment options in the second step 
can be considered (exercise therapy, dietary therapy, and NSAIDs). 
Multidisciplinary care, intra-articular injections, and transcutaneous electrical nerve 
stimulation (TENS) are treatment options in the third step and could be considered if 
treatment options in step one or two are ineffective.
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In the survey these non-surgical treatments were formulated as follows: education 
about the disease osteoarthritis, education about the possible treatment options in 
osteoarthritis, lifestyle advices (ie, stay active, lose weight), physical therapy/ exercise 
therapy, acetaminophen, anti-inflammatory painkillers (eg, NSAIDS such as Celebrex, 
Diclophenac, Cataflam, Voltaren), tramadol (eg, Tramal, Tramagetic, Tradonal, Zaldiar), 
multidisciplinary care (care of different health care providers at the same time, for 
example in a revalidation centre), injections in the knee, TENS (therapy that uses electrical 
current on the skin). Patients could choose one or more of the following answers: yes, 
received from the orthopaedic surgeon; yes, received from another healthcare provider; 
yes, received on my own initiative; no. 
Survey for orthopaedic surgeons
The survey for orthopaedic surgeons included questions about their background 
characteristics, and the prescription of non-surgical treatments. Characteristics 
of orthopaedic surgeons included: age, gender, work region, work setting, years of 
working experience as an orthopaedic surgeon, number of new patients with hip/ knee 
OA seen per month. Questions about prescribed treatments included all non-surgical 
options described in the SCS [26,27] and were formulated as follows: “If patients did 
not receive the following non-surgical treatments, do you prescribe these treatments?” 
In case of physical therapy or dietary therapy we asked whether they referred patients, 
rather than initiating this treatment themselves. Orthopaedic surgeons could choose 
one of the following answers: never, sometimes, often, or (almost)always. 
Analysis
Descriptive statistics were used to describe the characteristics of respondents, and the 
use of non-surgical treatments from the patients’ or orthopaedic surgeons’ perspectives. 
From the patient perspective we distinguished the use of non-surgical treatments 
prescribed by any healthcare provider, by the orthopaedic surgeon, or undertaken by 
their own initiative. From the orthopaedic surgeon perspective we dichotomised the 
answers into ‘prescribed’ (often/ almost always) and ‘not prescribed’ (never/ sometimes).
To assess the use of non-surgical treatments, we made a distinction between non-
surgical treatments recommended by various organisations (eg, OARSI, EULAR, 
AAOS, NOV)[14,16] and other non-surgical treatments. The recommended non-surgical 
treatments were education about OA, education about different treatment options, 
lifestyle advice, (referral to) dietary therapy, physical therapy containing exercises, 
acetaminophen, NSAIDs, and glucocorticoid injections. Other non-surgical treatments 
included glucosamine sulfate, tramadol, multidisciplinary care, TENS, and hyaluronic 
acid injections (for knee OA). These treatments are not supported by high quality 
evidence or clinical guidelines, but are nevertheless sometimes recommended and 
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used by patients with OA. BMI of patients was classified into normal weight if BMI<25 
kg/m2, overweight if BMI≥25 <30 kg/m2, and obese if BMI ≥30 kg/m2 to assess whether 
dietary therapy was indicated. If BMI was unknown, we assumed that dietary therapy 
was not indicated for that patient.
For each non-surgical treatment, we calculated the percentage of patients who had 
received this treatment, and the percentage of orthopaedic surgeons who always/ often 
prescribed this treatment for their patients. In addition, we calculated the percentage of 
participants who received/ prescribed the recommended non-surgical treatments listed 
in each step of the Dutch SCS including the previous steps (conditional percentage). 
The proportion of patients and orthopaedic surgeons using each non-surgical treatment 
was compared using the Chi square test.
In addition, we explored whether patients and orthopaedic surgeons using all 
recommended treatments differed from those who did not, in age, gender, region of 
residence, BMI, and level of education (for patients) and on differences in age, gender, 
work region, work setting, years of working experience, and number of new patients with 
hip/knee OA seen per month (for orthopaedic surgeons). We also explored differences 
in use of each treatment between patients with THA and TKA. The independent t-test 
or Mann Whitney U tests for continuous variables and χ2 tests or Fisher’s exact tests for 
proportions was used to compare differences between subgroups. Significance testing 
was done two-sided at α=0.05. SPSS V.20.0 was used for analyses.
Ethics
This study protocol was presented to the Medical Ethical Committee of the Leiden 
University Medical Center (CME P13.087/NV/nv). Ethical approval for this type of study 
is not required under the Dutch law.
RESULTS
Response
A total of 182 patients (response rate of 93%) completed the survey. Eight patients 
were subsequently excluded from the analyses, because they did not fulfil the inclusion 
criteria. This left 174 patients (89%) included in the final analyses.
One hundred and eighty one (response rate of 38%) orthopaedic surgeons completed 
the questionnaire. Nine orthopaedic surgeons were excluded because they indicated 
they did not see patients with OA in consultations. Thus a total of 172 (36%) orthopaedic 
surgeons were included in the final analyses.
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Characteristics of the population
Patients
Characteristics of patients who completed the questionnaire are described in table 1. 
The majority of the participants were female, 26% were obese (BMI≥30 kg/m2) and 
thus indicated for dietary therapy. Most of the respondents had already undergone 
THA or TKA at the time of recruitment, and a significant proportion of patients reported 
a duration of symptoms for more than five years. Almost all patients had additional 
insurance coverage, meaning that physical and dietary therapy was likely to be covered 
by their insurance rather than being subject to out of pocket expenses.
Table 1. Characteristics of included patients with hip or knee OA
Characteristics Patients (n=174)
Age in years (mean, SD) 64 (7.7)
Female, n (%) 125 (72)
Body mass index (BMI), n (%) 
   <25 36 (21)
   ≥25 <30 84 (48)
   ≥30 46 (26)
   Missing 8 (5)
Knee OA, n (%) 94 (54)
Joint replacement (THA or TKA), n (%)
    Yes 169 (97)
    Within 3 months 5 (3)
First joint replacement, n (%) 132 (73)
Duration of complaints of affected hip/ knee, n (%)
   < 1 year 13 (8)
   1-5 years 86 (49)
   6-10 years 42 (24)
   11-20 years 25 (14)
   >20 years 8 (5)
Pain before surgery, mean (SD)* 7.16 (1.8)
Comorbidities, n (%)
   Diabetes 10 (6)
   Stroke, cerebral hemorrhage, cerebral infarct 5 (3) 
   Cancer 10 (6)
   Cardiovascular disease 12 (7)
   Migraine or severe headaches 17 (10)
   High blood pressure 57 (33)
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Characteristics Patients (n=174)
   Asthma, chronic bronchitis, emphysema 14 (8)
   Chronic joint inflammation 32 (18)
   Other 20 (11)
Education, n (%)
   Basic 6 (3)
   Intermediate 120 (69)
   High 47 (27)
   Missing 1 (1)
Paid work, yes n (%) 55 (32)
Region of residence, n (%)
   North 70 (40)
   Middle 55 (32)
   South 49 (28)
Living situation, n (%)
   Live alone 39 (22)
   Live with others 135 (78)
Type of insurance, n (%)
   Basic only 4 (2)
   Basic with additional coverage 170 (98)
* Average pain during six months before surgery measured on a 0 (no pain)-10 (unbearable 
pain) scale. BMI, body mass index; OA, osteoarthritis; THA, total hip arthroplasty; TKA, total knee 
arthroplasty.
Orthopaedic surgeons
The characteristics of the orthopaedic surgeons who completed the questionnaires are 
presented in table 2. On average, they had been working for 13 years (SD 8) as an 
orthopaedic surgeon, and saw an average of 25 new patients with hip OA (SD 24) and 
31 (SD 22) new patients with knee OA per month. Orthopaedic surgeons from various 
parts of the country and different hospital types were included in the sample.
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Table 2. Characteristics of orthopaedic surgeons who treated patients with hip or knee OA
Characteristics Orthopaedic surgeons (n=172)
Age in years, mean (SD) 48.4 (8.6)
Female, n (%) 16 (9%)
Years working as an orthopaedic surgeon; mean (SD) 12.8 (8.0)
New patients with primary hip OA seen per month; mean (SD) 25.1 (22.2)
New patients with primary knee OA seen per month; mean (SD) 31.3 (23.9)
Work region*, n (%)
   North 54 (31)
   Middle 82 (48)
   South 41 (24)
Setting*, n (%)
   General hospital 89 (52)
   University medical center 13 (8)
   Private clinic 20 (12)
   Teaching hospital 54 (31)
   Other 7 (4)
* Multiple options possible, so the sum of percentages may be larger than 100%.
OA, osteoarthritis.
Use of recommended non-surgical treatments
Table 3 shows the percentage of patients that received recommended and non-
recommended non-surgical treatments as reported by patients.
The most frequently received non-surgical treatments were education about OA (80%), 
physical therapy (73%), acetaminophen (72%), education about different treatment 
options (66%) and NSAIDs (64%). Of these, education about OA and education about 
different treatment options were mostly received from the orthopaedic surgeon (table 
3), whereas the other treatments were received from another healthcare professional, 
or patients own initiative. Dietary therapy was used least frequently, even when non-
overweight patients were excluded. Only 11% of overweight patients and 30% of the 
obese patients reported they had received dietary therapy. A minority of these patients 
was referred to a dietician by their orthopaedic surgeon (table 3). 
In addition, looking at the conditional percentage in table 4, only 33% of the patients 
received all recommended treatments in step 1 of the SCS, and eleven (6%) patients 
reported to have received all recommended treatments in step 1 and 2 of the SCS. 
Because many patients did not remember which type of injection they received, we 
excluded glucocorticoid injections and did not calculated the conditional percentage of 
step 1, 2 and 3 together.
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Table 3. Received recommended and non-recommended non-surgical treatments by patients as 
reported by patients
Received by*
Non-surgical 
treatment
Received, n (%) Orthopaedic 
surgeon, n (%)
Other health care 
professional, n 
(%)
Own initiative, n 
(%)
Education about 
OA
139 (80) 95 (68) 30 (22) 31 (22)
Education about 
different treatment 
options
115 (66) 80 (70) 27 (23) 21 (18)
Lifestyle advice 107 (62) 37 (35) 40 (37) 40 (37)
Dietary therapy, if 
indicated
   BMI ≥25 <30 9 (11) 2 (22) 3 (33) 5 (56)
   BMI ≥30 14 (30) 1 (7) 7 (50) 6 (43)
Physical therapy 127 (73) 33 (26) 70 (55) 36 (28)
Contained 
exercises
116  (91)
Acetaminophen 125 (72) 26 (21) 30 (24) 73 (58)
NSAIDs 111 (64) 43 (39) 51 (46) 19 (17)
Tramadol 44 (25) 21 (48) 24 (55) 1 (2)
Glucosamine 
sulfate
58 (33) 7 (12) 9 (16) 46 (79)
Multidisciplinary 
care
12 (7) 4 (33) 8 (67) 1 (8)
TENS 10 (6) 0 10 (100) 0
Intra-articular 
injections (knee 
OA n=94) 
54 (57) 46 (85) 12 (22) 0
   Glucocorticoid 28 (30)
   Hyaluronic acid 7 (7)
   Unknown 20 (37)
* Multiple options possible, thus the sum of orthopaedic surgeon, other health care professional  and 
own initiative can be >100%. BMI, body mass index; NSAIDs, non-steroidal anti-inflammatory drugs; 
OA, osteoarthritis; TENS, transcutaneous electrical nerve stimulation.
Reasons for surgery according to patients (multiple answers possible) were: pain 
could not be controlled with painkillers (55% of the patients), insufficient effect of other 
treatments (eg, physical therapy, dietary advice) (51%), duration of symptoms (41%), 
difficulties with daily activities (75%) or other reasons (17%) (eg severe cartilage loss, 
difficulties with sports, immobility).
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Table 4. Conditional percentage of patients receiving recommended non-surgical treatments in 
stepped care strategy as reported by patients
Recommended non-surgical treatments in stepped care 
strategy
Conditional n (%)
Step 1: education about OA+education about different treatment 
options+lifestyle advice+acetaminophen
57 (33)
Step 1+2: step 1+(referral to) dietary therapy, when 
indicated+physical therapy+NSAIDs
11 (6)
Step 1, 2+3: step 1+ 2 + intra-articular injections (for knee OA 
n=94) 
n/c
n/c: not calculated, because many patients did not know which type of injection they received.
NSAIDs, non-steroidal anti-inflammatory drugs; OA, osteoarthritis.
Table 5 shows the percentage of orthopaedic surgeons that often or always 
prescribes recommended non-surgical treatments as reported by orthopaedic 
surgeons. Orthopaedic surgeons often reported to prescribe lifestyle advice (98%), 
education about different treatment options (95%), education about OA (87%), and 
acetaminophen (64%). However, table 6 shows that only 96 (56 %) of the orthopaedic 
surgeons reported prescribing all recommended treatments in step 1 of the SCS, 17 
(10%) reported prescribing all recommended treatments in step 1 and 2, and 10 (6%) 
reported prescribing all recommended treatments in step 1, 2 and 3, if the patient had 
not received these treatments in their previous care trajectory. As among patients, 
dietary therapy was reported as the least prescribed treatment (reported by 28% of the 
orthopaedic surgeons), followed by intra-articular injections (43%) and physical therapy 
(54%). 
Table 5. (Often or always) Prescribed recommended non-surgical treatments, as reported by 
orthopaedic surgeons
Recommended non-surgical treatments Population n (%)
Participants 172
Education about OA 149 (87)
Education about different treatment options 163 (95)
Lifestyle advice 168 (98)
(Referral to) dietary therapy, when indicated 49 (28)
 Physical therapy 93 (54)
Acetaminophen 112 (64)
NSAIDs 102 (59)
Intra-articular injections 74 (43)
NSAIDs, non-steroidal anti-inflammatory drugs; OA, osteoarthritis.
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Table 6. Conditional percentage of orthopaedic surgeons who prescribe recommended non-surgical 
treatments in stepped care strategy
Recommended non-surgical treatments in stepped care strategy Conditional n (%)
Step 1: education about OA+education about different treatment 
options+lifestyle advice+acetaminophen
96 (56)
Step 1+2: step 1+(referral to) dietary therapy, when indicated+physical 
therapy+NSAIDs
17 (10)
Step 1, 2+3: step 1+2+intra-articular injections (for knee OA n=94) 10 (6)
NSAIDs, non-steroidal anti-inflammatory drugs; OA, osteoarthritis.
No differences were found between patients receiving and not receiving all recommended 
non-surgical treatments in any of the patient characteristics tested. Similarly, no 
differences were found between orthopaedic surgeons prescribing and not prescribing 
all recommended non-surgical treatments in any of their characteristics. Patients with 
knee OA received acetaminophen more often than patients with hip OA (80% vs 63% 
respectively (p=0.01)), but no differences were found in the use of other treatments. 
Furthermore, comparing patients and orthopaedic surgeons, no differences were found 
in the proportion using education about OA (p=0.09), acetaminophen (p=0.18), NSAIDs 
(p=0.39), and the percentage using all recommended non-surgical treatments (p=0.22). 
A smaller percentage of patients compared to orthopaedic surgeons reported having 
received/prescribed education about different treatment options (p<0.001), lifestyle 
advice (p<0.001) and dietary therapy (p=0.03). The use of physical therapy on the other 
hand was reported to have been received by more patients than being prescribed by 
orthopaedic surgeons (73% vs 54% (p<0.001)). 
Use of other non-surgical treatments
Glucosamine sulfate was the most frequently used other non-surgical treatment, reported 
by 33% of patients, and mostly (79%) used on their own initiative. Multidisciplinary care 
(7%) and TENS (6%) were the least often reported other treatments. Thirty-three percent 
of the patients who received multidisciplinary care were referred by their orthopaedic 
surgeon, and none of the patients who used TENS was referred by their orthopaedic 
surgeon. Overall, orthopaedic surgeons rarely prescribed any of these treatments not 
recommended by published OA guidelines, the highest percentage (8%) was for the 
recommendation of glucosamine sulfate. 
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DISCUSSION
Our study showed that although most recommended non-surgical treatments seem to 
be frequently used as a single option in OA patients who receive(d) a THA or TKA, only 
a small percentage of patients received all recommended non-surgical treatments. For 
that matter, only 6% of patients and 10% of orthopaedic surgeons reported using all 
recommended non-surgical treatments in step 1 and 2 of the SCS [27]. Given the known 
effectiveness of each of these treatments individually, use of the full range of available 
modalities may improve patient outcomes [2-6].
Dietary therapy was the least frequently used recommended non-surgical treatment 
for OA. Only 11% of overweight patients and 30% of obese patients reported having 
received dietary therapy, and only 28% of orthopaedic surgeons reported they would 
prescribe dietary therapy. Another study in the Netherlands showed that only 14% of 
overweight and obese patients with OA reported receiving dietary therapy [16]. This 
is even lower than reported in our study, but these patients were recruited by general 
practitioners, and thus may have subsequently received dietary therapy later on in the 
care trajectory for example after referral to an orthopaedic surgeon. In our study, patients 
had visited multiple health care providers, potentially increasing the likelihood of being 
offered dietary therapy when indicated. In other countries, dietary therapy seems to be 
more commonly used, for example 59% of physicians prescribed ‘weight reduction’ in 
a study performed in France [13], and 31% of patients with OA in a study in Canada 
[17]. Although the numbers are higher, the overall low rates across studies suggest that 
there is room for improvement. Similarly, a considerable number of patients were not 
prescribed physical therapy. The use of physical therapy as a non-surgical treatment 
could even be overestimated, because orthopaedic surgeons sometimes prescribe 
physical therapy as preparation before surgery instead of a non-surgical treatment to 
delay surgery. Dietary therapy and physical therapy are the only two recommended non-
surgical treatments that an orthopaedic surgeon cannot provide himself, but for which 
referral is needed. Improving the use of these two treatments in orthopaedic care, may 
result in better quality of patient care as the combination of weight loss plus exercise is 
shown to provide better overall improvements in function, pain and mobility among older 
overweight and obese adults with knee OA compared with either intervention alone [24]. 
This study has some limitations. First, because of the retrospective nature of our study 
and the reliance on self-reported data, it is susceptible to recall bias. In an attempt to 
reduce this bias, we limited inclusion to patients who had a TKA or THA no longer than 
12 months ago, or were scheduled for surgery within the next 3 months. Second, the 
use of an internet-based survey could induce selection bias. It is known that the majority 
of THA and TKA patients prefer pen-and-paper questionnaires, and that patients 
who prefer electronic questionnaires differ from patients who prefer pen-and-paper 
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questionnaires [28]. It is possible that more elderly persons do not have internet or 
an email address compared to younger persons, which could have led to a selection 
of younger persons. The average age of patients with OA is 68.2 years [29] and our 
population is slightly younger, on average 64 (SD 7.7) years. However, age was not 
associated with the use of all recommended non-surgical treatments. Third, the use of 
a sample of patients responding to an advertisement may have introduced sampling 
bias. However, as our responding patients were distributed across different regions in 
the Netherlands, and had an age and gender distribution comparable to OA patients, 
we think that any bias that may have occurred is likely to be small. Similarly, selection 
bias may have occurred as a result of the low response rate (38%) among orthopaedic 
surgeons. However, such a response rate is comparable or higher than found in other 
online surveys among orthopaedic surgeons in the Netherlands [30,31]. It is possible that 
orthopaedic surgeons who are not interested in non-surgical treatment were less likely to 
complete the questionnaire or that orthopaedic surgeons overestimate their use of non-
surgical treatments. This would only lead to an overestimation of non-surgical treatment 
use and the use may be even lower. Furthermore, the use of acetaminophen, NSAIDs 
and tramadol could have been overestimated, as we were not able to define a minimum 
for the use of these treatments (eg, at least 1 tablet per day) due to differences between 
recommendations. Therefore, we simply reported whether patients took acetaminophen 
or NSAIDs (yes/ no) without any minimum dose. However, in some cases the use was 
less than multiple days per month (4% for acetaminophen and 5% for NSAIDs, results 
not shown). In addition, 57 patients (33%) suffered from hypertension and 12 (7%) from 
cardiovascular diseases, both of which are contraindications to NSAIDs use [6]. This 
may have resulted in underestimating the use of NSAIDs or Tramadol, as these patients 
should be excluded from these estimates. 
To our knowledge this is the first study that evaluated the full range of combinations 
of non-surgical treatments for OA, both from the perspective of orthopaedic surgeons 
and patients. While most recommended non-surgical treatments for OA were used 
frequently as single therapy, the combination is used in only a small percentage of OA 
patients who receive(d) a THA or TKA. Despite their potential for reducing symptoms 
of knee and hip OA, dietary therapy and physical therapy appear to be least frequently 
used. By increasing the use of these two non-surgical treatments, both primary care 
physicians and orthopaedic surgeons may be able to help patients better manage their 
symptoms, thereby improving quality of care and potentially postpone the need for joint 
arthroplasty, resulting in improved long-term patient outcomes. Future studies should 
focus on evaluating the reasons (barriers) why some orthopaedic surgeons do not use 
recommended non-surgical treatments. Such findings may be helpful in developing 
targeted strategies to improve the use of these treatments in orthopaedic practice and 
thereby to improve quality of care. Although the recommended non-surgical treatment 
options have been proven to be effective individually or in combination (eg, physical 
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therapy with dietary therapy [24]), there are no published studies that investigated the 
combined effect of all of these treatments. Nevertheless, it has been hypothesised that 
optimised non-surgical treatment could result in significantly greater pain reduction, 
functional improvement and increase in quality of life than usual care in knee OA [32]. 
The results from the present study suggest that such better outcomes may be achieved 
in a considerable part of OA patients.
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ABSTRACT
Introduction
International evidence-based guidelines for the management of patients with hip 
and knee osteoarthritis (OA) recommend to start with (a combination of) non-surgical 
treatments, and using surgical intervention only if a patient does not respond sufficiently 
to non-surgical treatment options. Despite these recommendations, there are strong 
indications that non-surgical treatments are not optimally used in orthopaedic practice. 
To improve the adoption of non-surgical treatments, more insight is needed into barriers 
and facilitators of these treatments. Therefore, this study assessed which barriers 
and facilitators are associated with the use and prescription of different non-surgical 
treatments before hip and knee OA in orthopaedic practice among patients and 
orthopaedic surgeons in the Netherlands.
Materials and Methods
We performed two internet-based surveys among 172 orthopaedic surgeons and 174 
OA patients. Univariate association and multivariable regression techniques are used 
to identify barriers and facilitators associated with the use of non-surgical treatments.
Results
Most barriers and facilitators among patients were associated with the use of physical 
therapy, lifestyle advice and dietary therapy. Among orthopaedic surgeons, most 
were associated with prescription of acetaminophen, dietary therapy and physical 
therapy. Examples of barriers and facilitators among patients included “People in my 
environment had positive experiences with a surgery” (facilitator for education about 
OA), and “Advice of people in my environment to keep on moving” (facilitator for lifestyle 
and dietary advice). For orthopaedic surgeons examples were “Lack of knowledge 
about guideline” (barrier for lifestyle advice), “Agreements/ deliberations with primary 
care” and “Easy communication with a dietician” (facilitators for dietary therapy). Also 
the belief in the efficacy of these treatments was associated with increased prescription.
Conclusions
Strategies to improve non-surgical treatment use in orthopaedic practice should be 
targeted at changing the beliefs of orthopedic surgeons, communication with other OA 
care providers and involving patient’s environment in OA treatment. 
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INTRODUCTION
Patients with symptomatic knee or hip osteoarthritis (OA) may suffer from pain and loss 
of function, which can be treated by performing a total hip arthroplasty (THA) or total 
knee arthroplasty (TKA). However, these treatments should not be given too early, given 
the limited lifespan of a prosthesis and the less successful outcomes after revision than 
after primary THA or TKA [1]. Therefore, international evidence-based guidelines for 
hip and knee OA recommend to start with (a combination of) non-surgical treatments 
[2-6]. These treatments aim to prevent progression and reduce symptoms such as 
joint pain and impairment of functions [6]. Following the existing guidelines in the 
Netherlands, patients with OA are first treated by the general practitioner and referred 
to an orthopedic surgeon if they do not respond sufficiently to non-surgical treatment 
options. In orthopaedic practice, the decision will be made to continue non-surgical 
treatments or to perform surgery. A stepped-care strategy (SCS) based on (inter)
national guidelines [7,8] was developed to facilitate the use of non-surgical treatments 
in three steps. 
Despite recommendations and the SCS, previous studies suggest that the use of 
non-surgical treatments in patients with hip or knee OA can be improved [9-12]. For 
example, Snijders et al. [9] found that 81% of patients with hip or knee OA did not 
receive all non-surgical treatments in the primary care setting. Many patients may thus 
be referred to orthopaedic practice without having received all recommended non-
surgical options. In these cases, the orthopaedic surgeon could provide additional non-
surgical treatments. However, our previous study showed that only 10% of the patients 
in orthopaedic practice received all recommended non-surgical treatments before 
surgery [13]. These findings are consistent with the rising number of THA and TKA in OA 
patients in the Netherlands [14]. In addition, the large variation in preoperative status 
(e.g. disease severity) across different centers in Europe and Australia [15,16] suggests 
differences in timing of surgery, possibly influenced by non-surgical treatment use. An 
improved use of non-surgical treatments may reduce surgery rates as well as variation 
in preoperative status.
More insight is needed into factors that hinder (barriers) and facilitate (facilitators) the 
use of recommended non-surgical treatments in orthopaedic practice. Some studies 
have been carried out focused at identifying barriers or facilitators for a specific non-
surgical treatment, [17-19], or carried out in primary care [20]. However, it is unknown 
whether identified factors in these studies also apply to non-surgical treatment use in 
orthopaedic practice. Furthermore, previous research mainly focused on barriers and 
facilitators at the patient level [10,21], such as people’s own perceptions of the need to 
seek treatment [22]. However, barriers or facilitators may exist among professionals or 
within organizations that influence non-surgical treatment use. 
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Therefore, the aim of the study is to assess which barriers and facilitators are associated 
with the use and prescription of different non-surgical treatments before hip or knee 
osteoarthritis (OA) in orthopaedic practice among patients and orthopaedic surgeons.
MATERIALS AND METHODS
Study design
Cross-sectional internet-based surveys among OA patients and orthopaedic surgeons. 
Survey development
To identify potential barriers and facilitators for non-surgical treatment use, semi-
structured interviews were performed among 10 orthopaedic surgeons involved in hip 
and knee surgery and 5 patients in whom TKA or THA was performed no longer than 12 
months ago. Purposive sampling was applied to obtain contrasting views and thereby 
identify all potential barriers and facilitators. Therefore, patients and orthopaedic 
surgeons were selected from Dutch regions with high and low surgery rates based 
on the report of Van Beek et al. [23], as participants from regions with lower surgery 
rates may perceive more facilitators and participants from regions with higher surgery 
rates more barriers. Furthermore, we selected participants from both academic and 
non-academic hospitals to take the possible impact of a different organization of care 
into account.
The interview questions were formulated to ensure the representation of all levels of 
the framework of Grol and Wensing [24] and the constructs of the Theoretical Domains 
Interview framework (TDI)[25]. The framework of Grol and Wensing distinguishes the 
following levels: the innovation, the professional, the patient, the social context, the 
organizational context, and the external environment (political and economic factors) 
[24]. The TDI framework includes 12 theoretical construct domains derived from 
33 psychological theories and covering 128 explanatory constructs that enhance 
implementation of evidence-based practice[25]. In addition, previously reported barriers 
and facilitators in primary care [26] were included. The semi-structured interviews were 
audio-taped, transcribed in full and analyzed using open coding. The qualitative analysis 
was executed using the software package ATLAS.ti (ATLAS.ti Scientific Software 
Development GmBH, Berlin, Germany). A total of 35 barriers and 23 facilitators were 
identified during the in-depth interviews among orthopaedic surgeons and 20 barriers 
and 12 facilitators among patients.
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Survey for patients
Population
The developed internet-based survey was sent to a sample of patients (n=195), to 
estimate a previously reported 19% use of non-surgical treatments among 47,000 
patients with hip and knee OA annually in the Netherlands, with a 5% margin of error 
[13,27]. Patients were recruited via advertisements in newspapers, and at websites or 
newsletters of patient associations. Inclusion criteria were: age ≥ 18 years, a doctor’s 
diagnosis of hip or knee OA, and either having TKA or THA performed no longer than 12 
months ago or being on the waiting list for surgery within three months. The latter criteria 
were included to ensure that the decision for surgery had already been made. Patients 
with an inability to understand written Dutch or who had undergone revision surgery 
were excluded. Two reminders were sent in case of non-response, one after 1.5 weeks 
and again after three weeks. Participants received a ten euro gift card as an incentive 
upon completion of the questionnaire.
Survey
The first part of the survey included questions on patient characteristics: age, gender, 
region of residence (north, middle, and south), educational level (basic education (no or 
only primary education), intermediate education (prevocational secondary education, 
senior secondary vocational training, senior secondary general education, pre-university 
education), or higher education (higher professional education or university (bachelor, 
master, or PhD degree)), work situation (paid work or no paid work), height and weight 
to calculate the Body Mass Index (BMI), and type of insurance (basic coverage 
and additional coverage). All inhabitants of the Netherlands have a basic insurance 
coverage (legally obliged) and have the option of purchasing supplementary insurance 
covering additional healthcare such as physical therapy and dietary therapy, rather 
than being subject to out of pocket expenses. In addition, questions were included 
about use of each of the recommended non-surgical options (education about OA, 
education about different treatment options, lifestyle advice, dietary therapy, physical 
therapy, acetaminophen, NSAIDs, and glucocorticoid injections (only for knee OA) [28]) 
which were formulated as follows: “Did you receive the following treatments for your 
complaints on your affected joint before the joint replacement surgery?” (yes/ no). The 
second part of the questionnaire consisted of 32 items covering the identified barriers 
and facilitators from the interviews. Patients were asked to indicate the influence of 
each facilitator and barrier on non-surgical treatment use. Answers could be given 
on a 4-point Likert scale ranging from not important to very important, or to indicate 
“not applicable to my situation” for example for the facilitator “guidance of the exercise 
therapist” if the patient had never visited one. The survey was pilot tested among three 
patients to test whether patients understood the questions and answering categories.
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Survey for orthopaedic surgeons
Population
All 482 Dutch orthopaedic surgeons listed with an email address in the registry of the 
Dutch Orthopaedic Association (NOV) and/or the Dutch medical address book were 
invited to participate. Inclusion criterion was: seeing patients with hip or knee OA. Non-
responders received two reminders, one after 1.5 weeks and again after three weeks. 
Survey
The first part of the survey included questions about background characteristics: age, 
gender, work region, work setting, years of working experience, number of new patients 
with hip/ knee OA per month. In addition, questions were included about prescription 
of each of the recommended non-surgical options and were formulated as follows: “If 
patients did not receive the following non-surgical treatments, do you prescribe these 
treatments?” In case of physical therapy and dietary therapy we asked whether they 
referred patients, rather than prescribe these treatments themselves. Answers could 
be given on a 4-point scale ranging from never to almost always. The second part of 
the questionnaire consisted of 58 items covering the identified barriers and facilitators 
from the interviews. Orthopaedic surgeons were asked to what degree each barrier and 
facilitator influenced the prescription of non-surgical treatments in patients with hip and/ 
or knee OA. Answers could be given on a 4-point Likert scale ranging from none to a 
large extent.
Analysis
Data from all respondents completing the survey and fulfilling the inclusion criteria were 
included in the analyses. Descriptive statistics showed that many patients reported 
barriers and facilitators as not applicable to their situation, even though a number of these 
seem to be applicable to any patients’ situation, e.g., “The practitioner took my problem 
seriously”. As each patient visited a practitioner, all patients should have been able to 
answer this question but this was not the case. Given this example, we assume that 
patients have misunderstood “not applicable” as “not important”, and that they selected 
an item as important only if they felt strongly about it. It was included accordingly in the 
analyses. We performed a sensitivity analysis treating the answers “not applicable” as 
missing in the univariate analyses. In addition, barriers and facilitators for patients were 
dichotomized into not important (grouping answering categories not important/ a little 
bit important/ not applicable on my situation) and important (grouping the answering 
categories important/ very important), because of few observations in some cells. 
For patients, we first assessed the extent to which each barrier/ facilitator was associated 
with the use of each non-surgical treatment using univariate logistic regression analysis, 
with the barrier/facilitator (not important/ important) as the independent variable and 
65 Chapter 4
4
use of each recommended treatment (yes/ no) as dependent variable. For orthopaedic 
surgeons this was done using the Spearman rank correlation as both the independent 
variable (influence of barrier/ facilitator for prescription of non-surgical treatments) and 
the dependent variable (prescription of the different non-surgical treatments) consisted 
of Likert scales with a clear ordering, but without information on the distance between 
the 4 points on the scale.
Secondly, as individual barriers/ facilitators may be related to others we included 
barriers/ facilitators significantly associated with use of each non-surgical treatment into 
a multivariable logistic regression model (p<0.05). Given the multiple testing in the first 
step, we used the more conservative p-value of 0.05 to include barriers/ facilitators 
in the multivariable model, rather than the commonly used o-value of 0.10 or 0.20. 
For orthopaedic surgeons, we dichotomized prescribed non-surgical treatments into 
“provided” (often/ almost always) and “not provided” (never/ sometimes) and barriers 
and facilitators into “0” (not at all/ a little bit) and “1” (to a reasonable extent/ to a large 
extent), because of few observations in some cells. All analyses were executed using 
the software package SPSS (IBM SPSS Statistics, version 20.0). 
RESULTS
Response and characteristics of the population
Of the 195 recruited patients, 8 did not fulfill the inclusion criteria because they did not 
receive a surgery in the last 12 months and were not on the waiting list to receive surgery 
within 3 months. Of the remaining 187 patients, 174 (93%) completed the questionnaire. 
Nine of the 482 orthopaedic surgeons were excluded because they did not see patients 
with OA in consultations and 172 (36%) completed the questionnaire. Patients who 
responded had an average age of 64 (SD 7.7), were mostly female (72%), overweight 
(78%), and intermediate educational level (69%). Five patients (3%) were still on the 
waiting list, the remaining 169 patients had received a joint replacement. For 73% of the 
174 patients it was their first joint replacement, 54% received a total knee and the history 
of complaints was less than 1 year for 8%, 1-5 years for 49% and more than 5 years for 
43% of the patients. Patients reported a median pain score of 8.0 before surgery on a 0 
(no pain)-10 (unbearable pain) Likert scale. Almost all patients had additional insurance 
coverage, meaning that physical and dietary therapy was also (partly) covered by their 
insurance rather than being subject to out of pocket expenses. 
Orthopaedic surgeons had an average age of 48.4 (SD 8.6), were mostly males (91%), 
had worked on average 12.8 (SD 8.0) years as an orthopaedic surgeon, and saw on 
average 25.1 (SD 22.2) new patients with hip OA and 31.3 (SD 23.9) patients with knee 
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OA per month. The majority worked at a general hospital (52%). Both patients and 
orthopaedic surgeons were spread across different regions of the Netherlands.
Barriers and facilitators among patients for non-surgical treatment use 
Table 1 shows all barriers (-) and facilitators (+) in the survey for each level of the 
framework of Grol and Wensing [24] and whether patients considered these barriers 
and facilitators as important. Most patients reported the following facilitators as very 
important:  “Important to exercise/ to keep on moving at home” (50.6%), “Guidance 
by the physical therapist” (36.8%) and “Sufficient time of the practitioner(s) to explain 
everything” (31.6%). Barriers reported by most patients as very important were: 
“Preference of practitioner for surgery” (31.6%), “Too much loss of cartilage to use non-
surgical treatments” (29.9%) and “People in my environment had positive experiences 
with a surgery” (26.4%).
Table 2 shows univariate associations between barriers/ facilitators and non-surgical 
treatments.  Physical therapy, lifestyle advice and dietary therapy were associated with 
the largest numbers of barriers and facilitators e.g. a higher use of physical therapy 
and dietary therapy was associated with “Because of the good contact with my treating 
practitioner(s), I was able to carry on with non-surgical treatments” OR 5.68 (95% CI 
2.71-11.93) and OR 4.17 (95% CI 1.33-13.07), respectively. A higher “use” of lifestyle 
advice was associated with “Important to exercise/ to keep on moving at home” (OR 
6.52 (95% CI 2.59-16.43)). Treating the answers “not applicable” as missing gave 
similar results in the univariate analyses (data not shown). 
Only a few of these barriers and facilitators were independently and significantly 
associated with non-surgical treatment use in the multivariable logistic regression 
analysis (table 3). People in patients’ environment with positive experiences with 
surgery was associated with an increased use of OA education, lack of trust in non-
surgical treatments was associated with a decreased use of education on different 
treatment options, and advice of people in patients’ environment to keep on moving 
was associated with increased use of lifestyle advice. For dietary therapy, advice of 
people in my environment to keep on moving and good collaboration between the 
practitioners were associated with an increased use. Guidance by the physical therapist 
increased the use of physical therapy where lack of information provision about the use 
of acetaminophen was associated with a decreased use. 
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Table 3. The independent effect of barriers and facilitators reported by patients for non-surgical 
treatment use (multivariable analyses)
Non-surgical 
treatment
Used, 
yes (%)
Barrier (B) or facilitator (F) Odds ratio (95% 
Confidence 
interval)
p-value
Education about OA 80 People in my environment 
had positive experiences 
with surgery (-)
3.42 (1.48-7.09) 0.004
Education about 
different treatment 
options
66 Lack of trust in non-surgical 
treatments (-)
0.28 (0.11-0.71) 0.008
Lifestyle advice 61 Advice of people in my 
environment to keep on 
moving (+)
3.11 (1.43-6.74) 0.004
(Referral to) dietary 
therapy (when 
indicated, n=130)
18 Advice of people in my 
environment to keep on 
moving (+)
11.56 (1.90-70.22) 0.008
Good collaboration 
between the practitioners 
(+)
12.12 (1.22-120.73) 0.033
(Referral to) physical 
therapy 
73 Guidance by the physical 
therapist (+)
20.52 (5.56-75.79) <0.001
Lack of information 
provision about the use of 
acetaminophen (-)
0.22 (0.06-0.75) 0.016
Acetaminophen 72 - - -
NSAIDs 64 - - -
Only barriers and facilitators with P-values ≤ 0.05 are shown in the table
Barriers and facilitators among orthopaedic surgeons for prescription of non-
surgical treatments 
Table 4 shows all barriers (-) and facilitators (+) in the survey for each level of the 
framework of Grol and Wensing [4] and whether orthopaedic surgeons considered these 
barriers and facilitators as important for the prescription of non-surgical treatments. 
Facilitators that influenced the prescription of non-surgical treatment to a large extent 
according to orthopaedic surgeons were: “Important to follow guidelines” (49.4%), 
“Important to try non-surgical treatments first” (49.4%) and “Acetaminophen has only a 
few side effects” (48.8%) (table 4). Barriers reported by most orthopedic surgeons were 
“Glucocorticoid injections is a symptomatic treatment” (14.0%), “No effect of physical 
therapy when there is an obvious loss of cartilage” (9.9%) and “Physical therapy for hip 
OA is not effective” (6.4%). 
Table 5 shows that the prescription of acetaminophen, dietary therapy and physical 
therapy were associated with the largest numbers of barriers and facilitators e.g. a 
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higher use of acetaminophen was associated with the belief that acetaminophen has 
only a few side effects (r=0.48, P<0.01). A higher prescription of dietary therapy was 
associated with the presence of an obesity clinic (r=0.36, P<0.01). Lower prescription 
of physical therapy is associated with the belief that physical therapy for hip OA was not 
effective (r=-0.29, P<0.01).
Only a few of these barriers and facilitators were independently and significantly 
associated with prescription of non-surgical treatments in the multivariable logistic 
regression analysis (table 6). Lack of knowledge about the guideline was associated 
with a decreased prescription of lifestyle advice. Agreements/ deliberations with primary 
care (GP, physical therapist, dietician) and easy communication with a dietician were 
both associated with increased prescription of dietary therapy. For acetaminophen, 
NSAIDs, and glucocorticoid injections, the belief in the efficacy of these treatments 
was associated with increased prescription. On the other hand, the belief that physical 
therapy for hip OA is not effective and that there is no effect when there is an obvious 
loss of cartilage was associated with decreased prescription of physical therapy. 
Table 6. The independent effect of barriers and facilitators reported by orthopaedic surgeons for 
prescription of non-surgical treatments (multivariable analyses)
Non-surgical 
treatment
Provided, 
yes (%)
Barrier (B) or facilitator (F) Odds ratio (95% 
Confidence 
interval)
p-value
Education about 
OA
87 - - -
Education about 
different treatment 
options
95 - - -
Lifestyle advice 98 Lack of knowledge about 
guideline
0.03 (0.001-0.50) 0.015
(Referral to) 
dietary therapy
28 Easy communication with a 
dietician
6.21 (1.48-26.10) 0.013
Agreements/ deliberations with 
primary care (GP, physical 
therapist, dietician)
2.41 (1.05-5.53) 0.037
Referral to) 
physical therapy 
54 Presence of an obesity clinic 4.12 (1.42-11.96) 0.009
Clarity on what the patient has 
done at the physical therapist
2.42 (1.07-5.47) 0.034
Physical therapy for hip OA is 
not effective
0.43 (0.20-0.92) 0.029
No effect of physical therapy 
when there is an obvious loss 
of cartilage
0.39 (0.18-0.82) 0.013
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Non-surgical 
treatment
Provided, 
yes (%)
Barrier (B) or facilitator (F) Odds ratio (95% 
Confidence 
interval)
p-value
Acetaminophen 64 Acetaminophen has only a few 
side effects
7.99 (2.16-29.64) 0.002
Important to try non-surgical 
treatments first  
5.15 (1.16-22.87) 0.031
Patients benefit from 
Acetaminophen
5.14 (1.80-14.72) 0.002
No effect of physical therapy 
when there is an obvious loss 
of cartilage
0.23 (0.09-0.58) 0.002
NSAIDs 59 Patients benefit from NSAIDs 5.96 (2.45-14.52) <0.001
Pressure by patient for surgery 3.92 (1.63-9.45) 0.002
Only barriers and facilitators with P-values ≤ 0.05 are shown in the table
DISCUSSION
This study revealed barriers and facilitators for non-surgical treatment use in patients with 
hip and knee OA in orthopaedic practice. Most of the identified facilitators and barriers 
reported by orthopaedic surgeons reflect views on the effectiveness of non-surgical 
treatments. For example the barriers “Physical therapy for hip OA is not effective” or “No 
effect of physical therapy when there is an obvious loss of cartilage” were associated 
with decreased prescription of physical therapy. The facilitators “Patients benefit from 
Acetaminophen, NSAIDs or Glucocorticoid injections” were associated with an increased 
prescription of Acetaminophen, NSAIDs and Glucocorticoid injections, respectively. 
This means that an intervention to improve non-surgical treatment use may be targeted 
at trying to change the beliefs regarding the efficacy of non-surgical treatments among 
orthopaedic surgeons. 
In addition, most of the barriers and facilitators reported by patients that were associated 
with the use of non-surgical treatment use reflect the importance of their environment 
e.g. “People in my environment had positive experiences with surgery” and “Advice of 
people in my environment to keep on moving”. Another study found that “help by others” 
was a facilitator for the use of analgesics in patients with knee OA [10]. Thus it seems to 
be important to involve patients’ environment (e.g. partners or other family members) so 
that they all understand the importance of non-surgical treatments, such as exercises 
and losing weight, and support the patient in using these treatments.
Previous studies focused on patients’ characteristics or on a specific treatment, whereas 
the present study adds that the patients’ environment and the views of orthopaedic 
surgeons on the effectiveness of non-surgical treatments play an important role in the use 
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of these treatments. This is consistent with the barrier reported by patients reflecting the 
view of their health care provider: “Lack of trust in non-surgical treatments”, “Preference of 
practitioner for surgery” and “Too much loss of cartilage to use non-surgical treatments”. 
Furthermore, in our previous study only 54% of the orthopaedic surgeons reported that 
they referred patients to a physical therapist if a patient did not have that before [13]. This 
could partly be explained by the barriers reported by orthopaedic surgeons that were 
significantly associated with a decreased prescription of physical therapy: “Physical 
therapy for hip OA is not effective” and “No effect of physical therapy when there is an 
obvious loss of cartilage”. This shows that orthopaedic surgeons do not always believe 
in the effectiveness of physical therapy, even though evidence based guidelines do 
advice this [28]. Orthopaedic surgeons also perceived many barriers and facilitators 
regarding communication with primary care. In addition, a good collaboration between 
health care providers was associated with reported increased use of dietary therapy, as 
reported by patients. Therefore, it seems that clear referral criteria are needed between 
primary and hospital care, and agreements about the organization of care, for example 
how the physical therapist treats a patient. Focusing on dietary therapy, it appeared that 
“Agreements/ deliberations with primary care (GP, physical therapist, dietician)” and 
“Easy communication with a dietician” may facilitate the prescription of this treatment. 
Therefore, strategies to improve the prescription of these non-surgical treatments should 
also focus on the communication between orthopaedic surgeons and other health care 
providers, clear referral criteria and agreement about the organization of care, apart 
from changing the beliefs of orthopedic surgeons regarding the effectiveness of these 
non-surgical treatments. 
This study has some limitations. First, because of the retrospective nature of our study 
and the reliance on self-reported data, it is susceptible to recall bias. To reduce this 
influence we only included patients who had a TKA or THA no longer than 12 months 
ago, or scheduled for surgery within the next 3 months. Second, the use of an internet-
based survey could have induced selection bias. It is possible that more elderly 
persons do not have internet or an email address compared to younger persons. 
Indeed, the average age of patients with OA is 68 years [29] whereas the average 
age of our population was slightly lower, i.e. 64 (SD 7.7) years. Furthermore, response 
bias may have occurred because orthopaedic surgeons with an interest in non-surgical 
treatments may be more motivated and willing to participate and may perceive other 
barriers or facilitators. However, our response rate is comparable or higher than found in 
other online surveys among orthopaedic surgeons regarding different subjects [30-32]. 
Given the equal spread of respondents across the Netherlands, we think we will have 
captured all regions and thereby a rather complete view of both barriers and facilitators. 
Another limitation is that patients could answer “not applicable to my situation” in our 
survey. Although we explained to patients to choose this option only when they did 
not visit for example an exercise therapist when referring to barriers and facilitators 
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for visiting an exercise therapist, it seems that this has been misunderstood. Despite 
this explanation and a previous pilot test of the questionnaire, we feel that patients 
misinterpreted this category. Therefore, we assumed that a patient would have selected 
an item if the patient had felt strongly about that item and interpreted “not applicable” as 
“not important”. Treating the answers “not applicable” as missing gave similar results in 
the univariate analyses (data not shown), which confirms the robustness of our results.
Strength of this study is that barriers and facilitators in the survey were identified during 
interviews with patients and orthopaedic surgeons in regions with low and high surgery 
rates. This ensures that the survey does not test the authors’ personal hypothesis 
but represents a rather complete set of possible barriers and facilitators based on 
existing frameworks. Another strong point is the finding that barriers and facilitators are 
independently associated with the use of non-surgical treatments. This ensures that 
identified barriers and facilitators are relevant to optimize of the use of non-surgical 
treatments. Still, the results of these multivariable regression analyses should be 
interpreted carefully, since answering categories were dichotomized [33]. For proper 
interpretation of results, the percentage using each non-surgical treatment, association 
of each barrier and facilitator and the multivariable analyses should all be taken into 
account. 
Insight into barriers and facilitators is essential to optimize the use and prescription 
of non-surgical treatments. Previous studies that tested implementation strategies 
all conclude that a prior inventory of barriers and facilitators to develop a tailored 
implementation strategy is useful and can confirm whether barriers differ between 
settings [34-36]. Such a prior inventory thereby reduces the number of costly trials 
evaluating different implementation strategies [34,37,38]. Although previous studies 
already explored barriers and facilitators for the use of non-surgical treatments, these 
studies were performed in other settings, did not include all barriers/ facilitators and their 
influence on different non-surgical treatments, and were mostly focused on the patient 
level thereby ignoring the influence of professionals and organizations. A different setting 
may result in another strategy given the results from the present study e.g. if the beliefs 
regarding the effectiveness of non-surgical treatments differ between primary care 
and orthopaedic practice. The next step will be the development of an implementation 
strategy based on all identified barriers and facilitators both on the patient, professional 
and organizational level, which will be presented to the Dutch Orthopaedic Association 
to be implemented in clinical practice. Future studies should show whether this strategy 
is effective in improving the use and prescription of non-surgical care as well as patient 
outcomes.
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ABSTRACT
Background 
Sciatica is a common condition worldwide that is characterized by radiating leg pain and 
regularly caused by a herniated disc with nerve root compression. Sciatica patients with 
persisting leg pain after six to eight weeks were found to have similar clinical outcomes 
and associated costs after prolonged conservative treatment or surgery at one year 
follow-up. Guidelines recommend that the team of professionals involved in sciatica 
care and patients jointly decide about treatment options, so-called interprofessional 
shared decision making (SDM). However, there are strong indications that SDM for 
sciatica patients is not integrated in daily practice. We designed a study aiming to 
explore the barriers and facilitators associated with the everyday embedding of SDM for 
sciatica patients. All related relevant professionals and patients are involved to develop 
a tailored strategy to implement SDM for sciatica patients.
Methods
The study consists of two phases: identification of barriers and facilitators and 
development of an implementation strategy. First, barriers and facilitators are 
explored using semi-structured interviews among eight professionals of each (para)
medical discipline involved in sciatica care (general practitioners, physical therapists, 
neurologists, neurosurgeons, and orthopedic surgeons). In addition, three focus groups 
will be conducted among patients. Second, the identified barriers and facilitators will be 
ranked using a questionnaire among a representative Dutch sample of 200 GPs, 200 
physical therapists, 200 neurologists, all 124 neurosurgeons, 200 orthopedic surgeons, 
and 100 patients. A tailored team-based implementation strategy will be developed 
based on the results of the first phase using the principles of intervention mapping and 
an expert panel. 
Discussion
Little is known about effective strategies to increase the uptake of SDM. Most 
implementation strategies only target a single discipline, whereas multiple disciplines 
are involved in SDM among sciatica patients. The results of this study can be used as 
an example for implementing SDM in other patient groups receiving multidisciplinary 
complex care (e.g., elderly) and can be generalized to other countries with similar 
context, thereby contributing to a worldwide increase of SDM in preference sensitive 
choices. 
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BACKGROUND
Sciatica, more accurately called lumbosacral radicular syndrome, is a form of radiating 
back pain, mostly caused by a herniated disc with nerve root compression. It is 
characterized by radiating leg pain in combination with dermatomal motor, sensory, 
or tendon reflex abnormalities. Sciatica is a common condition worldwide. In Western 
countries 5 to 10 per 1,000 persons annually develop sciatica, with variable pain 
intensities and disease course [1]. In the Netherlands, sciatica patients are initially 
diagnosed by general practitioners (GPs) and advised to continue daily activities with 
or without physical therapy (conservative treatment). After a period of six to eight weeks, 
the leg pain diminishes in 70 % of the patients [2]. The remainder of the patients is 
usually referred to a neurologist for further investigation, often involving an MRI. If the 
MRI confirms a herniated disc, compatible with the radicular symptoms, the patient 
can be referred to the neurosurgeon or orthopedic surgeon to consider surgery [3,4]. 
In general, surgery leads to more rapid relief than prolonged conservative treatment in 
patients suffering radiating leg pain for more than eight weeks, but with smaller risks 
for prolonged conservative treatment, and both treatments have similar outcomes 
and societal costs at one year follow-up [5-7]. Therefore, the Dutch multidisciplinary 
guideline recommends that the team of professionals involved in sciatica care and 
patients jointly decide about treatment after this six to eight week period, i.e., surgery or 
prolonged conservative treatment, based on the evidence regarding associated risks 
and benefits and preference of the patient [8]. After all, both treatment options have 
equivalent results and the choice thus can be considered preference sensitive. This 
situation is optimally suited for interprofessional shared decision making (SDM) [9]. 
SDM enables patients to make an informed choice in collaboration with the professionals 
involved, and is important for providing care consistent with patient preferences. The 
Dutch government tries to make healthcare more patient-orientated, for example, by 
enabling free choice of insurance company, and a law that obligates professionals to 
discuss consequences and risks of each treatment option [10]. Despite these efforts 
to deliver patient-centered care, and the sciatica guideline recommendation, there 
are strong indications that SDM for sciatica patients is not yet widely used. Recently, a 
comparison between regions in the Netherlands showed considerable variation in the 
number of patients that undergo surgery, ranging from 31 to 140 per 100,000 inhabitants 
[11]. In addition, Dutch surgery rates for sciatica patients are four times higher than 
those in the UK and two times higher than in Sweden [11]. Only the United States have 
a 40 % higher surgery rate than The Netherlands [12]. This is remarkable, because the 
guidelines in the United States and the UK show similarities, and both suggest referring 
patients to a specialist when they do not respond to standard noninvasive treatment or 
suffer from neurological deficits [13, 14]. It is very unlikely that this (inter)national variation 
is only caused by case mix and patient preferences. Research has shown that patients 
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prefer a shared approach over a physician-dominated one, and are more likely to favor 
conservative treatments over surgery after patients’ decision aid (DA) exposure [15, 
16]. Furthermore, it has been shown that Dutch patients are used to delegate treatment 
decisions to their professionals, so that professional preferences dominate treatment 
decisions [17]. Thus, it is far more likely that noncompliance with the evidence-based 
back pain guidelines, specifically the lack of applying SDM, combined with surgeon 
preferences are responsible for the varying surgery rates. SDM may diminish this 
variation, prevent underuse and overuse of surgery [18], and thereby improve quality of 
care., and thereby improve quality of care.
Objective
The DISC study (the Dutch Implementation Study of interprofessional Shared Decision 
Making in Sciatica) aims to explore the barriers and facilitators associated with the 
everyday embedding of SDM for sciatica patients in the Dutch healthcare context, 
among all involved professionals and patients, and to develop a tailored, team-based, 
strategy for SDM implementation among sciatica patients. 
METHODS
The study consists of two phases (table 1).
Table 1. Study phases and time schedule
Planning (months)
Phase A. Identification of barriers and facilitators
i. Barriers and facilitators are explored for SDM implementation
Literature study and preparation interviews/ focus groups 1 to 3
Interviews and focus groups 3 to 10
ii. Identified barriers and facilitators are ranked by importance in a 
representative sample
Survey among professionals and patients 11 to 13
Phase B. The development of an implementation strategy based on phase A
Development of the implementation strategy and expert panel 13 to 15
Writing report 16
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Identification of barriers and facilitators.
i. Barriers and facilitators are explored for SDM implementation
Study design 
Barriers and facilitators among relevant stakeholders are explored in an interview study 
among professionals and in a focus group study among patients. The semi-structured 
interviews and focus groups are based on the framework developed by Grol and 
Wensing [19] in combination with the Normalization Process Model (NPM) [20]. The 
framework of Grol and Wensing [19] describes barriers and facilitators at the levels 
of the innovation, the professional, the patient, the social context, the organizational 
context, and the external environment (political and economic factors). However, the 
organizational context of their framework does not cover all relevant aspects for the 
implementation of SDM in practice. Therefore, we additionally use the NPM, which 
includes more details with respect to the organizational context [20] than the framework 
of Grol and Wensing. Normalization in the NPM is defined as the routine embedding of 
a complex intervention in healthcare, and this model thus offers a robust structure for 
investigating the collective work that leads to this embedding (or not), including:
1. Endogenous factors 
a. Interactional workability: influence of SDM on interactions between people
and practices.
b. Relational integration: relationship of SDM to existing knowledge and          
relationships. 
2. Exogenous factors
a. Skill set workability: influence of SDM on current division of labor.
b. Contextual integration: relationship of SDM to the organizational setting.
The combination of the two frameworks thus ensures that all relevant aspects affecting 
implementation of SDM will be covered. The semi-structured interviews will be 
conducted among all professionals involved in the diagnosis and treatment of sciatica 
patients (GPs, physical therapists (PTs), neurologists, neurosurgeons, and orthopedic 
surgeons). 
The focus group procedures of Morgan et al. will be used in preparing and conducting 
the focus group sessions [21]. A moderator and an observer will guide the focus 
groups. A group will consist of six to eight participants. When information saturation is 
not reached after this initial round, the focus groups will be extended in specific groups.
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Figure 1. Hypothetical example of MaxDiff task.
Study population
We anticipate interviewing eight professionals in each of the target groups (GPs, PTs, 
neurologists, neurosurgeons, and orthopedic surgeons). In each group of professionals, 
we will continue until data saturation is reached, defined as three consecutive interviews 
without new ideas emerging (stopping criterion) [22]. To obtain contrasting views on 
barriers and facilitators, we select professionals from specific regions with either high 
surgery rates (most likely to raise barriers for SDM) or low surgery rates (most likely to 
raise facilitators for SDM) based on published reports [11, 23]. In addition, we ensure 
diversity of gender and hospital type (public hospital and private treatment centers), 
because this may influence the experienced barriers and facilitators. 
We anticipate organizing three focus groups, with six to eight patients in each group 
[24]. To create homogeneous groups, one focus group will include patients who have 
had surgery, one will include patients who have had conservative treatment, and one 
focus group will include patients that still have to decide on treatment. Patients will be 
recruited through advertisements in the local newspapers. When needed, additional 
patients will be recruited via the patient registries of GPs, neurologists, neurosurgeons, 
and orthopedic surgeons coordinated by the Spine Intervention Prognostic Study (SIPS) 
Group. 
Inclusion criteria for patients are: age ≥18 years, a doctor’s diagnosis of sciatica no 
longer than 12 months ago, and a written informed consent. Patients with an inability to 
understand written and oral Dutch instructions or with active diseases likely to interfere 
 
Please consider how important different features are for adoption of shared decision 
making among sciatica patients. 
Considering these 4 features, which is the most important and which is the least 
important feature that prevents shared decision making in clinical practice? 
Most important  Least important 
 Barrier 1  
 Barrier 2  
 Barrier 3  
 Barrier 4  
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with the purpose of this study, such as a terminal illness or severe psychiatric diseases, 
will be excluded from the study. 
Analysis 
The semi-structured interviews and focus group interviews will be audio-taped and 
transcribed in full. They will be qualitatively analyzed using thematic framework analysis 
[25] to classify and organize data according to key themes, concepts and predefined 
categories. The predefined categories of the framework of Grol and Wensing will be 
used [19] regarding the level of the innovation, the professional, the patient, the social 
context, the organizational context, and the external environment (political and economic 
factors). We will compare the barriers and facilitators, to look for differences that may 
explain lack of SDM implementation. We use Atlas.ti software for analysis. 
Outcome measures
This study phase results in a list of identified barriers and facilitators for the implementation 
of SDM, grouped in a commonly used theoretical framework.
ii. Identified barriers and facilitators are ranked by importance in a representative 
sample
Study design
We will conduct an internet-based questionnaire study among professionals and 
patients, to rank the identified barriers and facilitators from the interviews and focus 
groups. A maximum difference scaling (MaxDiff) exercise with an orthogonal design 
will be included in this questionnaire [26]. MaxDiff is a method to rank multiple items 
in a more efficient manner, with the additional advantage of scale-free rating so that it 
prevents scale use bias [27]. With this method, respondents choose the most and least 
important item within a set of items (Figure 1), with different sets offered to respondents 
a number of times.
Each set thus provides more information than a number of pairwise comparisons and 
forces tradeoffs between items, thereby resulting in greater discrimination. A MaxDiff 
task is easy to complete for participants, and results in ratio-scaled scores of importance 
[26,28]. The order of items will be randomized between respondents, and each item will 
be equally represented, to avoid higher importance given to first mentioned items. 
Study population
The survey will be sent to a representative sample of GPs (n = 200), PTs (n = 200), 
neurologists (n = 200), all neurosurgeons (n = 124), orthopedic surgeons (n = 200) and 
patients (n = 100). 
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The sample of professionals will be randomly selected from the Dutch medical address 
book and the membership lists of the professional organizations. The neurosurgeons 
(n = 124) are included from the same sources. We will sample patients using the patient 
registries of GPs, PTs, neurologists, neurosurgeons, and orthopedic surgeons, and 
advertisements in local newspapers. 
Analysis 
Based on the choices made by respondents, importance scores will be estimated for 
each barrier and facilitator, for each individual respondent, using hierarchical Bayes 
estimation [29]. Differences between groups of respondents will be further analyzed in 
SPSS. 
Outcome measures
A list of the 10 most important barriers and facilitators for implementation of SDM among 
sciatica patients.
B: Development of a tailored implementation strategy
Study design
The DISC study group will develop a tailored, team-based strategy to enhance 
the adoption of SDM. This strategy will focus on the 10 most important barriers and 
facilitators found in phase A. Because multifaceted strategies are more effective than 
single strategies [30,31] and our expectation that several barriers at different levels 
will be found, it is plausible that the developed implementation strategy will include 
several components directed at different levels. Furthermore, it is expected that the 
strategy components will include educational outreach, an interactive educational 
strategy, and/or patient-specific strategies, because these facets seem to be promising 
for implementation of SDM [31,32].
In the development process, the project team will use the intervention mapping approach 
of Bartholomew et al. [33]. This method begins with the creation of matrices, in which the 
performance objectives are set against the 10 most important barriers and facilitators. 
Subsequently, the project team will brainstorm about the strategy components needed to 
achieve the performance objective in the presence of the barrier or facilitator mentioned 
in the matrix. The cells of the matrices are then gradually filled with implementation 
strategy components [34]. Next, the project team will translate the formulated strategy 
components into practical strategies.
After the implementation strategy has been developed, an expert meeting will be held 
with a panel of GPs, PTs, neurologists, neurosurgeons, orthopedic surgeons, patient 
representatives of the Dutch back pain patients’ association, and implementation 
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experts (n = 10 to 20) to discuss the feasibility, to refine the developed implementation 
strategy, and to gain acceptance of relevant stakeholders with respect to SDM. 
Analysis
The expert meeting will be audiotaped and summarized by two observers and compared 
until consensus is reached. The participants of the expert meeting receive a summary 
of the meeting and are asked whether this summary is consistent with the conclusions 
reached in the meeting. 
Outcome measures
A tailored strategy likely to be effective to implement SDM among sciatica patients in 
daily practice.
Ethical approval
This study protocol has been presented to the Medical Ethical Committee of the Leiden 
University Medical Center. Ethical approval for this type of study is not required under 
Dutch law.
DISCUSSION
Implementation of SDM enables sciatica patients to make better informed decisions 
congruent with their preferences on whether to undergo prolonged conservative 
treatment or surgery. However, there are strong indications that SDM is not yet adopted 
in daily practice. Professional preferences seem to dominate treatment decisions, 
consistent with evidence that Dutch patients are used to delegate treatment decisions 
to their professionals [17]. Little is known about barriers and facilitators to SDM and 
effective strategies to increase the uptake of SDM [35]. For successful implementation 
of SDM in daily practice, a tailored strategy is needed focused on the barriers and 
facilitators of each domain influencing the adoption of SDM. 
To facilitate implementation of SDM in the treatment of sciatica patients, an evidence-
based guideline and a DA have already been developed. The goal of the DA was to 
inform sciatica patients about the two treatment options. However, this DA was not 
successful in stimulating SDM. This may be due to the fact that DAs are not primarily 
developed for use during the consultations, and thus do not necessarily stimulate SDM 
[18]. The extent to which the DA is used in clinical practice is unknown. Despite the 
Dutch multidisciplinary guideline for SDM and the availability of a DA, SDM has not 
been adopted in clinical practice so far. This emphasizes that barriers are likely to exist 
when it comes to guideline adherence and to adoption of SDM. We need to determine 
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these barriers to develop an effective implementation strategy that is not only evidence-
based, but also targets these barriers. 
Known barriers to SDM reported in previous studies include time constraints and lack 
of applicability, due to patient characteristics or to the clinical situation [36]. However, 
these studies focused on implementation among one discipline only, whereas insight 
into barriers and facilitators for the implementation of interprofessional SDM is lacking 
[37], and particularly relevant for the multidisciplinary sciatica care. To our knowledge, 
our study will be the first to examine barriers and facilitators to interprofessional SDM. 
This will generate new knowledge that may also be applied among other types of 
patients, given that these barriers and facilitators may not be patient-specific but rather 
organization or context-specific.
Limitations of this study may be the selection of patients and professionals. It is possible 
that selection bias occurs, because professionals who are familiar with SDM in daily 
practice may be more motivated and willing to participate. Professionals who are not 
using SDM in their consultation may be less likely to participate, and may experience 
other barriers. To minimize the bias in the interviews, we will stratify our sampling 
by selecting participants from regions with respectively low and high surgery rates. 
Another measure taken to avoid participation bias and to yield all relevant barriers is 
to continue with the interviews until three consecutive interviews emerge without new 
ideas (stopping criterion) [22]. Similarly, selection bias may occur in the focus groups 
as patients with pain or other symptoms may be less likely to travel to Leiden to attend a 
focus group. We will minimize selection bias in the survey by sending multiple reminders 
to increase the response. In addition, we will test for differences between responders 
and non-responders in distribution of gender, hospital type, and the location of the 
hospital to assess whether we may generalize our findings to the total sample. 
The generated knowledge and understanding of the implementation process can be 
used to implement SDM for sciatica patients in the Netherlands and in other countries with 
a similar context. Furthermore, our study can be used as an example for implementing 
SDM in other patient groups receiving multidisciplinary complex care such as elderly 
patients. Increased use of SDM may reduce referral, improve patient satisfaction [38], 
reduce overuse of one of the treatment options [16,18,39] and thus increase both quality 
and efficiency of healthcare [40,41]. 
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ABSTRACT
Background 
The Dutch multidisciplinary sciatica guideline recommends that the team of professionals 
involved in sciatica care and the patient together decide on surgical or prolonged 
conservative treatment (shared decision making [SDM]). Despite this recommendation, 
SDM is not yet integrated in sciatica care. Existing literature concerning barriers and 
facilitators to SDM implementation mainly focuses on one discipline only, whereas 
multidisciplinary care may involve other barriers and facilitators, or make these more 
complex for both professionals and patients. Therefore, this qualitative study aims 
to identify barriers and facilitators perceived by patients and professionals for SDM 
implementation in multidisciplinary sciatica care. 
Methods
We conducted 40 semi-structured interviews with professionals involved in sciatica 
care (general practitioners, physical therapists, neurologists, neurosurgeons, and 
orthopedic surgeons) and three focus groups among patients (six to eight per group). 
The interviews and focus groups were audiotaped and transcribed in full. Reported 
barriers and facilitators were classified according to the framework of Grol and Wensing. 
The software package Atlas.ti 7.0 was used for analysis. 
Results 
Professionals reported 53 barriers and 5 facilitators, and patients 35 barriers and 18 
facilitators for SDM in sciatica care. Professionals perceived most barriers at the level 
of the organizational context, and facilitators at the level of the individual professional. 
Patients reported most barriers and facilitators at the level of the individual professional. 
Several barriers and facilitators correspond with barriers and facilitators found in the 
literature (e.g., lack of time, motivation) but also new barriers and facilitators were 
identified. Many of these new barriers mentioned by both professionals and patients 
were related to the multidisciplinary setting, such as lack of visibility, lack of trust in 
expertise of other disciplines, and lack of communication between disciplines. 
Conclusions
This study identified barriers and facilitators for SDM in the multidisciplinary sciatica 
setting, by both professionals and patients. It is clear that more barriers than facilitators 
are perceived for implementation of SDM in sciatica care. Newly identified barriers 
and facilitators are related to the multidisciplinary care setting. Therefore, an effective 
implementation strategy of SDM in a multidisciplinary setting such as in sciatica care 
should focus on these barriers and facilitators.
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BACKGROUND
Sciatica is a common disorder that is characterized by radiating leg pain in combination 
with dermatomal motor, sensory, or tendon reflex abnormalities. It is mostly caused by 
a herniated disc with compression of the nerve root. The prevalence of sciatica in the 
general population ranges from 1.2% to 43%, depending on its definition [1]. In the 
Netherlands, most sciatica patients are primarily diagnosed by general practitioners 
(GPs). A total of 90% of the patients with sciatica recover with conservative therapy 
[2], with 70% doing so in the first six to eight weeks [3]. Given this favorable outcome 
during this first period of time, the GP advises to continue daily activities, if necessary 
with physical therapy and/or pain medication (conservative treatment) when severe 
neurologic symptoms are lacking. Patients who still suffer from sciatica after six to eight 
weeks are usually referred to a neurologist for further investigation, including an MRI. If 
the MRI confirms a herniated disc, the neurologist and patient can consider prolonged 
conservative treatment or surgery. If they consider surgery, the neurologist can refer the 
patient to a neurosurgeon or an orthopedic surgeon for the final decision.
A recent randomized controlled trial has shown no significant difference in clinical 
outcome between conservative treatment and (early) surgery after one or two years 
[4]. This trial concludes that surgery is more costly but also leads to more rapid relief 
from the pain, whereas conservative treatment is less invasive [4] but takes patients 
longer to recover, so that surgery is cost-effective [5]. However this is the only trial that 
investigated this properly. Other trials are of low quality [4,6]. Because the literature is not 
convincing about the best treatment option, the choice can be considered preference 
sensitive [7]. Therefore, the Dutch multidisciplinary guideline recommends that patients 
and the team of professionals involved in sciatica care jointly decide about treatment 
(shared decision making [SDM]). In SDM, clinicians and patients make decisions jointly, 
weighing the evidence regarding different treatment options [8]. In sciatica care, this 
means that patients are encouraged to consider both treatment options, to communicate 
their preferences and help select the best treatment for their situation. 
Despite the recommendation in the Dutch multidisciplinary sciatica guideline to integrate 
SDM in consultations [9], there are strong indications that SDM is not yet adopted 
in clinical practice. Within the Netherlands, surgery rates differ from 31 to 140 per 
100,000 inhabitants per region [10]. It is unlikely that this variation is caused by patient 
preferences or case mix only. Additionally, it has been shown that Dutch patients are 
used to delegating treatment decisions to their professionals [11]. Part of the variation 
in surgery rates may thus be associated with preferences of professionals for particular 
treatment and with a lack of SDM. Given the multidisciplinary nature of sciatica care, 
SDM has to be integrated in consultations by different professionals at different points in 
the care process, which may be more difficult than in those cases in which professionals 
from only one discipline are involved.
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To improve SDM implementation, more insight is needed into specific barriers and 
facilitators of SDM in sciatica care. Previous research concerning SDM implementation 
mainly focused on one discipline (uni-disciplinary). A systematic review outlines different 
studies towards barriers and facilitators in uni-disciplinary care [12,13]. Main barriers 
identified include time constraints and lack of applicability due to patient characteristics 
or the clinical situation [12]. Main facilitators include motivation of health professionals 
and the perception that SDM leads to improved patient outcomes and to improved 
healthcare processes [12]. However, an increasing number of health problems involve 
multiple disciplines (multidisciplinary care). SDM in multidisciplinary care utilizes the 
skills and experience of professionals from different disciplines, with each discipline 
approaching the patient from its own perspective. This mostly involves separate 
consultations with different professionals [14]. Despite the increase in multidisciplinary 
care delivery, research into barriers and facilitators for SDM in a multidisciplinary setting, 
as in sciatica patients, is limited. A previous study that explored barriers and facilitators 
to SDM focused on barriers and facilitators for integrating SDM in inter-professional 
(IP) teams, better known as inter-professional SDM (IP-SDM) [15]. Within an inter-
professional approach, efforts are made to integrate and translate themes and schemes 
shared by several professionals [16]. It involves separate disciplines that integrate 
different approaches mostly into a single consultation [14]. Main barriers related to IP-
SDM were an imbalance of power between health professionals of different disciplines, 
the existence of professional silos, and disagreement about roles and responsibilities 
between different disciplines [15]. Main facilitators related to IP-SDM were mutual 
knowledge and understanding of disciplinary roles, trust and respect between different 
disciplines. Part of these may also apply to multidisciplinary care. However, SDM in 
multidisciplinary sciatica care involves different disciplines in both primary care and 
hospital care working independently, who do not see the patient in one and the same 
consultation, but in several separate consultations [16]. This independent approach 
within different levels of healthcare may involve other (additional) barriers and facilitators 
than an inter-professional approach or healthcare that involves professionals working in 
the same organization. Therefore, the objective of this study is to explore and categorize 
all barriers and facilitators associated with the implementation of SDM in sciatica care 
perceived by professionals and patients.
METHODS/ DESIGN
To identify barriers and facilitators for SDM in sciatica care, we performed a semi-
structured interview study among professionals and a focus group study among patients. 
Interviews and focus groups reach the parts that quantitative methods cannot reach, 
because people’s knowledge and attitudes are not entirely encapsulated in reasoned 
105 Chapter 6
6
responses to direct questions. This type of data collection can provide rich and in-
depth information about the cognitions, motivations and experiences of individuals 
[17-20], which is well-suited for this type of study. The identification of similarities and 
differences in perceived barriers and facilitators between professionals and patients 
contributes to a further understanding of attitudes and beliefs. This is important for the 
prediction of whether professionals will use SDM, and enables us to develop a tailored-
based implementation strategy, with the main goal of improving the use of SDM in daily 
practice. 
Interviews among professionals
During the period of March 2012 to June 2012, we conducted 40 semi-structured 
interviews with professionals involved in sciatica care (GP’s, physical therapists [PT], 
neurologists [NL], neurosurgeons [NS] and orthopedic surgeons [OS] [eight per 
discipline]) at a location of the participant’s choice (workplace or at home). We applied 
purposive sampling for the selection of professionals. First, we selected professionals 
from regions in the Netherlands with high and low surgery rates [10,21], as SDM has 
been shown to lead to lower surgery rates [22], and we thus would obtain both barriers 
and facilitators. In addition, we selected professionals working in hospital care in such 
a way as to ensure diversity of hospital type (general hospitals, university medical 
centers, and private clinics). The selected professionals received an invitation by e-mail, 
followed by a telephone call. When professionals did not want to participate, we invited 
another professional from the same region. To reach the number of 8 professionals 
for each discipline, we had to approach 8 neurosurgeons (response rate 100%), 10 
orthopedic surgeons (response rate 80%), 14 physical therapists (response rate 57%), 
16 neurologists (response rate 50%), and 45 general practices (response rate 18%). The 
most common reasons why professionals did not want to participate were a lack of time 
or not seeing (many) patients with sciatica in their practice. During the interviews, a topic 
guide with open-ended questions was used (Additional file 1). The following explanation 
of SDM was given: ‘In SDM, clinicians and patients make decisions jointly, weighting 
the evidence regarding different treatment options [8]. In sciatica care this means that 
patients are encouraged to consider both conservative and surgical treatment options, 
to communicate their preferences and help select the best treatment for their situation.’ 
In addition, professionals were asked to give an example of SDM in daily practice to 
determine whether the explanation was clear enough. Participating professionals 
received a hundred euro gift card as an incentive. The average duration of an interview 
was one hour and all interviews were audiotaped and transcribed in full. Interviews 
were conducted by one of two trained interviewers (SH and MW). Both interviewers 
have a master’s degree in health sciences. Their education included training in the 
conduct of interviews and focus groups. The interviewers had no involvement in patient 
care, and the participants had no personal background information on the interviewers. 
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We continued with interviews until data saturation was reached. Data saturation was 
reached when no ideas emerged during three consecutive interviews [23]. 
Focus groups
In June 2012, we performed three focus group interviews (six to eight patients per group 
[17]) at the Leiden University Medical Center with patients who had been diagnosed 
with sciatica within the previous two years. The focus group procedures of Morgan et 
al. [24] were used in preparing and conducting the focus group sessions. We created 
three homogeneous groups to move patients more quickly to a discussion [24]. One 
focus group included patients who had had surgery, one included patients who had had 
conservative treatment, and one focus group included patients who still had to decide on 
treatment. Patients were recruited via advertisements in local newspapers. Participants 
≥18 years, and with a written informed consent were included in the study. Patients with 
an inability to understand written and oral Dutch instructions were excluded. Patients 
received a twenty euro gift card as an incentive, and travel costs reimbursement. 
Before the focus groups, participants received an information letter. They were asked 
to think about the decision making process for the treatment of their sciatica before 
attending the focus group. During the focus groups, a topic guide was used (Additional 
file 2). We explained the concept of SDM and gave an example of SDM in sciatica care. 
Participants were asked to write their positive and negative aspects about the decision 
making process on post-its, and posted these on separate boards. We used these 
post-its to stimulate discussions between participants. A trained moderator (SH) and 
an observer (MW) conducted the focus groups. The focus groups lasted two hours, 
including a 15-minute break. All focus-groups were audiotaped and transcribed in full. 
Analysis
Directed content analysis was used to analyze the interviews and focus groups. This 
method is well suited for research that would benefit from further description and to 
extend conceptually a theory or framework [25]. We used the framework of Grol and 
Wensing [26]. This framework describes how barriers and facilitators can be identified, 
categorized, and used for the development of a tailored-based intervention strategy 
to facilitate desired change, in this study implementing SDM [26]. Based on several 
theoretical reflections on behavioral change, this framework categorizes barriers and 
facilitators into six levels: the innovation (in our case SDM), the individual professional, 
the patient, the social context, the organizational context, and the external environment 
(political and economic factors). We used predetermined barriers/ facilitators of the 
framework of Grol and Wensing [26] to ensure that we would find all barriers and 
facilitators for the implementation of SDM in sciatica care. New codes were created 
for text that could not be categorized within these predetermined barriers/ facilitators. 
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Two researchers (SH and MW) independently coded the interviews and focus groups. 
Discrepancies were discussed until consensus was reached. In the next step, reported 
barriers and facilitators were classified according to levels of the framework of Grol and 
Wensing. After classification of barriers and facilitators within the levels of the framework, 
three researchers (SH, PM, and LB) independently grouped the barriers and facilitators 
into themes for comparison between patients and professionals. Discrepancies were 
discussed until consensus was reached. Participants did not receive feedback on the 
findings. The software package Atlas.ti 7.0 [27] was used for analysis.
Ethical approval
This study protocol was presented to the Medical Ethical Committee of the Leiden 
University Medical Center. An exemption was obtained, as ethical approval for this type 
of study is not required under Dutch law.
RESULTS
Characteristics of the population
Table 1 shows the characteristics of the professionals who participated in the semi-
structured interviews. The participating professionals covered a wide range with 
respect to age, experience and number of patients treated annually. Twenty-two 
patients participated in the focus groups. Eight patients per focus group were invited; 
two participants did not show up. Characteristics of the patients are described in Table 
2. Participating patients covered a wide range with respect to age and time since 
diagnosis. 
Barriers and facilitators
We identified 53 barriers and 5 facilitators perceived by professionals (Additional file 
3: Table S1) for the implementation of SDM in sciatica patients. These barriers and 
facilitators could be grouped into 15 themes (Table 3). Professionals perceived most 
barriers at the level of the organizational context, and facilitators at the level of the 
individual professional (Additional file 3: Table S1). During the focus groups, 35 barriers 
and 18 facilitators for SDM on 15 themes (Table 3) were reported by patients regarding 
their decision making for sciatica treatment (Additional file 4: Table S2). Patients 
mentioned most barriers and facilitators at the level of the individual professional 
(Additional file 4: Table S2). Table 3 shows the themes influencing SDM in sciatica 
care for both professionals and patients. It is clear that more barriers than facilitators 
were mentioned, particularly by professionals. We will discuss each theme, and which 
specific barriers and facilitators that were mentioned within these themes.
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Table 1. Characteristics of interviewed professionals
Discipline n Average age, 
years (range)
Male (%) Average work 
experience, 
years (range)
Average no. of 
sciatica patients 
treated per year 
(range)
Physical 
therapist
8 47 (30-58) 4 (50) 23 (8-33) 56 (6-240)
General 
practitioner 
8 49 (32-63) 5 (63) 17 (1-34) 20 (3-52)
Neurologist 8 49 (37-62) 6 (75) 11 (3.5-22) 311 (52-780)
Neurosurgeon 8 50 (38-62) 6 (75) 16 (5-27) 692 (300-1,404)
Orthopedic 
surgeon
8 52 (40-67) 8 (100) 16 (4-27) 444 (3-1,300)
Table 2. Characteristics of patients in focus groups
Focus group n Average age, 
years (range)
Male (%) Average time since 
diagnosis, months 
(range)
1. Surgery 8 51 (19-81) 2 (25) 6 (1-18)
2. Conservative 
therapy
8 56 (19-75) 3 (38) 9 (1-24)
3. Still had to 
decide
6 51 (33-75) 2 (33) 9 (3-24)
Innovation (SDM)
Professionals mentioned the unclear concept of SDM as a theme. The lack of clarity of 
the concept of SDM was regarded as a barrier for SDM. With respect to the definition 
of SDM, many professionals thought they were using SDM. However, when discussing 
SDM they wondered whether they really met all the conditions (e.g., information 
provision of both treatments’ options, ask patient’s preferences) for a decision to be a 
shared decision. (OS3: ‘Which conditions do you have to meet before you can say this 
is decision that has been taken jointly? That is not clear to me’.)
Individual professional
Both professionals and patients mentioned the three themes at this level of the framework: 
(poor) professional-patient relationship, professional’s attitude/ behavior towards SDM, 
and lack of knowledge about SDM/ treatment options of professional. In addition, 
patients mentioned lack of information provision/ explanation by the professional as a 
theme.
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Table 3. Themes influencing SDM in sciatica care according professionals and patients
Level Theme (Professionals) B F Theme (Patients) B F
Innovation 
(SDM)
Unclear concept of SDM X
Individual 
professional
Poor professional-patient 
relationship
X Professional- patient relationship X X
Negative (B)/ positive (F) 
professional’s attitude/ 
behavior toward SDM
X X Negative (B)/ positive (F) 
professional’s attitude/ behavior 
towards SDM
X X
Lack of knowledge of 
the professional about 
SDM/ treatment options
X Lack of knowledge of the 
professional about SDM/ 
treatment options
X
Lack of (B)/ sufficient (F) 
information provision/ explanation 
X X
Patient Negative patient’s 
attitude towards SDM 
X Negative (B)/ positive (F) patient’s 
attitude towards SDM 
X X
Lack of patient’s 
capabilities to decide 
X Lack of (B)/ sufficient (F) patient’s 
capabilities to decide 
X
Pressure by patient 
toward professional
X Lack of knowledge of patient 
about treatment options
X
Social context Lack of inter-
professional 
collaboration
X Lack of (B)/ sufficient (F) inter-
professional collaboration
X X
Social influences of third 
parties
X Social influences of third parties X
Organizational 
context
Lack of tools to facilitate 
SDM
X Lack of (B)/ sufficient (F) tools to 
facilitate SDM
X X
Situational factors (e.g., 
lack of time)
X Situational factors (e.g., lack of 
time)
X
Long waiting list 
influences decision 
process
X Long (B)/ short (F) waiting list 
influences decision process
X X
Poor logistics/ 
implementation
Conflicting information about 
treatment options
X
External 
environment
Environmental influences 
on the decision process
X Environmental influences on 
decision process
X X
Reimbursement in favor 
of surgery
X Reimbursement in favor of surgery X
B barrier, F facilitator
Regarding the first theme, professionals said that a poor professional-patient 
relationship is a barrier for the SDM process. The relationship may be influenced 
by the multidisciplinary care patients receive, as they have superficial contacts with 
multiple professionals, instead of visiting one professional who really knows the patient. 
Especially professionals in primary care experience difficulties in applying SDM when 
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they are not familiar with the background and personal situation of the patient or when 
they have a poor relationship with the patient. This may be due to how professionals in 
primary care in general have a better knowledge about the background and personal 
situation of most of their patients compared to professionals in hospital care. General 
practitioners said they have more and more patients in their practices, which makes it 
more difficult to really know their patients than before when practices were smaller. As 
a consequence, they experience more difficulties with applying SDM to patients they 
do not know, while professionals in hospital care are used to dealing with this lack of 
unfamiliarity. (NL3: ‘You should really know the patient to respond better to the factors 
playing a role in deciding whether or not the patient needs a surgery. Who knows the 
patient nowadays?’). Patients also mentioned the importance of a patient-professional 
relationship, as a barrier and facilitator (bad versus good relationship). For example, 
they mentioned that some professionals had a lack of attention for their anxiety, personal 
situation, and preferences, while the elicitation of patient preferences is crucial to SDM. 
(P3: ‘I had to impose my own will, and with a lot of difficulties the neurologist finally 
referred me to a surgeon, but I really had to push it through. The neurologist tried to stop 
me, whereas I had complaints for more than a year without any improvement’).
Another theme is the attitude/ behavior towards SDM. Professionals felt it is important 
to express their own view about which treatment option to follow, and to determine the 
next step in the care trajectory, rather than the patient. (OS8: ‘I am not a populist, I am 
not going to say “Oh this is what you want, you name it, we’ve got it”’). In addition, many 
professional had an explicit preference for conservative treatment or for surgery. This 
preference could influence SDM, if professionals push patients towards the treatment 
of their preference. (OS3: ‘As long as there are no neurological symptoms, no cauda 
equina syndrome, then of course you do nothing. In those cases you try to convince 
patients of not having a surgery’). Patients confirmed that some professionals have a 
strong preference for one of the treatment options and mentioned that professionals 
tried to push them into the direction of their preference. (P6: ‘My doctor insisted me to 
wait, to let my body recover by itself’). On the other hand, some professionals had a 
positive attitude towards SDM. For example, they said that SDM improves quality of care 
and patient outcomes, which may function as a facilitator for SDM.
The third theme is lack of knowledge of the professional about SDM/ treatment 
options. Patients felt that some professionals had a lack of knowledge about treatment 
options, especially in primary care. Professionals frequently told patients that there is 
only one treatment option. Again, this may be related to the complex structures in the 
multidisciplinary sciatica setting. Since many professionals are involved, professionals 
are likely to provide information regarding the treatment they can provide themselves, 
but have a lack of knowledge about other possible treatment options. (P6: ‘I went to 
the PT and GP and they said: “Nowadays doctors do not perform sciatica surgeries 
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anymore, you will just have to wait, because your body will recover your herniated disc 
itself”’). The sciatica guideline recommends that the patient and professional together 
decide on surgical or prolonged conservative treatment after considering the harms 
and benefits of each treatment option. This is impossible if not all the professionals are 
familiar with these options or with the sciatica guideline, and thus with the need for SDM 
in sciatica patients. (NS2: ‘I am not really a guideline person’).
A number of patients received the wrong diagnosis. Due to this wrong diagnosis, 
patients were suffering from sciatica for a long period of time. It sometimes took weeks 
or even months before they got the right diagnosis. As a result, the first six to eight 
weeks of conservative therapy had already passed, and they were referred to hospital 
care for surgery without given information about the care trajectory or alternative 
treatment options. The issue of not receiving SDM was thus a consequence of getting 
the wrong diagnosis. (P22: ‘My GP though there was something with my Achilles tendon 
or muscles, but it appeared to be an herniated disc’). Furthermore, some professionals 
perceived a lack of education and skills for SDM, especially communicative skills. 
(NL4: ‘You need some communication skills, and that is difficult. (…) Communication 
with the patient is the most important thing. Until now, there is not enough attention for 
communication skills’).
Patients also mentioned the theme of information provision and explanation, and 
thought that there is room for improvement concerning this theme. They perceived a 
lack of information provision with regard to treatment options and potential harms and 
benefits. (P6: ‘My doctor advised me to wait, and only told me about the disadvantages 
why I shouldn’t have a surgery. In the end I needed a surgery, but the only thing I 
could think of were all the disadvantages of having a surgery’). Some patients received 
sparse information about one of the treatment options. Others did not mention one of 
the treatment options at all. They also mentioned a lack of explanation by professionals 
of the care trajectory. (P10: ‘I went to the hospital, they gave me little explanation and 
no deliberation. They told me: you have a herniated disc, here you have morphine and 
you can go home now’). Besides these barriers, patients also mentioned facilitators 
regarding this theme. Most facilitators were in the opposite direction of the reported 
barriers (e.g., sufficient information provision, explanation about harms and benefits of 
each treatment option, and explanation of the care trajectory). 
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Patient
At the level of the patient, both professionals and patients mentioned the attitude/ 
capabilities of patients. Furthermore, professionals mentioned pressure by patients, 
and patients mentioned their own lack of knowledge about treatment options. 
Regarding the first theme of negative attitude toward SDM/ patient’s capabilities to 
decide, professionals stated that some patients preferred a professional-dominated 
over a shared approach. They think that patients do not want to decide together but 
want to leave the decision up to the professional. (NS7: ‘Not everybody wants a shared 
decision. Some people want a decision made by the doctor’). In the focus groups, 
one patient preferred a physician-dominated decision. The other patients preferred a 
shared decision. (P2: ‘I prefer to make the final decision, it is my body’).
The second theme for professionals is pressure by patients toward professionals. 
Professionals mentioned that some patients are demanding. Demanding patients are 
not willing to wait, and put pressure on the GP’s to refer early. Therefore, specialists are 
seeing patients during their first weeks with sciatica, and patients are demanding an 
MRI. In this first period, conservative treatment is recommended in the sciatica guideline. 
Often specialists order an MRI, but in the end, many patients recover during this first 
period, and the MRI at the hospital was unnecessary. (OS3: ‘Nowadays, patients are not 
willing to wait for six weeks. Everybody wants an MRI as soon as possible’).
The second theme for patients is their own lack of knowledge about treatment options. 
Patients said that they did not have enough knowledge to make the final decision. This 
reflects the information provision and explanation mentioned as barriers at the level of 
the individual professional, which was mentioned before. (P1: ‘I did not tell my GP that I 
wanted surgery, because I did not know that was a possibility’).
Social context
Themes mentioned by both patients and professionals at the level of the social context 
are (lack of) sufficient inter-professional collaboration and social influences of third 
parties. Most barriers mentioned are related to the multidisciplinary setting in sciatica 
care. 
Regarding the (lack of) sufficient inter-professional collaboration, professionals found it 
difficult to get into contact and communicate with each other, especially medical and 
paramedical professionals. (PT2: ‘Actually, we professionals are all doing our job on our 
own “island.” We do not have direct contact with each other’). Some patients perceived 
a good communication between professionals, and said the information exchange 
between different disciplines made the decision making easier, so that it becomes a 
facilitator for SDM.
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Other patients perceived a lack of communication between professionals. They visited 
multiple professionals during their care trajectory but had to tell their story many times. 
They thought it would help if professionals shared information with each other. (P9: ‘If 
my PT sends a letter to the GP, she does not get an answer. There was also a lack of 
communication between the medical professionals I visited. It is annoying if you visit 
a medical professional and there has been no communication at all with the medical 
professional you have visited previously’).
Besides the lack of communication, there is also a lack of trust in the expertise of other 
disciplines. Some professionals think that other (para)medical professionals do not have 
enough knowledge about sciatica or do not inform or treat patients in the right way. 
Therefore, some professionals do not refer patients, but give patients the treatment they 
can provide themselves. (NS3: ‘Despite the fact that the neurologist says he informs 
the patient about conservative treatment, it always is a surprise for patients that natural 
recovery is a possibility in sciatica’).
Within the theme social influences of third parties, a barrier perceived by professionals 
was the promotion of one of the treatment options by third parties (e.g., professional 
association). Patients perceived social pressure of family or friends, who sometimes 
have an outspoken opinion about which treatment the patient should follow. 
Organizational context
Themes mentioned by both patients and professionals at the level of the organizational 
context were tools to facilitate SDM, situational factors and (long/ short) waiting lists that 
influence the decision process. In addition, professionals mentioned the poor logistics/ 
implementation, and patients mentioned conflicting information. 
Tools to facilitate SDM were mentioned by both professionals and patients. Despite 
the availability of two decision aids, professionals mentioned a lack of tools to inform 
patients as a barrier. Patients mentioned conflicting information in leaflets as a barrier. 
Tools mentioned as facilitators were access to the professional if the patient wants to 
change treatment, and the possibility of having a telephone consultation.
The second theme concerns situational factors. Lack of time was mentioned by both 
professionals and patients. Many professionals perceived a high workload. The time 
of a consultation ranged from 10 minutes to 45 minutes in public and private hospitals. 
Professionals with little time said they did not have enough time to discuss everything 
with the patient, besides the diagnosis of sciatica. Patients also perceived this lack of 
time. (OS7: ‘I think the factor time is the biggest bottleneck’).
Financial interest is another example of a barrier mentioned by professionals within this 
theme. In some hospitals, specialists felt they could not apply SDM because they had 
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to reach certain production rates. Some specialists also stated that sciatica surgery is 
interesting for hospitals because the costs of surgeries are lower than the reimbursement 
they receive. Therefore, hospitals sometimes reserve the operating rooms for sciatica 
surgeries. (OS4: ‘For the hospital it is of financial interest that sciatica patients get 
surgery instead of conservative treatment, so hospitals prefer sciatica surgeries’).
Another theme was the (long/ short) waiting lists that influence the decision making 
process. Short waiting lists were mentioned by patients as a facilitator. On the other 
hand, long waiting lists for a hospital visit or surgery was mentioned by both professionals 
and patients as a barrier. These waiting lists influence the decision making process; for 
example, some surgeons make the decision (surgery yes or no) based on the length of 
the waiting list. As a result, the patient is not presented with all options and thus will not 
have a shared decision. Other professionals already put the patient on the waiting list, 
just in case the patient should need a referral in the future, and thereby patients miss a 
step (referral or not) in the decision making process. This referral is not a shared decision, 
but the decision of the involved professional. (GP4: ‘The neurologists in this region have 
an enormous waiting list. Sometimes that influences your way to get things done, for 
example you refer the patient early in the process, so that at least the appointment 
has already been made’). In addition, some patients said that once they had made 
the decision to have surgery, they had to wait for a long period of time, whereas the 
trajectory from primary to hospital care had already taken weeks, or sometimes months. 
Once the decision for surgery was made, they did not want to suffer pain any longer. 
(P6: ‘I had to wait for five weeks until I could visit the neurologist, and then another eight 
to nine week for a surgery. (...) Ultimately you have your surgery, but you are exhausted 
and the healing process stagnates’).
Professionals mentioned the theme of poor logistics/ implementation of SDM as a 
barrier. Especially in primary care, there is a lack of clear criteria for referral and/ or 
surgery, probably associated with multiple disciplines being involved. For instance, 
some professionals did not know when patients were eligible for surgery, and thus in 
which situations they can refer patients, offer patients different options for treatment, 
and can use SDM. (PT1: ‘It would be great if I had clear criteria when to refer the patient 
to the GP because patients do not need a referral for physical therapy and some have 
not seen a GP’.)
Furthermore, there is a lack of visibility into what other disciplines can do in sciatica care. 
Professionals said that if they had more insight in what other disciplines can do, they 
can better explain all the options to the patient, and would be more open to referrals. 
(NS7: ‘Sometimes anesthesiologists are saying, “you just perform surgeries, but one 
injection and the pain is gone,” so to speak, but I do not know everything they can do, 
and that is inadequate’).
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Patients reported conflicting information given by different professionals as a barrier. 
Some patients said they did not know which option they had to choose, because of 
conflicting information from professionals. In one case, a specialist advised surgery, 
and another professional advised conservative treatment. In addition, sometimes 
advices given to patients during the conservative treatment are conflicting as well. (P9: 
‘My PT said that it was important to be active, while the GP said I should not move a lot’).
External environment
With regard to the external environment, professionals and patients both mentioned 
the themes of reimbursement in favor of surgery and environmental influences on the 
decision process. 
Persons in the Netherlands have a basic insurance package and have the option of 
purchasing supplementary insurance for additional healthcare. The first nine visits to 
the physical therapists are included in the basic insurance package. If a patient does 
not have an optional complementary insurance, they have to cover the cost for the other 
visits themselves. For some patients, this is a reason to quit their physical therapy and 
to look for other possibilities. In these cases, professionals referred patients earlier to 
hospital care, to get surgery. 
(P2: ‘I will quit physical therapy as soon as I have to pay for it.’ PT8: ‘I can imagine that 
patients rather have surgery when they do not have a complementary insurance and 
have to pay for physical therapy’).
Unreliable and conflicting information on treatment options on the internet also hindered 
both professionals and patients in SDM. Patients read wrong information on the internet, 
which influenced their treatment or relationship with their caregiver. (P20: ‘I read on the 
internet about a method in China, where they attach a pole to your back, so you can’t 
move, but my PT didn’t want to do that’). Professionals also found it time-consuming to 
talk with patients about all the incorrect information their patients read, while they are 
already struggling with the factor time. They also said patients would have more anxiety 
because of all the negative stories they read, which makes it more difficult for the patient 
to make a well-balanced decision. (GP3: ‘The point is that especially doom diagnoses 
and complicated courses predominate on the internet and people cannot always 
correctly apply these to their personal situation’). Therefore, some patients suggested 
making one website with reliable information about sciatica.
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DISCUSSION
This study addresses several gaps in the literature on SDM. It identifies a large number 
of barriers and facilitators related to SDM in sciatica treatment, and provides new 
insights, particularly for multidisciplinary care. To our knowledge, no previous study has 
focused on barriers and facilitators for SDM in multidisciplinary care trajectories that 
involve both primary care and hospital care. This multidisciplinary setting, with each 
discipline approaching the patient from its own perspective in different consultations, 
makes SDM more complex. We identified barriers and facilitators for SDM in 
multidisciplinary sciatica care perceived at different levels of the framework of Grol and 
Wensing [26]. Both professionals and patients reported more barriers than facilitators. 
Professionals perceived most barriers at the level of the organizational context, and 
perceived all facilitators at the level of the individual professional. Patients, on the other 
hand, reported most barriers and facilitators at the level of the individual professional. 
It is possible that patients hold the professionals responsible for the care they receive, 
including the use of SDM, while any barriers on the organizational context that may be 
important are not visible to them. The professional, on the other hand, is able to see and 
identify organizational factors as barriers from their perspective, but may also use them 
as excuses for not having to do anything themselves. This underlines the importance 
of including both the patient and the professional perspective to identify all barriers for 
SDM implementation in sciatica. All barriers and facilitators could be classified into a 
total of 18 themes. A total of 12 themes were the same for patients and professionals and 
were often related to each other. Patients perceived more facilitators than professionals. 
This may be due to the fact that professionals have to find a way to integrate SDM 
during their consultations and have to change their daily practice. Therefore, they may 
perceive more barriers and fewer facilitators as compared to patients. In addition, most 
reported facilitators were also reported as barriers, but in the opposite direction. 
We found barriers and facilitators corresponding with the literature on uni-disciplinary 
settings (e.g., lack of applicability due to patient characteristics [12], insufficient provider 
training [28], lack of familiarity about SDM content [12], better patient adherence to 
treatment [29], motivation [12]). This suggests that barriers and facilitators in uni-
disciplinary care also apply to the multidisciplinary setting. Barriers reported in the 
literature specific to an IP approach and also mentioned in our study are an imbalance 
of power between health professionals of different disciplines, the existence of 
professional silos, and disagreement about roles and responsibilities between different 
disciplines [15]. 
This study adds barriers and facilitators specifically related to the multidisciplinary 
context to the literature. These identified barriers and facilitators, include the themes of 
poor logistics/ implementation, (lack of) sufficient inter-professional collaboration, and 
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reimbursement in favor of surgery. A specific barrier in the theme of poor logistics/ 
implementation is for instance the conflicting information or advice received from 
different professionals, so that patients did not know which option to choose. Most 
patients had visited a GP, physical therapist, and neurologist by the time they visited a 
surgeon. All of these disciplines have different backgrounds and education, and focus on 
different aspects of sciatica care, but still it is important that they provide unambiguous 
information. Regarding lack of inter-professional collaboration, professionals mentioned 
lack of visibility into what other disciplines can do, and lack of trust in the expertise 
of other medical disciplines. These barriers cause professionals to talk only about 
the treatment option they can provide themselves. This may conflict with information 
given by others. A (better) collaboration and communication between disciplines, and 
a structure in the information process is necessary (i.e., Which professional explains 
what in which phase of the care trajectory?). To prevent professionals from wasting their 
time by repeating information from the previously visited professional, it is important 
that they know what information has already been given to the patient, so that they will 
have time to integrate SDM in their consultation. As in other studies [12], lack of time 
was a frequently mentioned barrier for SDM [12]. Structuring the information process 
ensures that professionals provide sufficient information to the patient within a limited 
time frame. Furthermore, barriers related to reimbursement in favor of surgery hinder 
SDM implementation, e.g., lack of reimbursement for physical therapy, and financial 
compensation for sciatica surgery. The reimbursement for surgery is higher than the 
actual costs, and therefore of financial interest to hospitals. Some surgeons reported that 
they were encouraged by the hospital to perform surgeries, for example by reserving 
operating rooms for sciatica surgeries, or even allotting a small amount of money for 
every sciatica surgery doctors perform. In addition, many private clinics arise because 
of this reimbursement. These (perverse) incentives may influence the decision making 
in favor of surgery. On the other hand, physical therapists have a financial interest as 
well, because they are paid for each treatment. This may cause physical therapists 
to keep treating the patient instead of referring him or her (back) to the GP. Further 
research is needed to determine the role of health insurance in SDM, and how the 
influence of reimbursement on SDM can be reduced. After all, the costs of sustained 
conservative treatment will be lower than the cost of surgery for insurance companies.
Besides these barriers related to multidisciplinary care, professionals also mentioned 
that not all patients are able or willing to decide on their care. However, the majority 
of patients that participated in the focus groups indicated that they do want to decide 
themselves. The establishment of patient’s preference for his or her role in decision 
making [30] is an important part of the SDM process, and makes it clear what the 
patient and professional can expect from each other. Even if they decide jointly that the 
professional makes the final decision, it still is a shared decision. 
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A strength of this study is the use of purposive sampling to capture a broad range of 
perspectives reflecting a diversity of views. We applied purposive sampling by selecting 
participants from regions with respectively low and high surgery rates, and continued 
interviewing until data saturation was reached. The participating professionals covered 
a wide range with respect to age, experience, and number of patients treated annually, 
so that we can expect that most barriers and facilitators will have been captured by this 
group. A limitation of this study is the recruitment of patients. Patients were recruited 
in only one region responding to an advertisement; it is possible that this has caused 
over-reporting of barriers and facilitators because participating patients were motivated 
to give their opinion. In addition, patients in other regions, or patients who did not 
respond to the advertisement, may perceive other barriers or facilitators. On the other 
hand, participants of the focus groups differed in age, gender and ethnicity. They were 
also treated in different practices and (types of) hospitals, which ensures variety in 
perceived barriers and facilitators. A second limitation is the use of quantitative counts 
within this qualitative study. We reported all barriers and facilitators in tables, but 
only discuss those barriers and facilitators reported in at least eight interviews or two 
focus groups, without suggesting that other barriers or facilitators are less important. 
Based on this study, we cannot determine which barriers and facilitators are the most 
important barriers or facilitators for implementation of SDM, or how these are associated 
with characteristics of patients and professionals. Therefore, in the next phase of this 
study, we will carry out a quantitative study to determine which barriers and facilitators 
mentioned in this qualitative study are the most important for the adoption of SDM, and 
professionals’ behavior towards SDM and differences in most important barriers and 
facilitators between these groups will be determined.
Despite these limitations, our study generated new knowledge that can be used to 
improve SDM implementation for sciatica patients in the Netherlands and in other 
countries with a similar context. Furthermore, our study can be used as an example for 
other patient groups receiving multidisciplinary complex care, given that most perceived 
barriers by professionals were organization-specific. 
Conclusions
This study provides new insights into barriers and facilitators in a multidisciplinary 
setting, in primary and hospital care as perceived by both professionals and patients, 
which is also generalizable for other health problems with multiple disciplines involved. 
Insight into both barriers and facilitators is essential for the SDM implementation in 
a multidisciplinary setting. After all, we know from the literature that implementation 
strategies geared at barriers and facilitators are more effective [31]. Therefore, a multi-
faceted strategy is more likely to improve care given to sciatica patients.
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Additional file 1. Topic list professionals
Topic list professionals
1. Introduction
Introduction interviewer
Background study
Information about the interview
Introduction participant: profession, years of experience, number patients with 
sciatica per year, way of working (concerning sciatica), preferences
2. Which factors influence the use of SDM in sciatica treatment?
Topics:
SDM
Prompts: 
• Concept SDM – Do they know what SDM is?
• Explanation of SDM: In SDM, clinicians and patients make decisions jointly, 
weighting the evidence regarding different treatment options [8]. In sciatica 
care, this means that patients are encouraged to consider both conservative 
and surgical treatment options, to communicate their preferences and help 
select the best treatment for their situation. 
• Can you give an example of SDM in daily practice?
• Attitude towards SDM in sciatica
Applicability of SDM in patients 
Prompts:
• Attitude patient toward SDM
• Explanation scientific knowledge
• Questions patients ask
• Do patients want a more active role?
Requirements SDM
Prompt:
• Decision aid
Environment
Prompts:
• Role (other) professionals/ organization/ colleagues
• Multidisciplinary deliberation
• Factors/ policies at local/ national level
3. What are your recommendations for improving the implementation of SDM in sciatica 
treatment?
122 A qualitative study among professionals and patients
Additional file 2. Topic list focus groups
1. Introduction
Introduction moderator and observer
Background study
Information about the focus group
Introduction participant: when diagnosed with sciatica, their care trajectory
2. How was the decision for treatment made?
Topics:
Awareness of treatment options
Information about treatment options
Own preference
Treatment of own preference?
3. Positive and negative experiences
• Explanation SDM: In SDM, clinicians and patient make decisions jointly, 
weighting the evidence regarding different treatment options [8]. In sciatica 
care this means that patients are encouraged to consider both conservative 
and surgical treatment options, to communicate their preferences, and help 
select the best treatment for them.
• Patients are asked to write their positive and negative aspects about the 
decision making process on post-its, and post their negative aspect on a 
‘negative’ board and their positive aspect on a ‘positive’ board.
4. Questions and discussion based on the post-its
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Additional table S1. Barriers for SDM according to professionals
Level Barriers Facilitators
Innovation 
(SDM)
Unclear concept of SDM
Definition of SDM unclear (when is it truly 
shared?)
Individual 
professional
Poor professional-patient relationship
Poor quality of professional-patient 
relationship
Negative professional’s attitude/ behavior toward 
SDM
Lack of interest in sciatica
Importance to express your own view
No place for SDM in routines/ habits
No need for SDM
Preference for one of the treatment options*
Financial interest in one of the treatment options
Lack of knowledge of professional about SDM/ 
treatment options
Lack of skills for SDM 
Lack of education on SDM
Lack of knowledge on SDM 
Lack of knowledge about treatment options
Lack of knowledge about the sciatica guideline
Different interpretations of scientific literature 
leading to different opinions
Positive professional’s 
attitude/ behavior towards 
SDM
Motivation (professionals 
also want a shared decision 
if they were suffering from 
sciatica)
Importance of SDM
SDM is essential for good 
healthcare
SDM improves quality of 
care
SDM leads to improved 
patient outcomes/ 
compliance
Patient Negative patient’s attitude toward SDM/ Lack of 
patient’s capabilities to decide
Inability of patient to make the decision about 
treatment
Inability of patient to remember the information 
given during a visit
Misinterpretation of information by patient
Patient’s  unwillingness to decide
Pressure by patient toward professional
Demanding patient
Pressure for quick recovery of patient
Expectations of patient when visiting a sciatica 
pathway for having an MRI and surgery
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Level Barriers Facilitators
Social context Lack of inter-professional collaboration
Lack of communication with other medical 
disciplines
Lack of communication between medical 
professionals and paramedical professionals
Power struggle between professionals
Lack of trust in expertise other disciplines
Lack of interest in other disciplines
Social influences of third parties 
Value of repeat consultations underestimated by 
colleagues
Lack of encouragement from the professional 
group to apply SDM
Promotion of one of the treatment options third 
parties*
Organizational 
context
Lack of tools to facilitate SDM
Lack of financial compensation for 
multidisciplinary deliberation
Lack of financial compensation for SDM
Lack of tools to inform patients
Situational factors
Lack of time during consultation
Lack of opportunity for a repeat consultation
Financial interest practice/ hospital/ need for 
production
Lack of encouragement from the institution to 
apply SDM
Long waiting list influences decision process
Long waiting list for a visit to hospital
A large/ small number of patients on the 
professional’s waiting list / under treatment*
Poor logistics/ implementation
SDM is not my task
Lack of clear criteria for referral and/ or surgery
Lack of visibility into what other disciplines 
can do
Lack of clear policy for PT’s
Lack of agreement about the content and 
the timing of information provision in the care 
trajectory
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External 
environment
Environmental influences on the decision process
Preference for referral to private clinic/ clinic in 
another country
Availability of treatment options in the area
Unreliable and contradictory information about 
treatment options on the internet
Reimbursement in favor of surgery 
Additional payment for physical therapy not 
covered by insurance
Waiting list mediation by health insurer
Agreements with health insurance
Competition in Dutch healthcare
Note. Barriers indicated in bold were reported in at least eight interviews.
* Two separate barriers
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Additional table S2. Barriers for SDM according to patients
Level Barriers Facilitators
Innovation 
(SDM)
Individual 
professional
Professional-patient relationship
Poor quality of professional-patient relationship
Lack of empathy of the professional
Lack of attention for patient’s personal situation
Lack of attention for patient’s anxiety
Lack of attention for patient’s preferences
Lack of confidence in the professional
Negative professional’s attitude/ behavior 
towards SDM
PT keeps treating the patient without results 
because of belief in own treatment 
Preference of professional for one of the 
treatment options*
Lack of guidance in conservative treatment by 
the professional
Lack of information provision/ explanation
Lack of explanation about the diagnosis sciatica 
by the professional
Lack of information provision about 
treatment options and potential harm and 
benefits 
Lack of explanation of the professional about 
the care trajectory 
Lack of knowledge of the professional about 
SDM/ treatment options
Wrong diagnosis by professional
Lack of knowledge of the professional
Professional- patient relationship
A good professional-patient 
relationship
Attention for patient’s 
preferences
Attention for patient’s personal 
situation
GP knows patient’s background
Positive professional’s attitude/ 
behavior toward SDM
Guidance by the professional
Monitoring recovery
Sufficient information provision/ 
explanation
Sufficient information provision 
of the professional
Explanation about harms and 
benefits of each treatment
Explanation of the MRI images
Explanation of the care 
trajectory
Openness of professional
Explanation of outcomes 
scientific research
Patient Negative patient’s attitude toward SDM/ 
patient’s capabilities to decide
Difficulty to remember everything told during a 
visit
Anxiety to express own preferences
Lack of confidence in own choice
Anxiety to contradict the professional
Lack of knowledge of patient about treatment 
options
Lack of knowledge of patients about one of 
the treatment options*
Positive patient’s attitude toward 
SDM/ patient’s capabilities to 
decide
Motivation (important to 
decide about your own body)
Social context Lack of inter-professional collaboration 
Lack of communication between 
professionals
Lack of trust between professionals
Social influences of third parties
Social pressure of family/ friends on patients
Sufficient inter-professional 
collaboration
Communication between 
professionals
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Organizational 
context
Lack of tools to facilitate SDM
Conflicting information in leaflets 
Situational factors
Lack of time during a consultation
Lack of possibilities to discuss problems
Long waiting list influences decision process
Long waiting list for a visit to the neurologist/ 
for surgery*
Conflicting information about treatment options
Conflicting information of the professionals
Sufficient tools to facilitate SDM
Accessibility of the professional 
to change treatment
Telephonic consultation
Short waiting list influences 
decision process
Short waiting list/ quick referral
External 
environment
Environmental influences on the decision 
process
Pressure of employer for quick recovery
Unreliable and contradictory information on 
the internet
Reimbursement in favor of surgery 
Additional payment for physical therapy not 
covered by insurance
Individual mandate for a visit to a specialist
Environmental influences on 
decision process
One reliable website about 
sciatica
Note. Barriers indicated in bold were reported in at least two focus groups.
* Two separate barriers
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ABSTRACT
Introduction
Due to the increasing specialization of medical professionals, patients are treated by 
multiple disciplines. To ensure that delivered care is patient-centered, it is crucial that 
professionals and the patient together decide on treatment (shared decision making 
(SDM)). However, it is not known how SDM should be integrated in multidisciplinary 
practice. This study determines the most important factors for SDM implementation in 
sciatica care, as it is known that a prior inventory of factors is crucial to develop a 
successful implementation strategy.
Methods
246 professionals (general practitioners, physical therapists, neurologists, 
neurosurgeons, orthopedic surgeons) (30% response) and 155 patients (96% response) 
responded to an internet-based survey. Respondents ranked barriers and facilitators 
identified in previous interviews, on their importance using Maximum Difference Scaling. 
Feeding back the personal top 5 most important factors, each respondent indicated 
whether these factors were barriers or facilitators. Hierarchical Bayes estimation was 
used to estimate the relative importance (RI) of each factor. 
Results 
Professionals assigned the highest importance to: quality of professional-patient 
relationship (RI 4.87; CI 4.75-4.99); importance of quick recovery of patient (RI 4.83; CI 
4.69-4.97); and knowledge about treatment options (RI 6.64; CI 4.53-4.74), which were 
reported as barrier and facilitator. Professionals working in primary care had a different 
ranking than those working in hospital care. 
Patients assigned the highest importance to: correct diagnosis by professionals (barrier, 
RI 8.19; CI 7.99-8.38); information provision about treatment options and potential harm 
and benefits (RI 7.87; CI 7.65-8.08); and explanation of the professional about the care 
trajectory (RI 7.16; CI 6.94-7.38), which were reported as barrier and facilitator.
Conclusions
Knowledge, information provision and a good relationship are the most important 
conditions for SDM perceived by both patients and professionals. These conditions are 
not restricted to one specific disease or health care system, because they are mostly 
professional or patient dependent and require healthcare professional training.
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INTRODUCTION
Sciatica is a common disorder with prevalence reported up to 43% [1]. It is mostly 
caused by a herniated disc with compression of the nerve root, which gives radiating 
leg pain. Seventy percent of patients with sciatica recover in the first 6-8 weeks 
with conservative treatment [2]. After 6-8 weeks it is possible to consider prolonged 
conservative treatment or surgery. Care to sciatica patients is given by various 
disciplines: the general practitioner, physical therapist, neurologist and neurosurgeon 
or orthopedic surgeon are frequently involved.
A large, randomized clinical trial showed no significant difference in clinical outcomes 
between conservative treatment and surgery after 1 and 2 years in patients with sciatica 
[3]. Other, low quality studies showed conflicting results [4]. As the literature is not 
consistent regarding the best treatment option [3,4], the choice can be considered 
preference sensitive. Therefore, the Dutch multidisciplinary sciatica guideline [5] 
recommends to integrate shared decision making (SDM) in consultations. In SDM, 
clinicians and the patient make decisions jointly, weighting the best available evidence 
regarding different treatment options [6]. Patients are encouraged to consider prolonged 
conservative treatment or surgery and the likely benefits and harm of each so that they 
communicate their preferences and help to select the best treatment for them. Only 
when professionals and the patient together decide on treatment (SDM), delivered care 
can be truly patient-centered.
Despite the recommendation to integrate SDM in consultations [5], there are strong 
indications that SDM is not yet adopted in clinical management of patients with sciatica. 
Recently, a comparison between regions in the Netherlands showed considerable 
variation in the number of sciatica patients that undergo surgery, ranging from 31 to 
140 per 100,000 inhabitants [7]. In addition, Dutch surgery rates for sciatica patients 
are four times higher than in the United Kingdom and two times higher than in Sweden 
[7] while The United States have a 40% higher surgery rate than the Netherlands [8]. As 
enhancing the use of SDM was found to be associated with lower hospital admission 
rates through the prevention preference-sensitive surgeries [9], its use is likely to play a 
role in the variation in surgery, in addition to factors such as case mix. 
Previous research concerning the barriers for implementation of SDM in clinical 
practice mainly focussed on one discipline (monodisciplinary) or on inter-professional 
(IP) teams [10-12]. An inter-professional approach involves separate disciplines that 
integrate different approaches mostly into a single consultation [13]. However, due to 
the increasing specialization of medical professionals, patients nowadays are treated 
by multiple disciplines in several separate consultations as for example in sciatica 
care were the general practitioner, physical therapist, neurologist and neurosurgeon or 
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orthopedic surgeon are frequently involved. SDM in multidisciplinary care utilizes the 
skills and experience of professionals from different disciplines, with each discipline 
approaching the patient from their own perspective [13], so that different barriers and 
facilitators for SDM implementation may play a role and to a different extent than in a 
monodisciplinary setting or in an inter-professional team. This is currently unknown. 
Furthermore, most studies focus on professionals only, while patients are part of the 
SDM process and may perceive other barriers and facilitators which may be also 
important for the implementation of SDM. To our knowledge, this is the first quantitative 
study that focuses on barriers and facilitators of SDM perceived by professionals of 
different disciplines as well as patients. 
In a previous qualitative study among patients and professionals we explored the full 
spectrum of barriers and facilitators related to the use of SDM in sciatica care, including 
those related to the multidisciplinary setting [14]. However, these qualitative data do not 
provide the importance of these barriers and facilitators for SDM implementation. This 
is needed to focus an implementation strategy towards the most important barriers and 
facilitators. Therefore this study aims to answer the following research questions: 
1. Which factors are most important for SDM implementation in multidisciplinary 
sciatica care?
2. Are these factors mainly a barrier or a facilitator for SDM?
METHODS
Setting
In the Netherlands, the diagnosis sciatica is mostly made by general practitioners (GPs). 
The Dutch multidisciplinary guideline recommends conservative treatment during the 
first 6-8 weeks, provided when severe neurologic symptoms are lacking. After 6-8 
weeks patients are usually referred to a neurologist for further investigation if symptoms 
continue. The neurologist evaluates the presence of a radicular pain syndrome and orders 
an MRI to visualize the affected spinal nerve(s) and to judge possible compression. If 
the MRI confirms a nerve compressing herniated disc, a surgical intervention can be 
considered, but it is also possible to choose prolonged conservative treatment. In case 
of surgery, the neurologist will refer the patient to a neurosurgeon or orthopedic surgeon 
for further surgical decision making.
Population
We randomly selected 200 general practitioners (GPs), 200 physical therapists (PTs), 
200 neurologists and 200 orthopedic surgeons from the Dutch medical address book, 
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which includes most professionals in The Netherlands. All Dutch neurosurgeons (n = 
131) were invited to participate in the study. Patients were recruited via advertisements 
in local newspapers across the Netherlands. In addition, the professionals interviewed 
in our previous study were asked to recruit patients. We aimed to include at least 100 
patients. We included sciatica patients diagnosed in the last 12 months, 18 years and 
older and able to understand written Dutch instructions. Questionnaires were sent in 
November 2012. Non-responders (professionals and patients) received two reminders, 
each within a period of 1.5 weeks. Participants who completed the questionnaire 
received a ten euro gift card as an incentive.
Survey development and deployment
We developed two different internet-based surveys, one for professionals and one for 
patients, as the barriers and facilitators identified in the previous qualitative study differed 
between these groups [14]. Each questionnaire consisted of two parts. In the first part 
we assessed professionals’ and patients’ preferences for decision making using the 
control preference scale (CPS) [15]. We asked professionals about their use of shared 
decision making in routine practice (self-reported), and which discipline should have 
the leading role in SDM in practice. Furthermore, we asked patients about their care 
trajectory and the decision making preferences and practice.
For the second part, barriers and facilitators identified in our previous qualitative study 
were translated into neutral statements. The questionnaire included 53 factors for 
professionals and 35 factors for patients, that were used in a best-worst scaling (Maximum 
Difference scaling (MaxDiff)) exercise following an orthogonal design [16]. MaxDiff is an 
efficient method to rank multiple items. It is easy to complete for respondents, because 
they only have to choose the most and least important factor within a set. The other 
factors are then known to be in between those factors. This is more efficient than using 
Paired Comparisons [17]. Furthermore, the MaxDiff is scale free, and therefore prevents 
scale-use bias [18]. In this study, respondents were presented with 6 factors at a time. 
This was repeated a number of times so that all factors were presented in different 
combinations. To avoid higher importance given to the first mentioned items, the order 
of items was randomized between respondents. Each item was presented twice [19], 
and we created 300 versions of the questionnaires to ensure variation in combination 
of items. At the end of the MaxDiff exercise, each respondent saw their own top five 
factors, considered as most important given their previous answers. Respondents were 
asked to indicate for each factor if they perceived it as a barrier or facilitator in their 
current situation (e.g., knowledge about treatment options can be perceived as a barrier 
if there is a lack of knowledge, and a facilitator if they have sufficient knowledge). We 
used Sawtooth Software’s SSI Web 8.1 to construct the survey and the MaxDiff exercise.
Finally, we asked the following demographic information of all respondents: age, gender, 
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region (north, middle, and south) and ethnicity. In addition we asked professionals 
in which setting they work (general hospital, university medical center, private clinic, 
teaching hospital), and patients educational level. We distinguished three educational 
level groups: basic education (no or only primary education), intermediate education 
(prevocational secondary education, senior secondary vocational training, senior 
secondary general education, preuniversity education), or high education (higher 
professional education or university (bachelor, master, or PhD degree)).
Analysis
Descriptive statistics were used for the general characteristics of the respondents. 
We compared the characteristics (age, gender, ethnicity, discipline and setting), and 
decision making style (preferences and behavior) of professionals who did and did 
not complete the questionnaire during the MaxDiff exercise. In addition we examined 
differences between professionals and patients regarding preferences and perceived 
practice of SDM use. For these comparisons we used independent T-test, Mann Whitney 
U, Fisher’s exact or χ2 tests, as appropriate. Hierarchical Bayes (HB) estimation was used 
to estimate relative importance scores (RI) for each factor for each respondent, based 
on the choices made by respondents in the MaxDiff exercise [20]. These scores can 
be derived even though respondents evaluate only a part of all possible combinations 
of items [16]. HB estimation uses an iterative process, along with information from other 
respondents, to estimate the utilities that best fit the choices of each subject. The sum 
of all RIs is 100 for each individual. Factors more often chosen as most important get a 
higher RI, whereas factors chosen as least important get a lower RI. Therefore, a high RI 
indicates that a factor is very important for this individual, whereas a low RI indicates that 
a factor is less important. To assess which factors on average are the most important 
factors for the use of SDM in clinical practice, we calculated the RI for each factor over 
all respondents with its 95% confidence interval. We checked for random responders 
using the root likelihood (RLH), excluding respondents with a root likelihood less than 
208 [21]. The overall RLH was used as a measure of the goodness of fit. We examined 
differences in RI between primary care and hospital care professionals, as well as 
differences in decision making using χ2 tests. We divided professionals in three groups: 
professionals who let the patient decide, professionals who make a shared decision, 
and professionals who decide themselves. Sawtooth Software 8.1 and SPSS 20.0 were 
used for analyses. Significance testing was done two-sided at α = 0.05.
Ethical approval
This study protocol (P12.016) was presented to the Medical Ethical Committee of the 
Leiden University Medical Center. An exemption was obtained, as ethical approval for 
this type of study is not required under Dutch law.
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RESULTS
Response
Figure 1 shows the inclusion and response of professionals after two reminders. A total 
of 246 professionals completed the questionnaire and were included. A total of 162 
patients were invited for participation (91% via advertisement and 9% via professionals). 
One patient was excluded because he did not have sciatica. 155 patients (96%) 
completed the questionnaire. 
Characteristics of respondents
Among professionals GP’s had the lowest response rate (15%) and neurosurgeons 
had the highest response rate (36%). Characteristics of professionals and patients who 
completed the questionnaire are described in table 1. Most professionals were male, 
and of Dutch origin. Responding and non-responding professionals did not differ in 
age, gender, ethnicity, discipline and setting (data not shown). Concerning the work 
area of professionals and residence of patients, respondents came from all regions in 
the Netherlands (table 1). The majority of patients had an intermediate level of education 
(table 1).
Current care and SDM
For 118 (76%) patients it was the first time they were diagnosed with sciatica. Of all 
the patients 120 (77%) had been referred to hospital care, 53 patients (34%) already 
had surgery, and 5 patients (3%) were on a waiting list for surgery. Visited disciplines 
Figure	1.	Inclusion	and	response	of	professionals	
	
	
	 	
Unknown email addresses: 9 (1%) 
Non-responders: 642 (69%) 
 
Invited: 931 
Completed questionnaires: 280 
(30%) 
Included: 246 (26%) 
No sciatica patients at consultation: 33 (12%) 
Moved to another country: 1 (0%) 
 
Figure 1. Inclusion and response of professionals
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were the PT (79%), GP (88%), neurologist (76%), neurosurgeon (47%), the orthopedic 
surgeon (12%) and others (20%; e.g., anesthesiologist (4%), other therapists (Caesar or 
mensendieck) (3%), or chiropractor (2%)).
Table 1. Characteristics of participating professionals and patients
Characteristics Professionals (n=246) Patients (n=155)
Age, years (mean, SD) 46 (10.0) 50 (13.2)
Sex, no. (%)
   Male 173 (70) 68 (44)
Education, no. (%)
   Basic - 2 (1)
   Intermediate - 95 (61)
   High - 58 (37)
Ethnicity, no. (%)
   Dutch 198 (80) 149 (96)
   Western (except Dutch) 37 (15) 6 (4)
   Non-Western 11 (4) 0 (0)
Region, no. (%) Work area* Residence
   North 80 (33) 66 (43)
   Middle 112 (46) 53 (34)
   South 63 (26) 36 (23)
Discipline, no. (%)
   Physical therapist 63 (26) -
   General practitioner 29 (12) -
   Neurologist 58 (24) -
   Neurosurgeon 47 (19) -
   Orthopedic surgeon 49 (20) -
Setting* (hospital care n=154), no. (%)
   General hospital 78 (51) -
   University medical center 39 (25) -
   Private clinic 9 (6) -
   Teaching hospital 61 (40) -
* Multiple options possible
Figure 2 shows the preferences and practices of decision making in sciatica care 
according to professionals and patients. The majority of the professionals (61%) 
said that they prefer a shared decision, whereas 52% stated they actually use SDM 
in daily practice. Preferences of professionals for SDM and the actual use of SDM in 
their practice are associated (p<0.001). Fifty percent of the patients said they wanted 
the decision to be a shared decision. However, only  41% of the patients said they 
actually made the decision together with the professional in their own situation. These 
discrepancies between preference and actual use may be explained by different 
barriers and facilitators. 
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Barriers and facilitators for professionals
Table 2 presents the top 10 factors influencing SDM according to professionals. The 
factors in the tables are the factors presented to participants during the maximum 
difference exercise, translated from Dutch literally. Most important factors for 
professionals on average were: quality of professional-patient relationship, importance 
for quick recovery of patient, and knowledge about treatment options. The higher 
average RI of these factors means that more participants had this factor in their top 
5. However, if there is a lot of variation between participants, for example if part of 
the respondents rank a factor as most important and another part as least important, 
the average RI will be lower even though a considerable amount of professionals 
mentioned this factor in their top 5. For example the factor “ability of patients to make 
the decision about treatment” has an RI of 4.48 (CI 4.33-4.63), despite the fact that 46% 
of the professionals mentioned this factor in their top 5, which is higher than the 38% for 
“knowledge about treatment options” with a slightly higher average RI (4.64 (CI 4.53-
4.74) table 2). 
0
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Preference of professionals
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Practice according to professionals
Practice according to patients
Figure 2. Preferences and practice of decision making in sciatica care according to professionals and 
patients
Patient’s decision: Patient makes the final selection about treatment 
Shared decision: the doctor and patient share responsibility for deciding which treatment is best for the 
patient
Professional’s decision: the doctor makes the final decision about treatment
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Furthermore, table 2 shows that many factors are both barriers and facilitators, and 
that factors with the highest RI are also those most frequently mentioned as barriers 
and facilitators. For example 54% of the professionals reported “quality of professional-
patient relationship” in their top 5. This factor represented 11% of all facilitators, and 
11% of all barriers in the top 5’s. Overall in the top 5, more factors were perceived as 
facilitators than as barriers.
Table 2. Most important factors for SDM in sciatica care according to professionals
Factor Relative 
importance 
score (mean, 
95% CI)
% professional 
who reported 
factor in top 5
% of all top 
5 facilitators 
(n=1080)
% of all top 
5 barriers 
(n=150)
1. Quality of professional-
patient relationship
4.87 (4.75-4.99) 54 11 11
2. Importance for quick 
recovery of patient
4.83 (4.69-4.97) 52 11 8
3. Knowledge about 
treatment options
4.64 (4.53-4.74) 38 7 10
4. Skills to apply SDM 4.53 (4.42-4.65) 36 7 6
5. Ability of patients to make 
the decision about treatment
4.48 (4.33-4.63) 46 10 7
6. Patients’ willingness to 
decide
4.46 (4.32-4.61) 42 8 11
7. Availability of scientific 
literature
4.25 (4.09-4.41) 36 8 5
8. Criteria for referral and/ or 
surgery
4.20 (4.05-4.35) 28 6 5
9. Interpretation of 
information by patients
3.92 (3.76-4.08) 22 4 7
10. Visibility into what other 
disciplines can do
3.77 (3.62-3.92) 13 2 4
 
We compared the ranking of factors for professionals working in primary (PT and GP) 
and hospital care (NL, NS and OS). Table 3 shows that the importance of factors from 
the overall top 10 depends on the work setting. For instance, professionals working in 
primary care considered “quick recovery of the patient” as more important compared 
to hospital care (RI 5.05 vs. 4.61) whereas professionals in hospital care found “skills 
to apply SDM” as more important (RI 4.73 vs. 4.28). Furthermore, professionals in 
primary care significantly more often considered “clarity of policy for PT’s in sciatica” 
(RI 3.97 vs. 0.82) and “communication between medical disciplines and paramedics” 
(RI 3.93 vs. 1.47) as important factors for SDM, which both are not in the overall top 
10 of most important factors. Their top 10 did not contain the factors “availability of 
scientific literature” (RI 3.90), and “interpretation of information by patients” (RI 3.21). 
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Professionals in hospital care on the other hand, significantly more often considered 
“the need for SDM” (RI 4.31 vs. 2.57) as an important factor. Their top 10 also included 
the “the clarity of the concept SDM” (RI 4.10 vs. 3.19) but did not contain “criteria for 
referral and/ or surgery” (RI 3.64), and “visibility into what other disciplines can do” (RI 
3.34). 
Table 3. Most important factors for SDM in sciatica care, by work setting of professionals and 
decision making
Factors in general 
top 10
Professional who reported factor in top 5 (%)
Work setting Practices in decision making
Overall 
(%)
Primary 
care (%) 
(n=92)
Hospital 
care (%) 
(n=154)
P-value Patient 
decide 
(%) 
(n=56)
SDM (%) 
(n=128)
Professional 
decide (%) 
(n=62)
P-value
1. Quality of 
professional-
patient 
relationship
54 46 60 0.032 55 54 55 0.981
2. Importance for 
quick recovery of 
patient
52 68 42 <0.001 54 47 61 0.170
3. Knowledge 
about treatment 
options
38 37 39 0.754 34 38 44 0.546
4. Skills to apply 
SDM
36 24 43 0.003 39 38 27 0.282
5. Ability of 
patients to make 
the decision 
about treatment
46 35 53 0.005 57 47 35 0.061
6. Patients’ 
willingness to 
decide
42 34 47 0.035 48 45 31 0.094
7. Availability of 
scientific literature
36 36 36 0.938 32 36 40 0.651
8. Criteria for 
referral and/ or 
surgery
28 48 16 <0.001 29 25 34 0.441
9. Interpretation 
of information by 
patients
22 13 27 0.012 29 16 26 0.116
10. Visibility 
into what other 
disciplines can do
13 20 9 0.018 13 14 11 0.861
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In addition, we examined differences in decision making (self-reported) (table 3). Even 
though the differences were not statistically significant, it seemed that professionals who 
would let the patient decide, more often had the “ability of patients to make the decision 
about treatment” in the top 5 compared to professionals who decide themselves (p 
= 0.06, table 3). Furthermore, professionals who used SDM in their practice reported 
“clarity of the concept SDM” (RI 4.19) and “need for SDM” (RI 4.11) as important, 
whereas their top 10 did not include “interpretation of information by patients” (RI 3.74), 
and “visibility into what other disciplines can do” (RI 3.89). The top 10 of professionals 
who make the decision themselves, did not include “visibility into what other disciplines 
can do” (RI 3.21) but instead “knowledge about the sciatica guideline” (RI 3.97).
Barriers and facilitators for patients
Table 4 presents the top 10 factors influencing SDM according to patients. Patients on 
average perceived “correct diagnosis by the professional”, “information provision about 
treatment options and potential harm and benefits”, and “explanation of the professional
 
Table 4. Most important factors for SDM in sciatica care according to patients
Factor Relative 
importance score 
(mean, 95% CI)
% patients 
who 
reported 
factor in 
top 5
% of all 
top 5 
facilitators 
(n=671)
% of all 
top 5 
barriers 
(n=104)
1. Correct diagnosis by 
professional
8.19 (7.99-8.38) 62 13 3
2. Information provision about 
treatment options and potential 
harm and benefits
7.87 (7.65-8.08) 53 10 12
3. Explanation of the 
professional about the care 
trajectory
7.16 (6.94-7.38) 37 7 10
4. Confidence in the professional 7.02 (6.82-7.23) 37 8 2
5. Knowledge of the professional 6.94 (6.68-7.20) 38 8 2
6. Guidance in conservative 
treatment by the professional
6.35 (6.09-6.61) 32 7 4
7. Explanation about the 
diagnosis sciatica by the 
professional
6.33 (6.05-6.62) 34 8 0
8. Attention for patient's personal 
situation
4.98 (4.54-5.43) 31 7 3
9. Attention for patient's 
preferences
4.71 (4.46-4.96) 17 3 5
10. Information materials about 
the diagnosis and treatment 
options and potential harms and 
benefits
4.24 (3.81-4.67) 17 3 3
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about the care trajectory” as the most important factors, given the average RI. However, 
some factors may be perceived as important by a small group of patients, and thus will 
have a lower RI on average, which does not necessarily have to mean that these are 
not important barriers and facilitators. For example “contradictory information of the 
professionals”, “waiting list for surgery” and “waiting list for a visit to the neurologist” on 
average have a low importance  (RI 1.16 (CI 1.45-1.77), RI 2.36 (CI 1.96-2.76) and RI 
2.02 (CI 1.66-2.38), respectively) but relatively many of these patients perceived it as 
barriers and represented respectively 8%, 8% and 12% of all barriers. So these may be 
barriers for a smaller group of patients. As for professionals, more factors in the top 5 for 
patients were perceived as facilitators than as barriers. 
DISCUSSION
This study shows which factors are most important for the implementation of SDM in 
sciatica care. Overall, more facilitators than barriers were perceived. For professionals 
the most important factors are “quality of professional-patient relationship”, “importance 
for quick recovery of patient”, and “knowledge about treatment options”. Patients 
perceived “correct diagnosis by professional”, “information provision about treatment 
options and potential harm and benefits”, and “explanation of the professional about the 
care trajectory” as the most important factors. In short: knowledge, information provision 
and a good relationship are perceived as important conditions for SDM by both patients 
and professionals.
Previous research concerning SDM implementation mainly focussed on one discipline 
(monodisciplinary). Main barriers mentioned in literature included time constraints, the 
lack of applicability due to patient characteristics or the clinical situation [10]. Main 
facilitators pertained to the motivation of health professionals, the perception that SDM 
leads to improved patient outcomes and to improved health care processes [10]. The 
lack of applicability due to patient characteristics as mentioned in the literature overlaps 
with some barriers mentioned in professionals top 10 in the current study (e.g., ability 
of patients to make the decision about treatment), but the other barriers and facilitators 
reported in the literature are not among the most important barriers and facilitators as 
reported in the present study. This may be due to the fact that available studies mainly 
assessed barriers and facilitators to implement SDM in a monodisciplinary setting, 
whereas sciatica care involves multiple disciplines. Barriers reported in a study related 
to interprofessional SDM were imbalance of power between health professionals of 
different disciplines, the existence of professional silos, and disagreement about 
roles and responsibilities between different disciplines. Main facilitators were mutual 
knowledge and understanding of disciplinary roles, trust and respect between different 
disciplines [12]. Visibility into what other disciplines can do and criteria for referral and/ 
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or surgery are related to the barrier “disagreement about roles and responsibilities 
between different disciplines” and the facilitator “understanding of disciplinary roles”, 
but the other barriers and facilitators reported in this interprofessional SDM study are 
not among the most important barriers and facilitators as reported in the present study. 
Furthermore, many studies used qualitative methods [10,11] allowing an analysis 
of which barriers and facilitators play a role, but do not provide information on the 
importance of each barrier or facilitator. The barriers and facilitators most mentioned in 
our previous qualitative study [14], using interviews and focus groups were not always 
consistent with the highest ranked barriers or facilitators as seen in the present study. 
For example, during interviews professionals mentioned lack of knowledge about 
treatment options only a few times, whereas it was ranked as an important barrier for 
SDM. On the other hand lack of time during a consultation was mentioned often during 
interviews, and is also the most mentioned barrier for SDM in other studies [10]. In the 
present study, time during a consultation only took a 33th place, and did not occur in 
any of the professionals top 5. This emphasizes the importance of the ranking of barriers 
and facilitators after a qualitative study.
As professionals and patients mentioned different factors during (focus group) interviews, 
they therefore ranked different factors in the current study so that it is not possible to 
make an explicit comparison. However, many factors are related to each other. In view 
of the ranking of barriers and facilitators, there seems to be a need for more knowledge 
and information about sciatica and SDM, and skills to apply SDM. Therefore, healthcare 
professional training in knowledge regarding treatment options and SDM may improve 
SDM [22] and should be part of the implementation strategy. Another intervention may 
be the implementation of the existing decision aid for SDM in sciatica patients to facilitate 
information provision and SDM [22]. Furthermore, professionals working in primary or 
hospital care assigned a different importance to factors that may influence SDM, so that 
a multifaceted intervention is needed to integrate SDM in the complex multidisciplinary 
organization of sciatica care. For example who is responsible for which part of the 
information provision or guidance in which step of the care trajectory?  Clear criteria 
are thus needed not only for (timing of) referral (especially important in primary care), 
but also regarding which part of the information on treatment is given by whom in which 
part of the care trajectory. The first mentioned intervention, training in knowledge and 
SDM will act on different factors. For example, professionals mentioned knowledge on 
treatment options, which is needed to provide information about both treatment options 
and potential harms and benefits to patients (which patients considered important). This 
training also gears at other important factors, such as skills to apply SDM, the importance 
for quick recovery of patient, and patients’ willingness to decide. For example when 
professionals use SDM in their consultations the patients will tell them whether they 
want to recover quickly or not, and to determine patients willingness to decide is part of 
the SDM process. The second mentioned intervention, the use of a decision aid, may 
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improve the interpretation of information by patients and the ability of patients to make 
the decision about treatment. Additionally, research has shown that patients are more 
likely to favor conservative treatments over surgery after patients’ decision aid (DA) 
exposure [23,24], which may lead to the reduction of preference-sensitive surgeries. 
A strength of this study is the use of Maximum Difference scaling. MaxDiff is a relatively 
new method in health care research and was introduced by McIntosh and Louviere in 
2002 [25]. As mentioned before, MaxDiff is scale free, and therefore prevents scale-use 
bias [18]. Furthermore, it is easy for respondents to complete, and results in ratio-scaled 
scores of importance [16,26]. Factors with the highest importance score on average are 
not always the most important barriers or facilitators for all participants. A factor with a 
lower importance score can be considered as an important barrier by a smaller group 
of people. Therefore, it is important to take both the importance score and percentage of 
the total barriers or facilitators into consideration. Furthermore, we see that some factors 
are classified as both facilitator and barrier. This may reflect a difference in experience, 
where it was mainly a facilitator for some participants and a barrier for others, as they 
were asked to indicate this for their current situation. Another interpretation may be that it 
was difficult to classify a factor as a facilitator or barrier, especially for patients, given the 
neutral formulation of each factor. However, regardless of the interpretation, the ranking 
clearly shows which factors are more important than others for SDM to be implemented. 
A limitation of this study pertains to the recruitment of patients and professionals. This 
study is limited by its low response rate. Regarding the recruitment of patients, the 
procedure does not allow for a calculation of a response rate. It is possible that selection 
bias occurred, because patients who responded to the advisements may perceive the 
importance of barriers and facilitators differently than patients who did not respond. For 
the professionals, the response rate was only 30% of which 26% was included. Although 
this rate is relatively low, it is comparable to the response seen in another online survey 
(25% response rate) on the management of sciatica among physicians [27]. In addition, 
the response rate of online surveys is often lower compared to traditional surveys, due 
to server rejection, spam filters, automated forwarding or out-of-office replies [28]. 
Overall there is a decline in response rates over the past decades [29]. Especially GPs 
were extremely difficult to reach over email (15% response), possibly explained by that 
they see only a few sciatica patients per year. A similar lower response rate among 
GPs (18%) was also found in a previous study [27]. We recommend that future studies 
consider other approaches to reach respondents in order to improve the response to 
surveys, especially the response of the  GPs. A more effective approach may be the 
presentation of a survey in power point slide format during a meeting of the target group 
with the response recorded upon entering a choice on a remote controlled device, 
as Raja et al. [30] (response 96%). Furthermore, it is possible that selection bias has 
occurred if professionals who do not use SDM in their consultation were less likely to 
complete the questionnaire, and experience other barriers and facilitators or rank them 
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differently. We analyzed differences in groups of professionals who did and did not 
use SDM, and observed large overlap in their rankings even though there were some 
differences. Therefore, we think that the response rate does not bias the results of this 
study.
CONCLUSIONS
This study showed the most important factors reported by patients and professionals 
for SDM implementation in sciatica care. Our study also demonstrates that the ranking 
of factors is an important step to determine which factors are the most important for 
which group of people, and thus on which factors an implementation strategy should be 
based. Several studies evaluated different interventions for an increase in the adoption 
of SDM among healthcare professionals, but there is a lack of evidence which type of 
intervention is the most effective [22]. Therefore, a multifaceted implementation strategy 
for SDM in sciatica care needs to be developed based on the most important factors as 
identified in this study. The effect of this strategy needs to be assessed to fill the gap 
between theories and clinical practice. This study focuses on SDM in sciatica care in the 
Netherlands, but the generated knowledge and understanding of the implementation 
process can also be used to implement SDM in other patients groups or other health care 
systems in which multiple disciplines are involved. Knowledge, information provision 
and a good relationship are the most important conditions for SDM perceived by both 
patients and professionals. These conditions are not restricted to one specific disease 
or health care system, because they are mostly professional or patient dependent and 
require healthcare professional training.
145 
7
Chapter 7
REFERENCES 
1.  Konstantinou K, Dunn KM: Sciatica: review 
of epidemiological studies and prevalence 
estimates. Spine 2008, 33: 2464-2472.
2.  Vroomen PC, de Krom MC, Knottnerus JA: 
Predicting the outcome of sciatica at short-term 
follow-up. Br J Gen Pract 2002, 52: 119-123.
3.  Peul WC, van den Hout WB, Brand R, Thomeer 
RT, Koes BW: Prolonged conservative care versus 
early surgery in patients with sciatica caused 
by lumbar disc herniation: two year results of a 
randomised controlled trial. BMJ 2008, 336: 1355-
1358.
4.  Jacobs WC, van TM, Arts M, Rubinstein SM, van 
MM, Ostelo R et al.: Surgery versus conservative 
management of sciatica due to a lumbar herniated 
disc: a systematic review. Eur Spine J 2011, 20: 
513-522.
5.  Quality Institute for Health Care CBO: Guideline 
Lumbosacral Radicular Syndrome. (In Dutch) 
Utrecht: CBO; 2008.
6.  Elwyn G, Laitner S, Coulter A, Walker E, Watson 
P, Thomson R: Implementing shared decision 
making in the NHS. BMJ 2010, 341: c5146.
7.  Van Beek E, Lemmers K, Van Schooten G, Vlieger 
E. Reduction of variation in clinical practice: 
budgetary effects of more precise indications. (In 
Dutch): PLEXUS; 2010.
8.  Cherkin DC, Deyo RA, Loeser JD, Bush T, Waddell 
G: An international comparison of back surgery 
rates. Spine  1994, 19: 1201-1206.
9.  Veroff D, Marr A, Wennberg DE: Enhanced support 
for shared decision making reduced costs of care 
for patients with preference-sensitive conditions. 
Health Aff 2013, 32: 285-293.
10.  Legare F, Ratte S, Gravel K, Graham ID: Barriers 
and facilitators to implementing shared decision-
making in clinical practice: update of a systematic 
review of health professionals’ perceptions. 
Patient Educ Couns 2008, 73: 526-535.
11.  Gravel K, Legare F, Graham ID: Barriers and 
facilitators to implementing shared decision-
making in clinical practice: a systematic review of 
health professionals’ perceptions. Implement Sci 
2006, 1: 16.
12.  Legare F, Stacey D, Gagnon S, Dunn S, Pluye P, 
Frosch D et al.: Validating a conceptual model for 
an inter-professional approach to shared decision 
making: a mixed methods study. J Eval Clin Pract 
2011, 17: 554-564.
13.  Jessup RL: Interdisciplinary versus 
multidisciplinary care teams: do we understand 
the difference? Aust Health Rev 2007, 31: 330-
331.
14.  Hofstede SN, Marang-van de Mheen PJ, Wentink 
MM, Stiggelbout AM, Vleggeert-Lankamp CLA, 
Vliet Vlieland TPM et al.: Barriers and facilitators 
to implement shared decision making in 
multidisciplinary sciatica care: a qualitative study. 
Implement Sci 2013, 8: 95.
15.  Degner LF, Sloan JA: Decision making during 
serious illness: what role do patients really want to 
play? J Clin Epidemiol 1992, 45: 941-950.
16.  Sawtooth Software I. The MaxDiff/Web v6.0 
Technical Paper. Sequim: wa, Sawtooth Software; 
2007.
17.  Cohen S, Orme B: What’s your preference? 
Marketing Research 2004, 32-37.
18.  Cohen, Steven H., Markowitz P. Renewing market 
segmentation: Some new tools to correct old 
problems. Congress Proceedings, Amsterdam, 
the Netherlands, ESOMAR; 2002.
19.  Wirth R, Wolfrat A. Using MaxDiff for Evaluating 
Very Large Sets of Items: Introduction and 
Simulation-Based Analysis of a New Approach. 
New York City, International Meeting of GfK 
Statisticians and Methodologists (IMSM); 2011. 
20.  Sawtooth Software I. The CBC/HB System for 
Hierarchical Bayes Estimation Version 5.0. 
Technical Pape, Sequim: WA, Sawtooth Software; 
2009.
21.  Sawtooth Software I. SSI Web v8.1: Software for 
Web Interviewing and Conjoint Analysis. Edited 
by Orme B. Sequin: WA, Sawtooth Software, Inc; 
2012.
22.  Legare F, Ratte S, Stacey D, Kryworuchko J, 
Gravel K, Graham ID et al.: Interventions for 
improving the adoption of shared decision making 
by healthcare professionals. Cochrane Database 
Syst Rev 2010, CD006732.
23.  O’Connor AM, Bennett CL, Stacey D, Barry M, 
Col NF, Eden KB et al.: Decision aids for people 
facing health treatment or screening decisions. 
Cochrane Database Syst Rev 2009, CD001431.
24.  Lurie JD, Berven SH, Gibson-Chambers J, 
Tosteson T, Tosteson A, Hu SS et al.: Patient 
preferences and expectations for care: 
determinants in patients with lumbar intervertebral 
disc herniation. Spine 2008, 33: 2663-2668.
25.  McIntosh E, Louviere JJ. Separating weight 
and scale value: an exploration of best-attribute 
scaling in health economics. Brunel University, In 
Health Economists’ Study Group meeting;  2002.  
26.  Flynn TN, Louviere JJ, Peters TJ, Coast J: Best-
worst scaling: What it can do for health care 
research and how to do it. J Health Econ 2007, 26: 
171-189.
27.  Webster BS, Courtney TK, Huang YH, Matz S, 
Christiani DC: Physicians’ initial management 
of acute low back pain versus evidence-based 
guidelines. Influence of sciatica. J Gen Intern Med 
2005, 20: 1132-1135.
28.  Dobrow MJ, Orchard MC, Golden B, Holowaty 
146 Ranking among professionals and patients
E, Paszat L, Brown AD et al.: Response audit of 
an Internet survey of health care providers and 
administrators: implications for determination of 
response rates. J Med Internet Res 2008, 10: e30.
29.  Wiebe ER, Kaczorowski J, MacKay J: Why are 
response rates in clinician surveys declining? Can 
Fam Physician 2012, 58: e225-e228.
30.  Raja R, Kingsbury SR, Wise E, Conaghan PG: 
Primary care approaches to musculoskeletal 
multiple-site joint pain pharmacological therapy: a 
survey of general practitioners. Prim Health Care 
Res Dev 2014, 1-6.
147 
7
Chapter 7

Part 2
 The optimization of surgical care in knee and hip osteoarthritis

Chapter 8
Indication criteria for total hip or knee arthroplasty in
osteoarthritis: a state-of-the-science overview
Maaike GJ Gademan, Stefanie N Hofstede, Thea PM Vliet-Vlieland,
Rob GHH Nelissen, Perla J Marang-van de Mheen
Submitted
152 Indication criteria for surgery
ABSTRACT
Objective 
To examine the evidence base of existing indication criteria for primary total hip and 
knee arthroplasty (THA/TKA) in osteoarthritis (OA), to provide a state-of-the-science 
overview to guide decision making on timing of surgery.
Methods
Websites of orthopaedic and arthritis organizations (English/Dutch language) were 
independently searched by two authors for THA/TKA guidelines for OA. Furthermore, a 
systematic search strategy in several databases through August 2014 was performed. 
Quality of the guidelines was assessed with the AGREE II instrument, which consists 
of 6 domains (maximum summed score of 6 indicating high quality). Also, the level of 
evidence of all included studies was assessed.
Results
We found 6 guidelines and 18 papers, out of 3065 references. The quality of the 
guidelines summed across 6 domains ranged from 0.46 to 4.78. In total, 12 THA, 10 TKA 
and 2 THA/TKA indication sets were found. Four studies stated that no evidence-based 
indication criteria are available. Indication criteria concerning THA/TKA consisted of 
the following domains: pain (in respectively 11 and 10 sets), function (12 and 7 sets), 
radiological changes (10 and 9 sets), failed conservative therapy (8 and 4 sets) and 
other indications (6 and 7 sets). Specific cut-off values or ranges were often not stated 
and the level of evidence was low.
Conclusion
The indication criteria for THA and TKA are based on limited evidence. Empirical 
research is needed, especially regarding domain specific cut-off values or ranges at 
which the best postoperative outcomes are achieved for patients, taking into account 
the limited lifespan of a prosthesis.
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INTRODUCTION
Total hip and knee arthroplasty (THA/TKA) have been widely performed since the 
1970s. In 2009 over a million of THA and TKA were carried out in the United States 
[1]. Osteoarthritis (OA) is the main clinical indication for which these procedures are 
performed [2]. Due to the ageing society as well as the obesity epidemic, the prevalence 
of OA is increasing [3]. As a result the procedure rates of THA and TKA are expected to 
rise, some estimates even indicate a quadruple demand by 2030 [4,5]. 
The rise in THA/TKA surgery has important implications for health care costs as well as 
capacity. In addition, a substantial part of the patients is unsatisfied after THA and TKA 
(10-30%), indicating that outcomes are less than expected [6]. Therefore, evidence-
based indication criteria are warranted, so that these procedures are optimally timed to 
achieve the best possible patient outcomes, that revision surgery is prevented thereby 
reducing costs. The importance of such criteria is internationally acknowledged [7-12]
Guidelines concerning THA and TKA indications have been published and several 
studies regarding the appropriateness of THA and TKA have been conducted [3,7,13-
15]. However, an overview of the evidence on which the proposed indication criteria are 
based is lacking, to guide decision making on timing of THA and TKA. In the present 
study the available guidelines and their indication sets for primary THA and TKA will be 
reviewed. In addition, we assess the quality of these guidelines and the evidence on 
which the indication sets are based. In the second part a systematic search is conducted 
of scientific publications containing proposed indication sets for primary THA and TKA 
in OA or expert opinion.
METHODS
Search strategy
Websites of orthopaedic and arthritis organizations (English or Dutch websites) were 
independently searched by two authors for guidelines concerning primary THA/TKA 
for OA. When these websites cross-linked to guidelines from other organizations these 
were also included. All available guidelines published since January 1, 2000 were 
included. A librarian-assisted search strategy was performed on August 3 2014 to 
retrieve additional publications on THA/TKA indications. The following databases were 
searched: Pubmed, MEDLINE, Embase, Web of Science, the COCHRANE Librabry, 
CENTRAL and CINAHL. Searches were limited to English, Dutch and German language 
papers published since January 1, 2000 (see Supplement 1).
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Selection of publications
First titles and abstracts were independently screened by two authors (MG/SH).The 
full-text articles were reviewed by MG and were included when the following criteria 
were met: studies reporting about indication criteria and/or appropriateness of decision 
tools for primary THA/TKA in OA. Papers involving guidelines on unicompartimental 
replacements, resurfacing or revision of THA/TKA were excluded if no separate 
indications for primary THA/TKA were provided. Also papers on prioritizing tools to 
reduce waiting times were excluded. 
The included papers where checked by a second author (SH). If disagreement existed 
the authors tried to reach consensus, when necessary a third author had the decisive 
vote (PM). When a guideline was also published as a scientific paper, only the guideline 
was included. 
Data extraction
The following information was extracted from the guidelines by MG: orthopaedic or 
arthritis organization, publication date, indication criteria and the level of evidence on 
which indication criteria were based (see below). From the publications the following 
information was extracted: first author, publication date, country where the indication 
criteria were developed, organization(s) initiating development of the criteria, study 
type, indication criteria and the level of evidence on which indication criteria were 
based. Table 1 shows the criteria to score the level of evidence [3].
Data extraction and level of evidence score was checked by SH. 
Table 1. Level of evidence
Level Evidence
Ia evidence from meta-analysis of randomized controlled trials
Ib evidence from at least one randomized controlled trial
IIa evidence from at least one controlled study without randomization
IIb evidence from at least one well-designed quasi-experimental study
III evidence from at least one non-experimental descriptive study, such as 
comparative studies, correlation studies, and case-control studies
IV evidence from expert committee reports or opinions or clinical experience of 
respected authorities or both
Quality of the guidelines
Guideline quality was assessed with the validated AGREE-II instrument (Appraisal of 
Guidelines for Research and Evaluation, Dutch version)[16]. This instrument evaluates 
the process of practice guideline development and the quality of reporting. Two authors 
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independently scored the guidelines according to the AGREE-II protocol (MG/SH). 
When large differences existed the authors tried to reach consensus, when necessary a 
third author had the decisive vote (PM).
AGREE-II consists of six quality domains: 1) scope and purpose, 2) stakeholder 
involvement, 3) rigour of development, 4) clarity of presentation, 5) applicability and 6) 
editorial independence. Each domain entails several questions which are rated from 1 
(lowest score) to 7 (highest score), with 1 rated for items with no clear discussion or no 
specific information , 7 for exceptional reporting quality, 2–6 for items not fully meeting 
the AGREE-II criteria. Scaled domain scores were calculated using the following formula: 
(Obtained score – Minimum possible score)
(Maximum possible score – Minimum possible score)
The scores will always lie between 0 and 1, with scores closer to 1 indicating higher 
quality. The scaled domain scores from the two authors were averaged to obtain one 
quality score for each domain. We summed the scaled domain scores across the 6 
domains to obtain 1 overall guideline score. The maximum summed score was thus 6, 
indicating high quality.
RESULTS
Across guidelines and studies, 12 THA, 10 TKA and 2 THA/TKA indication sets were 
found.
Guidelines
We found six guidelines concerning THA, of which three specific OA guidelines (EULAR 
[14], NICE [17] and OARSI [3]). In addition, five guidelines concerning TKA were found, 
of which four OA specific guidelines (BOA [18], EULAR [13], NICE [17] and OARSI [3]) 
(Table 2). 
Indication criteria concerning THA and TKA
Most indication criteria consisted of the following three domains: pain, function and 
radiological changes, with the prerequisite that pain could not be controlled by 
conservative therapy (Table 2). Specific cut-off values or ranges for pain and function 
were not reported. For radiological changes only the BOA TKA guideline reported a cut-
off value (Kellgren Lawrence grade ≥ III). The evidence on which the indication criteria 
were based was rated as low quality evidence (level IV).
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Quality of the guidelines
The quality of the guidelines differed considerably between the AGREE-II domains and 
the guidelines (Figure 1). The ranges of the scaled domain scores were: scope and 
purpose 0.06-0.81, stakeholder involvement 0.19-0.75, rigour of development 0.03-
0.88, clarity of presentation 0.33-0.89, applicability 0-0.50, editorial independence 
0-0.96. Low scores were frequently attained in the editorial independence domain due 
to no clear statement on the influence of the funding body and competing interests. 
In addition, low scores were often attained in the applicability domain, due to no clear 
statements on monitoring/auditing criteria of the guideline or facilitators and barriers to 
the application of the guideline. The OARSI and NOV guidelines attained the highest 
overall scores, 4.78 and 4.46 respectively. This is explained because both guidelines 
were developed according to the AGREE-II. The lowest scores were attained by the NZ 
guidelines, THA (0.84) and TKA (0.46). These guidelines primarily consisted of a, from 
the BOA guidelines derived, summary of statements concerning THA/TKA but limited 
information on the required 6 domains. 
Although the process of guideline development and quality of reporting differed 
considerably between the guidelines, the given indication criteria for primary THA and 
TKA are similar across guidelines (pain, function, radiological changes). Hence, it seems 
that guideline quality did not influence the main domains included in the indication sets.
Publications 
Our literature search yielded 3065 references (Figure 2), the full-text of 88 papers 
was assessed on eligibility. Of these 70 were excluded mainly because no indication 
criteria for THA/TKA in OA patients were reported. Finally, 18 papers were included (12 
reviews/6 original studies).
Reviews 
Only 2 systematic reviews were included (Table 3) [19,20]. Furthermore, only 2 reviews 
focussed on indications for THA/TKA as their main topic [21,22]. In addition, 1 review 
investigated the indications for THA/TKA referral [23]. Other topics on which the reviews 
focussed were management of THA/TKA [24-26], effectiveness of THA/TKA [20] and 
state of art overviews of THA/TKA [8,27,28].
Pain not responsive to conservative treatment, in patients who have functional limitations 
and radiographic evidence of joint degeneration was most often reported as THA/TKA 
indication (Table 3). No specific cut-off values were mentioned. It was often not stated 
if deviations in all these domains should be apparent, or which combinations should be 
apparent to indicate THA or TKA. Furthermore, the evidence behind all these indication 
criteria was very low (level IV). In 3 of the reviews the experts explicitly stated that no 
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Figure 1. AGREE II guideline quality scores. 
1 Panel A: AGREE II quality scores of the guidelines concerning hip replacement
1 Panel B: AGREE II quality scores of the guidelines concerning knee replacement
1 Panel C: AGREE II quality scores of the guidelines concerning joint replacement in osteoarthritis
Domain 1: scope and purpose, domain 2: stakeholder involvement, domain 3: rigour of development, 
domain 4: clarity of presentation, domain 5: applicability, domain 6: editorial independence.
160 Indication criteria for surgery
Ta
bl
e 
3.
 R
ev
ie
w
s 
on
 in
di
ca
tio
n 
cr
ite
ria
 c
on
ce
rn
in
g 
to
ta
l h
ip
 a
rth
ro
pl
as
ty
 a
nd
 to
ta
l k
ne
e 
ar
th
ro
pl
as
ty
Au
th
or
Ye
ar
 o
f 
pu
bl
ic
at
io
n
St
ud
y 
gr
ou
p 
re
gi
on
Sy
st
em
at
ic
 
re
vi
ew
Ev
id
en
ce
In
di
ca
tio
n 
cr
ite
ria
Pa
in
Fu
nc
tio
n
Ra
di
ol
og
ic
al
 c
ha
ng
es
Fa
ile
d 
or
 fu
til
e 
co
ns
er
va
tiv
e 
th
er
ap
y
Ot
he
r c
rit
er
ia
Kn
ee
H
an
ss
en
 [2
8]
20
00
US
A
No
le
ve
l I
V
A
s 
th
e 
in
di
ca
tio
ns
 c
on
tin
ue
 
to
 e
xp
an
d,
 th
e 
de
cis
ion
 
to
 p
ro
ce
ed
 w
ith
 to
ta
l k
ne
e 
ar
th
ro
pl
as
ty
 in
 y
ou
ng
, 
ac
tiv
e 
pa
tie
nt
s’
 n
ee
ds
 to
 b
e 
in
di
vi
du
al
iz
ed
 a
fte
r c
ar
ef
ul
 
co
ns
id
er
at
io
n 
of
 a
lte
rn
at
iv
es
.
K
irs
ch
ne
r [
44
]
20
11
G
er
m
an
y
No
le
ve
l I
V
pa
in
 d
ur
in
g 
ac
tiv
itie
s o
r 
re
st
ra
di
olo
gi
c 
ev
id
en
ce
 o
f 
ar
th
rit
is
va
n 
M
an
en
 [2
4]
20
12
US
A
No
le
ve
l I
V
se
ve
re
, 
re
fra
ct
or
y 
kn
ee
 p
ain
, 
of
te
n 
at
 
nig
ht
di
ffi
cu
lty
 w
ith
 
ac
tiv
itie
s o
f 
da
ily
 li
vi
ng
; 
de
cr
ea
se
d 
m
ob
ili
ty
Ra
di
og
ra
ph
ic 
Ev
id
en
ce
 o
f 
Pr
im
ar
y 
or
 In
fla
m
m
at
or
y 
D
eg
en
er
at
iv
e 
Jo
in
t D
is
ea
se
: 
N
ar
ro
w
ed
 jo
in
t s
pa
ce
; 
O
st
eo
ph
yt
es
 (s
pu
rr
in
g)
 a
nd
 
bo
ne
 c
ys
ts
; s
qu
ar
in
g 
of
 
co
nd
yl
es
; b
on
e 
sc
le
ro
si
s.
 
fa
ilu
re
 to
 
re
sp
on
d 
to
 
co
ns
er
va
tiv
e 
m
ea
su
re
s
C
ur
re
nt
 h
ea
lt 
st
at
us
: M
ed
ic
al
ly
 
op
tim
iz
ed
 fo
r s
ur
ge
ry
; n
o 
ev
id
en
ce
 o
f i
nf
ec
tio
n;
 in
ta
ct
 
ex
te
ns
or
 m
ec
ha
ni
sm
; i
nf
or
m
ed
 
co
ns
en
t o
bt
ai
ne
d.
M
ed
ic
al
 A
dv
is
or
y 
Se
cr
et
ar
ia
t [
20
]
20
05
Ca
na
da
Ye
s
le
ve
l I
V
pa
in
fu
nc
tio
na
l 
ab
ili
ty
Sc
hn
ep
pe
nh
ei
m
 
[2
2]
20
01
G
er
m
an
y
No
le
ve
l I
V
de
bi
lita
tin
g 
pa
in
se
ve
re
 
re
str
ict
ion
s 
on
 th
e 
ac
tiv
itie
s o
f 
th
e 
pa
tie
nt
s 
in
 d
ai
ly
 li
fe
.
si
gn
ifi
ca
nt
 ra
di
og
ra
ph
ic
 
fin
di
ng
s
ye
s
Hi
p
K
irs
ch
ne
r [
44
]
20
11
G
er
m
an
y
No
le
ve
l I
V
hi
p:
 p
ai
n 
du
rin
g 
ac
tiv
itie
s o
r 
re
st
co
ns
tri
ct
ed
 ra
ng
e 
of
 m
ot
io
n
ra
di
olo
gi
c 
ev
id
en
ce
 
of
 a
rth
rit
is
La
ne
 [2
7]
20
07
US
A
No
le
ve
l I
V
su
bs
ta
nt
ia
l 
fu
nc
tio
na
l 
im
pa
irm
en
t
ch
ro
ni
c 
di
sc
om
fo
rt
Le
vi
ne
 [2
5]
20
13
US
A
No
le
ve
l I
V
pa
in
 re
fra
ct
or
y 
to
 n
on
su
rg
ic
al
 
m
an
ag
em
en
t
fu
nc
tio
na
l 
im
pa
irm
en
t 
Ra
di
olo
gr
ap
hic
 
fin
di
ng
s 
(jo
in
t 
sp
ac
e 
na
rro
wi
ng
, 
bo
ne
 sc
ler
os
is,
 
bo
ne
 c
ys
ts
 
fe
m
or
al
/ a
ce
ta
bu
la
r 
os
te
op
hy
te
s
ye
s
ph
ys
ic
al
 e
xa
m
 fi
nd
in
gs
 (g
ro
in
 
pa
in 
an
d 
de
cr
ea
se
d 
int
er
na
l 
ro
ta
tio
n)
, r
ul
ed
 o
ut
 c
au
se
s 
of
 
re
fe
rr
ed
 p
ai
n 
in
cl
ud
in
g 
sp
in
e 
pr
ob
le
m
s 
an
d 
bu
rs
iti
s
161 Chapter 8
8
Au
th
or
Ye
ar
 o
f 
pu
bl
ic
at
io
n
St
ud
y 
gr
ou
p 
re
gi
on
Sy
st
em
at
ic
 
re
vi
ew
Ev
id
en
ce
In
di
ca
tio
n 
cr
ite
ria
Pa
in
Fu
nc
tio
n
Ra
di
ol
og
ic
al
 c
ha
ng
es
Fa
ile
d 
or
 fu
til
e 
co
ns
er
va
tiv
e 
th
er
ap
y
Ot
he
r c
rit
er
ia
Pi
ve
c 
[8
]
20
12
US
A
No
le
ve
l I
V
pa
in
fu
nc
tio
na
l 
im
pa
irm
en
t 
ra
di
og
ra
ph
ic 
fin
di
ng
s
in
iti
al
 c
ou
rs
e 
of
 c
on
se
rv
at
iv
e 
th
er
ap
y 
sh
ou
ld
 a
lw
ay
s 
be
 
at
te
m
pt
ed
 w
ith
 a
na
lg
es
ia
, 
ac
tiv
ity
 m
od
ifi
ca
tio
n,
 a
m
bu
la
to
ry
 
ai
ds
, a
nd
 w
ei
gh
t l
os
s.
Kn
ee
 a
nd
 H
ip
A
ltm
an
 [1
9]
20
05
US
A,
 F
ra
nc
e,
 
Po
rtu
ga
l, 
B
el
gi
um
, 
Sp
ain
, 
G
er
m
an
y,
 
A
us
tri
a,
 
Cz
ec
h 
R
ep
ub
lic
, 
Th
e 
Ne
th
er
lan
ds
Ye
s
lev
el 
III
Th
e 
cr
ite
ria
 fo
r w
he
n 
to
 p
er
fo
rm
 
su
ch
 s
ur
ge
ry
 a
re
 n
ot
 c
le
ar
. 
D
ow
se
y 
[2
1]
20
14
A
us
tra
lia
No
lev
el 
III
Se
le
ct
io
n 
of
 s
ui
ta
bl
e 
ca
nd
id
at
es
 fo
r T
JR
 is
 c
rit
ic
al
 
bu
t a
pp
ro
pr
ia
te
 c
rit
er
ia
 a
re
 n
ot
 
cl
ea
rly
 d
efi
ne
d
M
an
dl
 [2
3]
20
13
US
A
No
le
ve
l I
V
 
 
 
 
Th
er
e 
ar
e 
no
 d
efi
ni
tiv
e 
re
co
m
m
en
da
tio
ns
 fo
r d
ec
id
in
g 
w
hi
ch
 p
at
ie
nt
s 
sh
ou
ld
 b
e 
re
fe
rr
ed
 fo
r T
JA
*T
hi
s 
st
ud
y 
fo
cu
ss
es
 o
n 
TH
A
 in
 o
ld
er
 p
eo
pl
e 
(>
65
 y
ea
rs
 o
f a
ge
)
un
i: 
un
ic
om
pa
rtm
en
ta
l e
xc
lu
de
d 
pa
te
llo
-fe
m
or
al
 is
ol
at
ed
; b
i: 
un
ic
om
pa
rtm
en
ta
l p
lu
s 
pa
te
llo
-fe
m
or
al
; t
ri:
 tr
ic
om
pa
rtm
en
ta
l
162 Indication criteria for surgery
appropriate indication sets are available for performing THA/TKA. 
Original publications
Three original publications reported on TKA [29-31] and 3 on THA [32]. Yambabe et 
al. [29] considered severe cartilage defects as an optimal indication for TKA. In their 
discussion section they also included pain but no referral was made to any evidence 
or the way these indications were established. The other 5 included original studies 
investigated decision tools to assess the appropriateness of TKA (n=2) [30,31] or THA 
(n=3) [32-34] in OA patients.
TKA appropriateness
Two studies evaluated algorithms to assess TKA appropriateness [30,31]. The Escobar 
algorithm was established using the RAND/UCLA appropriateness method, in which 
expert opinion is combined with available scientific evidence [35]. The following 
variables where taken into account in different combinations: symptomatology, 
radiology, age, mobility and stability, previous surgical management and localization. 
Symptomatology and radiology were the largest contributors in explaining the variability 
of appropriateness in their model. Table 4 depicts various scenarios in which TKA was 
considered inappropriate, uncertain or appropriate [30]. However, appropriateness was 
rated uncertain in a high percentage of scenarios (24.5%). Another study showed that 
patients who were rated appropriate were more likely to achieve better health-related 
quality of life than patients rated as inappropriate [36]. 
Figure 2. Flow diagram
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Table 4. Different scenarios in which TKA is deemed appropriate, uncertain or inappropriate according 
to Escobar et al. [30]
Symptoms Radiology Age Mobility Localisation
Total knee 
arthroplasty
slight or moderate Ahlbäck I-III inappropriate
slight Ahlbäck IV-V inappropriate
moderate Ahlbäck IV-V <55 inappropriate
moderate Ahlbäck IV-V ≥55 uni inappropriate
moderate Ahlbäck IV-V ≥55 bi-tri appropriate
intense-severe Ahlbäck I-III <55 uni-bi inappropriate
intense-severe Ahlbäck I-III <55 tri uncertain
intense-severe Ahlbäck I ≥55 normal inappropriate
intense-severe Ahlbäck II-III ≥55 normal uncertain
intense-severe Ahlbäck I 55-65 limited uncertain
intense Ahlbäck I >65 limited uncertain
severe Ahlbäck I >65 limited appropriate
intense-severe Ahlbäck II-III ≥55 limited appropriate
intense-severe Ahlbäck IV-V <55 uni uncertain
intense-severe Ahlbäck IV-V <55 bi-tri appropriate
intense-severe Ahlbäck IV-V ≥55 appropriate
Riddle et al. modified the Escobar algorithm to attain a decision tool for US patients 
[31]. They used the Kellgren Lawrence score rather than the Ahlbäck classification 
and quantified symptomatology using the Western Ontario and McMaster osteoarthritis 
index (WOMAC). In 21.7% of patients appropriateness of TKA was rated as uncertain. 
THA appropriateness
Quintana et al. developed three THA appropriateness algorithms in OA patients [32-
34]. Two were established using the RAND/UCLA appropriateness method. These 
algorithms took the following variables into account: age, surgical risk, previous 
nonsurgical treatments, pain and functional limitation. Table 5 depicts various scenarios 
in which THA was considered inappropriate, uncertain or appropriate [32]. In both 
algorithms, appropriateness was rated uncertain in a large part of patients, 46.2% and 
32.4%. Both algorithms were validated in a population of OA patients scheduled for THA 
[32,34]. Patients rated appropriate THA candidates had better outcomes at 3 months 
on the WOMAC stiffness and functional limitation domains compared to inappropriate 
candidates. 
The other algorithm was based on the WOMAC as they wanted to develop a tool based 
on a disease specific instrument rather than on expert opinion [33]. Surgical risk, pre-
intervention pain and functional limitations were found to significantly predict changes in 
the WOMAC pain domain 6 months after THA and pre-intervention functional limitations 
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Table 5. Different scenarios in which THA is deemed appropriate, uncertain or inappropriate according 
to Quintana et al. [32]
Pain
Non-surgical 
procedure
Functional 
limitation
Surgical 
risk Age
Total hip 
arthroplasty
severe correctly severe appropriate
severe correctly
minor or 
moderate appropriate
severe
not done or not done 
correctly severe appropriate
mild or moderate correctly severe low appropriate
mild minor inappropriate
mild moderate high inappropriate
mild moderate low inappropriate
moderate or 
severe
not done or not done 
correctly <50 years inappropriate
moderate or 
severe
not done or not done 
correctly minor >50 years inappropriate
mild or moderate
not done or not done 
correctly severe low uncertain 
mild or moderate
not done or not done 
correctly severe high uncertain 
mild or moderate correctly severe high uncertain 
severe
not done or not done 
correctly
minor or 
moderate uncertain 
moderate correctly
minor or 
moderate high uncertain 
moderate correctly
minor or 
moderate low uncertain 
moderate
not done or not done 
correctly moderate >50 uncertain 
mild correctly moderate low uncertain 
predicted changes in the functional limitation domain [33]. In addition, by means of a 
classification and regression tree analysis a summary tree was constructed. THA was 
rated as appropriate when pain was qualified as severe (according to the pain and 
limitation short scales), when WOMAC pain pre-intervention score >60 or when WOMAC 
functional limitation pre-intervention >60 with pain pre-intervention >40. Surgical risk 
was not included in the decision tree. However, the authors stated that one should be 
aware that higher surgical risk often results in a worse outcome and that conservative 
treatment should always be performed before considering THA. Again this decision 
tool was validated in a THA cohort. They assessed sensitivity and specificity of being 
classified as appropriate compared with the appropriateness based on the minimal 
clinical important difference values (gain in WOMAC 6 months after THA, pain domain 
≥30, function domain ≥25). A sensitivity of 95.0% and a specificity of 41.0% was found, 
suggesting that it seems difficult to identify the non-appropriate cases. 
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DISCUSSION
In this systematic review we examined the quality and evidence base of existing indication 
criteria and guidelines for primary THA and TKA in OA patients. Across guidelines and 
publications we found, 12 THA, 10 TKA and 2 THA/TKA indication sets. Only 6 guidelines 
included indication criteria for THA/TKA with differing quality. Overall quality of the 
guidelines summed across the 6 domains ranged from 0.46 to 4.78 Low scores were 
frequently attained in the editorial independence domain and the applicability domain. 
High scores were often attained in the clarity of presentation domain. In the additional12 
reviews and 6 original publications most indication criteria included the following three 
domains: pain, function and radiological changes. Frequently a prerequisite was that 
conservative treatment had been insufficient in controlling pain. However, domain 
specific cut-off values or ranges, were mostly not reported. Also, it was often not 
stated if pain, functional disability and radiological changes should all exist, or which 
combinations of domain-specific deviations should be apparent to indicate THA or TKA. 
The level of evidence was low (level IV). 
We were not able to discriminate between high en poor quality guidelines as the 
AGREE-II has not given a set of rules to define a high quality guideline. Given the low 
scores in the applicability and the editorial independence domains, we advise guideline 
developers to pay more attention in reporting these issues. A limitation of the current 
study may be that the scoring of guidelines according to the AGREE-II is not completely 
objective, even though the manual clearly articulates how each item should be scored 
including the criteria and considerations for each item. However, the weighting of 
criteria and considerations in the overall scoring of the item is not mentioned, which 
could introduce inter-observer variability. To cope with this, the AGREE-II proposes to 
use more than one observer, which is why the guidelines were scored independently by 
two investigators and compared to reach consensus (with or without a decisive vote of 
a third investigator). A such, we tried to minimalize subjectivity.
Irrespective of the quality of individual guidelines, the same domains concerning THA/
TKA indications were reported across most guidelines. Based on the design of included 
studies, the highest level of evidence was reported by the OARSI and EULAR guidelines 
(only non-experimental studies, level III evidence). The evidence on which indication 
sets were based came from studies investigating the effectiveness and safety of THA/
TKA, but these studies did not specifically address THA/TKA indication sets. Therefore 
the evidence from these guidelines was rated as level IV evidence, so that the evidence 
on which indication criteria are based, is low quality evidence.
Looking at other literature, most of the reviews also did not specifically focus on THA/
TKA indications and none of the systematic reviews did. Moreover, in 2 of 3 reviews with 
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THA/TKA indication as main topic it was concluded that no conclusive evidence on THA/
TKA indications are currently available. Furthermore, few original papers investigating 
THA/TKA indications were found, which may be partly due to the employed language 
restrictions, possibly resulting in language bias. Four of 5 original studies came from 
the same group and 4 were based on the RAND/UCLA method [30-32,34]. Although 
this is a respected approach , the limitation is that the indication set is mainly based on 
expert opinion if little research is available. Thus, even with an optimal composition of 
experts in the panel, the level of evidence will still be low. This is currently the case for 
THA/TKA indication sets. In addition, within the proposed THA/TKA decision tools, the 
appropriateness of surgery was rated as uncertain in many patients. This makes these 
decision tools difficult to use in daily practice, as uncertain rated patients may have 
similar improvements in health outcomes as patients rated as appropriate. Therefore, 
no evidence-based indications concerning THA/TKA are currently available which can 
be uniformly used in daily practice. 
Nonetheless, when indications were reported, the same domains were included. 
Hence, although evidence based studies are lacking, expert opinion seems reasonably 
consistent. This is promising as these domains may give clues to the targets on which 
future research for THA/TKA indications should focus. It seems evident that pain, 
function, radiological changes and failed conservative therapy should be part of future 
studies on THA/TKA indications. The research of indication criteria is, however, difficult. 
One of the difficulties is that pain and function are relatively subjective measures both 
when reported by the patient or when judged by the physician. This is illustrated by the 
fact that although consensus on the indication domains seems to exist, disease severity 
greatly varies at the time of surgery across different centres in Europe and Australia 
[37,38]. This suggests no agreement on the cut-off values or ranges within these domains 
or between combinations of domains as an indication for surgery. Another difficulty is 
that it is not possible to conduct controlled trials with the timing of surgery randomized, 
so that other designs are needed. As a consequence the highest level of evidence 
is not likely to be obtained, but likely to be relatively low given mainly observational 
studies (level II and III). However, outcomes of observational studies can be valid and 
may provide similar results as RCTs. For instance, meta-analyses comparing RCTs and 
observational studies of treatment effects found no large systematic differences [39]. 
Furthermore, randomization will avoid confounding by indication but this can also be 
achieved with advanced statistical analyses and pseudo-randomization in observational 
studies. To obtain the best possible evidence, we should try to identify predictors for 
a (less than) good outcome after THA/TKA. With the identified predictors we might be 
able to simulate with mathematical modelling at which cut-off points surgery has the 
best postoperative outcomes, taking into account the limited lifespan of a prosthesis 
and the fact that revision surgery mostly has worse outcomes than primary surgery.
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In conclusion, our current study gives an overview of the available evidence base of 
THA/TKA indication criteria in both guidelines and original studies. We showed that 
the currently available THA/TKA indication criteria are based on limited and low quality 
evidence. Hence, empirical research on this topic is needed, especially regarding 
domain specific cut-off values or ranges at which the best postoperative outcomes are 
achieved.
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SUPPLEMENT 1
The websites of several orthopaedic associations and arthritis organizations (with 
English or Dutch websites) were independently searched by two authors for guidelines 
concerning primary hip/knee replacement for OA : American Academy of Orthopaedic 
Surgeons, American College of Rheumatology, American Association of Orthopaedic 
Medicine,  American Orthopaedic Association, Asia Pacific Orthopaedic Association, 
Asia Pacific League of Association for Rheumatology, Australian Orthopaedic 
Association, Australian Rheumatology Association, British Orthopaedic Association 
(BOA), British Society for Rheumatology, Canadian Orthopaedic association, 
Canadian Rheumatology Association, Dutch Society of Rheumatology, the European 
league against rheumatism (EULAR), European Federation of National Associations 
of Orthopaedics and Traumatology, European Orthopaedic Research Society, Irish 
Society of Orthopaedic Medicine, Irish Institute of Trauma and Orthopaedic Surgery, 
Irish Society for Rheumatology, Indian Rheumatology Association, Indian Orthopaedic 
Association, National Institute for Health Care Excellence, Netherlands Orthopaedic 
Association (NOV), New Zealand Orthopaedic Association (NZ), Nordic orthopaedic 
association, National Institute for Health and Care Excellence (NICE), New Zealand 
Rheumatology Association, Osteoarthritis Research Society International (OARSI), 
South African League Against Rheumatism and Arthritis Organization and South African 
Orthopaedic Association.
The search strategy for identification of publications on indications for THA and TKA is 
depicted in the table here below.
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Databases Search Strategy
Number 
unique 
references
PubMed (("Arthroplasty, Replacement, Knee"[majr] OR "Knee Prosthesis"[majr] OR "knee replacement 
arthroplasty"[ti] OR "total knee arthroplasty"[ti] OR "total knee"[ti] OR tka[ti] OR "tkr"[ti] OR "total 
knee replacement"[ti] OR "knee prosthesis"[ti] OR "knee implantation"[ti] OR "knee implant"[ti] 
OR "knee implants"[ti] OR "knee prosthesis"[ti] OR "knee joint replacement"[ti] OR "knee joint 
arthroplasty"[ti] OR "Knee Replacement Arthroplasties"[ti] OR "Total Knee Replacements"[ti] 
OR "Knee Prostheses"[ti] OR "Knee endoprosthesis"[ti] OR "Knee endoprostheses"[ti] OR 
"Knee joint arthroplasty"[ti] OR "Knee joint arthroplasties"[ti] OR "knee joint prosthesis"[ti] 
OR "knee joint prostheses"[ti] OR "knee prosthetic"[ti] OR "Knee endoprosthetic"[ti] OR 
"knee joint prosthetic"[ti] OR "Knee joint endoprosthetic"[ti] OR "knee prosthetics"[ti] OR 
"Knee endoprosthetics"[ti] OR "knee joint prosthetics"[ti] OR "Knee joint endoprosthetics"[ti] 
OR "Knee replacement"[ti] OR "Knee replacements"[ti] OR "knee arthroplasty"[ti] OR "knee 
arthroplasties"[ti] OR "Arthroplasty, Replacement, Hip"[majr] OR "Hip Prosthesis"[majr] OR 
"hip replacement arthroplasty"[ti] OR "total hip arthroplasty"[ti] OR "total hip"[ti] OR tha[ti] OR 
"thr"[ti] OR "total hip replacement"[ti] OR "hip prosthesis"[ti] OR "hip implantation"[ti] OR "hip 
implant"[ti] OR "hip implants"[ti] OR "hip prosthesis"[ti] OR "hip joint replacement"[ti] OR "hip 
joint arthroplasty"[ti] OR "Hip Replacement Arthroplasties"[ti] OR "Total Hip Replacements"[ti] 
OR "Hip Prostheses"[ti] OR "Hip endoprosthesis"[ti] OR "Hip endoprostheses"[ti] OR "Hip 
joint arthroplasty"[ti] OR "Hip joint arthroplasties"[ti] OR "hip joint prosthesis"[ti] OR "hip joint 
prostheses"[ti] OR "hip prosthetic"[ti] OR "Hip endoprosthetic"[ti] OR "hip joint prosthetic"[ti] 
OR "Hip joint endoprosthetic"[ti] OR "hip prosthetics"[ti] OR "Hip endoprosthetics"[ti] OR 
"hip joint prosthetics"[ti] OR "Hip joint endoprosthetics"[ti] OR "Hip replacement"[ti] OR 
"Hip replacements"[ti] OR "hip arthroplasty"[ti] OR "hip arthroplasties"[ti] OR (("total joint 
arthroplasty"[ti] OR "total joint replacement"[ti] OR "total joint prosthesis"[ti] OR 
"Arthroplasty, Replacement"[Majr:NoExp]) NOT (shoulder*[ti] OR ankle*[ti]))) AND 
((decision[ti] AND "to operate"[ti]) OR "decision to treat"[ti] OR "treatment decision"[ti] OR 
"operation decision"[ti] OR "surgery decision"[ti] OR "intervention decision"[ti] OR "treatment 
decisions"[ti] OR "operation decisions"[ti] OR "surgery decisions"[ti] OR "intervention 
decisions"[ti] OR "Patient Selection"[Mesh] OR "patient selection"[ti] OR "Patient Selections"[ti] 
OR "Selection for Treatment"[ti] OR "Selection for Treatments"[ti] OR "Selection of Subjects"[ti] 
OR "Subjects Selection"[ti] OR "Subjects Selections"[ti] OR "Selection Criteria"[ti] OR "priority 
tool"[ti] OR "priority tools"[ti] OR "priority criteria"[ti] OR  "priority criterium"[ti] OR "indication 
set"[ti] OR "priority"[ti] OR "priorities"[ti] OR priorit*[ti] OR "indication"[ti] OR "indications"[ti] 
OR "appropriateness criteria"[ti] OR ("evidence"[tw] AND ("indication"[tw] OR 
"indications"[tw])) OR (("Checklist"[Mesh] OR "checklist"[tw] OR "checklists"[tw]) 
AND ("indication"[tw] OR "indications"[tw])) OR "Guideline"[Publication Type] OR 
"Practice Guideline"[Publication Type] OR "Guidelines as Topic"[majr] OR "Practice 
Guidelines as Topic"[majr] OR (("guideline"[ti] OR "guidelines"[ti]) NOT "Guidelines 
for Authors"))) OR (("Osteoarthritis"[Mesh] OR "Osteoarthritis"[tw] OR "Osteoarthritides"[tw] 
OR "Osteoarthrosis"[tw] OR "Osteoarthroses"[tw] OR "Degenerative Arthritides"[tw] OR 
"Degenerative Arthritis"[tw] OR OA[ti]) AND ("Arthroplasty, Replacement, Knee"[majr] OR 
"Knee Prosthesis"[majr] OR "knee replacement arthroplasty"[ti] OR "total knee arthroplasty"[ti] 
OR "total knee"[ti] OR tka[ti] OR "tkr"[ti] OR "total knee replacement"[ti] OR "knee prosthesis"[ti] 
OR "knee implantation"[ti] OR "knee implant"[ti] OR "knee implants"[ti] OR "knee prosthesis"[ti] 
OR "knee joint replacement"[ti] OR "knee joint arthroplasty"[ti] OR "Knee Replacement 
Arthroplasties"[ti] OR "Total Knee Replacements"[ti] OR "Knee Prostheses"[ti] OR "Knee 
endoprosthesis"[ti] OR "Knee endoprostheses"[ti] OR "Knee joint arthroplasty"[ti] OR "Knee 
joint arthroplasties"[ti] OR "knee joint prosthesis"[ti] OR "knee joint prostheses"[ti] OR "knee 
prosthetic"[ti] OR "Knee endoprosthetic"[ti] OR "knee joint prosthetic"[ti] OR "Knee joint 
endoprosthetic"[ti] OR "knee prosthetics"[ti] OR "Knee endoprosthetics"[ti] OR "knee joint 
prosthetics"[ti] OR "Knee joint endoprosthetics"[ti] OR "Knee replacement"[ti] OR "Knee 
replacements"[ti] OR "knee arthroplasty"[ti] OR "knee arthroplasties"[ti] OR "Arthroplasty, 
Replacement, Hip"[majr] OR "Hip Prosthesis"[majr] OR "hip replacement arthroplasty"[ti] OR 
"total hip arthroplasty"[ti] OR "total hip"[ti] OR tha[ti] OR "thr"[ti] OR "total hip replacement"[ti] 
OR "hip prosthesis"[ti] OR "hip implantation"[ti] OR "hip implant"[ti] OR "hip implants"[ti] 
OR "hip prosthesis"[ti] OR "hip joint replacement"[ti] OR "hip joint arthroplasty"[ti] OR "Hip 
Replacement Arthroplasties"[ti] OR "Total Hip Replacements"[ti] OR "Hip Prostheses"[ti] OR 
"Hip endoprosthesis"[ti] OR "Hip endoprostheses"[ti] OR "Hip joint arthroplasty"[ti] OR "Hip joint 
arthroplasties"[ti] OR "hip joint prosthesis"[ti] OR "hip joint prostheses"[ti] OR "hip prosthetic"[ti] 
OR "Hip endoprosthetic"[ti] OR "hip joint prosthetic"[ti] OR "Hip joint endoprosthetic"[ti] OR 
"hip prosthetics"[ti] OR "Hip endoprosthetics"[ti] OR "hip joint prosthetics"[ti] OR "Hip joint 
endoprosthetics"[ti] OR "Hip replacement"[ti] OR "Hip replacements"[ti] OR "hip arthroplasty"[ti] 
OR "hip arthroplasties"[ti] OR (("total joint arthroplasty"[ti] OR "total joint replacement"[ti] 
OR "total joint prosthesis"[ti] OR "Arthroplasty, Replacement"[Majr:NoExp]) NOT 
(shoulder*[ti] OR ankle*[ti]))) AND ((decision[tw] AND "to operate"[tw]) OR "decision to 
treat"[tw] OR "treatment decision"[tw] OR "operation decision"[tw] OR "surgery decision"[tw] 
OR "intervention decision"[tw] OR "treatment decisions"[tw] OR "operation decisions"[tw] 
OR "surgery decisions"[tw] OR "intervention decisions"[tw] OR "Patient Selection"[Mesh] 
OR "patient selection"[tw] OR "Patient Selections"[tw] OR "Selection for Treatment"[tw] OR 
"Selection for Treatments"[tw] OR "Selection of Subjects"[tw] OR "Subjects Selection"[tw] 
OR "Subjects Selections"[tw] OR "Selection Criteria"[tw] OR "priority tool"[tw] OR "priority 
tools"[tw] OR "priority criteria"[tw] OR  "priority criterium"[tw] OR "indication set"[tw] OR 
"priority"[tw] OR "priorities"[tw] OR priorit*[tw] OR "indication"[tw] OR "indications"[tw] 
OR "appropriateness criteria"[tw] OR ("evidence"[tw] AND ("indication"[tw] OR 
"indications"[tw])) OR (("Checklist"[Mesh] OR "checklist"[tw] OR "checklists"[tw]) 
AND ("indication"[tw] OR "indications"[tw])) OR "Guideline"[Publication Type] OR 
"Practice Guideline"[Publication Type] OR "Guidelines as Topic"[Mesh] OR "Practice 
Guidelines as Topic"[Mesh] OR (("guideline"[tw] OR "guidelines"[tw]) NOT "Guidelines 
for Authors")))
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MEDLINE 
(OVID-
version)
((exp *Arthroplasty, Replacement, Knee/ OR exp *Knee Prosthesis/ OR "knee replacement 
arthroplasty".ti OR "total knee arthroplasty".ti OR "total knee".ti OR tka.ti OR "tkr".ti OR "total 
knee replacement".ti OR "knee prosthesis".ti OR "knee implantation".ti OR "knee implant".ti 
OR "knee implants".ti OR "knee prosthesis".ti OR "knee joint replacement".ti OR "knee joint 
arthroplasty".ti OR "Knee Replacement Arthroplasties".ti OR "Total Knee Replacements".ti OR 
"Knee Prostheses".ti OR "Knee endoprosthesis".ti OR "Knee endoprostheses".ti OR "Knee 
joint arthroplasty".ti OR "Knee joint arthroplasties".ti OR "knee joint prosthesis".ti OR "knee joint 
prostheses".ti OR "knee prosthetic".ti OR "Knee endoprosthetic".ti OR "knee joint prosthetic".
ti OR "Knee joint endoprosthetic".ti OR "knee prosthetics".ti OR "Knee endoprosthetics".
ti OR "knee joint prosthetics".ti OR "Knee joint endoprosthetics".ti OR "Knee replacement".
ti OR "Knee replacements".ti OR "knee arthroplasty".ti OR "knee arthroplasties".ti OR exp 
*Arthroplasty, Replacement, Hip/ OR exp *Hip Prosthesis/ OR "hip replacement arthroplasty".
ti OR "total hip arthroplasty".ti OR "total hip".ti OR tha.ti OR "thr".ti OR "total hip replacement".
ti OR "hip prosthesis".ti OR "hip implantation".ti OR "hip implant".ti OR "hip implants".
ti OR "hip prosthesis".ti OR "hip joint replacement".ti OR "hip joint arthroplasty".ti OR "Hip 
Replacement Arthroplasties".ti OR "Total Hip Replacements".ti OR "Hip Prostheses".ti OR 
"Hip endoprosthesis".ti OR "Hip endoprostheses".ti OR "Hip joint arthroplasty".ti OR "Hip joint 
arthroplasties".ti OR "hip joint prosthesis".ti OR "hip joint prostheses".ti OR "hip prosthetic".
ti OR "Hip endoprosthetic".ti OR "hip joint prosthetic".ti OR "Hip joint endoprosthetic".ti OR 
"hip prosthetics".ti OR "Hip endoprosthetics".ti OR "hip joint prosthetics".ti OR "Hip joint 
endoprosthetics".ti OR "Hip replacement".ti OR "Hip replacements".ti OR "hip arthroplasty".
ti OR "hip arthroplasties".ti OR (("total joint arthroplasty".ti OR "total joint replacement".
ti OR "total joint prosthesis".ti OR *Arthroplasty, Replacement/) NOT (shoulder*.ti OR 
ankle*.ti))) AND ((decision.ti AND "to operate".ti) OR "decision to operate".ti OR "decision 
to treat".ti OR "treatment decision".ti OR "operation decision".ti OR "surgery decision".ti OR 
"intervention decision".ti OR "treatment decisions".ti OR "operation decisions".ti OR "surgery 
decisions".ti OR "intervention decisions".ti OR exp Patient Selection/ OR "patient selection".
ti OR "Patient Selections".ti OR "Selection for Treatment".ti OR "Selection for Treatments".
ti OR "Selection of Subjects".ti OR "Subjects Selection".ti OR "Subjects Selections".ti OR 
"Selection Criteria".ti OR "priority tool".ti OR "priority tools".ti OR "priority criteria".ti OR  "priority 
criterium".ti OR "indication set".ti OR "priority".ti OR "priorities".ti OR priorit*.ti OR "indication".ti 
OR "indications".ti OR "appropriateness criteria".ti OR ("evidence".mp AND ("indication".
mp OR "indications".mp)) OR ((Checklist/ OR "checklist".mp OR "checklists".mp) AND 
("indication".mp OR "indications".mp)) OR exp Guideline/ OR exp Practice Guideline/ OR 
exp *"Guidelines as Topic"/ OR exp *"Practice Guidelines as Topic"/ OR (("guideline".
ti OR "guidelines".ti) NOT "Guidelines for Authors".ti,ab))) OR ((exp Osteoarthritis/ OR 
"Osteoarthritis".mp OR "Osteoarthritides".mp OR "Osteoarthrosis".mp OR "Osteoarthroses".
mp OR "Degenerative Arthritides".mp OR "Degenerative Arthritis".mp OR OA.ti) AND (exp 
*Arthroplasty, Replacement, Knee/ OR exp *Knee Prosthesis/ OR "knee replacement 
arthroplasty".ti OR "total knee arthroplasty".ti OR "total knee".ti OR tka.ti OR "tkr".ti OR "total 
knee replacement".ti OR "knee prosthesis".ti OR "knee implantation".ti OR "knee implant".ti 
OR "knee implants".ti OR "knee prosthesis".ti OR "knee joint replacement".ti OR "knee joint 
arthroplasty".ti OR "Knee Replacement Arthroplasties".ti OR "Total Knee Replacements".ti OR 
"Knee Prostheses".ti OR "Knee endoprosthesis".ti OR "Knee endoprostheses".ti OR "Knee 
joint arthroplasty".ti OR "Knee joint arthroplasties".ti OR "knee joint prosthesis".ti OR "knee joint 
prostheses".ti OR "knee prosthetic".ti OR "Knee endoprosthetic".ti OR "knee joint prosthetic".
ti OR "Knee joint endoprosthetic".ti OR "knee prosthetics".ti OR "Knee endoprosthetics".
ti OR "knee joint prosthetics".ti OR "Knee joint endoprosthetics".ti OR "Knee replacement".
ti OR "Knee replacements".ti OR "knee arthroplasty".ti OR "knee arthroplasties".ti OR exp 
*Arthroplasty, Replacement, Hip/ OR exp *Hip Prosthesis/ OR "hip replacement arthroplasty".
ti OR "total hip arthroplasty".ti OR "total hip".ti OR tha.ti OR "thr".ti OR "total hip replacement".
ti OR "hip prosthesis".ti OR "hip implantation".ti OR "hip implant".ti OR "hip implants".
ti OR "hip prosthesis".ti OR "hip joint replacement".ti OR "hip joint arthroplasty".ti OR "Hip 
Replacement Arthroplasties".ti OR "Total Hip Replacements".ti OR "Hip Prostheses".ti OR 
"Hip endoprosthesis".ti OR "Hip endoprostheses".ti OR "Hip joint arthroplasty".ti OR "Hip joint 
arthroplasties".ti OR "hip joint prosthesis".ti OR "hip joint prostheses".ti OR "hip prosthetic".
ti OR "Hip endoprosthetic".ti OR "hip joint prosthetic".ti OR "Hip joint endoprosthetic".ti OR 
"hip prosthetics".ti OR "Hip endoprosthetics".ti OR "hip joint prosthetics".ti OR "Hip joint 
endoprosthetics".ti OR "Hip replacement".ti OR "Hip replacements".ti OR "hip arthroplasty".
ti OR "hip arthroplasties".ti OR (("total joint arthroplasty".ti OR "total joint replacement".
ti OR "total joint prosthesis".ti OR *Arthroplasty, Replacement/) NOT (shoulder*.ti OR 
ankle*.ti))) AND ((decision.mp AND "to operate".mp) OR "decision to operate".mp OR "decision 
to treat".mp OR "treatment decision".mp OR "operation decision".mp OR "surgery decision".mp 
OR "intervention decision".mp OR "treatment decisions".mp OR "operation decisions".mp OR 
"surgery decisions".mp OR "intervention decisions".mp OR exp Patient Selection/ OR "patient 
selection".mp OR "Patient Selections".mp OR "Selection for Treatment".mp OR "Selection for 
Treatments".mp OR "Selection of Subjects".mp OR "Subjects Selection".mp OR "Subjects 
Selections".mp OR "Selection Criteria".mp OR "priority tool".mp OR "priority tools".mp OR 
"priority criteria".mp OR  "priority criterium".mp OR "indication set".mp OR "priority".mp OR 
"priorities".mp OR priorit*.mp OR "indication".mp OR "indications".mp OR "appropriateness 
criteria".mp OR ("evidence".mp AND ("indication".mp OR "indications".mp)) OR 
((Checklist/ OR "checklist".mp OR "checklists".mp) AND ("indication".mp OR 
"indications".mp)) OR exp Guideline/ OR exp Practice Guideline/ OR exp "Guidelines 
as Topic"/ OR exp "Practice Guidelines as Topic"/ OR (("guideline".mp OR "guidelines".
mp) NOT "Guidelines for Authors".mp)))
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Embase 
(OVID-
version)
(exp *Knee Arthroplasty/ OR exp *Knee Prosthesis/ OR "knee replacement arthroplasty".ti OR 
"total knee arthroplasty".ti OR "total knee".ti OR tka.ti OR "tkr".ti OR "total knee replacement".
ti OR "knee prosthesis".ti OR "knee implantation".ti OR "knee implant".ti OR "knee implants".
ti OR "knee prosthesis".ti OR "knee joint replacement".ti OR "knee joint arthroplasty".ti OR 
"Knee Replacement Arthroplasties".ti OR "Total Knee Replacements".ti OR "Knee Prostheses".
ti OR "Knee endoprosthesis".ti OR "Knee endoprostheses".ti OR "Knee joint arthroplasty".ti 
OR "Knee joint arthroplasties".ti OR "knee joint prosthesis".ti OR "knee joint prostheses".ti 
OR "knee prosthetic".ti OR "Knee endoprosthetic".ti OR "knee joint prosthetic".ti OR "Knee 
joint endoprosthetic".ti OR "knee prosthetics".ti OR "Knee endoprosthetics".ti OR "knee 
joint prosthetics".ti OR "Knee joint endoprosthetics".ti OR "Knee replacement".ti OR "Knee 
replacements".ti OR "knee arthroplasty".ti OR "knee arthroplasties".ti OR exp *Hip Arthroplasty/ 
OR exp *Hip Prosthesis/ OR "hip replacement arthroplasty".ti OR "total hip arthroplasty".
ti OR "total hip".ti OR tha.ti OR "thr".ti OR "total hip replacement".ti OR "hip prosthesis".
ti OR "hip implantation".ti OR "hip implant".ti OR "hip implants".ti OR "hip prosthesis".ti OR 
"hip joint replacement".ti OR "hip joint arthroplasty".ti OR "Hip Replacement Arthroplasties".
ti OR "Total Hip Replacements".ti OR "Hip Prostheses".ti OR "Hip endoprosthesis".ti OR 
"Hip endoprostheses".ti OR "Hip joint arthroplasty".ti OR "Hip joint arthroplasties".ti OR "hip 
joint prosthesis".ti OR "hip joint prostheses".ti OR "hip prosthetic".ti OR "Hip endoprosthetic".
ti OR "hip joint prosthetic".ti OR "Hip joint endoprosthetic".ti OR "hip prosthetics".ti OR "Hip 
endoprosthetics".ti OR "hip joint prosthetics".ti OR "Hip joint endoprosthetics".ti OR "Hip 
replacement".ti OR "Hip replacements".ti OR "hip arthroplasty".ti OR "hip arthroplasties".ti) 
AND ("decision to operate".ti OR "decision to treat".ti OR "treatment decision".ti OR "operation 
decision".ti OR "surgery decision".ti OR "intervention decision".ti OR "treatment decisions".
ti OR "operation decisions".ti OR "surgery decisions".ti OR "intervention decisions".ti OR 
exp Patient Selection/ OR "patient selection".ti OR "Patient Selections".ti OR "Selection for 
Treatment".ti OR "Selection for Treatments".ti OR "Selection of Subjects".ti OR "Subjects 
Selection".ti OR "Subjects Selections".ti OR "Selection Criteria".ti OR "priority tool".ti OR 
"priority tools".ti OR "priority criteria".ti OR  "priority criterium".ti OR "indication set".ti OR 
"priority".ti OR "priorities".ti OR priorit*.ti OR "indication".ti OR "indications".ti OR * treatment 
indication/ OR "appropriateness criteria".ti OR ("evidence".ti AND ("indication".ti OR 
"indications".ti)) OR ((Checklist/ OR "checklist".ti OR "checklists".ti) AND ("indication".
ti OR "indications".ti)) OR exp *practice guideline/ OR (("guideline".ti OR "guidelines".
ti) NOT "guidelines for authors".mp))) OR ((exp Osteoarthritis/ OR "Osteoarthritis".ti,ab OR 
"Osteoarthritides".ti,ab OR "Osteoarthrosis".ti,ab OR "Osteoarthroses".ti,ab OR "Degenerative 
Arthritides".ti,ab OR "Degenerative Arthritis".ti,ab OR OA.ti) AND (exp *Knee Arthroplasty/ OR 
exp *Knee Prosthesis/ OR "knee replacement arthroplasty".ti OR "total knee arthroplasty".ti 
OR "total knee".ti OR tka.ti OR "tkr".ti OR "total knee replacement".ti OR "knee prosthesis".
ti OR "knee implantation".ti OR "knee implant".ti OR "knee implants".ti OR "knee prosthesis".
ti OR "knee joint replacement".ti OR "knee joint arthroplasty".ti OR "Knee Replacement 
Arthroplasties".ti OR "Total Knee Replacements".ti OR "Knee Prostheses".ti OR "Knee 
endoprosthesis".ti OR "Knee endoprostheses".ti OR "Knee joint arthroplasty".ti OR "Knee joint 
arthroplasties".ti OR "knee joint prosthesis".ti OR "knee joint prostheses".ti OR "knee prosthetic".
ti OR "Knee endoprosthetic".ti OR "knee joint prosthetic".ti OR "Knee joint endoprosthetic".
ti OR "knee prosthetics".ti OR "Knee endoprosthetics".ti OR "knee joint prosthetics".ti OR 
"Knee joint endoprosthetics".ti OR "Knee replacement".ti OR "Knee replacements".ti OR "knee 
arthroplasty".ti OR "knee arthroplasties".ti OR exp *Hip Arthroplasty/ OR exp *Hip Prosthesis/ 
OR "hip replacement arthroplasty".ti OR "total hip arthroplasty".ti OR "total hip".ti OR tha.ti 
OR "thr".ti OR "total hip replacement".ti OR "hip prosthesis".ti OR "hip implantation".ti OR "hip 
implant".ti OR "hip implants".ti OR "hip prosthesis".ti OR "hip joint replacement".ti OR "hip 
joint arthroplasty".ti OR "Hip Replacement Arthroplasties".ti OR "Total Hip Replacements".
ti OR "Hip Prostheses".ti OR "Hip endoprosthesis".ti OR "Hip endoprostheses".ti OR "Hip 
joint arthroplasty".ti OR "Hip joint arthroplasties".ti OR "hip joint prosthesis".ti OR "hip joint 
prostheses".ti OR "hip prosthetic".ti OR "Hip endoprosthetic".ti OR "hip joint prosthetic".
ti OR "Hip joint endoprosthetic".ti OR "hip prosthetics".ti OR "Hip endoprosthetics".ti OR 
"hip joint prosthetics".ti OR "Hip joint endoprosthetics".ti OR "Hip replacement".ti OR "Hip 
replacements".ti OR "hip arthroplasty".ti OR "hip arthroplasties".ti) AND ("decision to operate".
ti,ab OR "decision to treat".ti,ab OR "treatment decision".ti,ab OR "operation decision".ti,ab 
OR "surgery decision".ti,ab OR "intervention decision".ti,ab OR "treatment decisions".ti,ab OR 
"operation decisions".ti,ab OR "surgery decisions".ti,ab OR "intervention decisions".ti,ab OR 
exp Patient Selection/ OR "patient selection".ti,ab OR "Patient Selections".ti,ab OR "Selection 
for Treatment".ti,ab OR "Selection for Treatments".ti,ab OR "Selection of Subjects".ti,ab OR 
"Subjects Selection".ti,ab OR "Subjects Selections".ti,ab OR "Selection Criteria".ti,ab OR 
"priority tool".ti,ab OR "priority tools".ti,ab OR "priority criteria".ti,ab OR  "priority criterium".ti,ab 
OR "indication set".ti,ab OR "priority".ti,ab OR "priorities".ti,ab OR priorit*.ti,ab OR "indication".
ti,ab OR "indications".ti,ab OR treatment indication/ OR "appropriateness criteria".ti,ab OR 
("evidence".ti,ab AND ("indication".ti,ab OR "indications".ti,ab)) OR ((Checklist/ OR 
"checklist".ti,ab OR "checklists".ti,ab) AND ("indication".ti,ab OR "indications".ti,ab)) 
OR exp practice guideline/ OR (("guideline".mp OR "guidelines".mp) NOT "guidelines 
for authors".mp)))
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TI=((Knee Arthroplasty OR Knee Prosthesis OR "knee replacement arthroplasty" OR "total knee 
arthroplasty" OR "total knee" OR tka OR "tkr" OR "total knee replacement" OR "knee prosthesis" 
OR "knee implantation" OR "knee implant" OR "knee implants" OR "knee prosthesis" OR "knee 
joint replacement" OR "knee joint arthroplasty" OR "Knee Replacement Arthroplasties" OR 
"Total Knee Replacements" OR "Knee Prostheses" OR "Knee endoprosthesis" OR "Knee 
endoprostheses" OR "Knee joint arthroplasty" OR "Knee joint arthroplasties" OR "knee joint 
prosthesis" OR "knee joint prostheses" OR "knee prosthetic" OR "Knee endoprosthetic" 
OR "knee joint prosthetic" OR "Knee joint endoprosthetic" OR "knee prosthetics" OR "Knee 
endoprosthetics" OR "knee joint prosthetics" OR "Knee joint endoprosthetics" OR "Knee 
replacement" OR "Knee replacements" OR "knee arthroplasty" OR "knee arthroplasties" 
OR Hip Arthroplasty OR Hip Prosthesis OR "hip replacement arthroplasty" OR "total hip 
arthroplasty" OR "total hip" OR tha OR "thr" OR "total hip replacement" OR "hip prosthesis" 
OR "hip implantation" OR "hip implant" OR "hip implants" OR "hip prosthesis" OR "hip joint 
replacement" OR "hip joint arthroplasty" OR "Hip Replacement Arthroplasties" OR "Total Hip 
Replacements" OR "Hip Prostheses" OR "Hip endoprosthesis" OR "Hip endoprostheses" 
OR "Hip joint arthroplasty" OR "Hip joint arthroplasties" OR "hip joint prosthesis" OR "hip 
joint prostheses" OR "hip prosthetic" OR "Hip endoprosthetic" OR "hip joint prosthetic" 
OR "Hip joint endoprosthetic" OR "hip prosthetics" OR "Hip endoprosthetics" OR "hip joint 
prosthetics" OR "Hip joint endoprosthetics" OR "Hip replacement" OR "Hip replacements" OR 
"hip arthroplasty" OR "hip arthroplasties") AND ("decision to operate" OR "decision to treat" 
OR "treatment decision" OR "operation decision" OR "surgery decision" OR "intervention 
decision" OR "treatment decisions" OR "operation decisions" OR "surgery decisions" OR 
"intervention decisions" OR Patient Selection OR "patient selection" OR "Patient Selections" 
OR "Selection for Treatment" OR "Selection for Treatments" OR "Selection of Subjects" OR 
"Subjects Selection" OR "Subjects Selections" OR "Selection Criteria" OR "priority tool" OR 
"priority tools" OR "priority criteria" OR  "priority criterium" OR "indication set" OR "priority" 
OR "priorities" OR priorit* OR "indication" OR "indications" OR * treatment indication OR 
"appropriateness criteria" OR ("evidence" AND ("indication" OR "indications")) OR 
((Checklist OR "checklist" OR "checklists") AND ("indication" OR "indications")) OR 
"guideline" OR "guidelines")) 
OR
TS=((Osteoarthritis OR "Osteoarthritis" OR "Osteoarthritides" OR "Osteoarthrosis" OR 
"Osteoarthroses" OR "Degenerative Arthritides" OR "Degenerative Arthritis" OR OA) AND 
(Knee Arthroplasty OR Knee Prosthesis OR "knee replacement arthroplasty" OR "total knee 
arthroplasty" OR "total knee" OR tka OR "tkr" OR "total knee replacement" OR "knee prosthesis" 
OR "knee implantation" OR "knee implant" OR "knee implants" OR "knee prosthesis" OR "knee 
joint replacement" OR "knee joint arthroplasty" OR "Knee Replacement Arthroplasties" OR 
"Total Knee Replacements" OR "Knee Prostheses" OR "Knee endoprosthesis" OR "Knee 
endoprostheses" OR "Knee joint arthroplasty" OR "Knee joint arthroplasties" OR "knee joint 
prosthesis" OR "knee joint prostheses" OR "knee prosthetic" OR "Knee endoprosthetic" 
OR "knee joint prosthetic" OR "Knee joint endoprosthetic" OR "knee prosthetics" OR "Knee 
endoprosthetics" OR "knee joint prosthetics" OR "Knee joint endoprosthetics" OR "Knee 
replacement" OR "Knee replacements" OR "knee arthroplasty" OR "knee arthroplasties" 
OR Hip Arthroplasty OR Hip Prosthesis OR "hip replacement arthroplasty" OR "total hip 
arthroplasty" OR "total hip" OR tha OR "thr" OR "total hip replacement" OR "hip prosthesis" 
OR "hip implantation" OR "hip implant" OR "hip implants" OR "hip prosthesis" OR "hip joint 
replacement" OR "hip joint arthroplasty" OR "Hip Replacement Arthroplasties" OR "Total Hip 
Replacements" OR "Hip Prostheses" OR "Hip endoprosthesis" OR "Hip endoprostheses" 
OR "Hip joint arthroplasty" OR "Hip joint arthroplasties" OR "hip joint prosthesis" OR "hip 
joint prostheses" OR "hip prosthetic" OR "Hip endoprosthetic" OR "hip joint prosthetic" 
OR "Hip joint endoprosthetic" OR "hip prosthetics" OR "Hip endoprosthetics" OR "hip joint 
prosthetics" OR "Hip joint endoprosthetics" OR "Hip replacement" OR "Hip replacements" OR 
"hip arthroplasty" OR "hip arthroplasties") AND ("decision to operate" OR "decision to treat" 
OR "treatment decision" OR "operation decision" OR "surgery decision" OR "intervention 
decision" OR "treatment decisions" OR "operation decisions" OR "surgery decisions" OR 
"intervention decisions" OR Patient Selection OR "patient selection" OR "Patient Selections" 
OR "Selection for Treatment" OR "Selection for Treatments" OR "Selection of Subjects" OR 
"Subjects Selection" OR "Subjects Selections" OR "Selection Criteria" OR "priority tool" OR 
"priority tools" OR "priority criteria" OR  "priority criterium" OR "indication set" OR "priority" 
OR "priorities" OR priorit* OR "indication" OR "indications" OR treatment indication OR 
"appropriateness criteria" OR ("evidence" AND ("indication" OR "indications")) OR 
((Checklist OR "checklist" OR "checklists") AND ("indication" OR "indications")) OR 
"guideline" OR "guidelines"))
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COCHRANE 
Library
title
((Knee Arthroplasty OR Knee Prosthesis OR "knee replacement arthroplasty" OR "total knee 
arthroplasty" OR "total knee" OR tka OR "tkr" OR "total knee replacement" OR "knee prosthesis" 
OR "knee implantation" OR "knee implant" OR "knee implants" OR "knee prosthesis" OR "knee 
joint replacement" OR "knee joint arthroplasty" OR "Knee Replacement Arthroplasties" OR 
"Total Knee Replacements" OR "Knee Prostheses" OR "Knee endoprosthesis" OR "Knee 
endoprostheses" OR "Knee joint arthroplasty" OR "Knee joint arthroplasties" OR "knee joint 
prosthesis" OR "knee joint prostheses" OR "knee prosthetic" OR "Knee endoprosthetic" 
OR "knee joint prosthetic" OR "Knee joint endoprosthetic" OR "knee prosthetics" OR "Knee 
endoprosthetics" OR "knee joint prosthetics" OR "Knee joint endoprosthetics" OR "Knee 
replacement" OR "Knee replacements" OR "knee arthroplasty" OR "knee arthroplasties" 
OR Hip Arthroplasty OR Hip Prosthesis OR "hip replacement arthroplasty" OR "total hip 
arthroplasty" OR "total hip" OR tha OR "thr" OR "total hip replacement" OR "hip prosthesis" 
OR "hip implantation" OR "hip implant" OR "hip implants" OR "hip prosthesis" OR "hip joint 
replacement" OR "hip joint arthroplasty" OR "Hip Replacement Arthroplasties" OR "Total Hip 
Replacements" OR "Hip Prostheses" OR "Hip endoprosthesis" OR "Hip endoprostheses" 
OR "Hip joint arthroplasty" OR "Hip joint arthroplasties" OR "hip joint prosthesis" OR "hip 
joint prostheses" OR "hip prosthetic" OR "Hip endoprosthetic" OR "hip joint prosthetic" 
OR "Hip joint endoprosthetic" OR "hip prosthetics" OR "Hip endoprosthetics" OR "hip joint 
prosthetics" OR "Hip joint endoprosthetics" OR "Hip replacement" OR "Hip replacements" OR 
"hip arthroplasty" OR "hip arthroplasties") AND ("decision to operate" OR "decision to treat" 
OR "treatment decision" OR "operation decision" OR "surgery decision" OR "intervention 
decision" OR "treatment decisions" OR "operation decisions" OR "surgery decisions" OR 
"intervention decisions" OR Patient Selection OR "patient selection" OR "Patient Selections" 
OR "Selection for Treatment" OR "Selection for Treatments" OR "Selection of Subjects" OR 
"Subjects Selection" OR "Subjects Selections" OR "Selection Criteria" OR "priority tool" OR 
"priority tools" OR "priority criteria" OR  "priority criterium" OR "indication set" OR "priority" 
OR "priorities" OR priorit* OR "indication" OR "indications" OR * treatment indication OR 
"appropriateness criteria" OR ("evidence" AND ("indication" OR "indications")) OR 
((Checklist OR "checklist" OR "checklists") AND ("indication" OR "indications")) OR 
"guideline" OR "guidelines")) 
OR 
title, abstract, keyword
((Osteoarthritis OR "Osteoarthritis" OR "Osteoarthritides" OR "Osteoarthrosis" OR 
"Osteoarthroses" OR "Degenerative Arthritides" OR "Degenerative Arthritis" OR OA) AND 
(Knee Arthroplasty OR Knee Prosthesis OR "knee replacement arthroplasty" OR "total knee 
arthroplasty" OR "total knee" OR tka OR "tkr" OR "total knee replacement" OR "knee prosthesis" 
OR "knee implantation" OR "knee implant" OR "knee implants" OR "knee prosthesis" OR "knee 
joint replacement" OR "knee joint arthroplasty" OR "Knee Replacement Arthroplasties" OR 
"Total Knee Replacements" OR "Knee Prostheses" OR "Knee endoprosthesis" OR "Knee 
endoprostheses" OR "Knee joint arthroplasty" OR "Knee joint arthroplasties" OR "knee joint 
prosthesis" OR "knee joint prostheses" OR "knee prosthetic" OR "Knee endoprosthetic" 
OR "knee joint prosthetic" OR "Knee joint endoprosthetic" OR "knee prosthetics" OR "Knee 
endoprosthetics" OR "knee joint prosthetics" OR "Knee joint endoprosthetics" OR "Knee 
replacement" OR "Knee replacements" OR "knee arthroplasty" OR "knee arthroplasties" 
OR Hip Arthroplasty OR Hip Prosthesis OR "hip replacement arthroplasty" OR "total hip 
arthroplasty" OR "total hip" OR tha OR "thr" OR "total hip replacement" OR "hip prosthesis" 
OR "hip implantation" OR "hip implant" OR "hip implants" OR "hip prosthesis" OR "hip joint 
replacement" OR "hip joint arthroplasty" OR "Hip Replacement Arthroplasties" OR "Total Hip 
Replacements" OR "Hip Prostheses" OR "Hip endoprosthesis" OR "Hip endoprostheses" 
OR "Hip joint arthroplasty" OR "Hip joint arthroplasties" OR "hip joint prosthesis" OR "hip 
joint prostheses" OR "hip prosthetic" OR "Hip endoprosthetic" OR "hip joint prosthetic" 
OR "Hip joint endoprosthetic" OR "hip prosthetics" OR "Hip endoprosthetics" OR "hip joint 
prosthetics" OR "Hip joint endoprosthetics" OR "Hip replacement" OR "Hip replacements" OR 
"hip arthroplasty" OR "hip arthroplasties") AND ("decision to operate" OR "decision to treat" 
OR "treatment decision" OR "operation decision" OR "surgery decision" OR "intervention 
decision" OR "treatment decisions" OR "operation decisions" OR "surgery decisions" OR 
"intervention decisions" OR Patient Selection OR "patient selection" OR "Patient Selections" 
OR "Selection for Treatment" OR "Selection for Treatments" OR "Selection of Subjects" OR 
"Subjects Selection" OR "Subjects Selections" OR "Selection Criteria" OR "priority tool" OR 
"priority tools" OR "priority criteria" OR  "priority criterium" OR "indication set" OR "priority" 
OR "priorities" OR priorit* OR "indication" OR "indications" OR treatment indication OR 
"appropriateness criteria" OR ("evidence" AND ("indication" OR "indications")) OR 
((Checklist OR "checklist" OR "checklists") AND ("indication" OR "indications")) OR 
"guideline" OR "guidelines"))
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CENTRAL title
(Knee Arthroplasty OR Knee Prosthesis OR "knee replacement arthroplasty" OR "total knee 
arthroplasty" OR "total knee" OR tka OR "tkr" OR "total knee replacement" OR "knee prosthesis" 
OR "knee implantation" OR "knee implant" OR "knee implants" OR "knee prosthesis" OR "knee 
joint replacement" OR "knee joint arthroplasty" OR "Knee Replacement Arthroplasties" OR 
"Total Knee Replacements" OR "Knee Prostheses" OR "Knee endoprosthesis" OR "Knee 
endoprostheses" OR "Knee joint arthroplasty" OR "Knee joint arthroplasties" OR "knee joint 
prosthesis" OR "knee joint prostheses" OR "knee prosthetic" OR "Knee endoprosthetic" 
OR "knee joint prosthetic" OR "Knee joint endoprosthetic" OR "knee prosthetics" OR "Knee 
endoprosthetics" OR "knee joint prosthetics" OR "Knee joint endoprosthetics" OR "Knee 
replacement" OR "Knee replacements" OR "knee arthroplasty" OR "knee arthroplasties" 
OR Hip Arthroplasty OR Hip Prosthesis OR "hip replacement arthroplasty" OR "total hip 
arthroplasty" OR "total hip" OR tha OR "thr" OR "total hip replacement" OR "hip prosthesis" 
OR "hip implantation" OR "hip implant" OR "hip implants" OR "hip prosthesis" OR "hip joint 
replacement" OR "hip joint arthroplasty" OR "Hip Replacement Arthroplasties" OR "Total Hip 
Replacements" OR "Hip Prostheses" OR "Hip endoprosthesis" OR "Hip endoprostheses" 
OR "Hip joint arthroplasty" OR "Hip joint arthroplasties" OR "hip joint prosthesis" OR "hip 
joint prostheses" OR "hip prosthetic" OR "Hip endoprosthetic" OR "hip joint prosthetic" 
OR "Hip joint endoprosthetic" OR "hip prosthetics" OR "Hip endoprosthetics" OR "hip joint 
prosthetics" OR "Hip joint endoprosthetics" OR "Hip replacement" OR "Hip replacements" OR 
"hip arthroplasty" OR "hip arthroplasties") AND ("decision to operate" OR "decision to treat" 
OR "treatment decision" OR "operation decision" OR "surgery decision" OR "intervention 
decision" OR "treatment decisions" OR "operation decisions" OR "surgery decisions" OR 
"intervention decisions" OR Patient Selection OR "patient selection" OR "Patient Selections" 
OR "Selection for Treatment" OR "Selection for Treatments" OR "Selection of Subjects" OR 
"Subjects Selection" OR "Subjects Selections" OR "Selection Criteria" OR "priority tool" OR 
"priority tools" OR "priority criteria" OR  "priority criterium" OR "indication set" OR "priority" 
OR "priorities" OR priorit* OR "indication" OR "indications" OR treatment indication OR 
"appropriateness criteria" OR ("evidence" AND ("indication" OR "indications")) OR 
((Checklist OR "checklist" OR "checklists") AND ("indication" OR "indications")) OR 
"guideline" OR "guidelines")
OR 
title, abstract, keyword
((Osteoarthritis OR "Osteoarthritis" OR "Osteoarthritides" OR "Osteoarthrosis" OR 
"Osteoarthroses" OR "Degenerative Arthritides" OR "Degenerative Arthritis" OR OA) AND 
(Knee Arthroplasty OR Knee Prosthesis OR "knee replacement arthroplasty" OR "total knee 
arthroplasty" OR "total knee" OR tka OR "tkr" OR "total knee replacement" OR "knee prosthesis" 
OR "knee implantation" OR "knee implant" OR "knee implants" OR "knee prosthesis" OR "knee 
joint replacement" OR "knee joint arthroplasty" OR "Knee Replacement Arthroplasties" OR 
"Total Knee Replacements" OR "Knee Prostheses" OR "Knee endoprosthesis" OR "Knee 
endoprostheses" OR "Knee joint arthroplasty" OR "Knee joint arthroplasties" OR "knee joint 
prosthesis" OR "knee joint prostheses" OR "knee prosthetic" OR "Knee endoprosthetic" 
OR "knee joint prosthetic" OR "Knee joint endoprosthetic" OR "knee prosthetics" OR "Knee 
endoprosthetics" OR "knee joint prosthetics" OR "Knee joint endoprosthetics" OR "Knee 
replacement" OR "Knee replacements" OR "knee arthroplasty" OR "knee arthroplasties" 
OR Hip Arthroplasty OR Hip Prosthesis OR "hip replacement arthroplasty" OR "total hip 
arthroplasty" OR "total hip" OR tha OR "thr" OR "total hip replacement" OR "hip prosthesis" 
OR "hip implantation" OR "hip implant" OR "hip implants" OR "hip prosthesis" OR "hip joint 
replacement" OR "hip joint arthroplasty" OR "Hip Replacement Arthroplasties" OR "Total Hip 
Replacements" OR "Hip Prostheses" OR "Hip endoprosthesis" OR "Hip endoprostheses" 
OR "Hip joint arthroplasty" OR "Hip joint arthroplasties" OR "hip joint prosthesis" OR "hip 
joint prostheses" OR "hip prosthetic" OR "Hip endoprosthetic" OR "hip joint prosthetic" 
OR "Hip joint endoprosthetic" OR "hip prosthetics" OR "Hip endoprosthetics" OR "hip joint 
prosthetics" OR "Hip joint endoprosthetics" OR "Hip replacement" OR "Hip replacements" OR 
"hip arthroplasty" OR "hip arthroplasties") AND ("decision to operate" OR "decision to treat" 
OR "treatment decision" OR "operation decision" OR "surgery decision" OR "intervention 
decision" OR "treatment decisions" OR "operation decisions" OR "surgery decisions" OR 
"intervention decisions" OR Patient Selection OR "patient selection" OR "Patient Selections" 
OR "Selection for Treatment" OR "Selection for Treatments" OR "Selection of Subjects" OR 
"Subjects Selection" OR "Subjects Selections" OR "Selection Criteria" OR "priority tool" OR 
"priority tools" OR "priority criteria" OR  "priority criterium" OR "indication set" OR "priority" 
OR "priorities" OR priorit* OR "indication" OR "indications" OR treatment indication OR 
"appropriateness criteria" OR ("evidence" AND ("indication" OR "indications")) OR 
((Checklist OR "checklist" OR "checklists") AND ("indication" OR "indications")) OR 
"guideline" OR "guidelines"))
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CINAHL title
(Knee Arthroplasty OR Knee Prosthesis OR "knee replacement arthroplasty" OR "total knee 
arthroplasty" OR "total knee" OR tka OR "tkr" OR "total knee replacement" OR "knee prosthesis" 
OR "knee implantation" OR "knee implant" OR "knee implants" OR "knee prosthesis" OR "knee 
joint replacement" OR "knee joint arthroplasty" OR "Knee Replacement Arthroplasties" OR 
"Total Knee Replacements" OR "Knee Prostheses" OR "Knee endoprosthesis" OR "Knee 
endoprostheses" OR "Knee joint arthroplasty" OR "Knee joint arthroplasties" OR "knee joint 
prosthesis" OR "knee joint prostheses" OR "knee prosthetic" OR "Knee endoprosthetic" 
OR "knee joint prosthetic" OR "Knee joint endoprosthetic" OR "knee prosthetics" OR "Knee 
endoprosthetics" OR "knee joint prosthetics" OR "Knee joint endoprosthetics" OR "Knee 
replacement" OR "Knee replacements" OR "knee arthroplasty" OR "knee arthroplasties" 
OR Hip Arthroplasty OR Hip Prosthesis OR "hip replacement arthroplasty" OR "total hip 
arthroplasty" OR "total hip" OR tha OR "thr" OR "total hip replacement" OR "hip prosthesis" 
OR "hip implantation" OR "hip implant" OR "hip implants" OR "hip prosthesis" OR "hip joint 
replacement" OR "hip joint arthroplasty" OR "Hip Replacement Arthroplasties" OR "Total Hip 
Replacements" OR "Hip Prostheses" OR "Hip endoprosthesis" OR "Hip endoprostheses" 
OR "Hip joint arthroplasty" OR "Hip joint arthroplasties" OR "hip joint prosthesis" OR "hip 
joint prostheses" OR "hip prosthetic" OR "Hip endoprosthetic" OR "hip joint prosthetic" 
OR "Hip joint endoprosthetic" OR "hip prosthetics" OR "Hip endoprosthetics" OR "hip joint 
prosthetics" OR "Hip joint endoprosthetics" OR "Hip replacement" OR "Hip replacements" OR 
"hip arthroplasty" OR "hip arthroplasties") AND ("decision to operate" OR "decision to treat" 
OR "treatment decision" OR "operation decision" OR "surgery decision" OR "intervention 
decision" OR "treatment decisions" OR "operation decisions" OR "surgery decisions" OR 
"intervention decisions" OR Patient Selection OR "patient selection" OR "Patient Selections" 
OR "Selection for Treatment" OR "Selection for Treatments" OR "Selection of Subjects" OR 
"Subjects Selection" OR "Subjects Selections" OR "Selection Criteria" OR "priority tool" OR 
"priority tools" OR "priority criteria" OR  "priority criterium" OR "indication set" OR "priority" 
OR "priorities" OR priorit* OR "indication" OR "indications" OR treatment indication OR 
"appropriateness criteria" OR ("evidence" AND ("indication" OR "indications")) OR 
((Checklist OR "checklist" OR "checklists") AND ("indication" OR "indications")) OR 
"guideline" OR "guidelines")
OR 
title, abstract, keyword
((Osteoarthritis OR "Osteoarthritis" OR "Osteoarthritides" OR "Osteoarthrosis" OR 
"Osteoarthroses" OR "Degenerative Arthritides" OR "Degenerative Arthritis" OR OA) AND 
(Knee Arthroplasty OR Knee Prosthesis OR "knee replacement arthroplasty" OR "total knee 
arthroplasty" OR "total knee" OR tka OR "tkr" OR "total knee replacement" OR "knee prosthesis" 
OR "knee implantation" OR "knee implant" OR "knee implants" OR "knee prosthesis" OR "knee 
joint replacement" OR "knee joint arthroplasty" OR "Knee Replacement Arthroplasties" OR 
"Total Knee Replacements" OR "Knee Prostheses" OR "Knee endoprosthesis" OR "Knee 
endoprostheses" OR "Knee joint arthroplasty" OR "Knee joint arthroplasties" OR "knee joint 
prosthesis" OR "knee joint prostheses" OR "knee prosthetic" OR "Knee endoprosthetic" 
OR "knee joint prosthetic" OR "Knee joint endoprosthetic" OR "knee prosthetics" OR "Knee 
endoprosthetics" OR "knee joint prosthetics" OR "Knee joint endoprosthetics" OR "Knee 
replacement" OR "Knee replacements" OR "knee arthroplasty" OR "knee arthroplasties" 
OR Hip Arthroplasty OR Hip Prosthesis OR "hip replacement arthroplasty" OR "total hip 
arthroplasty" OR "total hip" OR tha OR "thr" OR "total hip replacement" OR "hip prosthesis" 
OR "hip implantation" OR "hip implant" OR "hip implants" OR "hip prosthesis" OR "hip joint 
replacement" OR "hip joint arthroplasty" OR "Hip Replacement Arthroplasties" OR "Total Hip 
Replacements" OR "Hip Prostheses" OR "Hip endoprosthesis" OR "Hip endoprostheses" 
OR "Hip joint arthroplasty" OR "Hip joint arthroplasties" OR "hip joint prosthesis" OR "hip 
joint prostheses" OR "hip prosthetic" OR "Hip endoprosthetic" OR "hip joint prosthetic" 
OR "Hip joint endoprosthetic" OR "hip prosthetics" OR "Hip endoprosthetics" OR "hip joint 
prosthetics" OR "Hip joint endoprosthetics" OR "Hip replacement" OR "Hip replacements" OR 
"hip arthroplasty" OR "hip arthroplasties") AND ("decision to operate" OR "decision to treat" 
OR "treatment decision" OR "operation decision" OR "surgery decision" OR "intervention 
decision" OR "treatment decisions" OR "operation decisions" OR "surgery decisions" OR 
"intervention decisions" OR Patient Selection OR "patient selection" OR "Patient Selections" 
OR "Selection for Treatment" OR "Selection for Treatments" OR "Selection of Subjects" OR 
"Subjects Selection" OR "Subjects Selections" OR "Selection Criteria" OR "priority tool" OR 
"priority tools" OR "priority criteria" OR  "priority criterium" OR "indication set" OR "priority" 
OR "priorities" OR priorit* OR "indication" OR "indications" OR treatment indication OR 
"appropriateness criteria" OR ("evidence" AND ("indication" OR "indications")) OR 
((Checklist OR "checklist" OR "checklists") AND ("indication" OR "indications")) OR 
"guideline" OR "guidelines"))
51
Total 3065
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ABSTRACT
Background
This systematic review examines which patient related factors influence functional and 
clinical outcomes after total hip arthroplasty (THA) in patients with hip osteoarthritis 
(OA).
Methods
We performed a systematic review according to the PRISMA guidelines. We searched 
databases and trial registries for prospective studies including OA patients who 
underwent primary THA. Studies with preoperative measurements on predictors, with 
at least 1 year follow-up were included. Risk of bias and confounding was assessed for 
two domains: follow-up rate and looking at independent effects.
Results
Thirty-five studies were included (138,039 patients). Only nine studies (29 %) had low 
risk of bias for all domains thus suggesting an overall low quality of evidence. Studies 
were heterogeneous in the predictors tested and in the observed directions of the 
associations. Overall, preoperative function (13 studies (37 %), 2 with low risk of bias) 
and radiological OA (6 studies (17 %), 1 with low risk of bias) were predictors with the 
most consistent findings. Worse preoperative function and more severe radiological 
OA were associated with larger postoperative improvement. However, these patients 
never reached the level of postoperative functioning as patients with better preoperative 
function or less severe radiological OA. For age, gender, comorbidity, pain and quality 
of life the results of studies were conflicting. For BMI, some studies (n = 5, 2 with low 
risk of bias) found worse outcomes for patients with higher BMI. However, substantial 
improvement was still achieved regardless of their BMI.
Conclusion
There is not enough evidence to draw succinct conclusions on preoperative predictors 
for postoperative outcome in THA, as results of studies are conflicting and the 
methodological quality is low. Results suggest to focus on preoperative function and 
radiological osteoarthritis to decide when THA will be most effective. The present 
mapping of current evidence on the relationship between patient related factors and 
outcomes provides better information compared to individual studies and may help to 
set patient expectations before surgery. In addition, these findings may contribute to 
discussions on how to achieve the best possible postoperative outcome for specific 
patient groups.
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BACKGROUND
Total Hip Arthroplasty (THA) is an effective treatment for most individuals who suffer 
from pain and loss of function due to end stage symptomatic hip osteoarthritis (OA). 
Parallel to the rising prevalence of hip OA, surgery rates are rising as well [1-4].
THA should not be given too early since the longevity of a prosthesis is limited [5] and 
outcomes after revision THA are generally worse compared to primary THA. Furthermore, 
about 10-15% of the patients is not satisfied after primary THA [6,7]. Therefore, defined 
criteria to assess when patients will benefit most from surgery are clearly warranted, as 
it may sometimes be better to first optimize the patient’s preoperative condition. Current 
practice suggests that disease severity and timing of surgery vary largely among centers 
and countries [8,9]. The development of defined criteria to assess which patients will 
benefit most from surgery would preferably be based on the best available evidence. 
Previous reviews on which predictors determine outcome after THA were conducted 
some time ago or mainly focused on patient characteristics such as age, gender, 
socio economic status (SES)/ education and BMI [10,11]. Other patient related factors, 
such as preoperative function, pain and quality of life, were not included. Providing 
such an overview may contribute to discussions on how to achieve the best possible 
postoperative outcome for specific patient groups. 
Therefore, aim of this study is to conduct a systematic review examining which 
preoperative patient related factors influence functional and clinical outcomes after THA 
in OA patients.
METHODS
We performed a systematic review according to the PRISMA guidelines. This systematic 
review was registered in Prospero, registration number RD42014009977.
Search strategy
A search strategy was composed together with a trained librarian (see Additional file 
1). On PubMed, MEDLINE (Ovid version), EMBASE (Ovid version), Web of Science, 
The Cochrane Library, CENTRAL, and CINAHL articles were searched published up to 
August 8, 2014. The search strategy consisted of the AND combination of five concepts: 
osteoarthritis, hip replacement, predictive determinants, postoperative, and functional 
and clinical outcomes. All relevant keyword variations were used, not only those in the 
controlled vocabularies of the various databases, but the free text word variations of 
these concepts as well.
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The search strategy was optimized for all databases, taking into account differences of 
the controlled vocabularies as well as database-specific technical variations (e.g., the 
use of quotation marks). Animal-only studies were excluded. Additional strategies were 
composed for PubMed to find (1) studies not focusing on OA, (2) studies on patient 
satisfaction or activities of daily living, and (3) studies with the word after instead of 
postoperative.
Inclusion of articles
We included prospective studies among primary hip OA patients who underwent 
primary THA, with preoperative and postoperative measurements on functional or 
clinical outcomes and a follow-up of at least one year. If studies included both THA 
and TKA patients, we only extracted the THA data. Thus the results after THA had to be 
described separately. We included predictors that could be determined using standard 
tests or questions used in clinical practice (i.e. patient characteristics, radiological 
images, questionnaires or physical exams). These variables could be the focus of the 
study, or included as confounder or covariate.
Articles were excluded with metal-on-metal prostheses, osteotomies before THA, only 
including bilateral surgeries, more than 5% of the patients had other diagnoses than 
primary OA (i.e. secondary OA or rheumatoid arthritis) or different diagnoses could not 
be stratified, or more than 5% of the population had received a revision and could not be 
stratified from primary THA. Furthermore, we excluded articles when results for hip and 
knee OA could not be stratified, data were collected retrospectively (i.e. preoperative 
status assessed after surgery) or if no full text was available online, via our library or after 
mailing the authors. In addition, studies were excluded when baseline scores were not 
reported, which is important to interpret the postoperative outcomes. Only for adverse 
outcomes such as loosening or complications, this was not applicable therefore these 
studies were included.
Selection of studies
Articles were selected in two steps. First, two researchers (SH and MG) independently 
excluded articles based on the title and/or the abstract. Second, one researcher (SH) 
excluded articles based on the full text. A second researcher (MG) checked whether 
selected articles met the inclusion criteria.
Assessment of risk of bias in included studies 
Risk of bias was assessed by one author (SH) and checked by a second author (MG). 
It is unclear from the literature which elements causing risk of bias in observational 
studies should be assessed. Therefore, we tailored the risk of bias assessment to our 
research question, focusing on study design features that could potentially bias the 
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association between exposure and outcome. Risk of bias was thus assessed for the 
following domains: 
Follow-up rate: less than 20% loss to follow-up at 1 year was considered to represent 
low risk of bias [12,13]. For longer follow-up, we considered 10% loss to follow-up extra 
for each additional year as low risk of bias. Since reasons for loss to follow-up/ non-
responders were often not reported, we counted all loss to follow-up regardless of the 
reason.
Looking at independent effects: e.g. the use of a multivariable model in etiological 
studies or a prediction model. For example when adjustments in analyses were made 
for confounding factors (at least one), it was considered as low risk of bias. 
When no consensus between the two review authors was reached, a third review author 
(PM) was consulted for the final decision.
Data extraction
Data were extracted using a pre-defined data extraction form. Articles meeting the 
criteria were closely examined and data were extracted by one author (SH) and checked 
by a second author (MG). When no consensus could be reached, a third review author 
(PM) was consulted. We extracted the following information: sample size, gender, age, 
follow-up time, follow-up rate and adjustments in statistical analyses. Furthermore, we 
reported each predictor for all outcomes per study and their direction. 
The following predictors were included:
• Patient characteristics: age, gender, SES/education, BMI
• Disease characteristics: radiological OA severity, comorbidities
• Patient expectations
• Pain
• Function
• Health related quality of life
• Mental well-being
All reported outcomes at different follow-up moments (≥1 year) for the above described 
predicting factors were extracted as reported in the included study. We examined both 
the change in outcome scores (postoperative score - preoperative score) and the level 
of the postoperative outcome, as patients with lower baseline scores are more likely 
to improve, but may not reach the same postoperative levels as patients with higher 
baseline scores.
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Given the heterogeneity of predictors and outcomes, pooling of data using meta-
analysis was not possible so that only descriptive analyses were conducted.
RESULTS
Search
The bibliographic databases yielded a total of 2,595 references and 46 additional 
studies in trial registers (figure 1). Full-text papers of 208 references were assessed for 
eligibility. We excluded 170 articles, mainly because more than 5% of the population 
had a diagnosis other than primary OA or a revision surgery. Thirty-five studies fulfilled 
our inclusion criteria. 
Risk of bias 
Table 1 shows that 14 studies (40%) had low risk of bias for the follow-up domain. Eight 
studies [14-21] had a high risk of bias on this domain. One study [22] had a loss to 
follow-up of >20% in the first and third year, but a low loss to follow-up at 5 and 7 years, 
so that risk of bias was unclear. Twelve studies had unclear risk of bias as the loss to 
follow-up was not described. Four of these studies were registry studies [23-26] and one 
study [27] was based on Medicare claims. 
Most studies (n=28) adjusted for confounders or used a prediction model (low risk of 
bias), but differed from stratifying for one variable to multivariable adjustment (table 1). 
Seven studies [26,28-33] did not adjust for other factors in the analyses (high risk of 
bias). 
Only nine studies (29%) had low risk of bias across both domains: Cushnaghan [34], 
Davis [35], Gandhi [36], Gordon [37,38], Fortin [39], Judge [40], McHugh [41], and 
	
Figure	1.	Flow	diagram	of	included	and	excluded	publications	
	
	
	
	 	
Publications	retrieved	through	electronic	searches	(n=5,428)	
Potential	relevant	publications	(n=2,595)	and	trials	(n=46)	
Duplicates	(n=2,787)	
Publications	selected	based	on	abstract	(n=208)	
Publications	excluded	based	on	title/	abstract	(n=2,433)	
Publications	selected	based	on	full	text	(n=35)	
Publications	excluded	based	on	exclusion	criteria	(n=170)	
Figure 1. Flow diagram of included and excluded publications
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Table 1. Risk of bias and confounding
First author, year Follow-up 
(years)
Follow-up (% 
missing)
Looking at independent effects 
Bethge, 2010 [14] 1 28.9 Age, gender and self-efficacy expectations
Clement, 2011 [43] 1 ND Age
Clement, 2011 [47] 1 ND Age, SF-12 scores and length of stay
Cushnaghan, 2007 
[34]
Mean 8.8 48 cases
53 controls
Prediction model
Davis, 2011 [35] 5 HHS: 28
SF-36: 32
Age, gender, operating consultant, and 
a diagnosis of cancer, atherosclerotic 
disease, cardiac disease, diabetes mellitus, 
osteoporosis and phlebitis
Duivenvoorden, 2013 
[15]
1 31 Age, gender, time spent on waiting list and 
unbalanced characteristics between study 
population and patients lost to follow-up
Gandhi, 2010 [36] Mean 3.3 14 at 1 year 
follow-up
Age, gender, BMI, SF-36 Mental Health (MH) 
scores, method of fixation (cemented vs 
uncemented), and comorbidity
Gordon, 2014 [37] 1 8 Age, gender, Charnley classification, 
previous contralateral THR, and preoperative 
pain VAS
Gordon, 2014 [38] 1 8 Gender, previous contralateral hip surgery, 
pain, and Charnley classification
Greene, 2014 [16] 1 66.7 Bayesian model averaging with age, 
gender, Charnley classification, presence of 
comorbidities, whether the included hip was 
the first or second in the time interval, marital 
status, and education level
Fortin, 2002 [39] 2 25.7a Age, gender, education, and comorbidity
Haverkamp, 2013 [28] Mean 2.3 18.6a No
Heiberg, 2013 [17] 1 27.3 Prediction model
Ieiri, 2013 [49] 1 and 3 ND Canonical correlation analysis
Johansson, 2010 [29] 2 ND No
Judge, 2014 [19] 1 30.8 Age, sex, SF-36 mental health, comorbidities, 
fixed flexion, analgesic use, college 
education, OA in other joints, expectation 
of less pain, radiological K&L grade, ASA 
grade, years of hip pain
Judge, 2013 [40] each year up 
to 5
20 at 1 year, 
30 at 5 year
Multivariable model
Judge, 2012 [48] Mean 8 61.3b Prediction model
Judge, 2011 [18] 1 31.6 Age, sex, school education, ASA grade, K&L 
grade, BMI, medication use
Katz, 2012 [27] 12 ND Patient age, sex, race, Medicaid eligibility, 
comorbidity and hospital and surgeon annual 
THA volume
Kennedy, 2011 [44] Up to 1.3 ND Age, gender, body mass index
Keurentjes, 2013 [20] 1.5-6 54.1a Age, sex, Charnley Comorbidity 
Classification and BMI
McHugh, 2013 [41] 1 11.7 Multivariable model
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First author, year Follow-up 
(years)
Follow-up (% 
missing)
Looking at independent effects 
Meding, 2000 [22] Mean 2.7 11.4 at 1 
year, 37.2 at 
3 years, 64.8 
at 5 years and 
84.3 at 7 years
Age and gender
Nikolajsen, 2006 [30] 1-1.5 6.4 No
Nilsdotter, 2003 [42] Mean 3.6 9.6 Multivariable model
Nilsdotter, 2002 [32] 1 16.2 No
Nilsdotter, 2001 [31] 1 11.9 No
Röder, 2007 [24] Mean 4.3 ND (registry 
study)
Gender, age, and follow-up year
Rolfson, 2009 [23] 1 ND (registry 
study)
Age, gender and comorbidity
Sadr Azodi, 2008 [25] 3 ND (registry 
study)
Age at the time of surgery, calendar period, 
and fixation principle
Sarasqueta, 2012 [21] 1 29 Prediction model
Stickles, 2001 [26] 1 ND (registry 
study)
No
Street, 2005 [33] 1 and 2 ND No
Tanaka, 2010 [45] 1 ND Age, sex, changes in the LLD,
vertical ATD, femoral offset, and the 
horizontal and vertical position of the 
center of the femoral head, stage of hip 
OA (advanced or terminal); HHS, and the 
duration of OA
SF-12: 12-item Short Form Health Survey; HHS: Harris Hip Score; SF-36: 36-item Short Form Health 
Survey; BMI: Body Mass Index; MH: Mental Health; THR: Total Hip Replacement; VAS: Visual Analogue 
Scale; OA: OsteoArthritis; K&L grade: Kellgren-Lawrence; ASA: American Society of Anesthesiologists; 
LLD: Leg Length Discrepancy; ATD: Articulotrochanteric Distance
ND: not described or partly described
aFor patients with THA and TKA, not separately described
bAt six months
Nilsdotter [42], to which we will refer as low risk of bias studies. Thus most studies had 
unclear or high risk of bias for least one domain, to which we will refer as high risk of bias 
studies, suggesting overall low quality of evidence.
Study characteristics
The 35 included studies were all observational cohort studies. Table 2 shows that 
studies differ considerably in which factors predict outcomes after THA, given that only 
few significant associations were found per combination of a prognostic factor and 
outcome. Many studies assessed the effect of a prognostic factor on more than one 
outcome, as such it was possible to find a significant association for one outcome while 
no association with another outcome was found. As a result, a study may be described 
below both as a significant and a non-significant association. Most studies 
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assessed outcomes through self-reported questionnaires and if the Harris Hip Score 
was used [29,33] it was often not described who performed the physical examination. 
Additional file 2 shows the number of patients in each included study, the gender and 
age distribution, follow-up time, and significant associations observed. A total of 138,039 
patients were included with average age from 60-84 years. Four studies used registry 
data [23-26] and one study used Medicare claims data [27]. The follow-up time varied 
from 1 year to a mean of 12 years [27]. 
Prognostic factors
Age
Eleven studies (31%) reported that the outcome was significantly influenced by age 
(additional file 2), of which five studies had low risk of bias. Two of these low risk of bias 
studies found a nonlinear relationship with age. Gordon et al. [38] found that outcomes 
were fairly unaffected by age until patients were in their late sixties, after which age 
had a negative effect on the EQ-5D. Judge et al. [40] found a small, not clinically 
relevant, effect of patients aged 50-60 reaching better postoperative Oxford Hip Scores 
(OHS). The three other studies found that older patients had smaller improvements or 
worse outcomes, but most differences were small [34,36,42]. Furthermore, the study of 
Cushnaghan et al. [34] was one of the few studies with a longer follow-up (~8 years) 
and a control group. Although a higher age predicted smaller changes in the SF-36 
(Physical Function (PF)) in this study, this difference was also found in the control group 
suggesting that the effect is explained by ageing. Most of the high risk of bias studies 
also found that older patients had smaller improvements or worse outcomes, but that 
most differences were small [17,32,43-45]. Furthermore, Clement et al. [43] found 
that patients aged ≤80 years had a greater, but not clinically relevant improvement 
on the SF-12. Despite smaller improvements for older patients (>80 years), they were 
more satisfied after THA. Another study found that older patients (>75 years) had a 
higher revision rate than younger patients (65-75 years) [27]. Eight studies tested the 
association between age and outcomes such as SF-12 MCS, OHS (pain), post-operative 
complications, walking distance, LEFS, SF-36, WOMAC, EQ-5D and gait improvement, 
but did not find significant effects [16,18,21,32,41,43-45]. One of these studies had low 
risk of bias [41].
Gender
Ten studies (29%) reported associations between gender and outcomes in different 
directions. Three studies had low risk of bias. Cushnaghan et al. [34] reported that 
females had smaller improvements on the SF-36 (PF) scale. However, this was found 
in both cases and controls regardless of arthroplasty. Gandhi et al. [36] on the other 
hand, reported worse outcomes for males on the SF-36 (PF) and Gordon et al. [37] 
reported higher EQ-5D scores for males. Of the other high risk of bias studies, Greene 
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et al. and Rolfson et al. [16,23] found women were less satisfied. Heiberg et al. [17] 
found that males reached better scores of walking distance (on the 6-minute walk test 
(6MWT)) (60.3 meters more than women), which is a clinically relevant difference [46]. 
However, they did not use a control group and it may be that healthy male controls also 
reach better scores of walking distance compared to females. Furthermore, Katz et al. 
[27] found higher rates of revision in men than in women. Many studies investigated the 
association but did not find any significant associations of gender and various outcomes 
such as WOMAC, SF-36, pain, EQ VAS and gait improvement [16,18,21,23,31,32,36,37,
41,42,45]. Four of these studies had low risk of bias [36,37,41,42].
SES/ education
Only three studies (9%) reported an association between socioeconomic status 
or education and outcomes. None of these studies had low risk of bias. The studies 
reported more favorable outcomes following surgery in patients with a higher education 
[16,18] or SES [47]. Sarasqueta et al. [21] did not find an association between education 
level and WOMAC.
Comorbidities
Comorbidities were associated with worse outcomes in 7 studies (20%), of which four 
studies had low risk of bias [34,36,37,40]. These low risk of bias studies found that 
patients with comorbidities had worse outcomes. However, the size of the effects varied 
from having a small effect for patients with comorbidities on the OHS [40] to a large 
effect for patients with diabetes on the SF-36 [34]. Gandhi et al. [36] found that patients 
with comorbidities scored worse on the WOMAC and the SF-36. Another low risk of 
bias study found that a higher Charnley comorbidity class was associated with worse 
outcomes on the EQ-5D [37]. The same results were also found in two high risk of bias 
studies [16,23]. In addition, Judge et al. [48] found an association between number of 
painful joint sites and worse outcomes on the SF-36. However, six studies did not find 
significant associations between different comorbidities and outcomes such as SF-36, 
revision, chronic hip pain and WOMAC [21,27,30,34,41,48]. Two of these studies had 
low risk of bias [34,41].
Body Mass Index
Five studies (14%) reported an association between BMI and postoperative outcomes. 
Two of these studies had low risk of bias [35,40] where the study of Davis et al. [35] 
reported the largest effect with morbidly obese patients (BMI ≥35 kg/m2) having a 
4.42 times higher dislocation rate than those with BMI <25 kg/m2. The authors also 
found associations between higher BMI and more superficial infections, poorer HHS 
and lower SF-36 postoperative scores [35]. Judge et al. [40] reported that patients 
with higher BMI had smaller absolute improvement on the OHS. However, regardless 
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of their BMI, patients achieved substantial improvement in the OHS which outweighs 
the small absolute difference in attained OHS. The same was found in a high risk of 
bias study [19]. Other high risk of bias studies found that overweight and obesity were 
associated with a 3.7 fold increased risk of implant dislocation [25], and with lower SF-
36 postoperative scores [49]. Furthermore, eight studies did not find an association with 
BMI and different outcomes, such as 6MWT, LEFS, WOMAC, SF-36 and chronic hip 
pain [21,30,34,36,41,42,44,48]. Four of these studies had low risk of bias [34,36,41,42].
Radiological OA severity
Six studies (17%) reported significant associations between radiological OA severity 
and outcomes. Only one study had low risk of bias [34]. This study found that changes in 
physical functioning were markedly better in those with worse preoperative radiological 
OA grades. This was also found in two other high risk of bias studies [20,48]. However, 
these studies focused on changes and not on final outcomes. Patients with lower 
baseline scores are more likely to improve, but the question is whether they reach 
the same postoperative levels. Another high risk of bias study found that patients with 
less severe radiological change had better postoperative outcomes [18]. Furthermore, 
Tanaka et al. [45] showed that a worse radiological OA stage predicted worse gait 
improvements after surgery. On the other hand, Meding et al. [22] found that patients 
with a greater degree of preoperative cartilage space loss had less hip pain 1 year after 
surgery, but no association was found at 3 years after surgery. Nilsdotter et al. [31] found 
that patients with severe preoperative radiological OA did not differ in postoperative 
outcome compared with patients with only moderate preoperative radiological OA. 
Patient expectations
Two included high risk of bias studies (6%) reported an association between patient 
expectations and outcomes. Bethge et al. [14] found that patients who expected an 
enduring illness and did not expect treatment to be helpful had worse postoperative 
scores on the HHS. Judge et al. [18] showed that patients with high expectations were 
more likely to improve on the WOMAC scale. 
Pain
Six studies (17%) reported an effect of preoperative pain on outcomes. The results were 
conflicting. Two studies that had low risk of bias showed that pain was related to worse 
outcomes. Nilsdotter et al. [42] reported that a higher degree of pain predicted worse 
function at 3.6 years after surgery. McHugh et al. [41] found that worse pain at baseline 
was negatively associated with improvement. In other high risk of bias studies, patients 
with the worst pre-operative WOMAC pain scores and SF-36 (Bodily Pain) also performed 
worse at 1 year postoperatively [32]. On the other hand, Judge et al. [18] found that 
patients with worse baseline pain had a greater improvement post-surgery on pain. 
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Haverkamp et al. [28] showed that more preoperative pain at rest or at night resulted in 
more improvement on the WOMAC and VAS pain scale, but the patients maintained at a 
lower level at final follow up. Furthermore, Street et al. [33] looked at different pain areas 
and found that patients with knee pain showed less improvement (on HHS, WOMAC and 
SF-36) than those with hip or thigh pain. Röder et al. [24] concluded that pain relief was 
independent of the preoperative pain level. No significant associations were found in 5 
other studies with outcomes such as pain, WOMAC and satisfaction [21,24,28,30,39]. 
One of these studies had low risk of bias [39]. 
Function
Several questionnaires were used to assess preoperative function and associations 
were found in 13 studies (37%). Two of these studies had low risk of bias [34,39]. 
One of these studies showed that patients with a worse preoperative function had a 
greater improvement [34], which was also found in other studies [18,43,48]. The other 
low risk of bias study showed that although patients with worse preoperative function 
had a greater improvement, they did not achieve the postoperative level of those with 
higher preoperative function [39]. This was also confirmed in other high risk of bias 
studies [17,24,29,32,40,44]. In most studies these observed differences were regarded 
as clinically relevant by the authors. Four studies did not find associations between 
function and various outcomes such as 6MWT, LEFS, ROM, deformity, HHS, SF-36 and 
gait improvement [17,29,44,45]. None of these studies had low risk of bias.
Health related quality of life
Ten studies (29%) reported significant associations between preoperative health related 
quality of life (HRQoL) and postoperative outcomes, three of these studies had low risk 
of bias [34,40,42]. In these low risk of bias studies, better preoperative quality of life 
was associated with better postoperative scores. Judge et al. [40] reported a small 
but statistically significant effect on the OHS. Nilsdotter [42] found an association with 
worse WOMAC scores. Cushnaghan [34] found that patients with a higher SF-36 score 
had less improvement postoperatively. This was also found in a high risk of bias study 
by Gordon et al. [38], in which the authors stated that patients with low preoperative 
scores had the highest gain, although they did not reach the same absolute levels as 
patients with high preoperative scores. No associations were found in eight studies 
that tested associations of different HRQoL scores on outcomes, such as WOMAC, 
pain, satisfaction, EQ-5D, SF-36 and WOMAC [14,16,18,21,23,32,36,42]. Two of these 
studies had low risk of bias [36,42].
Mental well-being
Five studies (14%) reported that mental well-being, such as anxiety and depressive 
symptoms, was associated with postoperative outcomes. Two of these studies had low 
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risk of bias and found that worse mental well-being was associated low OHS [40] and 
less change in SF-36 PCS [41]. The three other high risk of bias studies also found that 
worse mental well-being was associated with various worse outcomes, such as pain 
relief, EQ-5D, satisfaction, SF-36 and Hip disability and Osteoarthritis Outcome Score 
(HOOS) [15,23,49].
DISCUSSION
We know that THA improves clinical and functional outcomes in most patients, and for 
some more than others. We also know that some patients achieve better postoperative 
levels of these outcomes than other patients. Hence it is relevant to assess which variables 
predict the outcome and the extent of improvement after THA. Therefore, we performed 
a systematic review in which multiple preoperative factors were included. Our review 
shows that the results on which predictors affect specific outcomes after THA were not 
consistent, even when looking only at low risk of bias studies. Some predictors were 
examined in many studies, but the results were conflicting as to whether an association 
was found (e.g. for age, comorbidity, pain and preoperative health related quality 
of life). Sometimes the associations could even go in different directions such as for 
gender. Other predictors were only reported in a few studies, such as SES/ education, 
patient expectations, and mental well-being. Consistent and clinically relevant effects on 
postoperative outcomes were only found for preoperative radiological OA severity and 
preoperative function. However, only one study that assessed radiological OA severity 
and two studies that assessed preoperative function had low risk of bias. Overall, even 
though greater improvements were found in patients with more severe radiological OA 
and lower function baseline scores, these patients did not reach the same postoperative 
levels in functioning as patients with less severe OA or higher baseline function scores. 
Moreover, these associations were not found in all studies [17,29,31,44,45] and these 
studies had a high risk of bias.
Even though BMI is often considered as a relevant predictor of postoperative outcome, 
our review shows that only 5 out of the 13 studies (2 low risk of bias studies) reported 
a significant association between BMI and outcomes. Furthermore, complication 
rates after surgery were higher for patients with a higher BMI, but the patient reported 
outcomes did not show clinically relevant differences depending on BMI in both low and 
high risk of bias studies. This may be explained partly because we focused on long term 
follow-up (≥1 year) and did not investigate short term complications, which more often 
occur in patients with a higher BMI. Patients achieved substantial improvement in the 
patient reported outcomes regardless of their BMI [19,35] so that patients should not 
be withheld from surgery only because of their high BMI. Furthermore, age was a major 
confounder in many studies, as with increasing age people tend to be for example less 
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physically active and may have comorbidities as part of a physiological aging process 
which will bias the observed associations between other predictors and outcomes. As a 
result, some studies may have found smaller improvement in elderly people. However, 
it may be possible that elderly people are satisfied with a small improvement since their 
lifestyle may be less active as well. Since only one study compared the outcomes with a 
control group (without THA), it is difficult to conclude whether differences are based on 
the “prognostic” factor or that it is just the natural course of life. 
An earlier systematic review on preoperative predictors on outcomes in THA [50] included 
studies until 2005. They concluded that THA resulted in pain relief, improved physical 
function and enhanced health-related quality of life regardless of patients’ characteristics, 
type of operation or type of prosthesis. The only factor affecting patient outcomes was 
patients’ poor preoperative function. Furthermore, the authors did not perform a risk of 
bias assessment. Most studies included in the present review were published after 2005 
(31 of the 35). Still, we found similar results even when focusing on low risk of bias studies 
only. Furthermore, two reviews focused on patients’ characteristics. Santaguida et al. 
[11] found in their systematic review that age and gender were associated with risk of 
revision and mortality after total hip and knee arthroplasty and that age was associated 
with function. However, they found that all patients benefited from total joint arthroplasty 
regardless of their age and gender. Waheeb et al. [10] also showed that high variability 
and conflicting findings were reported on the effect of age, gender and BMI on patient 
reported outcomes. While these reviews focused on patients’ characteristics, our review 
adds how other factors such as radiological OA severity, preoperative quality of life and 
preoperative function affect postoperative outcomes. 
Studies in our systematic review were heterogeneous and differed in follow-up time 
(beyond one year), prognostic factors and outcomes, which may explain the conflicting 
findings and make it difficult to compare studies. It also shows that there is no 
consensus in which outcomes should be used to assess the impact of surgery and 
which prognostic factors should be considered. Differences in reported associations 
may be partly explained by differences in the measurement of these predictors and 
outcomes (e.g. function is measured with HOOS, WOMAC, OHS etc.). The majority 
of the included studies assessed outcomes through self-reported questionnaires, 
which may bias results due to response shift [51]. Patients may report changes over 
time due to changes in their internal standards, values, or conceptualization of health 
related quality of life [51] so that it seems as if scores change, but this may not be 
reflected in objective measurements. In addition, radiological OA severity may vary due 
to inter- and intra-observer variability. Therefore, more uniformity is needed regarding 
types of measurements and questionnaires. Furthermore, some studies focused on 
improvements while other studies focused on the final outcome, so that regression to 
the mean should be taken into account.
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Loss to follow-up was a problem in 18 studies, which is likely to bias the associations 
found. For instance, patients who are less satisfied or have poor outcome after a THA 
are less likely to further participate in a study and therefore be lost to follow-up. Hence, 
satisfied patients with good outcomes may be over-represented [52]. Another problem 
may be reporting bias. Although some authors described both significant associations 
and non-significant associations within a study, it is likely that the same associations 
were investigated by others, but not reported if results were non-significant. Since most 
studies examining these topics were observational studies, outcome reporting bias is 
possible as primary outcomes of observational studies are not documented in a trial 
register as for randomized controlled trials. Furthermore, predictors and outcomes 
were measured with questionnaires covering multiple domains. For example the SF-
36 has eight domains and two summary scores (MCS and PCS). Studies using these 
questionnaires often did not correct for multiple testing so that it is possible that some 
associations were in fact chance findings (5%). Also some of the studies included 
overlapping cohorts, but most often did assess different prognostic variables on 
different outcomes. A strength of this review is the strict inclusion criteria concerning 
patients with primary OA who underwent a THA. This made the populations in the 
selected studies better comparable. This also led to exclusion of many studies that 
analyzed THA and TKA as one group or included other patient groups. Since THA and 
TKA are two different surgeries including these studies would have made results even 
more heterogeneous.
CONCLUSION
In this systematic review we synthesized information about multiple preoperative factors 
and their relation with postoperative outcomes. However, there is too little high quality 
evidence to draw firm conclusions on prognostics factors for specific outcomes after 
THA. Overall, preoperative function and radiological OA were predictors with the most 
consistent findings in studies with low risk of bias. Worse preoperative function and 
more severe radiological OA were associated with larger postoperative improvement. 
However, these patients did not reach the level of postoperative functioning as patients 
with better preoperative function or less severe radiological OA. The present mapping 
of current evidence on the relationship between patient related factors and outcomes 
provides better information compared to individual studies and may help to set patient 
expectations before surgery.
Implications for future research
Insight into preoperative patient related factors and their relation with postoperative 
outcomes brings us a step closer to the determination of the optimal timing of THA. 
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Procedures should not be performed too early, as the lifespan of a prosthesis is limited, 
and revision arthroplasty is less successful than primary TKA or THA [53]. A surgeon 
could possibly decide to postpone a THA by first optimizing preoperative function 
using different non-surgical treatments, if patients would then reach the same or better 
postoperative functional levels. Therefore, further research is needed to determine 
optimal preoperative (range of) cutoff points to recommend implant surgery, using a 
patients’ lifetime perspective and our results on which preoperative factors determine 
the outcomes after THA. In addition, as we focused on patient related factors only, there 
are also many other factors that might influence the outcome, such as type of prosthesis 
(e.g. type of stem, head size, cemented/ uncemented), experience of the surgeon or 
hospital type. These factors should also be taken into account when determining the 
optimal timing of surgery.
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Additional file 1. Search Strategy 
Databases Search Strategy Number of 
references
Number 
of unique 
references
PubMed ("Osteoarthritis"[mesh] OR "Osteoarthritis"[tw] OR osteoarthrit*[tw] OR "osteoarthrosis"[tw] OR "osteoarthroses"[tw] OR 
"Degenerative Arthritis"[all fields] OR "coxarthrosis"[tw] OR "gonarthrosis"[tw] OR "oa"[tw]) AND ((("Arthroplasty"[majr] 
OR "Joint Prosthesis"[majr] OR "Prostheses and Implants"[majr] OR arthroplast*[tiab] OR joint prosthe*[tiab] OR 
prosthe*[tiab]) AND ("Hip"[majr] OR "Hip Joint"[majr] OR hip[tiab] OR hips[tiab])) OR (("Arthroplasty, Replacement, 
Hip"[majr] OR "Hip Prosthesis"[majr] OR "hip prosthesis"[tiab] OR "hip prostheses"[tiab] OR "hip replacement"[tiab] 
OR "hip replacements"[tiab] OR "hip arthroplasty"[tiab] OR "hip arthroplasties"[tiab] OR (("tha"[tiab] OR "thr"[tiab] OR 
"thas"[tiab] OR "thrs"[tiab]) AND (hip[tiab] OR hips[tiab] OR replace*[tiab] OR replacement[tiab] OR replacing[tiab] OR 
replaced[tiab] OR arthroplast*[tiab] OR arthroplasty[tiab] OR arthroplastic[tiab] OR prosthe*[tiab] OR prosthesis[tiab] 
OR prostheses[tiab] OR prosthetic[tiab] OR endoprosthe*[tiab] OR implant*[tiab] OR implant[tiab] OR implants[tiab] 
OR implanted[tiab])) OR ((Hip[ti] OR Hips[ti] OR Hip*[ti]) AND (replace*[ti] OR replacement[ti] OR replacing[ti] 
OR replaced[ti] OR arthroplast*[ti] OR arthroplasty[ti] OR arthroplastic[ti] OR prosthe*[ti] OR prosthesis[ti] OR 
prostheses[ti] OR prosthetic[ti] OR endoprosthe*[ti] OR implant*[ti] OR implant[ti] OR implants[ti] OR implanted[ti]))))) 
AND ("determinant"[tw] OR "determinants"[tw] OR "predictor"[tw] OR "predictors"[tw] OR "predictive"[tw] OR "Predictive 
Value of Tests"[Mesh] OR "factor"[tw] OR "factors"[tw] OR "Epidemiologic Factors"[Mesh] OR "Risk Factors"[mesh] OR 
"associated"[tw] OR "association"[tw] OR "association"[mesh] OR "cause"[tw] OR "causal"[tw] OR "Causality"[Mesh] 
OR "causality"[tw] OR "attribute"[tw] OR "attributes"[tw] OR "Psychometrics"[Mesh] OR "psychometrics"[tw] OR 
psychometric*[tw] OR "prognostic"[tw] OR "Prognosis"[Mesh:noexp] OR "Prognosis"[tw] OR "timing"[tw] OR "Time 
Factors"[mesh] OR "non-surgical"[tw] OR "nonsurgical"[tw] OR "conservative"[tw]) AND ("postoperative"[tw] OR 
"post-operative"[tw] OR "Postoperative Period"[Mesh] OR "Postoperative Complications"[Mesh] OR "Postoperative 
Care"[Mesh] OR "postsurgical"[tw] OR "postsurgery"[tw] OR "post-surgical"[tw] OR "post-surgery"[tw]) AND ("QOL"[tw] 
OR "Quality of Life"[mesh] OR "quality of life"[tw] OR "Pain"[mesh] OR "pain"[tw] OR "Pain Measurement"[mesh] OR 
"function"[tw] OR functional[tw] OR "Range of Motion, Articular"[Mesh] OR "Mobility Limitation"[mesh] OR "Recovery 
of Function"[Mesh] OR "Musculoskeletal Physiological Phenomena"[Mesh] OR "adverse"[tw] OR "adverse effects" 
[Subheading] OR "Prosthesis Failure"[mesh] OR "mortality"[tw] OR "Mortality"[Mesh] OR  "mortality"[Subheading] OR 
"revision"[tw] OR "Reoperation"[Mesh] OR "Reoperation"[tw] OR "outcome"[tw] OR "outcomes"[tw] OR "Outcome and 
Process Assessment (Health Care)"[Mesh] OR "clinical"[tw]) NOT ("Animals"[mesh] NOT "Humans"[mesh])
Three additional strategies for PubMed only:
1.
(hip[ti] OR hips[ti] OR tha[ti] OR thr[ti] OR (("total joint"[ti]) AND (hip[tw] OR hips[tw])))  AND (((("Arthroplasty"[majr] OR 
"Joint Prosthesis"[majr] OR "Prostheses and Implants"[majr] OR arthroplast*[ti] OR joint prosthe*[ti] OR prosthe*[ti]) 
AND ("Hip"[majr] OR "Hip Joint"[majr] OR hip[ti] OR hips[ti])) OR (("Arthroplasty, Replacement, Hip"[majr] OR "Hip 
Prosthesis"[majr] OR "hip prosthesis"[ti] OR "hip prostheses"[ti] OR "hip replacement"[ti] OR "hip replacements"[ti] 
OR "hip arthroplasty"[ti] OR "hip arthroplasties"[ti] OR (("tha"[ti] OR "thr"[ti] OR "thas"[ti] OR "thrs"[ti]) AND (hip[ti] OR 
hips[ti] OR replace*[ti] OR replacement[ti] OR replacing[ti] OR replaced[ti] OR arthroplast*[ti] OR arthroplasty[ti] 
OR arthroplastic[ti] OR prosthe*[ti] OR prosthesis[ti] OR prostheses[ti] OR prosthetic[ti] OR endoprosthe*[ti] OR 
implant*[ti] OR implant[ti] OR implants[ti] OR implanted[ti])) OR ((Hip[ti] OR Hips[ti] OR Hip*[ti]) AND (replace*[ti] 
OR replacement[ti] OR replacing[ti] OR replaced[ti] OR arthroplast*[ti] OR arthroplasty[ti] OR arthroplastic[ti] OR 
prosthe*[ti] OR prosthesis[ti] OR prostheses[ti] OR prosthetic[ti] OR endoprosthe*[ti] OR implant*[ti] OR implant[ti] OR 
implants[ti] OR implanted[ti]))))) AND ("determinant"[ti] OR "determinants"[ti] OR "predictor"[ti] OR "predictors"[ti] OR 
"predictive"[ti] OR "Predictive Value of Tests"[majr] OR "factor"[ti] OR "factors"[ti] OR "Epidemiologic Factors"[majr] OR 
"Risk Factors"[majr] OR "associated"[ti] OR "association"[ti] OR "association"[majr] OR "cause"[ti] OR "causal"[ti] OR 
"Causality"[majr] OR "causality"[ti] OR "attribute"[ti] OR "attributes"[ti] OR "Psychometrics"[majr] OR "psychometrics"[ti] 
OR psychometric*[ti] OR "prognostic"[ti] OR "Prognosis"[majr:noexp] OR "Prognosis"[ti] OR "timing"[ti] OR "Time 
Factors"[majr] OR "non-surgical"[ti] OR "nonsurgical"[ti] OR "conservative"[ti]) AND ("postoperative"[ti] OR "post-
operative"[ti] OR "Postoperative Period"[majr] OR "Postoperative Complications"[majr] OR "Postoperative Care"[majr] 
OR "postsurgical"[ti] OR "postsurgery"[ti] OR "post-surgical"[ti] OR "post-surgery"[ti] OR "after"[ti]) AND ("QOL"[ti] OR 
"Quality of Life"[majr] OR "quality of life"[ti] OR "Pain"[majr] OR "pain"[ti] OR "Pain Measurement"[majr] OR "function"[ti] 
OR functional[ti] OR "Range of Motion, Articular"[majr] OR "Mobility Limitation"[majr] OR "Recovery of Function"[majr] 
OR "Musculoskeletal Physiological Phenomena"[majr] OR "adverse"[ti] OR "adverse effects" [Subheading] OR 
"Prosthesis Failure"[majr] OR "mortality"[ti] OR "Mortality"[majr] OR  "mortality"[Subheading] OR "revision"[ti] OR 
"Reoperation"[majr] OR "Reoperation"[ti] OR "outcome"[ti] OR "outcomes"[ti] OR "Outcome and Process Assessment 
(Health Care)"[majr] OR "clinical"[ti]) NOT ("Animals"[majr] NOT "Humans"[majr])) 
2.
(((("Arthroplasty"[majr] OR "Joint Prosthesis"[majr] OR "Prostheses and Implants"[majr] OR arthroplast*[tiab] OR joint 
prosthe*[tiab] OR prosthe*[tiab]) AND ("Hip"[majr] OR "Hip Joint"[majr] OR hip[tiab] OR hips[tiab])) OR (("Arthroplasty, 
Replacement, Hip"[majr] OR "Hip Prosthesis"[majr] OR "hip prosthesis"[tiab] OR "hip prostheses"[tiab] OR "hip 
replacement"[tiab] OR "hip replacements"[tiab] OR "hip arthroplasty"[tiab] OR "hip arthroplasties"[tiab] OR (("tha"[tiab] 
OR "thr"[tiab] OR "thas"[tiab] OR "thrs"[tiab]) AND (hip[tiab] OR hips[tiab] OR replace*[tiab] OR replacement[tiab] OR 
replacing[tiab] OR replaced[tiab] OR arthroplast*[tiab] OR arthroplasty[tiab] OR arthroplastic[tiab] OR prosthe*[tiab] 
OR prosthesis[tiab] OR prostheses[tiab] OR prosthetic[tiab] OR endoprosthe*[tiab] OR implant*[tiab] OR implant[tiab] 
OR implants[tiab] OR implanted[tiab])) OR ((Hip[ti] OR Hips[ti] OR Hip*[ti]) AND (replace*[ti] OR replacement[ti] OR 
replacing[ti] OR replaced[ti] OR arthroplast*[ti] OR arthroplasty[ti] OR arthroplastic[ti] OR prosthe*[ti] OR prosthesis[ti] 
OR prostheses[ti] OR prosthetic[ti] OR endoprosthe*[ti] OR implant*[ti] OR implant[ti] OR implants[ti] OR implanted[ti]))))) 
AND ("determinant"[tw] OR "determinants"[tw] OR "predictor"[tw] OR "predictors"[tw] OR "predictive"[tw] OR "Predictive 
Value of Tests"[Mesh] OR "factor"[tw] OR "factors"[tw] OR "Epidemiologic Factors"[Mesh] OR "Risk Factors"[mesh] OR 
"associated"[tw] OR "association"[tw] OR "association"[mesh] OR "cause"[tw] OR "causal"[tw] OR "Causality"[Mesh] 
OR "causality"[tw] OR "attribute"[tw] OR "attributes"[tw] OR "Psychometrics"[Mesh] OR "psychometrics"[tw] OR 
psychometric*[tw] OR "prognostic"[tw] OR "Prognosis"[Mesh:noexp] OR "Prognosis"[tw] OR "timing"[tw] OR "Time 
Factors"[mesh] OR "non-surgical"[tw] OR "nonsurgical"[tw] OR "conservative"[tw]) AND ("postoperative"[tw] OR 
"post-operative"[tw] OR "Postoperative Period"[Mesh] OR "Postoperative Complications"[Mesh] OR "Postoperative 
Care"[Mesh] OR "postsurgical"[tw] OR "postsurgery"[tw] OR "post-surgical"[tw] OR "post-surgery"[tw] OR "after"[tiab]) 
AND ("Patient Satisfaction"[majr] OR "Activities of Daily Living"[majr]) NOT ("Animals"[mesh] NOT "Humans"[mesh])) 
3.
(("Osteoarthritis"[mesh] OR "Osteoarthritis"[tw] OR osteoarthrit*[tw] OR "osteoarthrosis"[tw] OR "osteoarthroses"[tw] OR 
"Degenerative Arthritis"[all fields] OR "coxarthrosis"[tw] OR "gonarthrosis"[tw] OR "oa"[tw]) AND ((("Arthroplasty"[majr] 
OR "Joint Prosthesis"[majr] OR "Prostheses and Implants"[majr] OR arthroplast*[tiab] OR joint prosthe*[tiab] OR 
prosthe*[tiab]) AND ("Hip"[majr] OR "Hip Joint"[majr] OR hip[tiab] OR hips[tiab])) OR (("Arthroplasty, Replacement, 
Hip"[majr] OR "Hip Prosthesis"[majr] OR "hip prosthesis"[tiab] OR "hip prostheses"[tiab] OR "hip replacement"[tiab] 
OR "hip replacements"[tiab] OR "hip arthroplasty"[tiab] OR "hip arthroplasties"[tiab] OR (("tha"[tiab] OR "thr"[tiab] OR 
"thas"[tiab] OR "thrs"[tiab]) AND (hip[tiab] OR hips[tiab] OR replace*[tiab] OR replacement[tiab] OR replacing[tiab] OR 
replaced[tiab] OR arthroplast*[tiab] OR arthroplasty[tiab] OR arthroplastic[tiab] OR prosthe*[tiab] OR prosthesis[tiab] 
OR prostheses[tiab] OR prosthetic[tiab] OR endoprosthe*[tiab] OR implant*[tiab] OR implant[tiab] OR implants[tiab] 
OR implanted[tiab])) OR ((Hip[ti] OR Hips[ti] OR Hip*[ti]) AND (replace*[ti] OR replacement[ti] OR replacing[ti] 
OR replaced[ti] OR arthroplast*[ti] OR arthroplasty[ti] OR arthroplastic[ti] OR prosthe*[ti] OR prosthesis[ti] OR 
prostheses[ti] OR prosthetic[ti] OR endoprosthe*[ti] OR implant*[ti] OR implant[ti] OR implants[ti] OR implanted[ti]))))) 
AND ("determinant"[tw] OR "determinants"[tw] OR "predictor"[tw] OR "predictors"[tw] OR "predictive"[tw] OR "Predictive 
Value of Tests"[Mesh] OR "factor"[tw] OR "factors"[tw] OR "Epidemiologic Factors"[Mesh] OR "Risk Factors"[mesh] OR 
"associated"[tw] OR "association"[tw] OR "association"[mesh] OR "cause"[tw] OR "causal"[tw] OR "Causality"[Mesh] 
OR "causality"[tw] OR "attribute"[tw] OR "attributes"[tw] OR "Psychometrics"[Mesh] OR "psychometrics"[tw] OR 
psychometric*[tw] OR "prognostic"[tw] OR "Prognosis"[Mesh:noexp] OR "Prognosis"[tw] OR "timing"[tw] OR "Time 
Factors"[mesh] OR "non-surgical"[tw] OR "nonsurgical"[tw] OR "conservative"[tw]) AND ("postoperative"[tw] OR 
"post-operative"[tw] OR "Postoperative Period"[Mesh] OR "Postoperative Complications"[Mesh] OR "Postoperative 
Care"[Mesh] OR "postsurgical"[tw] OR "postsurgery"[tw] OR "post-surgical"[tw] OR "post-surgery"[tw] OR 
"after"[tiab]) AND ("QOL"[tw] OR "Quality of Life"[mesh] OR "quality of life"[tw] OR "Pain"[mesh] OR "pain"[tw] OR 
"Pain Measurement"[mesh] OR "function"[tw] OR functional[tw] OR "Range of Motion, Articular"[Mesh] OR "Mobility 
Limitation"[mesh] OR "Recovery of Function"[Mesh] OR "Musculoskeletal Physiological Phenomena"[Mesh] OR 
"adverse"[tw] OR "adverse effects" [Subheading] OR "Prosthesis Failure"[mesh] OR "mortality"[tw] OR "Mortality"[Mesh] 
OR  "mortality"[Subheading] OR "revision"[tw] OR "Reoperation"[Mesh] OR "Reoperation"[tw] OR "outcome"[tw] OR 
"outcomes"[tw] OR "Outcome and Process Assessment (Health Care)"[Mesh] OR "clinical"[tw]) NOT ("Animals"[mesh] 
NOT "Humans"[mesh]))
2.040 2.040
200 A systematic review on preoperative predictors
MEDLINE 
(OVID-
version)
(exp Osteoarthritis/ OR "Osteoarthritis".mp OR osteoarthrit*.mp OR "osteoarthrosis".mp OR "osteoarthroses".mp OR 
"Degenerative Arthritis".mp OR "coxarthrosis".mp OR "gonarthrosis".mp OR "oa".mp) AND (((exp *Arthroplasty/ OR 
exp *Joint Prosthesis/ OR exp *"Prostheses and Implants"/ OR arthroplast*.ti,ab OR joint prosthe*.ti,ab OR prosthe*.
ti,ab) AND (exp *Hip/ OR exp *Hip Joint/ OR hip.ti,ab OR hips.ti,ab)) OR ((exp *"Arthroplasty, Replacement, Hip"/ 
OR exp *Hip Prosthesis/ OR "hip prosthesis".ti,ab OR "hip prostheses".ti,ab OR "hip replacement".ti,ab OR "hip 
replacements".ti,ab OR "hip arthroplasty".ti,ab OR "hip arthroplasties".ti,ab OR (("tha".ti,ab OR "thr".ti,ab OR "thas".
ti,ab OR "thrs".ti,ab) AND (hip.ti,ab OR hips.ti,ab OR replace*.ti,ab OR replacement.ti,ab OR replacing.ti,ab OR 
replaced.ti,ab OR arthroplast*.ti,ab OR arthroplasty.ti,ab OR arthroplastic.ti,ab OR prosthe*.ti,ab OR prosthesis.
ti,ab OR prostheses.ti,ab OR prosthetic.ti,ab OR endoprosthe*.ti,ab OR implant*.ti,ab OR implant.ti,ab OR implants.
ti,ab OR implanted.ti,ab)) OR ((Hip.ti OR Hips.ti OR Hip*.ti) AND (replace*.ti OR replacement.ti OR replacing.ti OR 
replaced.ti OR arthroplast*.ti OR arthroplasty.ti OR arthroplastic.ti OR prosthe*.ti OR prosthesis.ti OR prostheses.ti OR 
prosthetic.ti OR endoprosthe*.ti OR implant*.ti OR implant.ti OR implants.ti OR implanted.ti))))) AND ("determinant".
mp OR "determinants".mp OR "predictor".mp OR "predictors".mp OR "predictive".mp OR exp "Predictive Value of 
Tests"/ OR "factor".mp OR "factors".mp OR exp "Epidemiologic Factors"/ OR exp "Risk Factors"/ OR "associated".
mp OR "association".mp OR exp "association"/ OR "cause".mp OR "causal".mp OR exp Causality/ OR "causality".
mp OR "attribute".mp OR "attributes".mp OR exp Psychometrics/ OR "psychometrics".mp OR psychometric*.mp OR 
"prognostic".mp OR Prognosis/ OR "Prognosis".mp OR "timing".mp OR exp Time Factors/ OR "non-surgical".mp OR 
"nonsurgical".mp OR "conservative".mp) AND ("postoperative".mp OR "post-operative".mp OR exp Postoperative 
Period/ OR exp Postoperative Complications/ OR exp Postoperative Care/ OR "postsurgical".mp OR "postsurgery".mp 
OR "post-surgical".mp OR "post-surgery".mp OR "after surgery".mp OR "after total hip".mp OR "after hip".mp OR "after 
tha".mp OR "after thr".mp) AND ("QOL".mp OR exp "Quality of Life"/ OR "quality of life".mp OR exp Pain/ OR "pain".mp 
OR exp Pain Measurement/ OR "function".mp OR functional.mp OR exp "Range of Motion, Articular"/ OR exp Mobility 
Limitation/ OR exp "Recovery of Function"/ OR exp "Musculoskeletal Physiological Phenomena"/ OR "adverse".mp OR 
"adverse effects".fs OR exp "Prosthesis Failure"/ OR "mortality".mp OR exp Mortality/ OR "mortality".fs OR "revision".
mp OR exp Reoperation/ OR "Reoperation".mp OR "outcome".mp OR "outcomes".mp OR exp "Outcome and Process 
Assessment (Health Care)"/ OR "clinical".mp) NOT (exp Animals/ NOT exp Humans/)
1.569 39
Embase 
(OVID-
version)
(exp *Osteoarthritis/ OR "Osteoarthritis".ti,ab OR osteoarthrit*.ti,ab OR "osteoarthrosis".ti,ab OR "osteoarthroses".
ti,ab OR "Degenerative Arthritis".ti,ab OR "coxarthrosis".ti,ab OR "gonarthrosis".ti,ab) AND (((exp *Arthroplasty/ OR 
exp *Joint Prosthesis/ OR exp * "orthopedic prosthesis and orthosis"/ OR exp *"orthopedic prostheses, orthoses and 
implants"/ OR arthroplast*.ti OR joint prosthe*.ti,ab OR prosthe*.ti) AND (exp *Hip/ OR hip.ti OR hips.ti)) OR ((exp 
*hip arthroplasty/ OR exp *Hip Prosthesis/ OR "hip prosthesis".ti,ab OR "hip prostheses".ti,ab OR "hip replacement".
ti,ab OR "hip replacements".ti,ab OR "hip arthroplasty".ti,ab OR "hip arthroplasties".ti,ab OR (("tha".ti,ab OR "thr".ti,ab 
OR "thas".ti,ab OR "thrs".ti,ab) AND (hip.ti,ab OR hips.ti,ab OR replace*.ti,ab OR replacement.ti,ab OR replacing.ti,ab 
OR replaced.ti,ab OR arthroplast*.ti,ab OR arthroplasty.ti,ab OR arthroplastic.ti,ab OR prosthe*.ti,ab OR prosthesis.
ti,ab OR prostheses.ti,ab OR prosthetic.ti,ab OR endoprosthe*.ti,ab OR implant*.ti,ab OR implant.ti,ab OR implants.
ti,ab OR implanted.ti,ab)) OR ((Hip.ti OR Hips.ti OR Hip*.ti) AND (replace*.ti OR replacement.ti OR replacing.ti OR 
replaced.ti OR arthroplast*.ti OR arthroplasty.ti OR arthroplastic.ti OR prosthe*.ti OR prosthesis.ti OR prostheses.ti OR 
prosthetic.ti OR endoprosthe*.ti OR implant*.ti OR implant.ti OR implants.ti OR implanted.ti))))) AND ("determinant".
mp OR "determinants".mp OR "predictor".mp OR "predictors".mp OR "predictive".mp OR exp predictor variable/ 
OR exp " prediction and forecasting"/ OR "factor".mp OR "factors".mp OR exp Epidemiology/ OR exp "Risk Factor"/ 
OR "associated".mp OR "association".mp OR exp association/ OR exp disease association/ OR "cause".mp OR 
"causal".mp OR exp Causality/ OR "causality".mp OR "attribute".mp OR "attributes".mp OR exp Psychometry/ OR 
"psychometrics".mp OR psychometr*.mp OR "prognostic".mp OR Prognosis/ OR "Prognosis".mp OR "timing".mp 
OR Time/ OR "non-surgical".mp OR "nonsurgical".mp OR "conservative".mp OR exp conservative treatment/) AND 
("postoperative".mp OR "post-operative".mp OR exp Postoperative Period/ OR exp Postoperative Complication/ OR 
exp Postoperative Care/ OR "postsurgical".mp OR "postsurgery".mp OR "post-surgical".mp OR "post-surgery".mp OR 
"after surgery".mp OR "after total hip".mp OR "after hip".mp) AND ("QOL".mp OR exp "Quality of Life"/ OR "quality of 
life".mp OR exp Pain/ OR "pain".mp OR exp Pain Assessment/ OR "function".mp OR functional.mp OR exp "Range of 
Motion"/ OR exp walking difficulty/ OR exp convalescence/ OR exp musculoskeletal function/ OR "adverse".mp OR 
adverse outcome/ OR exp "Prosthesis Failure"/ OR "mortality".mp OR exp Mortality/ OR "mortality".fs OR "revision".mp 
OR exp Reoperation/ OR "Reoperation".mp OR "outcome".mp OR "outcomes".mp OR exp treatment outcome/) NOT 
(exp Animals/ NOT exp Humans/)
941 297
Web of 
Science
(TS=(Osteoarthritis OR "Osteoarthritis" OR osteoarthrit* OR "osteoarthrosis" OR "osteoarthroses" OR "Degenerative 
Arthritis" OR "coxarthrosis" OR "gonarthrosis" OR "oa") AND TI=(((Arthroplasty OR Joint Prosthesis OR arthroplast* OR 
joint prosthe* OR prosthe*) AND (Hip OR hip OR hips)) OR ((hip arthroplasty OR Hip Prosthesis OR "hip prosthesis" OR 
"hip prostheses" OR "hip replacement" OR "hip replacements" OR "hip arthroplasty" OR "hip arthroplasties" OR (("tha" 
OR "thr" OR "thas" OR "thrs") AND (hip OR hips OR replace* OR replacement OR replacing OR replaced OR arthroplast* 
OR arthroplasty OR arthroplastic OR prosthe* OR prosthesis OR prostheses OR prosthetic OR endoprosthe* OR 
implant* OR implant OR implants OR implanted)) OR ((Hip OR Hips OR Hip*) AND (replace* OR replacement OR 
replacing OR replaced OR arthroplast* OR arthroplasty OR arthroplastic OR prosthe* OR prosthesis OR prostheses 
OR prosthetic OR endoprosthe* OR implant* OR implant OR implants OR implanted)))))) AND TS=(("determinant" OR 
"determinants" OR "predictor" OR "predictors" OR "predictive" OR predictor variable OR " prediction and forecasting" 
OR "factor" OR "factors" OR Epidemiology OR "Risk Factor" OR "associated" OR "association" OR association OR 
disease association OR "cause" OR "causal" OR Causality OR "causality" OR "attribute" OR "attributes" OR Psychometry 
OR "psychometrics" OR psychometr* OR "prognostic" OR Prognosis OR "Prognosis" OR "timing" OR Time OR "non-
surgical" OR "nonsurgical" OR "conservative" OR conservative treatment) AND ("postoperative" OR "post-operative" 
OR Postoperative Period OR Postoperative Complication OR Postoperative Care OR "postsurgical" OR "postsurgery" 
OR "post-surgical" OR "post-surgery" OR "after surgery" OR "after total hip" OR "after hip") AND ("QOL" OR "Quality of 
Life" OR "quality of life" OR Pain OR "pain" OR Pain Assessment OR "function" OR functional OR "Range of Motion" OR 
walking difficulty OR convalescence OR musculoskeletal function OR "adverse" OR adverse outcome OR "Prosthesis 
Failure" OR "mortality" OR Mortality OR "mortality" OR "revision" OR Reoperation OR "Reoperation" OR "outcome" OR 
"outcomes"))
391 131
COCHRANE 
Library
((Osteoarthritis OR "Osteoarthritis" OR osteoarthrit* OR "osteoarthrosis" OR "osteoarthroses" OR "Degenerative Arthritis" 
OR "coxarthrosis" OR "gonarthrosis" OR "oa") AND (((Arthroplasty OR Joint Prosthesis OR arthroplast* OR joint prosthe* 
OR prosthe*) AND (Hip OR hip OR hips)) OR ((hip arthroplasty OR Hip Prosthesis OR "hip prosthesis" OR "hip 
prostheses" OR "hip replacement" OR "hip replacements" OR "hip arthroplasty" OR "hip arthroplasties" OR (("tha" OR 
"thr" OR "thas" OR "thrs") AND (hip OR hips OR replace* OR replacement OR replacing OR replaced OR arthroplast* 
OR arthroplasty OR arthroplastic OR prosthe* OR prosthesis OR prostheses OR prosthetic OR endoprosthe* OR 
implant* OR implant OR implants OR implanted)) OR ((Hip OR Hips OR Hip*) AND (replace* OR replacement OR 
replacing OR replaced OR arthroplast* OR arthroplasty OR arthroplastic OR prosthe* OR prosthesis OR prostheses 
OR prosthetic OR endoprosthe* OR implant* OR implant OR implants OR implanted)))))) AND (("determinant" OR 
"determinants" OR "predictor" OR "predictors" OR "predictive" OR predictor variable OR " prediction and forecasting" 
OR "factor" OR "factors" OR Epidemiology OR "Risk Factor" OR "associated" OR "association" OR association OR 
disease association OR "cause" OR "causal" OR Causality OR "causality" OR "attribute" OR "attributes" OR Psychometry 
OR "psychometrics" OR psychometr* OR "prognostic" OR Prognosis OR "Prognosis" OR "timing" OR Time OR "non-
surgical" OR "nonsurgical" OR "conservative" OR conservative treatment) AND ("postoperative" OR "post-operative" 
OR Postoperative Period OR Postoperative Complication OR Postoperative Care OR "postsurgical" OR "postsurgery" 
OR "post-surgical" OR "post-surgery" OR "after surgery" OR "after total hip" OR "after hip") AND ("QOL" OR "Quality of 
Life" OR "quality of life" OR Pain OR "pain" OR Pain Assessment OR "function" OR functional OR "Range of Motion" OR 
walking difficulty OR convalescence OR musculoskeletal function OR "adverse" OR adverse outcome OR "Prosthesis 
Failure" OR "mortality" OR Mortality OR "mortality" OR "revision" OR Reoperation OR "Reoperation" OR "outcome" OR 
"outcomes" OR treatment outcome OR "clinical"))
141 41
201 Chapter 9
9
CENTRAL ((Osteoarthritis OR "Osteoarthritis" OR osteoarthrit* OR "osteoarthrosis" OR "osteoarthroses" OR "Degenerative Arthritis" 
OR "coxarthrosis" OR "gonarthrosis" OR "oa") AND (((Arthroplasty OR Joint Prosthesis OR arthroplast* OR joint prosthe* 
OR prosthe*) AND (Hip OR hip OR hips)) OR ((hip arthroplasty OR Hip Prosthesis OR "hip prosthesis" OR "hip 
prostheses" OR "hip replacement" OR "hip replacements" OR "hip arthroplasty" OR "hip arthroplasties" OR (("tha" OR 
"thr" OR "thas" OR "thrs") AND (hip OR hips OR replace* OR replacement OR replacing OR replaced OR arthroplast* 
OR arthroplasty OR arthroplastic OR prosthe* OR prosthesis OR prostheses OR prosthetic OR endoprosthe* OR 
implant* OR implant OR implants OR implanted)) OR ((Hip OR Hips OR Hip*) AND (replace* OR replacement OR 
replacing OR replaced OR arthroplast* OR arthroplasty OR arthroplastic OR prosthe* OR prosthesis OR prostheses 
OR prosthetic OR endoprosthe* OR implant* OR implant OR implants OR implanted)))))) AND (("determinant" OR 
"determinants" OR "predictor" OR "predictors" OR "predictive" OR predictor variable OR " prediction and forecasting" 
OR "factor" OR "factors" OR Epidemiology OR "Risk Factor" OR "associated" OR "association" OR association OR 
disease association OR "cause" OR "causal" OR Causality OR "causality" OR "attribute" OR "attributes" OR Psychometry 
OR "psychometrics" OR psychometr* OR "prognostic" OR Prognosis OR "Prognosis" OR "timing" OR Time OR "non-
surgical" OR "nonsurgical" OR "conservative" OR conservative treatment) AND ("postoperative" OR "post-operative" 
OR Postoperative Period OR Postoperative Complication OR Postoperative Care OR "postsurgical" OR "postsurgery" 
OR "post-surgical" OR "post-surgery" OR "after surgery" OR "after total hip" OR "after hip") AND ("QOL" OR "Quality of 
Life" OR "quality of life" OR Pain OR "pain" OR Pain Assessment OR "function" OR functional OR "Range of Motion" OR 
walking difficulty OR convalescence OR musculoskeletal function OR "adverse" OR adverse outcome OR "Prosthesis 
Failure" OR "mortality" OR Mortality OR "mortality" OR "revision" OR Reoperation OR "Reoperation" OR "outcome" OR 
"outcomes" OR treatment outcome OR "clinical"))
143 11
CINAHL ((Osteoarthritis OR "Osteoarthritis" OR osteoarthrit* OR "osteoarthrosis" OR "osteoarthroses" OR "Degenerative Arthritis" 
OR "coxarthrosis" OR "gonarthrosis" OR "oa") AND (((Arthroplasty OR Joint Prosthesis OR arthroplast* OR joint prosthe* 
OR prosthe*) AND (Hip OR hip OR hips)) OR ((hip arthroplasty OR Hip Prosthesis OR "hip prosthesis" OR "hip 
prostheses" OR "hip replacement" OR "hip replacements" OR "hip arthroplasty" OR "hip arthroplasties" OR (("tha" OR 
"thr" OR "thas" OR "thrs") AND (hip OR hips OR replace* OR replacement OR replacing OR replaced OR arthroplast* 
OR arthroplasty OR arthroplastic OR prosthe* OR prosthesis OR prostheses OR prosthetic OR endoprosthe* OR 
implant* OR implant OR implants OR implanted)) OR ((Hip OR Hips OR Hip*) AND (replace* OR replacement OR 
replacing OR replaced OR arthroplast* OR arthroplasty OR arthroplastic OR prosthe* OR prosthesis OR prostheses 
OR prosthetic OR endoprosthe* OR implant* OR implant OR implants OR implanted)))))) AND (("determinant" OR 
"determinants" OR "predictor" OR "predictors" OR "predictive" OR predictor variable OR " prediction and forecasting" 
OR "factor" OR "factors" OR Epidemiology OR "Risk Factor" OR "associated" OR "association" OR association OR 
disease association OR "cause" OR "causal" OR Causality OR "causality" OR "attribute" OR "attributes" OR Psychometry 
OR "psychometrics" OR psychometr* OR "prognostic" OR Prognosis OR "Prognosis" OR "timing" OR Time OR "non-
surgical" OR "nonsurgical" OR "conservative" OR conservative treatment) AND ("postoperative" OR "post-operative" 
OR Postoperative Period OR Postoperative Complication OR Postoperative Care OR "postsurgical" OR "postsurgery" 
OR "post-surgical" OR "post-surgery" OR "after surgery" OR "after total hip" OR "after hip") AND ("QOL" OR "Quality of 
Life" OR "quality of life" OR Pain OR "pain" OR Pain Assessment OR "function" OR functional OR "Range of Motion" OR 
walking difficulty OR convalescence OR musculoskeletal function OR "adverse" OR adverse outcome OR "Prosthesis 
Failure" OR "mortality" OR Mortality OR "mortality" OR "revision" OR Reoperation OR "Reoperation" OR "outcome" OR 
"outcomes" OR treatment outcome OR "clinical"))
157 36
Total 2.595
Trialregisters
ClinicalTrials.
gov
http://
clinicaltrials.
gov/
(predictor OR predictors OR predictive OR predicting OR prediction OR predictions OR determinant OR determinants) 
AND (outcome OR outcomes) AND hip AND osteoarthritis  
27 27
Multi-register
http://www.
controlled-
trials.com/
mrct/
(predictor OR predictors OR predictive OR predicting OR prediction OR predictions OR determinant OR determinants) 
AND (outcome OR outcomes) AND hip AND osteoarthritis  
19 19
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Additional file 2. Reported predictors for outcomes
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Significant associations
Prognostic factor Outcome
Di
re
ct
io
n*
Studies with low risk of bias across both domains
Cushnaghan, 
2007 [34]
282 65 68 ~8 Higher SF-36 (PF) Change SF-36 (PF) ↓
Female Change SF-36 (PF) ↓
Higher age Change SF-36 (PF) ↓
Diabetes Change SF-36 (PF) ↓
Higher radiological 
grade
Change SF-36 (PF) ↑
Higher number of 
painful joint sites
Change SF-36 (PF) ↓
Davis, 2011 [35] 1,163 61 69 5 Higher BMI Dislocation ↑
Higher BMI Superficial infection ↑
Higher BMI HHS ↓
Higher BMI SF-36 (except for the 
domains mental health 
and change in health)
↓
Fortin, 2002 [39] 84 59 65.7 2 Higher WOMAC 
(physical function)
WOMAC (physical 
function)
↑
Higher WOMAC 
(physical function)
Assistance from 
another person for ADL
↑
Gandhi, 2010 
[36]
636 54 63 Mean 
3.3
Higher age WOMAC ↑
Comorbidities WOMAC ↑
Higher age SF-36 (PF) ↓
Comorbidities SF-36 (PF) ↓
Male SF-36 (PF) ↓
Higher age SF-36 (RP) ↓
Comorbidities SF-36 (RP) ↓
Gordon, 2014 
[37]
26,249 57 70 female 
80 male
1 Female EQ-5D ↓
Charnley class C EQ-5D ↓
Gordon, 2014 
[38]
27,245 57 67 1 Higher age from 60 
year
EQ-5D ↓
Higher age from 60 
year
EQ VAS ↓
Lower EQ-5D Improvement EQ-5D ↑
Lower EQ VAS Improvement EQ VAS ↑
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Judge, 2013 
[40]
1,375 62 70.0 each 
year 
up to 5
Age 50-60 OHS ↑
Higher BMI OHS ↓
Comorbidities OHS ↓
Lower SF-36 (Mental 
Health)
OHS (pain/ function) ↓
Lower OHS OHS ↓
McHugh, 2013 
[41]
206 57 66.3 1 Higher ESSI (social 
support)
SF-36 (MCS) ↑
Previous joint 
replacement
Change in SF-36 (PCS) ↓
Taking NSAIDs or COX-
2 inhibitors
Change in SF-36 (PCS) ↑
Higher HADS anxiety 
score
Change in SF-36 (PCS) ↓
Higher HADS 
depression score
Change in SF-36 (PCS) ↓
Higher WOMAC pain 
score
Change in SF-36 (PCS) ↓
Nilsdotter, 2003 
[42]
198 54 71 Mean 
3.6
Higher age WOMAC function ↑
Lower SF-36 (BP) WOMAC function ↑
Studies with high/unclear risk of bias in at least one of the domains
Bethge, 2010 
[14]
135 66 72 1 Higher BIPQ (subscale 
Expecting an enduring 
illness)
HHS ↓
Higher BIPQ (subscales 
expectation treatment is 
helpful)
HHS ↑
Clement, 2011 
[43]
163 ≥80y
376 <80y
55
63
84
70
1 Lower age SF-12 PCS ↑
Higher age Satisfaction ↑
Lower age OHS (function) ↑
Higher age Complications ↑
Clement, 2011 
[47]
1,312 58 68 1 Higher OHS OHS ↑
Higher DEPCAT OHS ↓
Higher DEPCAT Satisfaction ↓
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Duivenvoorden, 
2013 [15]
140 64 68 1 Anxiety symptoms HOOS (subscales pain, 
ADL, sports, QOL)
↓
Anxiety symptoms Satisfaction (overall, 
pain reduction, 
improvement ADL, 
improvement QOL)
↓
Depressive symptoms HOOS (subscales pain 
symptoms, ADL, QOL)
↓
Depressive symptoms Satisfaction 
(improvement QOL)
↓
Greene, 2014 
[16]
11,464 64 54 1 High education EQ-5D index ↑
EQ-5D index EQ-5D index ↑
Charnley class B or C EQ-5D index ↓
Comorbidities EQ-5D index ↓
Male EQ-5D index ↑
High education EQ VAS ↑
EQ-5D index EQ VAS ↑
Second hip EQ VAS ↓
Charnley class B or C EQ VAS ↓
Comorbidities EQ VAS ↓
High education Pain VAS ↓
EQ-5D index Pain VAS ↓
Widow/ married Pain VAS ↓
Charnley class B or C Pain VAS ↑
High education Satisfaction VAS ↓
EQ-5D index Satisfaction VAS ↓
Second hip Satisfaction VAS ↑
Charnley class B or C Satisfaction VAS ↑
Females Satisfaction VAS ↑
Haverkamp, 
2013 [28]
155 71† 68.3† Mean 
2.3†
Pain at rest/ at night Improvement WOMAC ↑
Pain at rest/ at night Improvement VAS pain ↑
Heiberg, 2013 
[17]
64 52 65 1 Younger age 6MWT ↑
Males 6MWT ↑
Higher 6MWT 6MWT ↑
ROM 6MWT ↑
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Ieiri, 2013 [49] 108 85 61.3  1 Contralateral hip OA SF-36 (PF, RP, MH, RE, 
BP, VT, GH, SF)
↓
Walking aids SF-36 (PF, RP, MH, RE, 
BP, VT, GH, SF)
↓
Lower contralateral hip 
ROM
SF-36 (PF, RP, MH, RE, 
BP, VT, GH, SF)
↓
Lower affected hip 
ROM
SF-36 (PF, RP, MH, RE, 
BP, VT, GH, SF)
↓
3 Higher age SF-36 (PF, RP) ↓
Walking aids SF-36 (PF, RP) ↓
Higher BMI SF-36 (PF, RP) ↓
Lower contralateral hip 
ROM
SF-36 (PF, RP) ↓
Higher pre SF-36 
mental health
SF-36 (MH, RP, GH, 
SF, VT, RE, BP)
↑
Not living alone SF-36 (MH, RP, GH, 
SF, VT, RE, BP)
↑
Not working SF-36 (MH, RP, GH, 
SF, VT, RE, BP)
↑
Johansson, 
2010 [29]
75 48 67 2 HHS poor (vs good) HHS ↓
HHS poor (vs good) WOMAC ↓
HHS poor SF-36 ↓
Judge, 2014 
[19]
4,413 62 68.5 1 Higher BMI OHS ↓
Judge, 2012 
[48]
249 64 67.2 Mean 
8
Female SF-36 (PF) ↓
Higher age SF-36 (PF) ↓
Lower SF-36 (PF) Improvement SF-36 
(PF)
↑
Previous hip injury SF-36 (PF) ↓
Greater number of 
painful joint sites
SF-36 (PF) ↓
Worse radiological 
grades
Improvement SF-36 
(PF)
↑
Judge, 2011 
[18]
908 56 65.9 1 Higher expectations Change WOMAC ↑
High education Change WOMAC ↑
Worse baseline pain Change WOMAC ↑
Worse baseline function Change WOMAC ↑
Less severe 
radiological change
Change WOMAC ↑
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Katz, 2012 [27] 49,136 63 60% 65-
75 y, 40% 
>75Y
12 Males Revision ↑
Younger patients Revision ↑
Kennedy, 2011 
[44]
75 43 61 Up to 
1.3
Higher 6MWT distance 6MWT distance ↑
Keurentjes, 
2013 [20]
445 63 66.6 1.5-6 Kellgren Grade 0-2 vs 
3-4
SF-36 (PF) ↑
Kellgren Grade 0-2 vs 
3-4
Numeric Rating Scale 
Satisfaction
↑
Meding, 2000 
[22]
1,015 55 67.2 Mean 
2.7
Greater degree of 
cartilage space loss
Pain at 1 year ↓
Nikolajsen, 2006 
[30]
1,048 ND ND 1-1.5 Females Daily, constant pain in 
hip and elsewhere
↑
Nilsdotter, 2002 
[32]
124 56 71 1 Age >72 year WOMAC (physical 
function)
↑
Age >72 year SF-36 all subscales 
except bodily pain
↓
Lower WOMAC 
(physical function and 
pain)
WOMAC (physical 
function and pain)
↓
Higher SF-36 (pain) SF-36 (pain) ↑
Nilsdotter, 2001 
[31]
74 
(WOMAC)
53 71.2 1 Higher WOMAC 
(physical function)
WOMAC (physical 
function)
↑
WOMAC (Pain) WOMAC (Pain) ↑
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Röder, 2007 
[24]
12,925 50 males 
68.6 
females 
66,3
Mean 
4.3
Better walking capacity Walking capacity ↑
Better Flexion Flexion ↑
Rolfson, 2009 
[23]
6,158 57 69 1 Charnley class C Pain relief (VAS) ↓
Anxiety/ depression 
(EQ-5D)
Pain relief (VAS) ↑
Female Satisfaction ↓
Anxiety/ depression 
(EQ-5D)
Satisfaction ↓
Charnley class C Satisfaction ↓
Female EQ-5D ↓
Anxiety/ depression 
(EQ5D) score 2 or 3
EQ-5D ↑
Charnley class C EQ-5D ↓
Sadr Azodi, 
2008 [25]
2,106 0 30-54: 
239, 55-
59: 324, 
60-64: 
387, 65-
69: 391, 
70-74: 
370, 75-
79: 244, 
80+: 151
3 Obesity Dislocation ↑
Sarasqueta, 
2012 [21]
166 47 67 1 Higher SF-12 (PC) Function (WOMAC) ↓
Function (WOMAC) 
≥76.48
Function (WOMAC) ↑
Stickles, 2001 
[26]
592 56 68.9 1 Higher BMI Ascending and 
descending stairs
↓
Street, 2005 [33] 236 ND 67.1 1 and 
2
Knee pain (vs hip and 
thigh pain)
HHS ↓
Knee pain (vs hip pain) WOMAC ↑
Knee pain (vs hip and 
thigh pain)
SF-36 (physical 
function, vitality, social 
function and mental 
health at 1 and 2 year 
f-up and role physical 
at 2 year f-up
↓
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Tanaka, 2010 
[45]
43 100 59.7 1 Severe stage hip OA 
(radiological)
Gait improvement ↓
BIPQ: The Brief Illness Perception Questionnaire; HHS: Harris Hip Score; SF-12: 12-item Short Form Health 
Survey; OHS: Oxford Hip Score; DEPCAT: Deprivation Categories; SF-36: 36-item Short Form Health 
Survey; PF: Physical Functioning; RP: Physical Role; BP: Bodily Pain; GH; General Health; VT: Vitality; SF: 
Social Functioning; RE: Role-Emotional; MH: Mental Health; MCS: Mental Component Summary score; 
PCS: Physical Component Summary score; BMI: Body Mass Index; HOOS: Hip disability and Osteoarthritis 
Outcome Score; ADL: Activities of Daily Living; QOL: Quality Of Life; EQ-5D: EuroQol 5 Dimensions 
WOMAC: Western Ontario & McMaster Universities Osteoarthritis Index; VAS: Visual Analogue Scale; 
6MWT: 6 Minute Walk Test; ROM: Range Of Motion; ESSI: The ENRICHD Social Support Instrument; HADS: 
Hospital Anxiety and Depression Scale; OA: OsteoArthritis 
§ Follow-up moments ≥1 year, when analyses were performed
† Based on both THA and TKA population
ND Not described
*Direction according to scale of the instrument (e.g. VAS pain, VAS Satisfaction, WOMAC: lower scores 
indicate better outcomes, SF-36, HOOS, HHS etc.: higher scores indicate better outcomes).
209 Chapter 9
9

Chapter 10
The influence of preoperative variables on health related 
quality of life, functioning and pain after total knee 
and hip replacement in patients with osteoarthritis: 
pooled analysis of existing cohorts in the Netherlands
Stefanie N Hofstede, Maaike GJ Gademan, Theo Stijnen, Rob GHH Nelissen, 
Perla J Marang- van de Mheen for the ARGON-OPTIMA study group
Submitted
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ABSTRACT
Background
Several studies have shown contradicting results preoperative variables that predict 
health related quality of life (QoL), functioning and pain after total knee or hip arthroplasty 
(TKA/THA) possibly due to lack of power and not adjusting for confounders. The present 
study aims to study the independent effect of these variables on postoperative QoL, 
functioning and pain. 
Methods
We pooled individual patient data (n=1783 TKA and n=2400 THA) from 19 cohorts 
with osteoarthritis (OA) patients in the Netherlands. We examined the influence of age, 
gender, BMI and preoperative values of QoL, functioning and pain on postoperative 
status and total improvement. Linear mixed models were used to estimate the effect of 
each preoperative variable on a particular outcome for each cohort separately. These 
effects were pooled across cohorts using a random effects model. 
Results
For each preoperative point in QoL, the postoperative QoL increased by 0.51 points in 
TKA and 0.37 points in THA. Similarly, each point in preoperative functioning, resulted 
in a higher postoperative functioning of 0.31 (TKA) and 0.21 (THA) points on the KOOS/
HOOS-ADL scale. For pain this was 0.18 (TKA) and 0.15 (THA) points higher on the 
KOOS/HOOS-pain scale (higher means less pain). Even though patients with better 
preoperative values achieved better postoperative outcomes, their improvement was 
smaller. Both gender and BMI influenced pain after a TKA and THA. Age and BMI 
influenced QoL, function and pain after a THA.
Conclusion
Patients with a better preoperative QoL, functioning and pain have better outcomes, but 
also less improvement. Even though the independent effects may seem small, combined 
results of preoperative variables may result in larger effects on postoperative outcomes. 
This information may help orthopaedic surgeons to estimate how much a patient and will 
allow them to counsel patients about the possible outcomes of a joint replacement may 
improve if surgery is done now versus alternative scenarios.
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INTRODUCTION
Total knee or hip arthroplasty (TKA/THA) is an effective treatment for most individuals 
who suffer from pain and loss of function due to end stage symptomatic hip osteoarthritis 
(OA). In 2010, 109 and 153 patients per 100,000 persons received a TKA or THA 
respectively in Europe [1]. The development and progression of OA is strongly influence 
by age and obesity and more common in women. Parallel to the rising prevalence of 
knee and hip OA, due to an ageing society and obesity, surgery rates are rising as well 
[2-4]. 
TKA and THA should not be given too early since revision rates are higher in younger 
patients and the length of life of a prosthesis is limited [5]. On the other hand performing 
a surgery earlier gives more years of productive quality-adjusted life years (QALY’s). 
However, outcomes after revision surgery are generally worse compared to primary 
surgery. Current practice shows that preoperative disease severity varies largely among 
centers and countries [6,7], suggesting differences in timing. In addition, about 10-20% 
of the patients is not satisfied after primary TKA/THA [8-11], possibly caused by unmet 
expectations of patients due to suboptimal timing of surgery.
Previous research has identified preoperative variables that influence outcomes, but 
these differed between studies and had opposite directions. This may be due to lack of 
power so that some studies did not find any effect, while other studies did not adjust for 
confounders. Pooling the data from available cohort studies may provide more reliable 
evidence on which variables influence the outcome after TKA/THA because of the larger 
sample size.
Therefore, the present study aims to study the independent effect of several preoperative 
variables for outcomes after TKA or THA by pooling individual patient data from available 
prospective cohorts in the Netherlands.
MATERIALS AND METHODS
The ARGON-OPTIMA (Outcome Predictors for TIMing of ArthropLasty) study is part 
of the ARGON program (Arthritis Research Group Orthopaedics in The Netherlands). 
Within this study, we pooled individual patient data from all available prospective 
TKA/THA cohorts in the Netherlands. All orthopaedic clinics in The Netherlands were 
invited to participate and submit data. We included prospective studies among patients 
with primary OA who underwent TKA or THA, with at least one preoperative and one 
postoperative measurement on functional or clinical outcomes and a follow-up of at 
least one year. Studies regarding metal-on-metal (MoM) prostheses were excluded, 
214 A pooled analysis of existing cohorts
since these are not recommended in current guidelines in The Netherlands.
The assessed preoperative variables were age, gender and BMI, since these were 
collected in each of the included cohorts. Only few cohorts had data on smoking, 
degree of radiological osteoarthritis, and comorbidities. Furthermore, we examined the 
influence of preoperative health related quality of life (QoL), functioning and pain. We 
studied the effect on the absolute level of the postoperative outcome, but also on the 
extent of improvement to assess which patients would benefit most from change in a 
preoperative variable.
Since different cohorts used different questionnaires, these were standardized to 
compare the same domains across different questionnaires. Furthermore, multiple 
questionnaires were sometimes used to measure the same domain within a cohort. As 
each patient should be included only once for each domain, we ordered questionnaires 
in their ability to measure each outcome reliably, determined by a group of experts 
within the ARGON consortium. Only the highest rated questionnaire in each dataset was 
included. The following ordering was used:
Health related quality of life: 1. Physical component summary scale of the SF-36/RAND-
36 (36 items), 2. Physical component summary scale of the SF-12 (12 items), 3. EQ-5D 
(5 items)
Functioning: 1. HOOS/ KOOS subscale ADL (17 items), 2. WOMAC subscale Physical 
Function (17 items), 3. HOOS-PS/KOOS-PS (5 items) 4. OHS subscale function (6 items)/ 
OKS subscale function (5 items) according to Harris et al. [12,13] 
Pain: 1. HOOS/ KOOS subscale Pain (10 items), 2. WOMAC subscale Pain (5 items), 
3. OHS subscale Pain (6 items)/ OKS subscale Pain (7 items) according to Harris et al. 
[12,13], VAS pain scale
Standardization was performed according to (functioning as example): 
Standardized Functioning score (at each time point) =
(functioning score (at each time point) - preoperative mean of functioning )
preoperative SD of functioning
Some questionnaires differed in the direction of the scale e.g. on the VAS pain scale, 
lower scores mean less pain whereas lower scores mean more pain on the HOOS/
KOOS subscale pain. The direction of all scales were recoded so that higher scores 
referred to better values).
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Statistical analysis
Data of TKA and THA were analyzed separately. As a first step, linear mixed models 
(LMM) were used to estimate the influence of each preoperative variable on each major 
outcome for each cohort separately, adjusted for the other variables. As determinants 
were included in the fixed part of the LMM: the standardized preoperative score (QoL, 
functioning and pain), age, sex, BMI and follow-up time. Interaction terms were fitted 
between the variables and follow-up time. In the LMM the patients were specified 
as the subjects, with an unstructured covariance matrix. This was done for each 
standardized postoperative outcome. In the second step, the regression coefficients 
from all cohorts were pooled using a random effects model to obtain one pooled 
estimate for each preoperative variable and outcome. Given the pooled estimates of 
the impact of preoperative status on postoperative status, we can also determine the 
total improvement (postoperative minus the preoperative status). If patients would have 
the same amount of improvement, 1 point higher in preoperative status would result in 
a postoperative status of 1 point higher. So if the increase in postoperative status is < 1 
(e.g. 0.4), this means that the improvement is 0.6 points smaller for every point increase 
in preoperative status.
Given that preoperative scores were standardized, the pooled regression coefficient 
should be interpreted as the number of standard deviations that an outcome will change, 
per point increase in the preoperative variable. For example looking at the effect of age 
on postoperative functioning with a standardized regression coefficient of 0.2 and the 
preoperative SD of functioning is 7, this means that one year increase in age is estimated 
to increase the postoperative functioning by:  0.2*7. To facilitate interpretation of the 
pooled standardized regression coefficients of age, BMI and gender, we transformed 
standardized regression coefficients back to a 0-100 scale (e.g. HOOS, SF-36), using 
the preoperative standard deviation (SD) of the most representative study. In addition, 
we will illustrate the potential size of the effects by describing scenarios.
SPSS 20 was used to perform the LLM and Stata 11.1 for the meta-analyses. A p-value 
of 0.05 was considered significant in all analyses.
Assessment of heterogeneity
The I2 statistic was used to test for heterogeneity between cohorts. This can be 
interpreted as the percentage of total variability in a set of effect sizes due to between-
studies variability. We considered results as heterogeneous when I2 was 50% or greater 
[14].
Ethical approval
The Medical Ethical Committee of the Leiden University Medical Center (CME P15.043/
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SH/sh) confirmed that ethical approval for this type of study is not required under Dutch 
law.”
Source of funding
This research project is supported by a grant (ARGON) from The Dutch Arthritis 
Foundation (project number BP 12-3-401). The funder had no role in the investigation.
RESULTS
Twenty hospitals submitted data and 19 cohorts from 11 hospitals were included. 
Of these, 8 cohorts included 1783 knee OA patients undergoing primary TKA and 
11 cohorts included 2400 hip OA patients undergoing primary THA. Table 1 shows 
the characteristics of patients per cohort. Table 2 shows the pooled estimates of the 
effect of age, gender and BMI on outcomes as well as the transformed values. Most 
effects were small and homogeneous. For TKA, only gender and BMI were significantly 
associated with pain. Women had more pain postoperatively than men (3.92 points 
lower on a 0-100 scale, where 100 is no pain). An increase in BMI with one point, 
resulted in more postoperative pain (0.47 points on a 0-100 scale). For THA, age and 
BMI were significantly associated with QoL, functioning and pain. One year increase in 
age decreased postoperative functioning by 0.33 point on a 0-100 scale. Furthermore, 
females perceived more pain postoperatively (2 points on a 0-100 scale).
Health related quality of life
Four studies examined the effect of preoperative QoL on postoperative QoL in 760 
patients after TKA. Eight studies examined this effect in 1436 patients with a THA (figure 
1). A significant positive effect of preoperative QoL was found of 0.51 (95% CI 0.32 to 
0.71) for patients after TKA and 0.37 (95% CI 0.21 to 0.53) after THA. This means that 
a patient with 1 point higher preoperative QoL on average achieves a 0.51 point (TKA) 
and 0.37 point (THA) higher postoperative QoL on the SF-36 scale. At the same time, if 
patients with a 1 point higher preoperative QoL reach a 0.51 point higher postoperative 
QoL after TKA, this also means that their improvement is 0.49 (0.51-1) points less. For 
THA this implies 0.63 (0.37-1) points less improvement postoperative. The results were 
heterogeneous, meaning that included studies differed with respect to the estimated 
effect for either TKA or THA.
Functioning
Six studies examined the effect of preoperative functioning on postoperative functioning 
in 1021 patients with a TKA and 10 studies examined this effect in 1271 patients with a 
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Table 1. Description of included TKA and THA databases
Arthroplasty Study n Females (%) Age mean (SD) BMI mean (SD) Follow-up
TKA 1 340 228 (67) 68.9 (9.3) 29.3 (7.6) 2 weeks, 3 
months, 2-7 
years
TKA 2 382 271 (71) 67.0 (9.7) 29.5 (4.7) 1 year
TKA 3 45 20 (44) 67.8 (6.5) 29.3 (5.1) 3, 6, 12 months
TKA 4 101 66 (65) 68.9 (9.1) 30.9 (5.1) 6 weeks, 6, 12 
months, 5 years
TKA 5 496 274 (55) 65.9 (7.9) 27.6 (3.5) 6, 12, 24 months
TKA 6 169 120 (71) 69.8 (9.9) 29.2 (4.7) 6 weeks, 3 
months, 1 year
TKA 7 41 22 (54) 62.2 (9.5) 32.0 (5.4) 3, 6 months, 4 
years
TKA 8 209 127 (61) 66.4 (10.2) 29.7 (6.4) 6 weeks, 3, 6, 12 
months
THA 1 498 319 (64) 65.7 (10.8) 26.9 (4.0) 2 weeks, 3 
months, 2-7 
years
THA 2 149 106 (71) 60.4 (6.9) 26.8 (4.2) 6 weeks, 3, 6, 
12, 24 months
THA 3 398 247 (62) 66.6 (10.2) 27.2 (4.5) 1 year
THA 4 55 32 (58) 67.7 (9.7) 27.3 (3.6) 3, 6, 12 months
THA 5 73 46 (63) 65.2 (6.7) 28.0 (4.6) 6 weeks, 3, 
6, 12, 24, 60 
months
THA 6 26 18 (69) 62.9 (5.0) 24.5 (2.9) 6 weeks, 3, 6, 12 
months
THA 7 354 228 (64) 65.9 (7.9) 26.4 (3.4) 3, 12 months
THA 8 100 58 (58) 68.7 (10.0) 28.2 (4.0) 6 weeks, 3, 12 
months
THA 9 287 188 (66) 67.5 (10.6) 26.6 (4.1) 6 weeks, 3, 12 
months
THA 10 73 46 (63) 66.7 (12.0) 26.5 (4.2) 3, 6, 12 months
THA 11 33 22 (67) 63.0 (11.9) 26.6 (4.3) 3, 6, 48 months
THA 12 354 257 (73) 69.0 (10.9) 28.2 (4.5) 6, 12, 24 months
 
THA (figure 2). We found a significant positive effect of 0.31 (95% CI 0.23 to 0.39)  for 
TKA and 0.21 (95% CI 0.16 to 0.26) for THA. This means that a patient with a 1 point 
higher preoperative functioning on average achieves a 0.31 points higher postoperative 
functioning on the KOOS scale (TKA) and 0.21 points of the HOOS scale (THA). At the 
same time this means that these patients have a 0.69 and 0.79 point less improvement 
for TKA and THA respectively for every 1 point higher on preoperative functioning. The 
results were homogeneous meaning that the estimated effects did not differ between 
studies.
218 A pooled analysis of existing cohorts
Table 2. The influence of patients characteristics on postoperative outcomes after TKA and THA
Arthroplasty Patients 
characteristic
Outcome Studies 
(n)
Patients 
(n)
Standardized 
regression 
coefficients (95% 
CI)
Transformed 
regression 
coefficient 
(0-100 scale) 
I2 (%) 
TKA Age QoL 4 774 0.00 (-0.00, 0.01) 0.00 0.0
TKA Age Functioning 6 1021 -0.01 (-0.01, 0.00) -0.18 0.0
TKA Age Pain 6 1102 0.01 (-0.00, 0.02) 0.16 47.0
TKA Gender 
(women)
QoL 4 774 -0.05 (-0.23, 0.13) -0.38 0.0
TKA Gender 
(women)
Functioning 6 1021 -0.24 (-0.50, 0.01) -4.12 53.6
TKA Gender 
(women)
Pain 6 1102 -0.25 (-0.50, -0.01) -3.92 50.5
TKA BMI QoL 4 774 -0.02 (-0.06, 0.02) -0.23 76.1
TKA BMI Functioning 6 1021 -0.01 (-0.05, 0.02) -0.18 62.5
TKA BMI Pain 6 1102 -0.03 (-0.05, -0.01) -0.47 13.1
THA Age QoL 8 1436 -0.01 (-0.02, -0.01) -0.08 0.0
THA Age Functioning 10 1271 -0.02 (-0.02, -0.01) -0.33 0.0
THA Age Pain 10 1492 -0.01 (-0.01, -0.00) -0.18 0.0
THA Gender 
(women)
QoL 8 1436 -0.10 (-0.22, 0.01) -0.78 0.0
THA Gender 
(women)
Functioning 10 1271 -0.11 (-0.22, 0.01) -1.95 10.9
THA Gender 
(women)
Pain 10 1492 -0.11 (-0.21, -0.00) -2.00 0.0
THA BMI QoL 8 1436 -0.03 (-0.04, -0.01) -0.23 0.0
THA BMI Functioning 10 1271 -0.02 (-0.04, -0.01) -0.35 0.0
THA BMI Pain 10 1492 -0.02 (-0.03, -0.00) -0.36 0.0
Pain
Six studies examined the effect of preoperative pain on postoperative pain in 1102 TKA 
patients and 11 studies examined this effect in 1492 THA patients (figure 3). We found 
that every point increase in preoperative pain (i.e. less pain) was associated with 0.18 
(95% CI 0.11 to 0.26) point increase in postoperative pain after a TKA and 0.15 (95% 
CI 0.08 to 0.21) after a THA. This also means that patients with less preoperative pain 
improve 0.82 points less after TKA and 0.85 points less after THA. The results were 
homogeneous meaning that the estimated effects did not differ between studies.
Combined results
Even though the independent effect of one variable may be small, the combined effect 
of different variables may result in clinically relevant differences. Table 3 shows some 
hypothetical scenarios in which several variables are combined. The first scenario is 
that a patient first loses some weight and reduces the BMI with 5 points to improve the 
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postoperative functioning after THA. This takes some time (e.g. 5 years) and a higher 
age decreases the postoperative functioning. Suppose that due to the weight loss the 
preoperative functioning increases with 5 points (on a 0-100 scale). Taken together, 
this results in a 1.2 points higher postoperative outcome. The second scenario is that 
a surgeon thinks a patient is too young to perform a THA. If a patient receives this THA 
10 years later, and during this 10 years the patient also gains weight due to an inactive 
Figure 1. Forest plots - The influence of preoperative QoL on postoperative QoL after TKA (a) and THA 
(b)
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lifestyle (e.g. 10 points of BMI) and the functioning also reduces with 10 points (on 
a 0-100 scale), his/her postoperative functioning will be 9 points lower compared to 
the situation if she/he had received THA surgery 10 years earlier. The effect of these 
scenarios on QoL and pain are also shown in table 3. Overall effects vary between 1.2 
and 6.5 points better postoperative outcomes for scenario 1 and between 1.6 and 9 
points worse postoperative outcomes for scenario 2. 
Figure 2. Forest plots - The influence of preoperative functioning on postoperative functioning after TKA 
(a) and THA (b)
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Figure 3. Forest plots - The influence of preoperative pain on postoperative pain after TKA (a) and THA 
(b)
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Table 3. Combined data within scenarios
Scenario 1: A patient loses weight (X points) and increases preoperative status by Y points, this takes 
Z years
Arthroplasty Assessed 
outcome
Effect of age Effect of BMI Effect of 
preoperative 
status
Total effect on 
postoperative outcome 
(points)a
X, Y, Z=5 (e.g. in 5 years BMI decreases from 30 to 25, KOOS QoL/ functioning/ pain increases from 
35 to 40) 
TKA QoL 0 0 5*0.51 2.6
Functioning 0 0 5*0.31 1.6
Pain 0 5*0.47 5*0.18 3.3
THA QoL 5*-0.08 5*0.23 5*0.37 2.6
Functioning 5*-0.33 5*0.35 5*0.22 1.2
Pain 5*-0.18 5*0.36 5*0.15 1.7
X, Y, Z=10 (e.g. in 10 years BMI decreases from 35 to 25, KOOS QoL/ functioning/ pain increases 
from 35 to 45)
TKA QoL 0 0 10*0.51 5.1
Functioning 0 0 10*0.31 3.1
Pain 0 10*0.47 10*0.18 6.5
THA QoL 10*-0.08 10*0.23 10*0.37 5.2
Functioning 10*-0.33 10*0.35 10*0.22 2.4
Pain 10*-0.18 10*0.36 10*0.15 3.3
Scenario 2: A patient gains weight (X points) and decreases preoperative status by Y points, this takes 
Z years
X, Y, Z=5 (e.g. in 5 years BMI increases from 25 to 30, HOOS  QoL/ functioning/ pain decreases from 
40 to 35)
TKA QoL 0 0 5*-0.51 -2.6
Functioning 0 0 5*-0.31 -1.6
Pain 0 5*-0.47 5*-0.18 -3.3
THA QoL 5*-0.08 5*-0.23 5*-0.37 -3.4
Functioning 5*-0.33 5*-0.35 5*-0.22 -4.5
Pain 5*-0.18 5*-0.36 5*-0.15 -3.5
X, Y, Z=10 (e.g. in 10 years BMI increases from 25 to 35, HOOS QoL/ functioning/ pain decreases 
from 45 to 35)
TKA QoL 0 0 10*-0.51 -5.1
Functioning 0 0 10*-0.31 -3.1
Pain 0 10*-0.47 10*-0.18 -6.5
THA QoL 10*-0.08 10*-0.23 10*-0.37 -6.8
Functioning 10*-0.33 10*-0.35 10*-0.22 -9.0
Pain 10*-0.18 10*-0.36 10*-0.15 -6.9
aOn a 0-100 scale
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DISCUSSION
The present pooled analysis of 1783 knee and 2400 hip OA patients shows that patients 
with a higher preoperative quality of life or functioning and less pain also have better 
postoperative outcomes but that they improve less. Furthermore, women and patients 
with a higher BMI had more postoperative pain and less improvement after both TKA 
and THA. Higher age and higher BMI was associated with lower postoperative QoL and 
functioning and more pain after a THA. However, preoperative quality of life, functioning 
and pain seem to be most consistently associated with outcomes after both TKA and 
THA.
It is important to realize that the effects found in our study are not only the effect of the 
surgery, but also the effect of regression to the mean (RTM). RTM occurs because 
values are observed with random error, such as random fluctuations in a subject [15]. 
This means that patients with low preoperative scores are more likely to have higher 
scores during the next measurement and that patients with high preoperative scores are 
more likely to have lower scores during the next measurement, even without surgery. 
This results on average in a larger “improvement” for patients with lower preoperative 
scores compared to patients with higher baseline scores. Although different methods 
have been proposed to estimate the size of the RTM effect, but no solution is available 
to distinguish the real change due to surgery from the change due to RTM. 
Our results regarding the effect of preoperative status on outcomes are consistent 
with other studies that also found that patients with worse preoperative functioning had 
greater improvements [16-19], but did not achieve the postoperative level of those with 
higher preoperative functioning [20-26]. Contrary, other studies showed opposite results 
regarding the direction and size of the effect of age, gender and BMI. Santaguida et al. 
[27] performed a systematic review about patient characteristics affecting the prognosis 
after TKA/THA and concluded that an older age is related to worse functioning, but 
that age and sex do not influence postoperative pain level. We found that women had 
more pain after a TKA (4 points on a 100 point scale) and THA (2 points on a 100 
point scale), even though this may not be a clinically relevant difference [28]. For TKA 
no association with age or gender and functioning was found. In addition, a previous 
review about prognostic variables in THA reported that preoperative functioning was 
most consistently associated with better outcomes [29]. In addition, another systematic 
review on preoperative predictors on outcomes in THA [30] concluded that only patients’ 
poor preoperative functioning affects the outcome after THA. This was also found for 
patients with a TKA [31,32]. Consistent with our finding, Lingard et al. [32] found that 
patients with severe pain had worse outcomes after a TKA. Other studies also identified 
other variables, such as radiological scores or comorbidities. A disadvantage of using 
multiple studies with different protocols for data acquisition was that we could not 
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include these variables. The linear mixed model had to be the equal for each study, so 
that regression coefficients in each study have the same meaning. Thus the prognostic 
variables found in this present study are not exhaustive; there may be other variables 
that are also associated with the outcome.
The effect of different preoperative variables on the postoperative outcomes after TKA 
and THA may seem to be small on itself, but if taken together they may add up to 
a clinically relevant effect. However, the scenarios should be interpreted with care, 
because these are hypothetical examples based on observational data and cannot be 
interpreted causally. The overall effects of the virtual scenarios which were calculated as 
examples vary between 1.2 and 6.5 points better postoperative outcomes and between 
1.6 and 9 points worse postoperative outcomes. These scenarios provide more insights 
how small differences may add up or cancel each other out. This probably explains why 
most effects do not reach a clinically significant difference. Usually a 10% difference 
(i.e. 10 points on a 0-100 scale [28]) is considered as clinically relevant, but is a 10% 
difference the right criterion? Postoperative TKA/THA scores increases on average by 
20-40 points on a 0-100 scale (results not shown) compared to preoperative scores 
regardless of the preoperative status. Thus is it realistic to use a difference of 10 points 
to define whether it is clinically relevant to operate now or wait, based on differences in 
preoperative variables? 
The information regarding the combined effects of preoperative variables on postoperative 
outcomes will support orthopaedic surgeons to estimate differences in outcome after a 
joint replacement for specific patient groups, i.e. poorer outcomes for patients with a 
worse preoperative status, but with greater postoperative improvement compared to 
patients with higher preoperative scores. In addition, preoperative status may decline 
during a long surgical delay period and thereby lead to worse postoperative outcomes 
if no other non-surgical treatments are started. On the other hand, it may sometimes be 
better to first optimize the patient’s preoperative condition or to reduce for example their 
BMI. The present study may support orthopaedic surgeons in their decision making by 
giving an estimate of the magnitude of the effect for different scenarios. Future studies 
should combine the results of our study with observational cohort studies among OA 
patients who did not have surgery yet, specific survival data from medical literature and 
the effects on survival of the artificial joint to assess optimal timing of surgery. This is 
needed to assess the long-term impact for the patient of the decision to perform surgery 
at a certain preoperative state of specific patient groups.
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ABSTRACT
Background
It is unclear whether there are differences in benefits and harms between mobile and 
fixed prostheses for total knee arthroplasty (TKA). The previous Cochrane review 
published in 2004 included two articles. Many more trials have been performed since 
then; therefore an update is needed.
Objectives
To assess the benefits and harms of mobile bearing compared with fixed bearing 
cruciate retaining total knee arthroplasty for functional and clinical outcomes in patients 
with osteoarthritis (OA) or rheumatoid arthritis (RA).
Search methods
We searched The Cochrane Library, PubMed, EMBASE, CINAHL and Web of Science 
up to 27 February 2014, and the trial registers ClinicalTrials.gov, Multiregister, Current 
Controlled Trials and the World Health Organization (WHO) International Clinical Trials 
Registry Platform for data from unpublished trials, up to 11 February 2014. We also 
screened the reference lists of selected articles.
Selection criteria
We selected randomised controlled trials comparing mobile bearing with fixed bearing 
prostheses in cruciate retaining TKA among patients with osteoarthritis or rheumatoid 
arthritis, using functional or clinical outcome measures and follow-up of at least six 
months.
Data collection and analysis
We used standard methodological procedures as expected by The Cochrane 
Collaboration.
Main results
We found 19 studies with 1641 participants (1616 with OA (98.5%) and 25 with RA 
(1.5%)) and 2247 knees. Seventeen new studies were included in this update.
Quality of the evidence ranged from moderate (knee pain) to low (other outcomes). Most 
studies had unclear risk of bias for allocation concealment, blinding of participants and 
personnel, blinding of outcome assessment and selective reporting, and high risk of 
bias for incomplete outcome data and other bias.
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Knee pain
We calculated the standardised mean difference (SMD) for pain, using the Knee Society 
Score (KSS) and visual analogue scale (VAS) in 11 studies (58%) and 1531 knees (68%). 
No statistically significant differences between groups were reported (SMD 0.09, 95% 
confidence interval (CI) -0.03 to 0.22, P value 0.15). This represents an absolute risk 
difference of 2.4% points higher (95% CI 0.8% lower to 5.9% higher) on the KSS pain 
scale and a relative percent change of 0.22% (95% CI 0.07% lower to 0.53% higher). 
The results were homogeneous.
Clinical and functional scores
The KSS clinical score did not differ statistically significantly between groups (14 studies 
(74%) and 1845 knees (82%)) with a mean difference (MD) of -1.06 points (95% CI 
-2.87 to 0.74, P value 0.25) and heterogeneous results. KSS function was reported in 
14 studies (74%) with 1845 knees (82%) as an MD of -0.10 point (95% CI -1.93 to 
1.73, P value 0.91) and homogeneous results. In two studies (11%), the KSS total score 
was favourable for mobile bearing (159 vs 132 for fixed bearing), with MD of -26.52 
points (95% CI -45.03 to -8.01, P value 0.005), but with a wide 95% confidence interval 
indicating uncertainty about the estimate.
Other reported scoring systems did not show statistically significant differences: Hospital 
for Special Surgery (HSS) score (seven studies (37%) in 1021 knees (45%)) with an MD 
of -1.36 (95% CI -4.18 to 1.46, P value 0.35); Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC) total score (two studies (11%), 167 knees (7%)) with an 
MD of -4.46 (95% CI -16.26 to 7.34, P value 0.46); and Oxford total (five studies (26%), 
647 knees (29%) with an MD of -0.25 (95% CI -1.41 to 0.91, P value 0.67).
Health-related quality of life
Three studies (16%) with 498 knees (22%) reported on health-related quality of life, and 
no statistically significant differences were noted between the mobile bearing and fixed 
bearing groups. The Short Form (SF)-12 Physical Component Summary had an MD of 
-1.96 (95% CI -4.55 to 0.63, P value 0.14) and heterogeneous results.
Revision surgery
Twenty seven revisions (1.3%) were performed in 17 studies (89%) with 2065 knees 
(92%). In all, 13 knees were revised in the fixed bearing group and 14 knees in the 
mobile bearing group. No statistically significant differences were found (risk difference 
0.00, 95% CI -0.01 to 0.01, P value 0.58), and homogeneous results were reported.
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Mortality
In seven out of 19 studies, 13 participants (37%) died. Two of these participants had 
undergone bilateral surgery, and for seven participants, it was unclear which prosthesis 
they had received; therefore they were excluded from the analyses. Thus our analysis 
included four out of 191 participants (2.1%) who had died: one in the fixed bearing 
group and three in the mobile bearing group. No statistically significant differences were 
found. The risk difference was -0.02 (95% CI -0.06 to 0.03, P value 0.49) and results 
were homogeneous.
Reoperation rates
Thirty reoperations were performed in 17 studies (89%) with 2065 knees (92%): 18 knees 
in the fixed bearing group (of the 1031 knees) and 12 knees in the mobile group (of the 
1034 knees). No statistically significant differences were found. The risk difference was 
-0.01 (95% CI -0.01 to 0.01, P value 0.99) with homogeneous results.
Other serious adverse events
Sixteen studies (84%) reported nine other serious adverse events in 1735 knees (77%): 
four in the fixed bearing group (of the 862 knees) and five in the mobile bearing group 
(of the 873 knees). No statistically significant differences were found (risk difference 
0.00, 95% CI -0.01 to 0.01, P value 0.88), and results were homogeneous.
Authors’ conclusions
Moderate- to low-quality evidence suggests that mobile bearing prostheses may have 
similar effects on knee pain, clinical and functional scores, health-related quality of life, 
revision surgery, mortality, reoperation rate and other serious adverse events compared 
with fixed bearing prostheses in posterior cruciate retaining TKA. Therefore we cannot 
draw firm conclusions. Most (98.5%) participants had OA, so the findings primarily 
reflect results reported in participants with OA. Future studies should report in greater 
detail outcomes such as those presented in this systematic review, with sufficient follow-
up time to allow gathering of high-quality evidence and to inform clinical practice. Large 
registry-based studies may have added value, but they are subject to treatment-by-
indication bias. Therefore, this systematic review of RCTs can be viewed as the best 
available evidence.
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BACKGROUND
Description of the condition
Osteoarthritis (OA) and rheumatoid arthritis (RA) are conditions that can affect the knee 
joints. OA and RA lead to pain, loss of function and a lower quality of life. In some 
people, damage and pain in the knee from arthritis are so severe that joint replacement 
is required. Approximately 10% of men and 18% of women older than 60 years have OA 
[1]. Because of the ageing society as well as increasing obesity, the prevalence of knee 
OA continues to increase [2]. The prevalence of RA varies between 0.3% and 1% [1].
Description of the intervention
Total knee arthroplasty (TKA) is a very common and reliable orthopaedic procedure for 
end-stage arthritis of the knee. TKA has proved to be a successful surgical intervention 
that reduces pain and enhances physical function. It is a frequently performed procedure, 
and the number of TKAs is expected to increase exponentially in future years [3]).
Recent decennia have seen an expansion of technological developments in TKA, 
usually introduced into clinical practice without appropriate assessment [4]. The mobile 
(meniscal or rotating) bearing TKA with a polyethylene insert has some freedom of 
movement and is an example of such a new development. The main goal of the mobile 
bearing insert is to decrease contact stresses at the implant interface [5,6]. Contradictory 
views exist as to whether the mobile bearing prosthesis will improve functionality as 
compared with the fixed bearing prosthesis for cruciate retaining TKA.
Why it is important to do this review
Previously, we performed a systematic review of the literature to assess whether mobile 
bearing total knee prostheses provide better functional outcomes in patients with OA 
and RA [7]. This previous review included two randomised controlled trials. Performing 
a meta-analysis therefore was not possible. Since the time of that review, many trials 
have been performed to study the clinical and functional outcomes of mobile bearing 
TKA in comparison with fixed bearing TKA. Thus, an update of the previous review is 
warranted.
Objectives
To assess the benefits and harms of mobile bearing compared with fixed bearing 
cruciate retaining total knee arthroplasty for functional and clinical outcomes in patients 
with osteoarthritis or rheumatoid arthritis.
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METHODS
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) comparing mobile and fixed bearing cruciate 
retaining TKA published as full text in a peer-reviewed journal.
Types of participants
People who have had TKA for OA or RA.
Types of interventions
We included studies of primary, unconstrained, cruciate retaining, total (bi- or 
tricompartmental) knee arthroplasty with a mobile bearing (meniscal or rotational) or a 
fixed bearing polyethylene insert. We excluded studies with TKA after prior patellectomy 
and osteotomy.
Types of outcome measures
The outcome measurement in the studies had to be a functional or a clinical measure 
with a minimal follow-up of six months.
Major outcomes
• Knee pain (e.g. visual analogue score (VAS), Knee Society Score (pain), Western 
Ontario and McMaster Universities Arthritis Index (WOMAC) score (pain), Hospital 
for Special Surgery Score (HSS) (pain), Oxford Knee Score (OKS) (pain)).
• Clinical and functional questionnaire scores (e.g. WOMAC, Knee Injury and 
Osteoarthritis Outcome Score (KOOS), OKS, HSS, Bristol Knee Score, International 
Knee Documentation Committee Subjective Knee Form (IKDC) or Performance 
Outcome (Knee Society (functional) Score, Knee Society (clinical) Score), Knee 
Society (total) Score)).
• Health-related quality of life (e.g. Short Form (SF)-36, SF-12).
• Revision surgery.
• Mortality.
• Reoperation rate.
• Serious adverse events (excluding revision surgery, mortality and reoperation rate).
Minor outcomes
• Radiolucent lines.
• Femorotibial alignment.
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• Performance outcome (flexion, extension, range of motion (ROM)).
Search methods for identification of studies
Electronic searches
In co-operation with a trained medical librarian, we composed a new search strategy. We 
searched the following databases on 27 February 2014: The Cochrane Library (2014, 
Issue 1), PubMed (1944 to 27 February 2014), EMBASE (Ovid version) (1980 to 27 
February 2014), Web of Science (1945 to 27 February 2014) and the Cumulative Index 
to Nursing and Allied Health Literature (CINAHL) (EbscoHost-version) (1981 to 27 
February 2014). In addition, we searched the following trial registries on 11 February 
2014: ClinicalTrials.gov, Multi-register, Current Controlled Trials, the World Health 
Organization (WHO) International Clinical Trials Registry Platform and the Dutch trial 
registry.
The search strategy consisted of the AND combination of two main concepts: rheumatoid 
arthritis or osteoarthritis, and knee arthroplasty. For the different concepts, we used all 
relevant keyword variations, not only keyword variations in the controlled vocabularies 
of the various databases, but free-text word variations of these concepts as well. 
We optimised the search strategies for all consulted databases, taking into account 
differences in the various controlled vocabularies, as well as differences in database-
specific technical variations (e.g. use of quotation marks). We composed three different 
versions of the search strategy.
• The intervention concept used as a major subject, the disease concept used both 
a major or minor subject.
• The intervention concept and the disease concept used as both major and minor 
subjects, combined with the combination “mobile/fixed” as an additional concept.
• A limited intervention concept combined with an extended “mobile/fixed” concept.
Finally, the results were limited to RCTs including human participants. 
Searching other resources
We screened the reference lists of included studies to look for additional studies with the 
same selection criteria and processed them as the primary search results.
Data collection and analysis
We managed publications with the aid of Reference Manager. In addition, we recorded 
relevant information pertaining to database source, reason for exclusion and consensus 
of review authors. We conducted statistical analyses using Review Manager (RevMan) 
software 5.
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Selection of studies
Four review authors (KN, BP, SH, PM) conducted the literature search in co-operation 
with a trained medical librarian and retrieved the references to be evaluated. Two review 
authors (KN, BP or SH, PM) independently selected trials for inclusion in the review. 
We resolved disagreements by consensus. When we could not reach consensus, we 
consulted a third review author (WJ) for the decisive vote.
We selected articles in two steps. In the first step, we excluded articles when it was 
apparent from either the title or the abstract that the study did not meet the criteria as 
mentioned in the criteria for considering studies for this review. In the second step, we 
excluded articles when it was apparent from inspection of the printed article:
• that it did not meet the inclusion criteria for the review; and
• that the population had already been reported in another included study (most 
informative publication was included as primary reference, and additional 
publications as secondary reference).
We documented the reason for exclusion for each reference.
Data extraction and management
We closely examined articles that met all selection criteria with the aid of a checklist and 
a data extraction form. One review author (SH or KN) entered data into RevMan 5, and 
another review author (PJ or WJ) checked the data.
Assessment of risk of bias in included studies
Two out of five possible review authors (KN, BP, WJ, SH, PM) assessed the risk of bias 
in duplicate independently. We assessed risk of bias using the tool of The Cochrane 
Collaboration [8]), including the domains random sequence generation, allocation 
concealment, blinding of participants and personnel, blinding of outcome assessment, 
incomplete outcome data, selective reporting and other sources of bias. In the domain 
‘other bias,’ we checked for homogeneity of data and co-interventions. We scored each 
domain as low, high or unclear. Under ‘other bias,’ we assessed co-interventions and 
baseline imbalance such as group homogeneity and subgroup homogeneity, because 
heterogeneity is often encountered and accounts for lack of power in many orthopaedic 
surgery trials.
When two review authors could not reach consensus, we consulted a third review author 
until consensus was reached.
Measures of treatment effect
Studies eligible for the review were RCTs comparing a cruciate retaining mobile (rotating 
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or meniscal) TKA against a fixed TKA.
Dichotomous data
For dichotomous outcomes, we calculated Mantel Haenszel random-effects risk ratios 
(RRs). This RR refers to the risk of an event in the experimental group relative to the risk 
of an event in the control group. Therefore the RR can be calculated only when events 
are reported in the study groups. If the events were rare and empty cells were found 
in one of the groups in many studies, we calculated Mantel Haenszel random-effects 
risk differences (RDs). Risk difference is the difference between observed risk in the 
two groups. The RD can be calculated even when no events are reported in one of the 
study groups.
Continuous data
For continuous outcomes, we calculated a random-effects mean difference (MD) 
weighted by the inverse variance. The mean difference is a standard statistic that 
measures the absolute difference between mean values in two groups in a clinical 
trial while taking into account the precision by which this is estimated. It estimates 
the amount by which the experimental intervention on average changes the outcome 
compared with the control group. In addition, when the same outcome was reported on 
different scales, using differing units and methods of assessment (e.g. pain scales), we 
pooled the results by calculating a standardised mean difference (SMD). We corrected 
differences in the direction of the scale by subtracting mean values from the maximum 
value of the scale. To facilitate interpretation of the SMD, we transformed it back into a 
common scale, using data from the most representative study, with the largest weighting 
as mobile bearing group baseline and standard deviation.
Unit of analysis issues
An issue for studies on TKA is the possibility to perform bilateral surgery in which one 
knee is randomly assigned to receive mobile bearing and the other knee to fixed bearing 
prostheses. As not all studies have this design, we will analyse knee pain, clinical and 
functional scores and health-related quality of life with and without including these 
studies performing bilateral knee surgery to assess whether this affects our results. For 
mortality, we excluded from the analysis participants who underwent bilateral surgery.
Dealing with missing data
Standard deviation (SD) was used when available, or we imputed it from ranges if 
available. If only the average was reported and no other information was available to 
calculate the SD, we imputed the average SD from other studies in the same meta-
analysis.
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Assessment of heterogeneity
We tested heterogeneity by using the I2 statistic. The I2 statistic can be interpreted as the 
percentage of total variability in a set of effect sizes due to between-studies variability.
• Thresholds for interpretation of I2 of:
• 0% to 40%: might not be important;
• 30% to 60%: may represent moderate heterogeneity;
• 50% to 90%: may represent substantial heterogeneity; and
• 75% to 100%: show considerable heterogeneity.
Throughout this review, we considered results as heterogenous when I2 was 50% or 
greater.
Assessment of reporting biases
To determine publication bias, we searched the following trial registries: ClinicalTrials.
gov, Multiregister, Current Controlled Trials, the WHO International Clinical Trials 
Registry Platform and the Dutch trial registry.
Data synthesis
We used a random-effects model to pool data from each trial.
We conducted statistical analyses by using Review Manager 5.
Subgroup analysis and investigation of heterogeneity
We used the cutoff point of I2 ≥ 50% to indicate heterogeneity. If heterogeneity was 
present, we conducted subgroup analyses if possible. We intended to conduct 
subgroup analyses to investigate the effects of different follow-ups (one year, two years 
and more than two years of follow-up) on the observed effect.
Sensitivity analysis
We conducted sensitivity analyses to assess the effect on our results of including 
studies performing bilateral knee surgery. Therefore, we analysed knee pain, clinical 
and functional scores and health-related quality of life with and without including these 
studies to assess whether this would affect our results. Furthermore, if possible, we 
planned to assess the effect of including only high quality studies.
‘Summary of findings’ table
We reported all major outcomes in the ‘Summary of findings’ table generated using 
GRADEpro version 3.2.2.
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Grading strength of the evidence
We assessed the strength of the evidence by using the GRADE (Grades of 
Recommendation, Assessment, Development and Evaluation) approach, and added 
this information to the ‘Summary of findings’ table.
GRADE Working Group grades of evidence.
• High quality: Further research is very unlikely to change our confidence in the 
estimate of effect.
• Moderate quality: Further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate.
• Low quality: Further research is very likely to have an important impact on our 
confidence in the estimate of effect and is likely to change the estimate.
• Very low quality: We are very uncertain about the estimate.
Downgrading strength of the evidence
• We downgraded the quality of the evidence if any of these factors were present.
• Limitations in the design and implementation of available studies suggesting high 
likelihood of bias.
• Indirectness of evidence (indirect population, intervention, control, outcomes).
• Unexplained heterogeneity or inconsistency of results (including problems with 
subgroup analyses).
• Imprecision of results (wide confidence intervals).
• High probability of publication bias.
RESULTS
Description of studies
We found 19 studies (with 1641 participants and 2247 knees - 1616 participants with 
OA (98.5%) and 25 with RA (1.5%)), which were described in 22 articles. Seventeen of 
these studies were new since the time of the previous Cochrane review.
Results of the search
We searched the databases and identified 5660 references, of which 3290 were unique 
(Figure 1, PRISMA flowchart). Reference lists of studies selected for evaluation provided 
three additional titles, and citation tracking added two new references to the search. 
We screened 73 articles after removal of duplicates on the basis of title and abstract. 
We assessed the full text of 53 articles for eligibility. We excluded 34 articles, mostly 
because a posterior stabilised design was used for one or both types of prostheses in 
243 Chapter 11
11
the study. This left 19 studies for inclusion in the review and three additional articles, of 
which one described follow-up of an included study and two formed a subgroup of an 
included study.
Grey literature
We found nine proceedings that fulfilled the inclusion criteria. Five of these studies were 
later published as full text [9-13]. For one proceeding, no abstract was traceable [14]. 
The study of Chatterji et al. [15] found higher levels of dissatisfaction and patellar-femoral 
problems in the mobile bearing group. Jolles et al. [16] found better relative differences 
Figure 1. Study flow diagram (PRISMA)
244 Mobile vs fixed-bearing prostheses
between preoperative and postoperative ROM and KSS scores at three months and six 
months for the fixed bearing TKA in comparison with the mobile bearing TKA. However, 
they did not describe postoperative comparisons of both prostheses. Tibesku et al. 
[17] found no functional advantage of mobile bearing TKA over fixed bearing TKA in a 
fluoroscopic study. Furthermore, we found two studies (NCT00208286; NCT01150929) 
in trial registries that may fulfil our inclusion criteria. However, no results were posted, 
and it was unclear whether these studies were cruciate retaining. In addition, we found 
one ongoing study (Characteristics of ongoing studies) without (complete) results.
Included studies
We included 22 reports of 19 studies in this review. See the characteristics of included 
studies table for details. All studies were stated by their authors to be RCTs comparing 
mobile (rotating or meniscal) bearing versus fixed bearing, cruciate retaining, primary 
TKA.
Intervention
Nineteen studies compared mobile bearing versus fixed bearing prostheses. Of the 
mobile bearing group, 10 studies used a rotating design. Most prostheses were PFC 
Sigma systems [18-24]. Other prostheses were balanSys [25], Columbus [26] and 
Trekking MB [27]. Nine studies used a meniscal design, and three of these used the 
LCS [11,28,29]. Other prostheses were Rotaglide [30,31], MBK [32], e.motion-FP [33], 
TMK [34] and Genesis II [35,36].
In the fixed bearing group, most prostheses were PFC Sigma [18-21,24,28]. Other 
prostheses were Nuffield [30], NexGen [31,32], balanSys [25], AMK [11,29], Medial 
Pivot [22], Genesis II [33,35,36], Columbus [26], Multigen Plus FB [27], Natural Knee 
[23] and AGC [34].
Six studies performed only bilateral knee surgeries [11,21,22,31,33,34]. Five studies 
included some bilateral surgeries (Hansson et al. [30] 52 knees in 42 patients; Henricson 
et al. [32]: 52 knees in 47 patients; Higuchi et al. [20]: 76 knees in 68 patients; Lampe et 
al. [26]: 100 knees in 96 patients; Munro et al. [24]: 54 knees in 46 patients).
Participant characteristics
We have reported age and gender of study groups in characteristics of included 
studies. Most studies included participants with osteoarthritis. Three studies included 
both participants with RA and those with OA (Kim et al. [11]: six RA, 110 OA; Kim et 
al. [21]: one RA, 173 OA; Watanabe et al. [31]: 18 RA, four OA). In total, 98.5% of 
participants had OA.
In general we found participant populations from different studies to be comparable, 
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especially in studies with bilateral TKA [11,21,22,29,31,33,34]. Moreover, the groups 
are fairly homogeneous regarding etiology, with more than 90% of participants having 
OA. As we included only cruciate retaining TKA, the groups were homogeneous in this 
aspect.
However, selection criteria of included studies are sometimes absent, or they differ 
between studies, which might produce heterogeneous groups with regard to underlying 
disease [11,21,23,24,30,31].
Excluded studies
We excluded Aglietti et al. [37], Ball et al. [38], Bhan et al. [39], Breeman et 
al. [40], Breugem et al. [41] 2008, Chen et al. [42], Chiu et al. [43], Gioe et al. 
[44], Harrington et al. [45], Jawed et al. [46], Jolles et al. [47], KAT trial group [48], Kim 
et al. [49], Kim et al. [50], Kim et al. [51], Läderman et al. [52], Li et al.[53], Matsuda 
et al. [54], Sylvestre-Muñoz et al. [55], Pagnano et al. [56], Pijls et al. [57], Rahman 
et al. [58], Saari et al. [59], Shemshaki et al. [60], Tienboon et al. [61], Uvehammer 
et al. [62], Vasdev et al. [63], Wohlrab et al. [64], Woolson et al. [65], Wylde et al. 
[9] and Zeng et al. [66] because one, both or some of the implants used in these studies 
were posterior stabilised and thus were not posterior cruciate ligament retaining. In the 
trial NCT00289094, other inflammatory arthritis and avascular necrosis of bone were 
included. See also characteristics of excluded studies.
Risk of bias in included studies
The methodological quality scores of the individual studies are given in the ‘Risk of bias’ 
tables in the characteristics of included studies section. Figure 2 and Figure 3 show the 
risk of bias graph and the methodological quality summary, respectively, of all included 
studies. The studies Bailey et al. [18], Kim et al. [29], Lizaur-Utrilla et al. [27] and Price 
et al. [34] did not have high risk of bias in any of the domain assessed.
Allocation
The randomisation technique is described in most studies but is unclear in the following 
studies: Grodzki et al. [28], Henricson et al. [32], Kim et al. [11], Kim et al.  [22], Lampe 
et al. [26], Möckel et al. [23] and Watanabe et al. [31]. Methods of allocation sequences 
described include minimisation technique, computer-generated random numbers and 
sequential pool of random numbers. Study authors describe concealment of allocation 
in Hanusch et al. [19], Henricson et al. [32], Jacobs et al. [25], Kim et al. [22], Lizaur-
Utrilla et al. [27], Munro et al. [24] and Price et al. [34]. Methods described include 
sealed envelopes and telephone calls.
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Blinding
Study authors describe use of patient blinding only in Bailey et al. [18], Jacobs et al. 
[25], Lampe et al. [26], Lizaur-Utrilla et al. [27], Price et al. [34] and Tibesku et al. 
[35,36]. They explain use of assessor blinding in Bailey et al. [18], Kim et al. [21] , Kim 
et al. [22], Lampe et al. [26], Lizaur-Utrilla et al. [27] and Tibesku et al. [35,36].
Incomplete outcome data
Most studies reported the drop-outs and had an acceptable drop-out rate. One study 
[23] had too many (> 20%) participants lost to follow-up, and another study [25]
excluded 30 participants (28% of the fixed bearing group) as the result of randomisation 
error. Higuchi et al. [20] and Tibesku et al. [35,36] did not describe the drop-outs. 
The following studies used an intention-to-treat analysis: Grodzki et al. [28], Kim et al. 
[29], Kim et al. [33], Lizaur-Utrilla et al. [27], Möckel et al. [23], Munro et al. [24], Price 
et al. [34] and Watanabe et al. [31].
Selective reporting
We could find only online protocols for three included studies [18,25,26], and this 
limited our assessment of reporting bias. Data are selectively available for time points 
in these studies. Fourteen studies report short-term (up to one year) results [18-20,22-
28,30,32-34]. Six studies report midterm (longer than one year to two years) results 
[18,21,27,30,32,35,36], and eight studies report long-term (longer than two years) 
results [11,21,22,27,29,31,33,34]. However, the outcomes that studies reported varied, 
as did follow-up results. For example, Hansson et al. [30] reported HSS total only at two 
follow-up points.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as 
percentages across all included studies
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological 
quality item for each included study
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Other potential sources of bias
Other co-interventions used during the procedure of the arthroplasty were frequently 
not reported. Hansson et al. [30] and Higuchi et al. [20] did not describe treatment of 
the patella. Cementing is unclear in  Hansson et al. [30], Higuchi et al. [20] and Price 
et al. [34].
Effects of interventions
See the ‘Summary of findings’ table for major outcome measures in the comparison of 
mobile versus fixed bearing prostheses (Summary of findings for the main comparison.
Major outcomes
Knee pain
We calculated the standardised mean difference (SMD) for pain, using the KSS pain 
and VAS scores for 11 studies (58%) and 1531 knees (68%). For studies that reported 
Oxford pain, HSS pain or WOMAC pain and also reported KSS pain, the KSS pain 
was used. The SMD was 0.09 (95% CI -0.03 to 0.22, P value 0.15). This represents an 
absolute risk difference of 2.4% points higher (95% CI 0.8% lower to 5.9% higher) on 
the KSS pain scale and a relative percent change of 0.22% (95% CI 0.07% lower to 
0.53% higher) on the KSS pain scale, but these are not significant clinical or statistical 
differences.
All outcome measures for knee pain showed no statistically significant differences and 
wide confidence intervals, indicating considerable uncertainty in the estimates. Nine 
studies (47%) reported Knee Society pain score in 1392 (62%) knees. No significant 
differences were found; the mean difference was 0.41 (95% CI -0.06 to 0.88, P value 
0.08) in favour of fixed bearing. The results are homogeneous (I2 = 0%, P value 0.57). 
Three studies (16%) reported VAS pain in 300 knees (13%) with a mean difference of 
-0.13 points (95% CI -0.96 to 0.69, P value 0.75). The results are heterogeneous (I2 = 
77%, P = 0.01). Furthermore, Oxford pain was reported in two studies (11%) with 184 
knees (8%) with a mean difference of -0.42 (95% -0.89 to 0.05, P value 0.08). Other pain 
outcomes are WOMAC pain and HSS pain, but these were not available for pooling. 
WOMAC pain was reported in only one study. HSS pain was reported in three studies, 
but two of these studies did not report ranges or SDs.
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Clinical and functional scores
Given the differences in outcomes measured in different studies, calculating a single 
standardised mean difference was not appropriate.
The Knee Society score was reported in 14 studies (74%) (1845 knees (82%)). No 
significant differences between groups were found, and the mean difference in KSS 
clinical was -1.06 point (95% CI -2.87 to 0.74, P value 0.25). The mean difference in 
KSS function, as reported in 14 studies (1865 knees), was -0.10 points (95% CI -1.93 to 
1.73, P value 0.91). KSS clinical showed heterogeneity (I2 = 77%, P value < 0.01) and, 
for KSS function, homogeneous results (I2 = 45%, P value 0.04). Furthermore, we found 
uncertainty in the estimate of the KSS total score based on two studies [28,35,36]with 71 
knees. The mean difference between groups is -26.52 points (95% CI -45.03 to -8.01, P 
value 0.005). These results are homogeneous (I2 = 0%, P = 0.80).
Other reported scoring systems also showed uncertainty in their estimates, including 
HSS (seven studies (37%) in 1021 knees (45%)) with a mean difference of -1.36 (95% 
CI -4.18 to 1.46, P value 0.35) (I2 = 86%, P value < 0.01), WOMAC total score (two 
studies (11%) in 167 knees (7%)) with a mean difference of -4.46 (95% CI -16.26 to 
7.34, P value 0.46) (I2 = 87%, P value < 0.01) and Oxford total (five studies (26%) in 647 
knees (29%) with a mean difference of -0.25 (95% CI -1.41 to 0.91, P value 0.67) (I2 = 
0%, P = 0.79). No other validated scoring systems (KOOS, WOMAC function, WOMAC 
stiffness, Oxford function) were available for pooling because no studies or just one 
study reported these outcomes.
Health-related quality of life
Only the SF-12 (PCS and MCS) was reported in three studies (16%) [18,24,27] with 
498 knees (22%). The mean difference in PCS was -1.96 (95% CI -4.55 to 0.63, P value 
0.14). The mean difference in MCS was -1.26 points (95% CI -4.75 to 2.22, P = 0.48). 
Both results were heterogeneous (I2 = 61%, P value 0.09; I2 = 80%, P value 0.007), 
respectively).
Revision surgery
Orthopaedic surgeons performed a total of 27 revisions in 17 studies (89%) with 2065 
knees (92%) - 13 knees in the fixed bearing group (of the 1031 knees) and 14 knees 
in the mobile bearing group (of the 1034 knees). No significant differences between 
groups were found (RD 0.00, 95% CI -0.01 to 0.01, P value 0.58). Follow-up time of the 
studies ranged from 0.5 year to 10 to 12 years, and 13 studies reported a follow-up time 
less than three years. The groups were homogeneous (I2 = 0%, P value 1.00). Higuchi 
et al. [20] and Tibesku et al. [35,36] did not report the number of revisions. Reasons for 
revision surgery were polyethylene bearing dislocation (mobile bearing), ligamentous 
instability between the femur and the tibia (fixed bearing), complete wear of the tibial 
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bearing polyethylene (mobile bearing and fixed bearing), infection (mobile bearing 
and fixed bearing), severe osteolysis (fixed bearing), patella component added (fixed 
bearing), tibial aseptic loosening (fixed bearing) and dislocation of the meniscal 
component (mobile bearing).
Mortality
Seven studies (37%) reported mortality. A total of 13 participants died. However, two of 
those who died (in two studies – Price et al. [34]; Watanabe et al. [31]) had undergone 
bilateral surgery, so death could not be attributed to one particular group; they were 
thus excluded from the analysis. Hanusch et al. [19] reported four deaths and Munro et 
al. [24] reported three deaths, but it was unclear whether these participants received 
a fixed bearing or a mobile bearing prosthesis. Therefore, in our analyses we included 
one participant who died (of the 96 participants) in the fixed bearing group and three 
who died (of the 95 participants) in the mobile bearing group. No significant difference 
was found between groups in terms of RD (-0.02, 95% CI -0.06 to 0.03, P value 0.49). 
The groups were homogeneous (I² = 0%, P value 0.79). Kim et al. [33] stated that no 
deaths were related to surgery but did not report the number of persons who died. 
These studies thus were not included for this outcome.
Reoperation rate
A total of 30 reoperations were performed in 17 studies (89%) with 2065 knees (92%) 
- 18 knees in the fixed bearing group (of the 1031 knees) and 12 knees in the mobile 
bearing group (of the 1034 knees). No significant difference was found between groups 
in terms of RD (-0.01, 95% CI -0.01 to 0.01, P value 0.99). The groups were homogeneous 
(I2 = 0%, P = 0.81). Higuchi et al. [20]  2009 and Tibesku et al. [35,36] did not report 
the number of reoperations. Reasons for reoperation were patella resurfacing (mobile 
bearing and fixed bearing), femoral fracture (fixed bearing), infection (fixed bearing and 
mobile bearing), skin-edge necrosis (mobile bearing and fixed bearing) and soft tissue 
revision for hematoma (mobile bearing).
Other serious adverse events
In all, 16 studies (84%) reported nine other serious adverse events in 1735 knees (77%) 
- four in the fixed bearing group (of the 862 knees) and five in the mobile bearing group 
(of the 873 knees). No significant difference was found (mean RD 0.00, 95% CI -0.01 
to 0.01, P value 0.88). The groups were homogeneous (I² = 0%, P = 1.00). Serious 
adverse events included deep vein thrombosis or pulmonary embolism (three mobile 
bearing and two fixed bearing), deep peroneal nerve palsy (two mobile bearing and 
one fixed bearing) and periprosthetic infection (not described whether a revision or 
a reoperation was needed) (one fixed bearing). Revision surgeries, reoperations and 
mortality were excluded from this rate of other serious adverse events because they are 
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reported individually.
Minor outcomes
Five studies (26%) reported overall (not stratified by tibial or femoral) radiolucent lines 
in 978 knees (44%). A total of 90 events occurred in the fixed bearing group (of the 489 
knees) and 75 events in the mobile bearing group (of the 489 knees). No significant 
difference was found between groups (RR 1.20, 95% CI 0.93 to 1.55, P value 0.16). 
The results were homogeneous (I2 = 0%, P value 0.84). Six studies (32%) reported tibial 
radiolucent lines in 1258 knees (56%). No significant difference was found between 
groups (RR 0.92, 95% CI 0.49 to 1.72, P value 0.79). The results were heterogeneous 
(I2 = 68%, P value 0.008). Four studies (21%) reported femoral radiolucent lines in 1095 
knees (49%). No significant difference was found between groups (RR 0.92, 95% CI 
0.46 to 1.85, P value 0.82). The results were homogeneous (I2 = 0%, P value 0.49).
Furthermore, six studies (32%) reported femorotibial alignment in 1047 knees (47%). No 
difference was found between groups; the mean difference was -0.40 (95% CI -0.86 to 
0.06, P value 0.08). The results were heterogeneous (I2 = 60%, P value 0.03).
Nine studies (47%) in 838 knees (37%) reported flexion. A significant difference in 
flexion was found in favour of mobile bearing, but with uncertainty in the estimate. 
The mean difference was -1.84 ° (95% CI -3.48 to -0.20, P value 0.03). The results are 
homogeneous (I2 = 0%, P value 0.75). No significant difference was found regarding 
extension (four studies (21%), 291 knees (13%), 0.07 ° (95% CI -0.54 to 0.68, P value 
0.82)). No heterogeneity was observed (I2 = 0%, P value 0.43). Range of motion was 
reported in 10 studies (53%) in 1361 knees (61%). No significant difference between 
groups was found; the mean difference was -0.67 ° (95% CI -3.26 to 1.90, P value 0.61). 
However, the results were heterogeneous (I2 = 77%, P value < 0.001) and the estimate 
is uncertain.
Subgroup analysis
We did not perform any subgroup analysis because the number of studies per subgroup 
would be too small.
Sensitivity analysis
Six studies performed only bilateral surgeries [11,21,29,31,33,34]. We found similar 
results in outcomes if we excluded these studies from the analyses. The only exception 
was HSS, which became significant in favour of mobile bearing when these studies were 
excluded, with a mean difference of -3.68 (95% CI -7.18 to -0.17, P value 0.04) based 
on four studies. However, the results were heterogeneous (I2 = 72%, P value 0.01), with 
uncertainty in the estimate, and the difference is not clinically relevant. As very few 
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studies had a low or unclear risk of bias, sensitivity analyses by quality of evidence were 
not possible.
Publication bias
We found two unpublished terminated trials (NCT00208286; NCT01150929) that may 
fulfil our inclusion criteria. However, no results were posted, and it was unclear whether 
these studies were cruciate retaining. It is thus possible that some selection bias could 
have occurred. In addition, we found one ongoing study (NCT00740376) without 
(complete) results.
DISCUSSION
Summary of main results
In our search, we found 19 randomised trials and three additional articles about 
already included studies. Seventeen of these studies were new compared with studies 
included in the previous review [7]. In short, both types of prostheses do not show 
clinically important differences in benefits and harms. Although some studies found 
results in favour of the mobile bearing total knee arthroplasty (TKA), no clinically 
relevant differences were found between mobile bearing and fixed bearing posterior 
cruciate retaining total knee arthroplasty regarding knee pain, clinical and functional 
questionnaire scores and health-related quality of life.
Knee pain was measured in 11 studies, but no clinically relevant differences were 
found. For clinical and functional scores, meta-analyses showed statistically significant 
differences only for the Knee Society Score (KSS) total score. However, this finding was 
based on two studies [28,35,36] and includes a very large 95% confidence interval, 
indicating uncertainty in the estimate. Health-related quality of life was measured in only 
three studies [18,24,27], and no clinically relevant differences were found.
Furthermore, no significant differences between groups were seen in revision surgery, 
mortality, reoperation rates and other serious adverse event rates. Especially the 
numbers of serious adverse events and revision surgery procedures hardly differed. 
We could include only four of the 13 reported deaths in our analysis because of bilateral 
surgeries, and because some studies did not report which prosthesis participants 
received. Reoperations were reported in 18 of the 1031 knees in the fixed bearing group 
and in 12 of the 1034 knees in the mobile bearing group. The difference in number of 
reoperations was caused mainly by findings from the study of Kim et al. [22]. These 
investigators had a high incidence of infection in the fixed bearing group, and the study 
was temporarily stopped by the Infection Control Committee at their hospital, but no 
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specific factors leading to the high incidence of infection were found. Furthermore, 
most studies reported follow-up less than three years, so it is possible that there are 
differences in outcomes with longer follow-up, especially for these outcomes. Large 
registry-based studies with long-term follow-up may be of added value for further study 
potential differences in these outcomes. However, as these studies are subject to 
treatment-by-indication bias, findings must be interpreted cautiously.
The quality of the evidence, as assessed by the GRADE approach, ranged from 
moderate (knee pain) to low (other major outcomes) (Summary of findings for the main 
comparison).
Overall completeness and applicability of evidence
Results are frequently not split for different treatment modalities nor different patient 
categories. Although we can understand that the prime interest of some articles 
differs, we believe that reporting more detailed preoperative and postoperative data in 
orthopaedic surgery could greatly benefit interpretation of outcome results. Functional 
performance could be affected by patellar resurfacing. Resurfacing of the patella could 
increase the work line of the quadriceps tendon, thereby increasing muscle efficiency 
and thus walk ability capacity (e.g. staircase) of patients. Until the influence of such 
factors is known, it is paramount to have insight into the results per factor in each study, 
and thus to report data specifically for all subgroups. Otherwise it is impossible to draw 
conclusions about treatment efficacy within a particular study or to pool results from 
different studies.
Most of the included studies describe different types of prostheses for the comparison 
of mobile bearing versus fixed bearing TKA. It is therefore impossible to know whether 
observed results are due to use of a mobile bearing or fixed bearing TKA, or to differences 
in other design features or even preoperative patient characteristics. Accordingly, when 
such studies find a significant difference in outcomes between prostheses, this could 
be the result of these design differences rather than to use of a mobile bearing or fixed 
bearing TKA. Furthermore, it is currently unknown whether differences in outcome may 
change over time if either implant behaves differently with reference to survivorship. 
Applicability of the results of cohort-based clinical studies to the general population 
has long been a topic of controversy. Such data are available in national arthroplasty 
registers and can thereby contribute substantial added value to an informed discussion 
of arthroplasty outcomes [67], especially for outcomes that appear at long-term follow-
up such as mortality and revision.
The KSS total was 26.52 points higher in favour of mobile bearing, but as mentioned 
before, but this finding was based on only two studies with a wide 95% CI (-45.03 
to -8.01), indicating uncertainty in the estimate. The probability of publication bias 
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was high, as only two studies reported this outcome instead of the more commonly 
reported KSS functional and KSS clinical separately. It is possible that although the 
KSS functional and the KSS clinical separately showed no significant differences, a 
significant difference would have been shown if both scores were summed up.
Furthermore, most (98.5%) of the participants had osteoarthritis (OA), so the results 
primarily reflect results in individuals with OA.
Quality of the evidence
The quality of the evidence as graded by the GRADE approach ranged from moderate 
to low. This assessment was based on risk of bias of individual studies, indirectness, 
inconsistency of results, imprecision of results and high probability of publication bias, 
and provides the rationale or justification for downgrading the quality of the evidence.
The quality of knee pain, measured by KSS pain as moderate, and thus further research 
are likely to have an important impact on our confidence in the estimate of effect and may 
change the estimate. The quality of evidence of this outcome measure was downgraded 
because of the risk of bias of individual studies (see Figure 3). This risk of bias was 
also responsible for downgrading of the quality of evidence in all other major outcome 
parameters (Summary of findings for the main comparison).
We did not downgrade any of the outcomes because of indirectness of the evidence. 
Only randomised controlled trials (RCTs) comparing fixed versus mobile bearings were 
included in different settings. Clinical and functional scores (range of motion (ROM)) 
and health-related quality of life measures (measured as Short Form (SF)-12 Physical 
Components Summary (PCS)) were downgraded because of unexplained heterogeneity. 
This heterogeneity may affect interpretation of results.
The number of serious adverse events (SAEs) resulting in revision and mortality was less 
than 300; this was also downgraded because of imprecision of results. These outcomes 
are graded as low quality, which means that further research is very likely to have an 
important impact on our confidence in the estimate of effect and is likely to change the 
estimate.
Potential biases in the review process
This review has several strengths and limitations. We composed a new search 
strategy in cooperation with a trained medical librarian, and, besides the search in 
databases, we also searched trial registries. We found two unpublished terminated 
trials (NCT00208286;NCT01150929) that may fulfil our inclusion criteria. However, no 
results were posted, and it was unclear whether these studies were cruciate retaining. 
It is thus possible that some selection bias could have occurred. In addition, we found 
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one ongoing study (NCT00740376) without (complete) results. Two review authors 
independently selected trials for inclusion in the review and resolved disagreements by 
consensus. When no consensus could be found, a third review author was consulted for 
the decisive vote. Two review authors independently assessed in duplicate risk of bias. 
This reduces the possibility of observer bias. A limitation of this meta-analysis is that 
many studies report outcomes of only one postoperative follow-up moment, which limits 
the possibility of pooling intermediate results and may cause heterogeneity between 
studies. This also limits the possibility of analysing differences in follow-up moments. 
Furthermore, in our selection, we found rotating bearing and meniscal bearing types 
of implants. Differences could be present because of the anterior movement possibility 
of the meniscal bearing type. In the characteristics of included studies table, we have 
described each implant, so care providers can judge whether the results are applicable 
to their practice.
Agreements and disagreements with other studies or reviews
We found nine other systematic reviews on mobile bearing versus fixed bearing total 
knee arthroplasty.
Apostolopoulos et al.  [68] reviewed clinical and basic scientific studies that compared 
clinical results, biomechanical features and kinematic patterns of fixed bearing versus 
mobile bearing knee designs. They concluded that clinical studies have not proved the 
superiority of mobile bearing.
Bo et al. [69] included 12 studies in a meta-analysis. They included RCTs with bilateral 
mobile bearing and fixed bearing total knee replacements. We included six of these 
studies. The study did not include retainment of the posterior cruciate as one of the 
inclusion criteria. Investigators found no differences in clinical, functional, satisfaction, 
complication and radiological results.
Cheng et al. [70] included nine articles in a meta-analysis; only two of these articles are 
included in our selection. Study authors selected RCTs comparing mobile bearing and 
fixed bearing, including posterior stabilised/PCL resection with a mean follow-up > 5 
years. Researchers reported no differences in radiological outcomes or general health 
results between groups.
Van der Voort et al. [71] selected 41 studies; we included 14 of these articles. They 
included RCTs comparing mobile bearing and fixed bearing, regardless of whether or 
not they were cruciate retaining. Meta-analyses showed no clinically relevant differences 
in terms of revision rates, clinical outcome scores or patient-reported outcome measures 
between mobile bearing and fixed bearing total knee replacements (TKRs).
Smith et al. [72] identified 13 articles, but only four of these are included in our selection. 
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This study did not have retainment of the posterior cruciate as one of the inclusion 
criteria. This could explain the difference in included studies in comparison with our 
review. Study authors used a limited search strategy, which might explain the additional 
trials in our review. Regardless, this study could find no significant differences in clinical 
outcome scores.
Wen et al. [73] identified 15 articles, of which five are included in our selection. This can 
be explained by the inclusion of posterior stabilised/posterior cruciate ligament (PCL) 
resection designs in this review. This review could not find differences between the two 
designs in terms of clinical and radiological outcomes.
Post et al. [74] identified seven non-comparative long-term follow-up studies. They 
analysed not only functional outcomes, but also long-term survivorship with both 
designs. This review found no differences in clinical outcome scores.
Van der Bracht et al. [75] identified six articles, of which three are included in our 
selection. This can be explained by the inclusion of posterior stabilised/PCL resection 
designs and non-randomised studies in this review. Moreover, study authors searched 
in six major journals on orthopaedic surgery instead of searching medical databases. 
They found no superiority in the clinical outcome of mobile-bearing over fixed-bearing 
TKA.
Oh et al. [76] identified 10 articles, but only four of these are included in our selection. 
This can be explained by the inclusion of posterior stabilised/PCL resection designs and 
non-randomised studies in this review. Study authors used a limited search strategy, 
which might explain the additional trials in our review. Regardless, this review could find 
no differences in clinical outcome scores.
Although all of these reviews used different selection criteria to compare mobile 
bearing versus fixed bearing (e.g. uni/bilateral, posterior stabilised/cruciate retaining) 
and differed in outcome measures, their results are congruent with our findings. No 
clinically important differences were found regarding clinical, functional, complication 
and radiological outcomes.
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AUTHORS’ CONCLUSION
Implications for practice
Current evidence suggests similar patient outcomes for mobile bearing total knee 
arthroplasty and fixed bearing total knee arthroplasty, regarding knee pain, clinical and 
functional questionnaire scores, health-related quality of life, revision surgery, mortality, 
reoperation and other serious adverse events among patients. No statistically and 
clinically relevant differences were found for any of these outcomes. Also, given the 
moderate to low quality of the studies, we cannot draw firm conclusions for clinical 
practice.
Implications for research
Since the time of preparation of the previous version of this review, many new publications 
have reported randomised trials on this subject. To be able to compare and pool outcomes 
from different studies, the outcomes must be presented at comparable assessment 
moments. The present review clearly identifies the need for trials to present data at final 
follow-up, but also for intermediate follow-ups. In the included studies, we could find no 
evidence of significant or clinically relevant differences in favour of mobile bearing total 
knee arthroplasty in comparison with fixed bearing total knee arthroplasty. However, 
specific patient groups may benefit from a certain prosthesis, such as athletes. This is 
a potential area for further research. In addition, future studies should report in greater 
detail on the outcomes presented in this systematic review, with sufficient follow-up 
time to obtain high-quality evidence and inform clinical practice. Large registry-based 
studies may have added value, particularly for infrequent outcomes such as mortality, 
revision and serious adverse events. However, as these registry-based studies are 
subject to treatment-by-indication bias (which is not the case in RCTs), the present 
systematic review of RCTs can be viewed as the best available evidence.
A specific problem related to comparing different types of prostheses is that the 
differences are small, and consequently the effect on patient performance for a given 
parameter is hard to detect and can be detected only with large sample sizes. Even 
more, clinical differences are strongly associated with preoperative functional capacity 
[77]. The effect of an outcome parameter is often important in itself but of limited 
influence on the rest of the patient’s performance. For example, the extent of migration 
in a radiostereophotogrammetric analysis (RSA) study should always be accompanied 
by functional and clinical parameters. We welcome the development of guidelines, such 
as those published in the Journal of Bone and Joint Surgery [78]. Because of these 
methodological problems, more rigorous statistical methods must be performed so the 
coherence of several aspects of the outcome can be evaluated.
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CHARACTERISTICS OF INCLUDED STUDIES
Bailey 2014
Methods
RCT stated 
Randomisation determined by a third party randomisation process to 
ensure similar demographics between the 2 groups 
Duration of the study: 2 years
Participants
Inclusion: primary knee OA requiring a primary TKA, age > 35 
Exclusion: previous knee surgery, inflammatory arthroplasty, significant 
PMHx, complex surgery requiring bone grafting or revision prosthesis 
UK: 331 participants 
Fixed: n = 170, female 102, age 70.1 ± 7.9 years 
Mobile: n = 161, female 87, age 69.2 ± 8.6 years
Interventions
Fixed: PFC Sigma (Depuy) 
Mobile: PFC, rotating platform (Depuy) 
Decision to resurface the patella was made intraoperatively on the 
basis of intraoperative patellar tracking and clinical patellar wear 
Both the tibia and the femoral prosthesis were cemented
Outcomes
ROM, OKS, KSS, SF-12 and radiolucency 
Assessments: preoperative and at 12 and 24 months 
Average and SD given
Notes
Study funded by DePuy International 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection bias) Low risk
Randomisation determined by a third party 
randomisation process to ensure similar 
demographics between the 2 groups
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants and 
personnel (performance 
bias)  
All outcomes Low risk Participant was blinded; surgeon was not blinded
Blinding of outcome 
assessment (detection bias) 
All outcomes Low risk
Outcome assessor was blinded; statistician who 
carried out the analysis was blinded
Incomplete outcome data 
(attrition bias)  
All outcomes Unclear risk
Drop-out rate was given and acceptable; not clear 
whether intention-to-treat analysis was used
Selective reporting 
(reporting bias) Low risk
Protocol available and prespecified outcomes 
reported
Other bias Low risk
Homogeneity in participant groups on prognostic 
factors; co-interventions described in sufficient 
detail
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Grodzki 2001
Methods
RCT stated 
Randomisation technique not stated (1:2 factor?) 
Duration of study: 1 year
Participants
Inclusion: primary gonarthrosis 
Exclusion: local infection near the knee joint, RA, insulin-dependent 
diabetes mellitus, > 15 ° of varus/valgus, absolute medial or lateral 
collateral ligament instability 
Germany: 38 participants; sex ratio not stated 
Fixed: n = 12, age 73.9 (53-89) years 
Mobile: n = 26, age 73.1 (55-91) years
Interventions
Fixed: PFC Sigma (DePuy) 
Mobile: LCS, rotating platform (DePuy) 
Routine patellar resurfacing 
Tibial component cemented; femoral component cementless
Outcomes
KSS total, revision 
Assessments: preoperative and at 1 week, 2 weeks, 6 weeks, 3 
months, 6 months and 1 year 
Average and standard deviation given
Notes
Funding not stated 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence generation 
(selection bias) Unclear risk Randomised allocation. Probably with factor 1:2
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants and 
personnel (performance bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection bias)  
All outcomes Unclear risk Outcome assessor blinding not described
Incomplete outcome data 
(attrition bias)  
All outcomes Low risk
Drop-out rate given and acceptable; intention-to-
treat analysis
Selective reporting (reporting 
bias) Unclear risk No protocol available
Other bias High risk
No homogeneity in participant groups on 
prognostic factors; no subgroups given that are 
homogeneous; co-interventions described in 
sufficient detail
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Hansson 2005
Methods
RCT stated 
Randomisation technique not stated 
Duration of study: 2 years
Participants
No selection criteria stated; selection resulted in knee arthrosis grade 
II to IV 
Sweden: 42 participants (52 knees) 
Fixed: n = 27, 14 female, age 75 (64-86) years 
Mobile: n = 25, 12 female, age 74 (60-85) years
Interventions
Fixed: Niffield (Corin Medical) 
Mobile: Rotaglide, meniscal bearing (Corin Medical) 
Patellar resurfacing unclear 
Cementing unclear
Outcomes
RSA, ROM, alignment, HSS 
RSA: postoperative at 6 weeks and at 3 months, 6 months, 1 year and 
2 years. Clinical scores: preoperative and at 1 and 2 years 
Average and range scores given
Notes
Study supported by Lund University and Corin Medical Ltd 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection bias) Low risk Randomised allocation
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants and 
personnel (performance 
bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection bias) 
All outcomes High risk Outcome assessor not blinded
Incomplete outcome data 
(attrition bias) 
All outcomes Unclear risk
Drop-out rate given and acceptable; not clear 
whether intention-to-treat analysis was used
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias Unclear risk
Unclear whether there was homogeneity in 
participant groups; co-interventions described in 
sufficient detail
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Hanush 2010
Methods
RCT stated 
Randomisation based in part on minimisation technique, in part on 
schedule 
Duration of study: 13.4 months
Participants
Inclusion: patients with osteoarthritis, suitable for fixed bearing and mobile 
bearing 
Exclusion: patients with rheumatoid arthritis and those undergoing 
revision arthroplasty, requiring tibial component augmentation or a 
constrained prosthesis 
United Kingdom: 105 participants 
Fixed: n = 55, female 22, age 69.4 (± 7.9) years 
Mobile: n = 50, female 30, age 70 (± 8.4) years
Interventions
Fixed: PFC Sigma fixed bearing (DePuy) 
Mobile: PFC Sigma, rotating platform (DePuy) 
Routine patellar unresurfacing 
All components cemented
Outcomes
Flexion, extension, ROM, KSS pain (KSS), function (KSS); OKS pain 
(OKS), function (OKS); revision, osteolysis 
Assessments: preoperative and at 1-year follow-up 
Average and standard deviation given
Notes
Funded by DePuy International 
Study authors reported no conflict of interest
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection 
bias) Low risk
Randomisation: in part minimisation technique, in part 
schedule
Allocation concealment 
(selection bias) Low risk Closed envelopes
Blinding of participants 
and personnel 
(performance bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection 
bias)  
All outcomes Unclear risk Outcome assessor blinding not described
Incomplete outcome 
data (attrition bias)  
All outcomes High risk
Drop-out rate given and acceptable; no intention-to-
treat analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias High risk
No homogeneity in participant groups on prognostic 
factors; no subgroups given that are homogeneous; 
co-interventions described in sufficient detail
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Henricson 2006
Methods
RCT stated 
Randomisation based on sealed envelopes opened during surgery 
Duration of study: 2 years
Participants
Inclusion: primary gonarthrosis grade III-IV; age between 60 and 85 
years; body weight < 120 kg; no gonarthrosis secondary to arthritis or 
trauma; no previous knee surgery 
Sweden: 47 participants (52 knees) 
Fixed: n = 26, 14 female, age 72 (62-83) years 
Mobile: n = 26, 16 female, age 72 (62-84) years
Interventions
Fixed: NexGen (Zimmer) 
Mobile: MBK, meniscal bearing (Zimmer) 
Some participants with patellar component 
All components cemented
Outcomes
RSA, KSS, HSS 
Assessments: preoperative and at 3, 12 and 24 months 
Average, range or 95% CI given
Notes One of the study authors received funding from Zimmer Scandinavica
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection 
bias) Unclear risk Randomised allocation
Allocation concealment 
(selection bias) Low risk Sealed envelopes opened during operation
Blinding of participants 
and personnel 
(performance bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection 
bias)  
All outcomes Unclear risk Outcome assessor blinding not described
Incomplete outcome data 
(attrition bias)  
All outcomes High risk
Drop-out rate given and acceptable; no intention-to-
treat analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias Low risk
Homogeneity in participant groups on prognostic 
factors; co-interventions described in sufficient detail
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Higuchi 2009
Methods
RCT stated 
Randomisation based on computer-generated random numbers 
Duration of study: 4 years
Participants
Inclusion: patients with osteoarthritis of the knee 
Exclusion: rheumatoid arthritis 
Japan: 68 participants (76 knees) 
19 men and 49 women, age 68.4 (56-81) years
Interventions
Fixed: PFC (DePuy) 
Mobile: PFC Sigma, rotating platform (DePuy) 
Treatment of patella unclear 
Cementing unclear 
Flexion space with knee balancer
Outcomes
Flexion, extension 
Assessments: preoperative and at 12 months and 48 months 
Average and standard deviation given
Notes
Funding not stated 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection 
bias) Low risk Computer-generated random numbers
Allocation concealment 
(selection bias) Low risk Not described
Blinding of participants 
and personnel 
(performance bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection 
bias)  
All outcomes Unclear risk Outcome assessor blinding not described
Incomplete outcome 
data (attrition bias)  
All outcomes Unclear risk
No description of withdrawals and dropouts; not clear 
whether intention-to-treat analysis was used
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias High risk
No homogeneity in participant groups on prognostic 
factors; no subgroups given that are homogeneous; 
unsure whether co-interventions are described in 
sufficient detail
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Jacobs 2011
Methods
RCT, multi-centre 
Computer-generated block-stratified randomisation 
Duration of the study: 1 year
Participants
Inclusion: patient diagnosed with osteoarthritis; candidate for primary TKA; 
expected to undergo only 1 arthroplasty procedure within next 12 months; 
60–75 years old; preoperative alignment (varus or valgus) < 10 °; BMI < 30; 
lives independently 
Exclusion: missing/insufficient PCL 
The Netherlands/Switzerland: 92 participants 
Fixed: n = 46, 32 female, age 67.6 (± 4.4) years 
Mobile: n = 46, 33 female, age 66.7 (± 4.6) years
Interventions
Fixed: balanSysTM type (Mathys Medical Ltd) 
Mobile: balanSysTM type (Mathys Medical Ltd) 
No patellar resurfacing 
Tibia and femur components cemented
Outcomes
Active flexion, KSS function, KSS clinical 
Assessments: preoperative and at 3 months, 6 months and 12 months 
Average and standard deviation given
Notes
Funded by Mathys Medical Ltd 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation 
(selection bias) Low risk Computer-generated block-stratified randomisation
Allocation 
concealment 
(selection bias) Low risk Closed envelopes
Blinding of 
participants 
and personnel 
(performance bias)  
All outcomes Low risk Participant blinded; surgeon not blinded
Blinding of outcome 
assessment 
(detection bias)  
All outcomes High risk No blinding attempted at any of the assessments
Incomplete 
outcome data 
(attrition bias)  
All outcomes High risk
1 centre with 30 participants was excluded from analysis 
because of randomisation error; no intention-to-treat 
analysis
Selective reporting 
(reporting bias) Low risk Protocol available and prespecified outcomes reported
Other bias Low risk
Homogeneity in participant groups on prognostic factors; 
co-interventions described in sufficient detail
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Kim 2001
Methods
RCT stated 
Randomisation technique not stated 
Duration of study: 7.4 years
Participants
Inclusion: all patients with bilateral simultaneous TKA 
No exclusion criteria; PCL status not considered, could be retained in 
all cases 
Korea: 116 participants (232 knees) 
80 female, 36 male, 110 OA, 6 RA, age 65 (33-70) years
Interventions
Fixed: AMK (DePuy) 
Mobile: LCS, meniscal bearing (DePuy) 
Routine patellar resurfacing 
All components cemented
Outcomes
KSS, HSS, VAS for severity, location and frequency of pain, functional 
benchmarks, overall well-being and satisfaction, survival, radiolucency 
Short- (yearly) and long-term (> 6 years) follow-up stated, but only final 
follow-up results given 
Only point estimates given; not specified for indication groups
Notes
Funding not stated 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection bias) Unclear risk Randomised allocation
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants and 
personnel (performance 
bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection 
bias)  
All outcomes Unclear risk Outcome assessor blinding not described
Incomplete outcome data 
(attrition bias)  
All outcomes High risk
Drop-out rate given and acceptable; no intention-to-
treat analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias High risk
No homogeneity in participant groups on prognostic 
factors; no subgroups given that are homogeneous; 
co-interventions described in sufficient detail
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Kim 2007
Methods
RCT stated 
Randomisation based on sequential pool derived from a table of 
randomised numbers 
Duration of study: 5.6 years
Participants
Inclusion and exclusion criteria not described 
Selection yielded bilateral procedures on 173 patients with 
osteoarthritis and on 1 patient with rheumatoid arthritis 
Korea: 174 patients (348 knees) 
112 female, 62 male, age 67 (45-85) years
Interventions
Fixed: PFC Sigma (DePuy) 
Mobile: PFC Sigma, rotating platform (DePuy) 
Routine patellar resurfacing 
All components cemented 
Flexion space with bone resection
Outcomes
KSS, HSS, alignment, component positions, radiolucent lines, lateral 
patellar tilt 
Only final, long-term outcome (5.6 years) given 
Point estimates and ranges given
Notes
No benefits received from any commercial party 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence generation 
(selection bias) Low risk
Sequential pool based on a table of randomised 
numbers
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants and 
personnel (performance bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection bias)  
All outcomes Low risk Outcome assessor blinded
Incomplete outcome data 
(attrition bias)  
All outcomes High risk
Drop-out rate given and acceptable; no 
intention-to-treat analysis
Selective reporting (reporting 
bias) Unclear risk No protocol available
Other bias Low risk
Homogeneity in participant groups on 
prognostic factors; co-interventions described 
in sufficient detail
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Kim 2009a
Methods
RCT stated 
Randomisation technique not stated 
Duration of study: 2.6 years
Participants
Inclusion: bilateral cases with degenerative osteoarthritis with prior non-
operative therapy 
Exclusion: rheumatoid arthritis, septic arthritis history 
Korea: 92 participants (184 knees) 
85 female, 7 male, age 69.5 (± 7.92) years
Interventions
Fixed: Medial Pivot (Wright Medical) 
Mobile: PFC Sigma, rotating platform (DePuy) 
Routine patellar resurfacing 
All components cemented 
Flexion space with various bone referenced techniques
Outcomes
KSS, HSS, range of motion, satisfaction 
Only final follow-up (2.6 years) given 
Point estimates and ranges given
Notes
No commercial association of any of the study authors 
Study authors reported no conflict of interest
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection bias) Unclear risk Randomised allocation
Allocation concealment 
(selection bias) Low risk Sealed envelopes
Blinding of participants and 
personnel (performance 
bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection 
bias)  
All outcomes Unclear risk Outcome assessor blinding unclear
Incomplete outcome data 
(attrition bias)  
All outcomes High risk
Drop-out rate given and acceptable; no intention-
to-treat analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias Low risk
Homogeneity in participant groups on prognostic 
factors; co-interventions described in sufficient 
detail
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Kim 2009b
Methods
RCT stated 
Randomisation based on sequential pool derived from a table of 
randomised numbers 
Duration of study: 10-12 years
Participants
Inclusion: patients younger than 55 requiring bilateral TKA 
Exclusion: criteria not mentioned 
Korea: 61 participants (122 knees) 
45 female, 16 male, age 48.3 (34-55) years
Interventions
Fixed: AMK (DePuy) 
Mobile: LCS, meniscal bearing (DePuy) 
Routine patellar resurfacing 
All components cemented
Outcomes
KSS total, KSS functional, KSS pain, ROM, HSS total, HSS pain, alignment, 
radiolucent lines 
Assessments preoperative and at final follow-up 10 to 12 years 
postoperative 
Average given
Notes
No benefits or funds received in support of the study 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection 
bias) Low risk
Sequential pool based on a table of randomised 
numbers
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants 
and personnel 
(performance bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection 
bias)  
All outcomes Low risk Observer blinded for radiographic findings
Incomplete outcome 
data (attrition bias)  
All outcomes Low risk
Drop-out rate given and acceptable; intention-to-treat 
analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias Low risk
Homogeneity in participant groups on prognostic 
factors; co-interventions described in sufficient detail
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Kim 2010
Methods
RCT stated 
Randomisation performed using a randomisation table 
Duration of study: 2 years
Participants
Inclusion: osteoarthritic patients scheduled for bilateral TKA with 
flexion contracture < 15 °; mechanical tibial femoral angle < 20 °; 
intraoperative intact PCL 
Korea: 66 participants (132 knees) 
Fixed: n = 33 CR, 33 PS 
Mobile: n = 66, 64 female, age 70 (55-79) years
Interventions
Fixed: Genesis II (Smith and Nephew) 
Mobile: e.motion, meniscal bearing (BBraun-Aesculap) 
All patellae resurfaced 
All components cemented
Outcomes
Flexion, extension, KKS pain, KKS knee, KKS function, WOMAC 
stiffness, WOMAC pain, WOMAC function, preferred knee 
Assessments preoperative and at 6 months, 12 months and 24 months 
Average and standard deviation given
Notes
No funding stated 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection bias) Low risk Randomisation table
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants and 
personnel (performance 
bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection bias)  
All outcomes Unclear risk Outcome assessor blinding not described
Incomplete outcome data 
(attrition bias)  
All outcomes Low risk
Drop-out rate given and acceptable; intention-to-
treat analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias High risk
No homogeneity in participant groups on 
prognostic factors; no subgroups given that are 
homogeneous; co-interventions described in 
sufficient detail
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Lampe 2011
Methods
RCT stated 
Randomisation technique not stated 
Duration of study: 1 year
Participants
Inclusion: osteoarthritic patients (40-90) with failed non-operative 
treatment, no previous ipsilateral bone or joint surgery, no deformity > 20° 
varus or 15° valgus, no option for osteotomy or unicompartmental implant 
Germany: 96 participants (100 knees) 
Fixed: n = 52, 39 female, age 69 (± 8) years 
Mobile: n = 48, 34 female, age 70 (± 7) years
Interventions
Fixed: Columbus (BBraun Aesculap) 
Mobile bearing: Rotating Platform (BBraun Aesculap) 
No patella resurfaced 
All components cemented
Outcomes
KSS knee, KSS function, KSS pain, flexion, Oxford, radiographic alignment 
Assessments preoperative and at 3 months, 6 months and 12 months 
Average, standard deviation and range given
Notes
Study was funded by BBraun Aesculap 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection 
bias) Unclear risk Randomised allocation
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants 
and personnel 
(performance bias)  
All outcomes Low risk Participant blinded; surgeon not blinded
Blinding of outcome 
assessment (detection 
bias)  
All outcomes Low risk Observer blinded
Incomplete outcome 
data (attrition bias)  
All outcomes High risk
Drop-out rate given and acceptable; no intention-to-
treat analysis
Selective reporting 
(reporting bias) Low risk Protocol available and prespecified outcomes reported
Other bias High risk
No homogeneity in participant groups on prognostic 
factors; no subgroups given that are homogeneous; 
co-interventions described in sufficient detail
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Lizaur-Utrilla 2012
Methods
RCT 
Randomisation based on computer-generated random numbers table 
Duration of the study: 2.5 years
Participants
Inclusion: osteoarthritic patients with primary TKA, aged 70 years or 
older, without prior infection in the knee and with severe angular deformity 
or severe instability that required grafting, modular augmentation or a 
constrained design 
Spain: 119 participants 
Fixed: n = 58, 47 female, age 73.9 (± 3.2) years 
Mobile: n = 61, 47 female, age 74.6 (± 3.3) years
Interventions
Fixed: Trekking MB (Samo) 
Mobile: Multigen Plus FB (Lima) 
Patella resurfaced if there was degeneration 
Cementless femoral component design and a cemented tibial component
Outcomes
Maximum knee flexion assessments preoperative and at 3 months, 6 
months, 12 months and 24 months 
KSS function, WOMAC, SF-12, VAS, radiolucent lines assessments 
preoperative and at 3 months, 6 months and 12 months, and yearly 
thereafter, but only final follow-up results given 
Average, standard deviation and range given
Notes
No funding stated 
Study authors reported no conflict of interest
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection 
bias) Low risk Computer-generated random number tables
Allocation 
concealment (selection 
bias) Low risk Office staff
Blinding of participants 
and personnel 
(performance bias)  
All outcomes Low risk Participant blinded; surgeon not blinded
Blinding of outcome 
assessment (detection 
bias)  
All outcomes Low risk Observers blinded
Incomplete outcome 
data (attrition bias)  
All outcomes Low risk
Drop-out rate given and acceptable; intention-to-treat 
analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias Low risk
Homogeneity in participant groups on prognostic 
factors; co-interventions described in sufficient detail
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Munro 2010
Methods
RCT 
Randomisation based on computer-generated sequence with sealed envelopes 
Duration of study: 2 years
Participants
Inclusion: patients with degenerative knee disease undergoing TKA 
Exclusion: severe deformity (requiring femoral or tibial augment), inflammatory 
arthritis, younger than 45 years or older than 85 years, refusal of consent, 
previous failed TKA or unicompartmental arthroplasty, previous high tibial 
osteotomy, TKA of the contralateral knee 
New Zealand: 41 participants (48 knees) 
Fixed: n = 23, 10 female, age 67.7 (50-79) years 
Mobile: n = 25, 11 female, age 67.2 (47-83) years
Interventions
Fixed: PFC Sigma fixed-bearing (DePuy) 
Mobile: PFC Sigma, rotating-platform (DePuy) 
Patella: resurfacing at indication 
Cement for femoral and tibial components 
Flexion space with ligament balancing tool
Outcomes
SF-12 mental, SF-12 physical, KSS clinical, KSS function, WOMAC total, ROM, 
OKS, VAS pain, revisions, cancellous bone mineral density change, cortical 
bone mineral density change 
Assessments: preoperative and at 6 weeks, 12 months and 24 months 
Average and range given
Notes
Study was partially funded by DePuy International 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation 
(selection bias) Low risk Computer-generated sequence
Allocation 
concealment 
(selection bias) Low risk Sealed envelopes
Blinding of 
participants 
and personnel 
(performance bias) 
All outcomes Unclear risk Participant blinding not described; surgeon not blinded
Blinding of 
outcome 
assessment 
(detection bias)  
All outcomes Unclear risk Assessor for clinical evaluations blinded to implant type
Incomplete 
outcome data 
(attrition bias)  
All outcomes Low risk
Drop-out rate given and acceptable; intention-to-treat 
analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias High risk
No homogeneity in participant groups on prognostic factors; 
no subgroups given that are homogeneous; co-interventions 
described in sufficient detail
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Möckel 2004
Methods
RCT stated 
Randomisation technique not stated 
Duration of study: 6 months
Participants
Inclusion criteria: PCL sufficient 
Exclusion criteria: other existing implants in lower extremities, factors 
influencing gait analysis, BMI > 35 
Germany: 53 participants 
45 female, 17 male, mean age 69 years
Interventions
Fixed: Natural Knee (Centerpulse) or Maxim (Biomet Merck) 
Mobile: PFC Sigma, rotating platform (DePuy) 
No patellar resurfacing 
All components cemented
Outcomes
ROM, KSS, gait analysis, alignment 
3 months and 6 months follow-up given 
Average and some range given
Notes
No funding stated 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection bias) Unclear risk Randomised allocation
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants and 
personnel (performance bias) 
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection bias)  
All outcomes Unclear risk Outcome assessor blinding not described
Incomplete outcome data 
(attrition bias)  
All outcomes High risk
Drop-out rate given: > 20% lost at 6 months; 
intention-to-treat analysis
Selective reporting (reporting 
bias) Unclear risk No protocol available
Other bias Low risk
Homogeneity in participant groups on prognostic 
factors; co-interventions described in sufficient 
detail
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Price 2003
Methods
RCT, multi-centre 
Randomisation based on computer-generated randomisation to side of 
prosthesis 
Duration of study: 1 year
Participants
Inclusion: osteoarthritis, bilateral procedures 
Exclusion: no previous patellectomy or high tibial osteotomy, PCL status not 
clear as authors state AGC can be used in both sacrificing and retaining 
procedures; status of the PCL could not be identified. Study authors mention 
that the PCL is usually retained 
United Kingdom and Australia: n = 40 (80 knees) 
24 female, age 73.1 (54.8-86.4) years
Interventions
Fixed: AGC (Biomet Merck) 
Mobile: TMK, meniscal bearing (Biomet Merck) 
No routine arthroplasty of patella 
Cementing unclear
Outcomes
KSS, KSS pain subscore, Oxford score, Oxford pain sub score, ROM 
Only short-term (1-year) outcome 
Average and standard deviation given
Notes
1 or more study authors have received benefits; benefits have been directed at 
affiliated non-profit party
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation 
(selection bias) Low risk Computer-generated randomisation to side of prosthesis
Allocation 
concealment 
(selection bias) Low risk Telephone call
Blinding of 
participants 
and personnel 
(performance bias)  
All outcomes Low risk Participant blinded to implant type
Blinding of outcome 
assessment 
(detection bias)  
All outcomes Unclear risk Some assessors potentially unblinded
Incomplete 
outcome data 
(attrition bias)  
All outcomes Low risk
Drop-out rate given and acceptable; intention-to-treat 
analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias Low risk
Homogeneity in participant groups on prognostic factors; 
co-interventions described in sufficient detail
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Tibesku 2011
Methods
RCT stated 
Randomisation based on computer-generated list 
Duration of study: 2 years
Participants
Inclusion: 50-80 years, unilateral primary osteoarthritis, absence of 
mediolateral instability, deviation of the long leg axis of less than 10° 
Exclusion: any co-morbidity that negatively influenced gait 
Germany: 33 participants 
Fixed: n = 17, 12 female, age 66 (± 10) years 
Mobile: n = 16, 9 female, age 65 (± 9) years
Interventions
Fixed: Genesis II (Smith and Nephew) 
Mobile: Genesis II, meniscal bearing (Smith and Nephew) 
No patellar resurfacing 
Cementing unclear
Outcomes
Flexion, KSS, HSS, SF-36, Tegner, UCLA, VAS pain, gait analysis 
Assessments preoperative and at final follow-up 24 months postoperative 
Average and standard deviation given
Notes
No funding stated 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection 
bias) Low risk Computer-generated list
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants 
and personnel 
(performance bias)  
All outcomes Low risk Participant blinded
Blinding of outcome 
assessment (detection 
bias)  
All outcomes Low risk Observer blinded
Incomplete outcome 
data (attrition bias)  
All outcomes High risk
No description of withdrawals and dropouts; no 
intention-to-treat analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias High risk
No homogeneity in participant groups on prognostic 
factors; no subgroups given that are homogeneous; 
co-interventions not described in sufficient detail
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Watanabe 2005
Methods
RCT stated 
Randomisation technique not stated 
Duration of study: 98 months
Participants
Selection criteria not described 
Selection resulted in bilateral procedures in 18 patients with rheumatoid 
arthritis and 4 with osteoarthritis 
Japan: 22 participants (44 knees) 
21 female, age 59.6 (35-78) years
Interventions
Fixed: NexGen CR (Zimmer) 
Mobile: Rotaglide, meniscal bearing (Corin) 
Patellar resurfacing in all knees 
20 of 22 knees fully cemented, 2 hybrid
Outcomes
KSS, flexion, extension, femorotibial angle, radiolucent lines 
Only final follow-up (98.6/96.2 months) results given 
Average and range given
Notes
No funding stated 
No declarations of interest reported
Risk of bias
Bias
Authors' 
judgement Support for judgement
Random sequence 
generation (selection 
bias) Unclear risk Randomised allocation
Allocation concealment 
(selection bias) Unclear risk Not described
Blinding of participants 
and personnel 
(performance bias)  
All outcomes Unclear risk
Participant blinding not described; surgeon not 
blinded
Blinding of outcome 
assessment (detection 
bias)  
All outcomes Unclear risk Outcome assessor blinding not described
Incomplete outcome data 
(attrition bias)  
All outcomes Low risk
Drop-out rate given and acceptable; intention-to-treat 
analysis
Selective reporting 
(reporting bias) Unclear risk No protocol available
Other bias High risk
No homogeneity in participant groups on prognostic 
factors; no subgroups given that are homogeneous; 
unsure whether co-interventions are described in 
sufficient detail
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Characteristics of excluded studies
Study Reason for exclusion
Aglietti 2005 Fixed bearing type had a posterior stabilised design
Ball 2011 Posterior stabilised implants
Bhan 2005 Posterior stabilised implants
Breeman 2013
Treatment of PCL dependents of individual surgeon’s preference (updated 
KAT trial)
Breugem 2008 Posterior stabilised implants
Chen 2013 Cruciate ligaments excised
Chiu 2001 Fixed bearing type had a posterior stabilised design
Gioe 2009 Posterior stabilised implants
Harrington 2009 Posterior stabilised and cruciate retaining implants used
Jawed 2012 Posterior cruciate ligament sacrificed in all cases
Jolles 2012 Posterior stabilised implants
KAT trial group 2009 Treatment of PCL dependents of individual surgeon’s preference
Kim 2007b LCS stated as designed for implantation with resection of the PCL
Kim 2012 Posterior stabilised implants
Kim 2012b LCS stated as designed for implantation with resection of the PCL
Li 2008 Posterior stabilised implants
Läderman 2008 Posterior stabilised implants
Matsuda 2010 Posterior stabilised implants
McGonagle 2012 Treatment of PCL dependents of individual surgeon’s preference
Munoz 2008 Posterior stabilised implants
NCT00289094 Included also other inflammatory arthritis and avascular necrosis of bone
Pagnano 2004 Posterior stabilised implants
Pijls 2012 Posterior stabilised implants
Rahman 2010 Posterior stabilised implants
Saari 2003 Treatment of PCL dependents of individual surgeon’s preference
Shemshaki 2012 Posterior stabilised implants
Tienboon 2012 Posterior stabilised implants
Uvehammer 2007 Treatment of PCL dependents of individual surgeon’s preference
Vasdev 2009 Posterior stabilised implants
Wohlrab 2009 Posterior stabilised implants
Woolson 2004 Posterior stabilised implants
Woolson 2011 Posterior stabilised implants
Wylde 2008 Mixture of patients who had had the posterior cruciate sacrificed and retained
Zeng 2011 Posterior stabilised implants
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DATA AND ANALYSES
Comparison 1. Mobile vs fixed bearing, major outcome: knee pain
Outcome or 
subgroup title
No. of 
studies
No. of 
participants Statistical method Effect size
 1 KSS pain 9 1392
Mean Difference (IV, 
Random, 95% CI) 0.41 [-0.06, 0.88]
 2 VAS pain 3 200
Mean Difference (IV, 
Random, 95% CI) -0.13 [-0.96, 0.69]
 3 Oxford pain 2 184
Mean Difference (IV, 
Random, 95% CI) -0.42 [-0.89, 0.05]
 4 Knee pain 
(combined scores) 12 1592
Std. Mean Difference (IV, 
Random, 95% CI) 0.09 [-0.03, 0.22]
Comparison 2. Mobile vs fixed bearing, major outcome: clinical and functional 
scores
Outcome or 
subgroup title
No. of 
studies
No. of 
participants Statistical method Effect size
 1 KSS clinical 14 1845
Mean Difference (IV, 
Random, 95% CI) -1.06 [-2.87, 0.75]
 2 KSS function 14 1865
Mean Difference (IV, 
Random, 95% CI) -0.10 [-1.93, 1.73]
 3 KSS total 2 71
Mean Difference (IV, 
Random, 95% CI)
-26.52 [-45.03, 
-8.01]
 4 HSS 7 1021
Mean Difference (IV, 
Random, 95% CI) -1.36 [-4.18, 1.46]
 5 WOMAC total 2 167
Mean Difference (IV, 
Random, 95% CI)
-4.46 [-16.26, 
7.34]
 6 Oxford total 5 647
Mean Difference (IV, 
Random, 95% CI) -0.25 [-1.41, 0.91]
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Comparison 3. Mobile vs fixed bearing, major outcome: health-related quality of 
life
Outcome or 
subgroup title
No. of 
studies
No. of 
participants Statistical method Effect size
 1 Revision surgery 17 2065
Risk Difference (M-H, 
Random, 95% CI) -0.00 [-0.01, 0.01]
Comparison 4. Mobile vs fixed bearing, major outcome: revision surgery
Outcome or 
subgroup title
No. of 
studies
No. of 
participants Statistical method Effect size
 1 Revision surgery 17 2065
Risk Difference (M-H, 
Random, 95% CI) -0.00 [-0.01, 0.01]
Comparison 5. Mobile vs fixed bearing, major outcome: mortality
Outcome or 
subgroup title
No. of 
studies
No. of 
participants Statistical method Effect size
 1 Mortality 3 191
Risk Difference (M-H, 
Random, 95% CI) -0.02 [-0.06, 0.03]
Comparison 6. Mobile vs fixed bearing, major outcome: reoperation rate
Outcome or 
subgroup title
No. of 
studies
No. of 
participants Statistical method Effect size
 1 Reoperation rate 17 2065
Risk Difference (M-H, 
Random, 95% CI) 8.25 [-0.01, 0.01]
Comparison 7. Mobile vs fixed bearing, major outcome: other serious adverse 
events
Outcome or 
subgroup title
No. of 
studies
No. of 
participants Statistical method Effect size
 1 Serious adverse 
events 16 1735
Risk Difference (M-H, 
Random, 95% CI) -6.52 [-0.01, 0.01]
Comparison 8. Mobile vs fixed bearing, minor outcomes: radiological outcomes
Outcome or 
subgroup title
No. of 
studies
No. of 
participants Statistical method Effect size
 1 Radiolucent lines 
(tibial) 6 1258
Risk Ratio (M-H, 
Random, 95% CI) 0.92 [0.49, 1.72]
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 2 Radiolucent lines 
(femoral) 4 1095
Risk Ratio (M-H, 
Random, 95% CI) 0.92 [0.46, 1.85]
 3 Radiolucent lines 
(overall) 5 978
Risk Ratio (M-H, 
Random, 95% CI) 1.20 [0.93, 1.55]
 4 Femorotibial 
alignment 6 1047
Mean Difference (IV, 
Random, 95% CI) -0.40 [-0.86, 0.06]
Comparison 9. Mobile vs fixed bearing, minor outcomes: performance outcome
Outcome or 
subgroup title
No. of 
studies
No. of 
participants Statistical method Effect size
 1 Flexion 9 838
Mean Difference (IV, 
Random, 95% CI) -1.84 [-3.48, -0.20]
 2 Extension 4 291
Mean Difference (IV, 
Random, 95% CI) 0.07 [-0.54, 0.68]
 3 Range of motion 10 1456
Mean Difference (IV, 
Random, 95% CI) -0.67 [-3.21, 1.87]
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Chapter 12 
General Discussion
296 General discussion
The aim of the present thesis was to extend the knowledge in the field of implementation 
science by examining how care delivery for patients with hip and knee OA or sciatica 
can be optimized. Part 1 focused on the optimization of care delivery for patients with 
hip and knee OA and sciatica, when evidence is available in existing guidelines on 
what optimal care is. It is then important to gain insight into reasons why guidelines are 
not always followed (i.e. barriers and facilitators) to improve implementation. However, 
sometimes evidence underlying the guideline is still lacking and more evidence needs 
to be generated. Guidelines for patients with hip and knee OA for example do not 
include specific information on when to perform a THA or TKA. Since this evidence 
about optimal timing of THA or TKA is still lacking, more evidence is needed on which 
determinants influence outcome after surgery so that the timing of surgery is optimal 
and will lead to the best possible outcomes. Therefore, part 2 focused on getting more 
evidence regarding determinants that will optimize surgical care in hip and knee OA.
Part 1 Implementation of evidence based guidelines 
Part 1 aimed to contribute knowledge to improve guideline uptake regarding the use 
of non-surgical and surgical interventions in hip and knee OA and sciatica care. In 
hip and knee OA care, recommended non-surgical treatments are underused, while in 
sciatica care there is a lack of use of shared decision making (SDM) when to choose 
between non-surgical and surgical treatment. From the literature it is known that an 
inventory of barriers and facilitators is useful for the development of a tailor-made 
implementation strategy [1-3]. Such an inventory reduces the number of costly trials 
evaluating different implementation strategies [4-6]. Therefore, barriers and facilitators 
for the implementation of non-surgical interventions in hip and knee OA [7] and the use 
of SDM in sciatica care were determined [8]. By comparing two different implementation 
issues in different conditions, it is possible to determine whether generalized knowledge 
can be extracted from these different studies, or to conclude that it is necessary to 
perform a barriers and facilitators assessment for each implementation issue.
Barriers and facilitators for the implementation of guidelines: general findings
Although hip and knee OA and sciatica are two different conditions with different 
implementation issues, barriers and facilitators reported by health care providers showed 
similarities. For the implementation of evidence based guideline recommendations it 
appeared that knowledge and attitude of health care providers and organization of care 
played an important role whether guidelines were applied. 
Knowledge and attitudes
First, barriers and facilitators related to knowledge and attitudes of health care providers 
appeared to influence the use of guidelines in hip and knee OA and sciatica. In hip and 
knee OA, an important barrier for the use of non-surgical care was lack of knowledge 
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on the effectiveness of non-surgical interventions among orthopaedic surgeons. In 
sciatica care, an important barrier was knowledge about the outcomes of surgical 
and non-surgical treatment options in primary and secondary care, resulting in lack of 
usage of SDM in sciatica care. Sciatica patients also indicated that knowledge, in the 
form of information provision about treatment options and potential harm and benefits 
played a role in the usage of SDM. The finding that knowledge is important in the 
uptake of guidelines is in line with the literature. A systematic review regarding barriers 
to apply evidence-based medicine (EBM) also found that the most common barrier in 
management and decision making was a lack of knowledge [9], which is consistent with 
the findings in this thesis.
Implicitly related to the lack of knowledge was the attitude of orthopaedic surgeons 
to the effectiveness of non-surgical treatments. An example of this is the attitude of 
orthopaedic surgeons towards physical therapy: they think physical therapy is not an 
effective treatment for patients with hip OA. This attitude towards the effectiveness was 
associated with lower use of non-surgical treatments. However, this attitude towards 
physical therapy was not found in a previous study among GP’s [10]. The discrepancy 
in views may be due to different health care professionals seeing patients with the 
same condition at different stages: GP’s often are the first health care provider in a care 
trajectory, whereas orthopaedic surgeons more often see the patients who have already 
used several non-surgical treatments but still have complaints with the overall benefit 
being less.
Organization of care
Other important overlapping barriers and facilitators perceived by health care providers 
in both conditions concerned the organization of care, such as communication and 
collaboration between health care providers from different disciplines. This is possibly 
due to the multidisciplinary character of care for hip and knee OA and sciatica patients. 
In both conditions, there are not only multiple disciplines involved (e.g. GP and physical 
therapist), but they are also working within different settings of care (primary, secondary 
and tertiary care). Moreover, some treatments concerned interventions which can only 
be delivered by a specific health care provider, such as a physical therapist or dietician, 
so that referral by a physician or advice for self-referral is needed. Both health care 
providers and patients found that a good collaboration between health care providers 
was important for the use of non-surgical treatments in both conditions. Another example 
of barriers and facilitators related to the organization of care was a good patient-health 
provider relationship for the use of guidelines in both sciatica and OA care. In sciatica 
care, the quality of professional-patient relationship was considered as most important 
for the use of SDM in sciatica care. In OA care good guidance by the physical therapist 
was associated with more use of physical therapy. Other studies did not mention the 
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organization of care frequently as a barrier or facilitator. This can possibly be explained 
by the fact that previous studies into barriers and facilitators only included one discipline 
or one setting, whereas the barriers and facilitators in this thesis were assessed for 
two conditions where care is provided by multiple disciplines and in multiple settings. 
Furthermore, previous research mainly focused on barriers and facilitators at the patient 
level [11,12], but the results of this thesis show that it is important to also focus on other 
levels, such as the organization.
Barriers and facilitators: condition specific findings
Besides similarities in barriers and facilitators perceived by health care providers 
and patients, also condition specific barriers and facilitators were found regarding 
implementation of recommendations in guidelines. For OA care, the use of non-surgical 
treatment was hampered by the pressure that orthopaedic surgeons perceived from 
patients to perform a surgery and by the experience and advices from patients’ 
environment, which was not mentioned as an important barrier or facilitator in sciatica 
care. In sciatica care on the other hand, SDM was hampered by the assumption of 
health care providers that patients want to recover quickly. As a consequence of this 
assumption they did not make a shared decision, but recommended surgery. It is 
important though to determine patients’ views on the importance of speed of recovery 
and this is part of the SDM process. 
Comparison of identified barriers and facilitators with the literature
The results in this thesis showed that knowledge and attitude of health care providers 
and organization of care played an important role whether guidelines were applied, 
but is this also consistent with the literature? A recent systematic review on barriers for 
the implementation of guidelines included 106 studies [9]. In total, 155 barriers were 
identified. The most commonly reported barriers were: lack of resources (24/155 barriers) 
(e.g. inadequate facilities, lack of medical resources) and inadequate access (22/155 
barriers) (e.g. guidelines are too complicated or difficulty to find the information). Other 
common barriers were lack of time and research (e.g. conflicting methods, literature not 
being compiled in one place), which is also related to knowledge. Another systematic 
review focused on barriers and facilitators to implement SDM in clinical practice [13]. In 
this review only 7 out of the 38 studies reported that lack of knowledge (familiarity) was 
a barrier for using SDM. The three most often reported barriers were: time constraints 
(22/38 studies) and lack of applicability due to patient characteristics (18/38 studies) 
and the clinical situation (16/38 studies). The three most often reported facilitators were: 
provider motivation (23/38 studies) and positive impact on the clinical process (16/38 
studies) and patient outcomes (16/38 studies)[13].
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The previously mentioned reviews found some barriers and facilitators consistent 
with the findings in this thesis, but also different barriers and facilitators were found 
between the literature and this thesis. Part of these differences may be explained by 
the multidisciplinary character of care for hip and knee OA and sciatica patients. This 
comes with different barriers and facilitators compared to monodisciplinary care, which 
is mostly described in the literature. Next to this explanation, the difference in barriers 
and facilitators may also be caused by the use of different methods. So far, the use 
of qualitative methods is most common. For example in a review about barriers and 
facilitators to implement SDM 21 of the 38 studies used qualitative methods exclusively, 
11 used quantitative methods exclusively and only six studies used mixed methods 
[13]. With a qualitative study, the perspective of a respondent takes the center stage 
and the purpose is to gain some deeper understanding on the respondent’s perspective 
[14]. This is difficult, if not impossible, to reach with a quantitative design. Using only 
quantitative methods it is possible that the researchers’ personal hypothesis is tested 
instead of a rather complete set of possible barriers and facilitators since no ‘new’ 
perspectives will be explored [15]. On the other hand, information on the importance of 
each barrier or facilitator is also needed, warranting the need for a quantitative approach. 
In this thesis, a combination of qualitative and quantitative studies was employed, with 
the aim to obtain a complete view on barriers and facilitators. The added value of this 
approach was demonstrated by the observation that barriers and facilitators most often 
mentioned in the qualitative part of the studies in this thesis [16], were not always consistent 
with the highest ranked barriers or facilitators [17]. For example during interviews 
about SDM in sciatica care, health care providers mentioned lack of knowledge about 
treatment options only a few times, whereas it was ranked as an important barrier in the 
subsequent survey [17]. Likewise, lack of time during a consultation was mentioned 
often during interviews, and is also the most mentioned barrier for SDM in other studies 
[18]. But in the quantitative part, time during a consultation only took a 33rd place, and 
did not occur in any of the health care providers top 5. This emphasizes the importance 
of a combination of methods to determine barriers and facilitators.
Implementation strategies
The identification of barriers and facilitators is just the first step for the implementation 
of guidelines. If barriers and facilitators are identified, an effective implementation 
strategy needs to be developed. Different methods can be used to develop an 
implementation strategy. One of these methods is the intervention mapping approach 
of Bartholomew et al.[19]. This method begins with the creation of matrices in which 
the specific recommendations of guidelines are set against the most important barriers 
and facilitators. Subsequently, a project team can brainstorm about the interventions 
needed to achieve the performance objective in the presence of the barrier or facilitator 
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mentioned in the matrix. During this process a theoretical model can be identified to 
change the barriers and facilitators. The theoretical model proposed by Woolf [20] was 
used in this thesis that links the intensity of enforcement to the scientific and clinical 
quality of guidelines, called the “mechanism of action” of practice guidelines. This 
model says that guideline recommended outcomes can be reached through the steps 
of changing practitioner’s knowledge, attitudes, and behavior [20]. Eventually, the cells 
of the matrices are gradually filled with interventions [21] and the formulated strategy 
components are translated into interventions.
In this thesis two specific implementation strategies for the management of the two 
conditions using the intervention mapping approach were developed. Figure 1 shows 
the identified overlapping and condition specific barriers and facilitators related to each 
level of the mechanism of action (knowledge, attitude and behavior), the theory-based 
model that was used [20] and the different interventions geared at these barriers and 
facilitators to improve the implementation of the use of non-surgical treatments in hip 
and knee OA care and the use of SDM in sciatica care. The proposed interventions 
were interactive education, feedback about the use of SDM (specific for sciatica), 
tools for patients and health care providers such as an information booklet, obesity 
clinics (specific for OA) and agreements between disciplines. Figure 1 also shows 
at which barriers and facilitators these interventions are geared and with which level 
of the mechanism of action the barriers and facilitators are associated. The results of 
the inventory of barriers and facilitators indicated that both implementation strategies 
should be geared at improving the knowledge and attitude of health care providers and 
the organization of care.
Knowledge Attitude Behavior 
Interactive 
education  
Treatment options 
Physicians’ believe that 
all patients want a 
quick recovery 
(sciatica) 
Correct diagnosis 
(sciatica) 
Obesity 
clinic  
(OA) 
Agreements 
between 
disciplines 
Lack of knowledge 
about guideline 
Communication and 
collaboration between 
disciplines 
Information provision 
about treatment 
options 
Explanation about the 
care trajectory 
Quality of professional-
patient relationship  
Advices from people in 
environment (OA) 
Tools for 
patients and 
health care 
providers 
Feedback 
about use of 
SDM 
(sciatica) 
Physicians’ believe that 
certain treatments are 
not effective 
Figure 1. The mechanism of action [20] with identified barriers and facilitators at each level and different 
interventions to improve the implementation of the guidelines of hip and knee OA and sciatica
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Knowledge and attitude
Both implementation strategies should be geared at improving knowledge and attitude 
of health care providers by providing interactive education [4] on specific topics (e.g. 
about evidence underpinning the effectiveness of different treatments and SDM). For 
example a barrier for not using physical therapy was that orthopaedic surgeons did 
not belief in the effectiveness of this treatment for OA. This could be due to not making 
a clear distinction between the effectiveness of physical therapy in the non-surgical 
management of hip and knee OA and physical therapy in end stage OA where the 
indication for surgery is already set. The first physical therapy intervention aims to 
reduce patients’ symptoms in early stage OA and may thereby delay or diminish the 
need of surgery. This treatment is proven to be effective and recommended in multiple 
guidelines [22-26]. The second intervention concerns specific preoperative physical 
therapy programs aiming to improve postoperative recovery, which is not proven to be 
effective [27-30]. Interactive education about this and other topics can be provided to 
extend their knowledge for example by using e-learnings. The duration of interactive 
education in trainings may be less than 10 hours since research has shown that short-
term training (less than 10 hours) is as successful as longer training for promoting 
patient-centered care (e.g. using SDM) within clinical consultations [31].
The interactive education only focusses on health care providers while it is also 
important to involve patients. Research has shown that interventions targeting patients 
and healthcare professionals together show more promise than those targeting only one 
or the other [32]. Therefore, in addition to interactive education, specific tools for both 
patients and health care providers may improve the information provision and thereby 
improve knowledge and facilitate the decision making. An example of such a tool is 
the BART (Beating osteoARThritis) stepped care strategy for hip and knee OA, which 
is already available and introduced in primary care [33,34]. Part of this strategy is a 
booklet for patients, containing information about the disease and different treatments. 
However, this strategy should be updated, since treatments like glucosamine, hyaluronic 
acid and TENS are not proven effective treatments but still included in the stepped 
care strategy. Therefore health care providers may question this strategy rather than 
using it. For sciatica, a decision tool is also already available [35]. This tool may be 
useful to facilitate the SDM process. Research has shown that offering decision aids 
increases the number of patients who prefer non-surgical treatments, improve patient 
knowledge and reduce decisional conflict. It helps surgeons and patients to achieve 
well-considered and shared treatment decisions [36].
Organization of care
Even when health care providers have sufficient knowledge and their attitude towards 
recommendations is positive, the organization of care remains a problem. Therefore, 
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another part of the implementation strategies for both conditions is geared at improving 
the organization of care. An example concerns the relative underuse of the dietician 
in obese patients. Making referrals to a dietician in primary care, whom they may not 
know personally, was a barrier. During the interviews with orthopaedic surgeons some 
mentioned a successful collaboration with obesity clinics in their hospital. Dietary 
therapy becomes even more important due to the increasing number of obese people 
and an obesity clinic may facilitate this dietary therapy. However, additional research is 
necessary to assess the feasibility and cost-effectiveness of obesity clinics. 
Another improvement that can be made regarding the organization is that the care 
trajectory should become clearer by making agreements between disciplines about 
the moment of information provision in both OA and sciatica care. For example who is 
responsible for which part of the information provision or guidance in which step of the 
care trajectory? This is especially important in multidisciplinary settings such as in OA 
and sciatica care.
Generalized knowledge of implementation strategies
The previously mentioned elements on knowledge, attitude and organization of care are 
not restricted to one specific disease or health care system. Therefore, interventions 
geared at these topics may also be used for implementation of guidelines in other 
patients groups or other implementation problems with multiple disciplines involved. 
However, the condition specific barriers and facilitators that were also identified suggests 
that that there is no “one size fits all” solution for the implementation of guidelines, 
and implementation strategies should be partly tailored to a specific implementation 
problem. An inventory of disease specific barriers and facilitators remains necessary 
and may lead to more disease specific interventions. Therefore, in addition to interactive 
education and optimizing the organization of care, a strategy for OA should also focus 
on involving patient’s environment (partner, family members) for example during a 
consultation and if possible also provide the decision tools to these persons. Whereas 
the implementation strategy for SDM in sciatica care should also be targeted at 
feedback about the use of SDM. This can be done for example by examining the use 
of SDM from patients and professionals perspective, using the SDM-9 [37], the Dyadic 
OPTION scale [38,39], and the Control Preference Scale [40] and report the numbers to 
the health care provider. Since many health care providers already perceived they used 
SDM in sciatica care even when they in fact did not, feedback can provide them more 
insights into their actual use of SDM.
Comparison of implementation strategies with the literature
Other studies developed implementation strategies, but used different methods. 
Although a structured approach including barrier assessment for the development of 
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guideline implementation strategies is advocated, it is not yet commonly used. A scoping 
review on trends in guideline implementation found that only one out of the 32 studies 
mentioned the identification of barriers [41]. Another systematic review including 39 
studies that examined the effect of interventions to improve adoption of SDM in different 
conditions showed that only three of the 39 studies based their interventions on barriers 
assessments [32]. These three studies used multifaceted interventions and were all 
effective [42-44], while overall the authors of the review concluded that it was uncertain 
whether interventions to improve adoption of SDM are effective given the low quality of 
the evidence [32]. 
Besides that the implementation strategies in this thesis are based on identified barriers 
and facilitators, they also target both patients and health care providers. Gagliardi et al. 
[41] found that most studies focused on health care providers only. Legaré et al. [32] 
included 39 in a review, only three targeted more than one type of health care providers, 
but all these three studies had favorable outcomes. The authors also concluded that 
interventions targeting patients and healthcare professionals together show more 
promise than those targeting only one or the other [32]. 
Where to go next?
Most studies known in literature examined the effect of interventions without barriers 
assessment, in a monodisciplinary setting (only one type of health care provider) or 
among health care providers only (no patients included).  This led to a low quality of 
evidence regarding effectiveness of interventions to improve adoption of SDM [32]. In 
the studies in this thesis, barriers assessments were performed, in a multidisciplinary 
setting and among both health care providers and patients. Since the literature shows that 
such strategies are more effective [4-6] than interventions without barriers assessment, 
in a monodisciplinary setting (only one type of health care provider) or among health 
care providers only (no patients included), the proposed implementation strategies are 
likely to improve the use of non-surgical care in OA and SDM in sciatica. Future studies 
should assess whether the developed implementation strategies are indeed effective. 
This could be done for example by a cluster RCT or a controlled before-after study 
among health care providers including an effect-, process- and economic evaluation in 
intervention and control hospitals and primary health care providers in the same region. 
The control group should receive usual care (passive dissemination of evidence) and 
the intervention group should receive the strategies as described above. No such 
interventions have been performed so far regarding improvement of the use of non-
surgical care in OA and SDM in sciatica. 
Part 2 The optimization of surgical care in hip and knee osteoarthritis
Care delivery cannot always be optimized by implementing existing guidelines, for 
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example when evidence underlying the guideline is lacking. The hip and knee OA 
guidelines are for example not specific about when to perform a THA of TKA, partly 
because evidence is lacking about what the optimal timing of surgery is. If evidence 
is lacking, more knowledge needs to be generated to develop evidence based 
recommendations in guidelines and thereby optimize care. Specific issues about this 
topic that were addressed in part 2 of this thesis were: what are the evidence based 
indications to perform surgery and what are criteria and determinants to achieve the 
best possible patient outcomes after surgery? And does the type of prosthesis matter?
Criteria and determinants to reach the best outcomes after surgery
Guidelines are based on the best available evidence, but it is important to realize that 
sometimes the evidence is limited, and thus recommendations in guidelines are more 
expert based than evidence based. A review in this thesis showed that currently evidence-
based indication criteria for THA or TKA are lacking, so that it is more important to 
generate more evidence about this topic. To strengthen the evidence base for indication 
criteria, knowledge is needed on which patients reach the best outcomes after surgery. 
A literature search on the determinants suggested that future research should focus on 
preoperative function to decide when THA will be most effective. However, most results 
were contradictory both with respect to the association and direction of age, gender 
and BMI with postoperative outcomes. These conflicting results can possibly be due to 
the high risk of bias in many included studies or estimates based on studies with a lack 
of power. Thus regardless of the amount of existing studies, when all included studies 
are of low quality, more original research of high quality is needed.
To gather more evidence about which determinants influence outcomes after THA or 
TKA, a pooled analysis of 19 prospective observational cohort studies with OA patients 
(2400 THA and 1783 TKA) was performed from hospitals throughout the Netherlands 
so that lack of power could not be an issue. This pooled analysis showed that patients 
with better preoperative quality of life functioning and less pain had better postoperative 
outcomes. 
Timing of surgery
OA is often described as a progressive disease, meaning a (slowly) worsening condition 
over time. Optimal timing suggests that surgery can be delayed, but to what extent if 
the disease is worsening over time and given the above described results, that patients 
who received a joint replacement earlier in their clinical course (and thus with a better 
preoperative status) have a better outcome? There are two aspects that need to be 
considered. First, the natural course of the disease i.e. the prognosis of OA should be 
examined to assess whether worsening occurs in all patients. The second question that 
needs to be answered is whether the same outcomes can be reached when surgery is 
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delayed and only non-surgical treatment is given rather than THA or TKA.
Natural course of OA
Given the results in this thesis that patients with a better preoperative status have better 
postoperative results, it is important to examine whether functioning or pain in hip or 
knee OA patients become worse over time, so if a worsening of functioning or pain in hip 
or knee OA patients is followed by further worsening or whether this fluctuates randomly 
over time. Indications for such fluctuations were found in a study of De Rooij et al.[45]. 
The authors performed a meta-analysis on prognosis of pain and physical functioning in 
patients with knee OA in studies with a follow-up up to 8 years. They could not draw any 
conclusions with regard to the course of pain and physical functioning, due to the high 
heterogeneity across studies. 
Other studies that examined progression of OA also found inconclusive results. Van 
Dijk et al.[46] described the limitations in activities in hip or knee OA patients in a three-
year cohort study and found that at group level, limitations in activities of patients with 
hip or knee OA seemed fairly stable during the first three years of follow-up. However, 
at the level of individual patients, considerable variation occurred from deterioration to 
improvement. The same results were found after a follow-up of five years [47]. In another 
systematic review it was found that pain and functional status in hip or knee OA patients 
deteriorate slowly with limited evidence for worsening after three years. In specific 
subgroups, prognosis in the first three years of follow-up was either worse or better 
[48]. Bastick et al.[49] tried to identify these subgroups of patients who deteriorate. 
The authors examined prognostic factors for radiographic progression of knee OA in a 
meta-analysis and concluded that baseline knee pain, presence of Heberden nodes, 
varus alignment, and high levels of serum markers hyaluronic acid and tumor necrosis 
factor-α predicted knee OA progression. However, they also concluded that evidence 
for the majority of determined associations, was limited, conflicting, or inconclusive. 
The above mentioned studies showed heterogeneous findings regarding to progression 
of OA and thus it is important to gain more insights into subgroups of patients. Which 
patients deteriorate during time, which patients remain stable and which patients 
improve after a couple of years? Based on the previously described literature, there is 
no conclusive evidence whether there is continuous worsening or random fluctuation in 
pain and functioning over time for all patients or only for some subgroups.
Non-surgical versus surgical treatment
In addition to uncertainties about the natural course of the disease, the second question 
is whether the same outcomes can be reached if surgery is delayed with non-surgical 
treatment. The recommended non-surgical treatments in guidelines are proven to be 
effective, but are outcomes comparable with outcomes after THA or TKA? Recently, 
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Skou et al.[50] performed a randomized controlled trial (RCT) in which patients were 
randomly assigned in two groups. Patients in one group received a TKA followed by 
12 weeks of nonsurgical treatment, patients in the other group received only 12 weeks 
of non-surgical treatment. The authors concluded that patients with a TKA followed 
by non-surgical treatment resulted in greater pain relief and functional improvement 
after 12 months than did non-surgical treatment alone, but that both groups had 
clinically relevant improvements. In addition, TKA was associated with a higher number 
of serious adverse events. Thus a TKA resulted in greater pain relief and functional 
improvement, but also in a higher number of serious adverse events. Furthermore, 
the lifespan of a prosthesis is limited and outcomes are usually worse after revision 
than after primary arthroplasty [51]. Non-surgical treatments also resulted in clinically 
relevant improvements. Thus the best treatment option remains unclear. Furthermore, 
long term results are unknown and need to be examined. In addition, no such a study 
was conducted for THA. It is important to assess whether a comparable study for THA 
should have the same results. Future studies are needed to examine whether a delay in 
surgery achieves the same outcomes for patients.
Type of prosthesis
If the decision is made to replace a joint, the orthopaedic surgeon has to decide which 
implant should be used to reach the best possible outcomes. Therefore, another 
question in this thesis was: does the type of prosthesis matter? In recent decades 
a large variety of types of prostheses have become available. An example of a new 
development is the mobile (meniscal or rotating) bearing TKA with a polyethylene insert 
that has some freedom of movement. New types of prostheses are often introduced 
in clinical practice without appropriate assessment [52]. Therefore, in this thesis the 
mobile bearing prosthesis with a fixed bearing prosthesis were compared using a meta-
analysis of RCTs. Existing RCTs were included comparing mobile bearing with fixed 
bearing prostheses in cruciate retaining TKA among patients with OA or rheumatoid 
arthritis, using functional or clinical outcome measures and follow-up of at least six 
months. Moderate-to low-quality evidence suggests that mobile bearing prostheses 
may have similar effects on knee pain, clinical and functional scores, health-related 
quality of life, revision surgery, mortality, reoperation rate and other serious adverse 
events compared with fixed bearing prostheses in posterior cruciate retaining TKA. 
However, the meta-analysis was underpowered to detect differences in revision rate, 
specific reasons for revision and mortality. Because of the low numbers of revisions and 
mortality it is difficult to show differences using RCTs that on average have a follow-up 
period of a few years. 
To show possible differences regarding these outcomes and after a longer follow-up 
period, the scope may be widened to observational studies and include studies that 
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report outcomes in greater detail, with sufficient follow-up time to allow gathering of 
high-quality evidence and to inform clinical practice. Large registry-based studies may 
have added value, but they are subject to confounding by indication. More complex 
analyses are needed to control for this type of confounding and thereby improve the 
quality of evidence, for example by using an instrumental variable.
Where to go next?
In part 2, knowledge is generated to develop evidence based recommendations in 
the hip and knee OA guideline. However, a number of issues remain that need to be 
resolved before a clear guideline recommendation about the optimal timing of THA/ 
TKA can be formulated. This thesis showed that a better preoperative status leads to 
better postoperative outcomes, however if a patient’s status remain stable during the 
course of OA, postponing a surgery does not lead to a worse preoperative status with 
worse postoperative outcomes. In addition, previous studies searching for predictors or 
determinants for the best outcome and the studies in this thesis showed that evidence 
is often contradictory. Furthermore, research has shown that 10-20% of the patients are 
not satisfied after primary THA/TKA [53-56] while nothing seems to be clinically wrong 
with their prosthesis. Maybe there is not just one solution for all patients and researchers 
should stop quantifying all OA patients with their predefined assumptions and focus 
on patients’ perspectives. For example why are patients not satisfied? What were their 
expectations? And were these expectations met? These are questions that cannot be 
answered with a prediction model or other quantitative methods, although researchers 
tried to do so [57-59]. These questions can be answered using qualitative methods. 
Qualitative methods shift the balance between the researcher and the researched and 
remains open to concepts that emerge may be completely different. It can be used to 
get detailed findings on people’s views and experiences, which cannot be examined 
using quantitative methods only.
Conclusion
Part 1 of this thesis showed that there are general topics that need be focused on 
when evidence based guideline recommendations need to be implemented in a 
multidisciplinary setting, regardless of the condition. These topics are knowledge and 
attitude of health care providers and organization of care. Future implementation studies 
can start focusing on these topics if it is not feasible to perform a barrier assessment. 
However, also different barriers and facilitators for each different condition were found. 
This shows that each different condition needs a barrier assessment to be able to gear 
an implementation strategy at all existing barriers and facilitators. This will most likely 
result in improved implementation of evidence based guidelines.
If information in the literature is lacking, more knowledge needs to be generated to 
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develop evidence based recommendations in guidelines. Part 2 of this thesis showed 
that evidence based recommendations for indication criteria for THA or TKA are 
lacking in the literature. Pooling multiple cohort studies in the Netherlands showed 
that preoperative status is the most important variable for outcome after both THA 
and TKA, i.e. patients with better preoperative quality of life, functioning and less pain 
had better postoperative outcomes. This does not mean that patients who received a 
joint replacement earlier in their clinical course have a better outcome. To determine 
whether this is true, more knowledge is needed about the progression of OA in different 
subgroups and whether the same outcomes can be reached with non-surgical treatment 
as with THA and TKA since literature about these topics is inconclusive. 
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Many decisions are made in health care. For example when a patient is diagnosed with 
a certain disease the patient and health care provider are facing multiple decisions. 
One of these decisions for some musculoskeletal non-acute conditions is to choose 
between non-surgical and surgical treatments. Surgery is then often not the first choice 
of treatment. Initial treatment includes non-surgical treatments and surgery is only 
considered if the patient does not respond sufficiently to non-surgical treatment. Hip 
and knee osteoarthritis (OA) and sciatica are both non-acute conditions in which the 
decision of non-surgical versus surgical treatment is complex. 
This thesis aims to contribute to the optimal use of non-surgical treatment and timing 
of surgery among hip and knee OA and sciatica patients. Guidelines are important in 
this respect because these are based on the best available evidence, it is known from 
the literature that health care providers do not always follow guidelines. If the evidence 
regarding use of non-surgical treatment and when to perform surgery is already specific 
and included in the guideline, efforts can be undertaken to facilitate implementation of 
these guidelines. To that end, it is important to gain insight into reasons why guidelines 
are not always followed (i.e. barriers and facilitators). This is the focus of part 1 of this 
thesis.
However, care delivery cannot always be optimized by implementing existing guidelines. 
The hip and knee OA guidelines are for example not specific about when to perform a 
total hip or knee arthroplasty (THA or TKA), partly because evidence is lacking about 
what the optimal timing of surgery is. If evidence is lacking, more knowledge needs to 
be generated to develop evidence based recommendations in guidelines and thereby 
optimize care. Specific issues about this topic that are addressed in part 2 of this thesis 
are: what are the evidence based indications to perform surgery and what are criteria 
and determinants to achieve the best possible patient outcomes after surgery? And 
does the type of prosthesis influence these outcomes?
Part 1 Implementation of evidence based guidelines
The first part of this thesis focuses on implementation strategies to improve guideline 
uptake regarding the use of non-surgical and surgical interventions in hip and knee OA 
and sciatica care. National and international evidence-based guidelines for hip and 
knee OA recommend to start with (a combination of) non-surgical treatments, followed 
by surgical intervention if a patient does not respond sufficiently to non-surgical 
treatment options. In chapter 2, 3 and 4 the development of an implementation strategy 
to improve the use of non-surgical treatments in hip and knee OA is described. Chapter 
2 describes the two steps that need to be taken to develop such a strategy. First, current 
use of preoperative non-surgical treatments in patients with hip and knee OA was 
explored using internet-based surveys, one among 174 patients who had undergone 
TKA or THA no longer than 12 months ago or being on the waiting list for surgery with a 
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confirmed date within 3 months and one among 172 orthopaedic surgeons. In Chapter 
3 the results of this first step are described. The results showed that most recommended 
non-surgical treatments (education about OA/ treatment options, lifestyle advice, dietary 
therapy, physical therapy, acetaminophen, NSAIDs, and glucocorticoid injections) were 
used frequently as single therapy. However, the combination of all these treatments is 
used in only a small percentage (6%) of hip and knee OA patients. Dietary therapy in 
overweighed patients was used least frequently. 
The second step was to identify barriers and facilitators for the use of non-surgical 
treatments in orthopaedic practice. In Chapter 4 the results of this second step are 
described. To identify potential barriers and facilitators, semi-structured interviews were 
performed among 10 orthopaedic surgeons and 5 patients who received a TKA or THA no 
longer than 12 months ago. All barriers and facilitators mentioned in the interviews were 
used to develop two internet-based surveys to examine which barriers and facilitators 
were associated with the use and prescription of non-surgical treatments. The surveys 
were completed by 172 orthopaedic surgeons and 174 patients. Most barriers and 
facilitators among patients were associated with the use of physical therapy, lifestyle 
advice and dietary therapy. Among orthopaedic surgeons, most were associated 
with prescription of acetaminophen, dietary therapy and physical therapy. Examples 
of barriers and facilitators among patients included “People in my environment had 
positive experiences with a surgery”, and “Advise of people in my environment to keep 
on moving”. For orthopaedic surgeons examples were “Lack of knowledge about the 
guideline”, “Agreements/ deliberations with primary care” and “Short communication 
lines with a dietician”. Also the belief in the efficacy of these treatments was associated 
with increased prescription. 
In sciatica care, guidelines recommend that the team of professionals involved in sciatica 
care and patients jointly decide about treatment options, so-called interprofessional 
shared decision making (SDM). This is based on evidence that patients with persisting 
leg pain after six to eight weeks have similar clinical outcomes after prolonged non-
surgical treatment or surgery at one year follow-up. However, there are strong indications 
that SDM for sciatica patients is not integrated in daily practice. Chapter 5 describes the 
steps that need to be taken to develop a strategy to embed SDM in daily practice based 
on a barrier and facilitator assessment. Chapter 6 describes the exploration of barriers 
and facilitators using 40 semi-structured interviews among professionals of each (para)
medical discipline involved in sciatica care (general practitioners (GP’s), physical 
therapists, neurologists, neurosurgeons, and orthopaedic surgeons). In addition, three 
focus groups were conducted among patients. The results show that professionals and 
patients mentioned more barriers than facilitators for SDM in sciatica care. Professionals 
perceived most barriers at the level of the organizational context, and facilitators at the 
level of the individual professional. Patients reported most barriers and facilitators at 
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the level of the individual professional. Several barriers and facilitators correspond with 
barriers and facilitators found in the literature (e.g., lack of time, motivation) but also 
new barriers and facilitators were identified. Many of these new barriers mentioned by 
both professionals and patients were related to the multidisciplinary setting, such as 
lack of visibility, lack of trust in expertise of other disciplines, and lack of communication 
between disciplines. 
Next, the identified barriers and facilitators were ranked in Chapter 7 using Maximum 
Difference Scaling, to assess which barriers and facilitators found in the qualitative 
interviews were the most important for the use of shared decision making according 
to GPs, physical therapists, neurologists, neurosurgeons, orthopaedic surgeons, and 
patients. Professionals assigned the highest importance to: quality of professional-
patient relationship, importance of quick recovery of patient, and knowledge about 
treatment options. Patients assigned the highest importance to: correct diagnosis by 
professionals, information provision about treatment options and potential harm and 
benefits, and explanation of the professional about the care trajectory, which were 
reported both as barrier and facilitator. Therefore, knowledge, information provision and 
a good relationship seemed to be the most important conditions for SDM perceived by 
both patients and professionals.
Part 2 The optimization of surgical care in hip and knee osteoarthritis
In OA care, it is unclear what the optimal timing is to perform a THA or TKA. If evidence 
is lacking, more knowledge needs to be generated to develop evidence based 
recommendations in guidelines and thereby optimize care. Part 2 of this thesis therefore 
focused on studying criteria and determinants to reach the best possible outcomes 
after surgical care. In Chapter 8 the availability of evidence-based indication criteria for 
primary THA and TKA in OA was assessed in 6 guidelines and 18 papers. The quality 
of the guidelines differed. Across guidelines and included studies, four studies stated 
that no evidence-based indication criteria are available. In the other studies, 12 THA, 
10 TKA and 2 THA/ TKA indication sets were found. Indication criteria concerning THA/ 
TKA consisted of the following domains: pain (in respectively 10 and 11 sets), function 
(7 and 12 sets), radiological changes (9 and 10 sets), failed non-surgical therapy (4 and 
8 sets) and other indications (7 and 6 sets). Specific cut-off values or ranges were often 
not stated and the level of evidence was low. 
In Chapter 9 the literature was reviewed on which factors predict outcomes after THA to 
guide decisions on when surgery is most effective. Databases and trial registries were 
searched for prospective studies including hip OA patients who underwent primary 
THA. Studies with preoperative measurements on predictors, with at least one year 
follow-up were included. Thirty-five studies were included (138,039 patients). Overall, 
there was low quality of evidence. Studies were heterogeneous in the predictors tested 
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and in the observed directions of the associations. Preoperative function (13 studies) 
and radiological OA (6 studies) were predictors with the most consistent findings. 
Worse preoperative functioning and more severe radiological OA were associated with 
larger postoperative improvement. However, these patients never reached the level of 
postoperative functioning as patients with better preoperative functioning or less severe 
radiological OA. For age, gender and pain the results of studies were conflicting. For 
BMI, some studies (n=5) found worse outcomes for patients with higher BMI. However, 
substantial improvement was still achieved regardless of their BMI. 
Thus regardless of the amount of existing studies, when all included studies are of low 
quality, more original research of high quality is needed. Therefore, individual patient 
data from 19 prospective cohorts in the Netherlands with 1783 knee OA patients and 
2400 hip OA patients was pooled to determine preoperative variables for outcomes 
after a THA and TKA in Chapter 10. The results showed that patients with a higher 
preoperative quality of life or functioning have a higher postoperative quality of life 
or functioning and patients with less preoperative pain have less postoperative pain. 
Furthermore, women and patients with a higher BMI had more postoperative pain and 
less improvement after both THA and TKA. Higher age and higher BMI were associated 
with lower postoperative QoL and functioning and more pain after a THA. 
Another factor that may predict outcomes after a TKA is the type of prosthesis. Chapter 
11 compares two types of knee prostheses in a meta-analysis: mobile and fixed bearing. 
Randomized controlled trials comparing mobile bearing with fixed bearing prostheses 
in cruciate retaining TKA among patients with OA or rheumatoid arthritis were selected, 
using functional or clinical outcome measures and follow-up of at least six months. 
Moderate-to low-quality evidence suggests that mobile bearing prostheses may have 
similar effects on postoperative knee pain, clinical and functional scores, health-related 
quality of life, revision surgery, mortality, reoperation rate and other serious adverse 
events compared with fixed bearing prostheses in posterior cruciate retaining TKA. 
General discussion
The aim of the present thesis was to extend the knowledge in the field of implementation 
science by examining how care delivery for patients with hip and knee OA or sciatica can 
be optimized. In the first part strategies to improve guideline uptake in hip and knee OA 
and sciatica care were searched for. Looking across the different studies described in 
the first part of this thesis, there seem to be general domains relevant for implementation 
of evidence based guideline recommendations in a multidisciplinary setting. These 
domains are knowledge, attitude of health care providers and organization of care. Future 
implementation studies can start focusing on these topics if it is not feasible to perform a 
barrier assessment. However, also different barriers and facilitators were found for each 
specific condition. This shows that implementation problems of each specific condition 
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ideally needs a barrier assessment to be able to gear an implementation strategy at all 
existing barriers and facilitators. This will most likely result in improved implementation 
of evidence based guidelines.
In the second part of this thesis, a search for new evidence related to the question of 
optimal timing of THA/ TKA in hip and knee OA patients was done. Regarding the issue 
of optimal timing, information in the literature is lacking. Pooling multiple cohort studies 
in the Netherlands showed that preoperative status is the most important variable for 
outcome after both THA and TKA, i.e. patients with better preoperative quality of life, 
functioning and less pain had better postoperative outcomes. This does not necessarily 
mean that patients who received a joint replacement earlier in their clinical course have 
a better outcome. Given the results that patients with a better preoperative status have 
better postoperative results, it is important to examine whether functioning or pain in hip 
or knee OA patients become worse over time, so if a worsening of functioning or pain 
in hip or knee OA patients is followed by further worsening or whether this fluctuates 
randomly over time. To determine whether patients deteriorate over time, more 
knowledge is needed about the progression of OA in different subgroups. In addition, it 
is important to assess the same outcomes can be reached with non-surgical treatment 
as with THA and TKA. Focusing on these questions in future research is likely to improve 
quality of care delivered to these patients.
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In de gezondheidszorg worden vele beslissingen genomen. Eén van deze beslissingen 
voor diverse niet-acute aandoeningen van het bewegingsapparaat is de keuze 
om conservatief of chirurgisch te behandelen. Bij deze aandoeningen wordt eerst 
geprobeerd om met conservatieve behandelingen de symptomen te verminderen en 
wordt overgegaan tot een chirurgische ingreep wanneer een patiënt onvoldoende 
baat heeft bij conservatieve behandelingen. Heup en knieartrose en lage rughernia 
zijn voorbeelden van dergelijke niet-acute aandoeningen waar de beslissing voor 
conservatieve of chirurgische behandeling complex is.
Het doel van dit proefschrift is om bij te dragen aan optimaal gebruik van conservatieve 
en chirurgische behandelingen bij patiënten met artrose van de heup of knie en patiënten 
met een lage rughernia te optimaliseren. Richtlijnen zijn hierbij belangrijk, omdat ze 
gebaseerd zijn op de best beschikbare wetenschappelijke literatuur, maar toch worden 
ze niet altijd nageleefd door zorgverleners. Wanneer de richtlijnen aangeven bij welke 
patiënten en wanneer conservatief en wanneer chirurgisch moet worden behandeld, 
kan er worden gekeken hoe implementatie van deze richtlijnen gefaciliteerd kan 
worden. Inzicht in de belemmerende en bevorderende factoren is hierbij essentieel om 
een effectieve implementatiestrategie te ontwikkelen. Deel 1 van dit proefschrift richt 
zich daarom op het uitbreiden van kennis over deze belemmerende en bevorderende 
factoren.
De optimalisatie van zorg kan echter niet altijd bereikt worden door de implementatie van 
richtlijnen. Richtlijnen voor de behandeling van heup- en knieartrose zijn bijvoorbeeld 
niet specifiek over wanneer een patiënt een totale heup- of knieprothese moet krijgen. 
Dit komt deels omdat er een gebrek aan kennis is over wat de optimale timing van een 
operatie is. Wanneer deze kennis ontbreekt, moet er meer kennis worden verworven om 
goede aanbevelingen te kunnen doen en daarmee de zorg te optimaliseren. Daarom 
wordt in deel 2 van dit proefschrift meer kennis verworven over criteria en determinanten 
die nodig zijn om de chirurgische zorg te optimaliseren. Specifieke vragen zijn: wat zijn 
de beschikbare wetenschappelijk onderbouwde indicaties voor een operatie en welke 
determinanten bepalen de uitkomst na een operatie? En in welke mate beïnvloedt het 
type gewrichtsprothese de uitkomst?
Deel 1 Implementatie van wetenschappelijke richtlijnen 
Het eerste deel 1 van dit proefschrift richt zich op implementatiestrategieën om het 
gebruik van aanbevelingen in richtlijnen voor de behandeling van heup- en knieartrose 
en de lage rughernia te verbeteren. Richtlijnen voor heup- en knieartrose adviseren om 
eerst te starten met (een combinatie van) conservatieve therapieën en pas te opereren 
als een patiënt onvoldoende baat heeft bij deze behandelingen. In de hoofdstukken 2, 
3 en 4 worden de stappen beschreven die nodig zijn om een implementatiestrategie 
te ontwikkelen om het gebruik van conservatieve therapie te verbeteren. Hoofdstuk 
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2 beschrijft de studie opzet met de twee stappen die moeten worden genomen om 
een dergelijke implementatiestrategie te ontwikkelen. Als eerste is onderzocht in 
welke mate conservatieve therapieën op dit moment worden gebruikt. Een online 
vragenlijst werd ingevuld door 172 orthopedisch chirurgen en 174 patiënten die 
niet langer dan 12 maanden geleden een heup- of knieprothese hadden gehad of 
binnen 3 maanden geopereerd zouden worden. In hoofdstuk 3 worden de resultaten 
van deze eerste stap beschreven. Uit het vragenlijstonderzoek bleek dat de meeste 
conservatieve behandelingen (voorlichting over artrose/ behandelopties, leefstijladvies, 
diëtist, fysiotherapie, paracetamol, NSAIDs en glucocorticoïd injecties) als aparte 
behandelingen regelmatig werden gebruikt, maar dat weinig patiënten met heup- of 
knieartrose (6%) alle aanbevolen behandelingen kregen. Dieetadvies bij patiënten met 
overgewicht werd het minst gebruikt.
De tweede stap bestaat uit een analyse van belemmerende en bevorderende factoren 
voor het gebruik van verschillende conservatieve therapieën, voordat een heup of knie 
vervangende operatie wordt uitgevoerd. De resultaten van deze stap zijn beschreven 
in hoofdstuk 4. Om mogelijke belemmerende en bevorderende factoren te identificeren 
zijn 10 semigestructureerde interviews afgenomen bij 10 orthopedisch chirurgen en bij 
5 patiënten die niet langer dan 12 maanden geleden een heup- of knieprothese hebben 
gekregen. Alle genoemde belemmerende en bevorderende factoren genoemd in deze 
interviews zijn gebruikt om twee vragenlijsten te ontwikkelen. De vragenlijsten zijn 
ingevuld door 172 orthopedisch chirurgen en 174 artrosepatiënten. Hieruit bleek dat de 
meeste belemmerende en bevorderende factoren onder patiënten waren geassocieerd 
met het gebruik van fysiotherapie, leefstijladvies en dieetadvies. Voorbeelden hiervan 
zijn “mensen in mijn omgeving hadden goede ervaringen met operatie” en “advies 
van mijn omgeving om te blijven bewegen”. Onder orthopedisch chirurgen waren de 
meeste belemmerende en bevorderende factoren geassocieerd met het voorschrijven 
van paracetamol, dieet en fysiotherapie. Voorbeelden zijn “gebrek aan kennis over 
de richtlijn, “afspraken/ overleg met de eerste lijn” en “korte lijnen met een diëtist”. 
Daarnaast was geloof in de werking van de behandeling geassocieerd met toename in 
het voorschrijven van deze behandeling. 
De richtlijnen voor lage rughernia adviseren dat de betrokken zorgverleners samen met 
de patiënt besluiten welke behandeling het beste bij de patiënt past, oftewel om gedeelde 
besluitvorming toe te passen. Dit is gebaseerd op onderzoek dat heeft uitgewezen dat 
de uitkomsten van conservatieve en chirurgische behandeling bij patiënten met een 
lage rughernia na 1 jaar nagenoeg gelijk zijn. Toch zijn er aanwijzingen dat gedeelde 
besluitvorming nog niet veel wordt toegepast in de dagelijkse praktijk. Hoofdstuk 5 
beschrijft de stappen die moeten worden genomen om een strategie te ontwikkelen 
voor de implementatie van gedeelde besluitvorming. Hoofdstuk 6 beschrijft de eerste 
stap, namelijk de exploratie van belemmerende en bevorderende factoren. Hiervoor 
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werden 40 semigestructureerde interviews onder betrokken zorgverleners (huisartsen, 
fysiotherapeuten, neurologen, neurochirurgen, orthopedisch chirurgen) gehouden 
en drie focusgroepen met patiënten. Uit de interviews en focusgroepen bleek dat 
patiënten en zorgverleners meer belemmerende dan bevorderende factoren ervoeren. 
Zorgverleners ervoeren de meeste hinder op het gebied van organisatie van zorg en 
zagen de belangrijke bevorderende factoren bij kennis, attitude en ervaring van de 
individuele zorgverlener. Patiënten zagen de meeste bevorderende en belemmerende 
factoren bij de kennis, attitude en ervaring van de individuele zorgverlener. Een 
aantal geïdentificeerde belemmerende en bevorderende factoren kwam overeen met 
de bestaande literatuur (bijv. gebrek aan tijd, motivatie), maar er werden ook nieuwe 
factoren genoemd door zowel patiënten als zorgverleners. Veel van deze factoren 
waren gerelateerd aan de multidisciplinaire setting, zoals gebrek aan zichtbaarheid in 
de zorg, gebrek aan vertrouwen in zorgverleners van andere disciplines en gebrek aan 
communicatie tussen disciplines.
Vervolgens werden de geïdentificeerde belemmerende en bevorderende factoren 
gerangschikt in hoofdstuk 7 met behulp van Maximum Difference Scaling om vast 
te stellen welke factoren nu het meest belangrijk zijn voor het gebruik van gedeelde 
besluitvorming volgens de betrokken zorgverleners en patiënten. Zorgverleners vonden 
de volgende belemmerende en bevorderende factoren het belangrijkste voor het gebruik 
van gedeelde besluitvorming: kwaliteit van de patiënt-zorgverlener relatie, belang dat 
de patiënt snel herstelt en kennis over behandelopties. Patiënten vonden de volgende 
belemmerende en bevorderende factoren het belangrijkste: juiste diagnose door de 
zorgverlener, voorlichting over de voor- en nadelen van behandelingen en uitleg van de 
zorgverlener over het te doorlopen zorgtraject. Zorgverleners en patiënten ervoeren dus 
kennis, voorlichting en een goede relatie als de meest belangrijke voorwaarden voor het 
toepassen van gedeelde besluitvorming.
Deel 2 Het optimaliseren van chirurgische zorg bij heup- en knieartrose
Bij patiënten met heup- of knieartrose is het onduidelijk wat de beste timing voor een 
totale heup-(THP) en knieprothese (TKP) is. Het is dan dus zaak om meer kennis te 
verwerven, zodat aanbevelingen in richtlijnen kunnen worden opgesteld om daarmee 
de kwaliteit van zorg te optimaliseren. Deel 2 van dit proefschrift richt zich daarom op 
criteria en determinanten die de uitkomst na een operatie bepalen. In hoofdstuk 8 wordt 
gekeken naar de beschikbaarheid van wetenschappelijk onderbouwde indicatiecriteria 
voor totale heup- en knie prothese (THP/TKP) in 6 richtlijnen en 18 artikelen. De kwaliteit 
van de richtlijnen verschilde. In de geïncludeerde richtlijnen en artikelen, werd in 4 
studies gesteld dat er geen wetenschappelijk onderbouwde indicatiecriteria waren. In 
de andere studies werden 12 THP, 10 TKP en 2 THP/TKP indicatiesets gevonden. De 
indicatiecriteria bij TKP en THP hadden betrekking op de volgende domeinen: pijn (in 
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respectievelijk 10 en 11 sets), functieverlies (7 en 12 sets), radiologische afwijkingen (9 
en 10 sets), falende conservatieve therapie (4 en 8 sets) en overige indicaties (7 en 6 
sets). Specifieke afkapwaardes of ranges als indicatie voor een operatie werden vaak 
niet genoemd en het bewijs was van lage kwaliteit.
In hoofdstuk 9 is door middel van een systematische literatuurstudie gekeken welke 
preoperatieve factoren de uitkomst na een THP voorspellen, om te kijken wanneer 
een operatie het meest effectief is. Hierbij is gezocht in databases en trial registers 
naar prospectieve studies onder patiënten met heupartrose die een THP hadden 
ondergaan. Studies waarbij preoperatieve voorspellers gemeten waren met een follow-
up van tenminste 1 jaar na de operatie werden geïncludeerd. Vijfendertig studies met 
in totaal 138,039 patiënten die hieraan voldeden werden geïncludeerd. Gemiddeld 
genomen was de kwaliteit van de gevonden studies laag. Studies waren heterogeen 
in de preoperatieve factoren die werden bestudeerd en effecten verschilden van 
richting. Preoperatieve functie (13 studies) en radiologische ernst van artrose (6 
studies) waren de voorspellende factoren met de meest consistente bevindingen. 
Slechtere preoperatieve functie en de meest ernstige  radiologische ernst van artrose 
waren geassocieerd met een grotere mate van postoperatieve verbetering, maar deze 
patiënten bereikten uiteindelijk niet hetzelfde postoperatieve niveau als patiënten 
met een betere preoperatieve functie of een minder ernstige radiologische ernst van 
artrose. Ten aanzien van leeftijd, geslacht en pijn verschilden de resultaten van de 
studies. Enkele studies (n=5) vonden dat patiënten met een hogere Body Mass Index 
(BMI) slechtere uitkomsten hadden. Echter, zij concludeerden dat ondanks dit verschil, 
patiënten toch aanzienlijk verbeterden ongeacht hun BMI. 
Wanneer de bestaande studies van slechte kwaliteit zijn, is meer onderzoek nodig 
van betere kwaliteit. Daarom zijn in hoofdstuk 10 individuele patiënt data van 19 
bestaande prospectieve cohorten in Nederland met een follow-up van minstens 1 jaar 
samengevoegd om vast te stellen welke preoperatieve variabelen uitkomsten na een 
THP of TKP voorspellen. Deze cohorten bevatten samen 1783 patiënten met een TKP 
en 2400 patiënten met een THP. Uit de resultaten bleek dat patiënten met een betere 
preoperatieve kwaliteit van leven of functie ook een betere postoperatieve kwaliteit van 
leven en functie hadden en dat patiënten met minder preoperatieve pijn ook minder 
postoperatieve pijn hadden. Verder bleek dat vrouwen en patiënten met een hogere 
BMI meer pijn en minder verbetering hadden na zowel een THP als een TKP. Een 
hogere leeftijd en een hogere BMI waren geassocieerd met een lagere postoperatieve 
kwaliteit van leven en functie en meer pijn na een THP. 
Een andere factor die uitkomsten na een knievervangende operatie kan bepalen is het 
type prothese dat gebruikt wordt. In hoofdstuk 11 worden daarom twee knieprotheses 
(mobile en fixed bearing) met elkaar vergeleken in een meta-analyse. Dit is gedaan door 
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bestaande gerandomiseerde onderzoeken met controlegroep (RCT’s) te selecteren die 
mobile en fixed bearing protheses met elkaar vergeleken bij kruisbandsparende TKP’s 
onder patiënten met artrose of reumatoïde artritis. Deze studies werden geselecteerd als 
ze functionele of klinische uitkomsten hadden gemeten bij een follow-up van ten minste 
zes maanden. Uit de meta-analyse bleek dat mobile en fixed bearing protheses gelijke 
uitkomsten hebben met betrekking tot postoperatieve pijn, klinische en functionele 
scores, kwaliteit van leven, revisies, mortaliteit, her operaties en ernstige complicaties. 
Het wetenschappelijke bewijs hiervoor was van gemiddelde tot lage kwaliteit.
Algemene discussie
Het doel van dit proefschrift was om kennis op het gebied van implementatie te 
vergroten door te onderzoeken hoe de zorg aan bij patiënten met heup- of knieartrose 
of een lage rughernia geoptimaliseerd kan worden. In het eerste deel hebben is 
gezocht naar implementatiestrategieën om het gebruik heup- en knieartrose en lage 
rughernia richtlijnen te bevorderen. Uit de onderzoeken beschreven in het eerste deel 
van het proefschrift lijken er een aantal algemene domeinen van belang te zijn bij de 
implementatie van wetenschappelijk onderbouwde aanbevelingen in richtlijnen in een 
multidisciplinaire setting. Deze domeinen betreffen de kennis, attitude van zorgverleners 
en de organisatie van zorg. Toekomstige implementatiestudies zouden dus kunnen 
beginnen met deze onderwerpen, als het niet haalbaar is om een probleem analyse 
uit te voeren naar specifieke belemmerende en bevorderende factoren. Naast deze 
algemene belemmerende en bevorderende factoren werden er ook belemmerende en 
bevorderende factoren gevonden die specifiek waren voor beide aandoeningen. Dit 
toont aan dat bij de implementatie van richtlijnen voor elke verschillende aandoening 
idealiter toch een aparte probleem analyse nodig is om de implementatie te richten op 
alle belemmerende en bevorderende factoren. Dit zal waarschijnlijk resulteren in een 
verbeterde implementatie van wetenschappelijk onderbouwde richtlijnen.
Het tweede deel van dit proefschrift richtte zich op vragen gerelateerd aan de 
optimale timing van een THP/TKP bij patiënten met heup- of knieartrose. Bestaande 
wetenschappelijke literatuur over de optimale timing is op dit moment nog onvoldoende 
om aanbevelingen op te baseren. De gepoolde analyse van bestaande prospectieve 
studies in Nederland liet zien dat de preoperatieve status van patiënten voor een 
totale heup- of knieprothese de meest belangrijke factor is bij het voorspellen van 
de postoperatieve uitkomst. Oftewel patiënten met een betere preoperatieve kwaliteit 
van leven of functie en minder pijn hadden ook een betere postoperatieve kwaliteit 
van leven, functie en minder pijn. Dit betekent niet direct dat patiënten die eerder 
een gewricht vervangende operatie ondergaan ook betere uitkomsten hebben. Om 
hier meer inzicht in te krijgen is het nodig om te onderzoeken of bijvoorbeeld functie 
slechter wordt met de tijd en of een verslechtering in functie wordt gevolgd door een 
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verdere verslechtering, of dat het ook weer kan verbeteren en dus het ziekteverloop 
random fluctueert over de tijd. Om hier antwoord op te krijgen is meer kennis nodig 
over het ziekteverloop van artrose in verschillende subgroepen van patiënten. Verder is 
het belangrijk om te onderzoeken of de resultaten die met een gewricht vervangende 
operatie worden bereikt, ook kunnen worden bereikt met conservatieve behandelingen. 
Toekomstig onderzoek zal zich hierop moeten richten om de kwaliteit van zorg nog 
verder te verbeteren.
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